9339686|*Cerebrovascular Circulation|C0007818|674094|MH|RtM via: Cerebrovascular Circulation|TI;AB|MM;RC
9339686|Brain|C0006104|73568|MH|RtM via: Brain;RtM via: Entire brain|AB|MM;RC
9339686|Brain Injuries|C0270611|41629|MH|RtM via: Brain Injuries|AB|MM;RC
9339686|Ischemic Hypoxic Encephalopathy|C0752304|27748|ET|Entry Term Replacement for "Hypoxia-Ischemia, Brain";RtM via: Hypoxic-Ischemic Encephalopathy;Forced Lookup:hypoxic-ischemic encephalopathy|AB|MM
9339686|Intelligence|C0021704|26316|MH|RtM via: Intelligence|AB|MM;RC
9339686|Brain Ischemia|C0007786|18517|MH|||RC
9339686|Developmental Disabilities|C0008073|12849|MH|||RC
9339686|Blood Flow Velocity|C0005798|10912|MH|||RC
9339686|Blood Pressure|C0005823|8904|MH|||RC
9339686|Cognition Disorders|C0009241|8395|MH|||RC
9339686|Oxygen Consumption|C0030055|7450|MH|||RC
9339686|Electroencephalography|C0013819|7148|MH|||RC
9339686|Child Development|C0008071|6823|MH|||RC
9339686|Regional Blood Flow|C0034965|5972|MH|||RC
9339686|Tomography, X-Ray Computed|C0040405|5714|MH|||RC
9339686|Mental Retardation|C0025362|5338|MH|||RC
9339686|Neuropsychological Tests|C0027902|5305|MH|||RC
9339686|Carbon Dioxide|C0007012|4812|MH|||RC
9339686|Infant, Premature, Diseases|C0021295|3723|MH|||RC
9339686|Infant, Premature|C0021294|3404|MH|||RC
9339686|Respiration, Artificial|C0035205|3360|MH|||RC
9339686|Oxygen|C0030054|3226|MH|||RC
9339686|Risk Factors|C0035648|3192|MH|||RC
9339686|Child Behavior Disorders|C0008066|2699|MH|||RC
9339686|Cardiopulmonary Resuscitation|C0007203|2694|MH|||RC
9339686|Energy Metabolism|C0014272|2618|MH|||RC
9339686|Gestational Age|C0017504|2521|MH|||RC
9339686|Urokinase-Type Plasminogen Activator|C0042071|1717|MH|||RC
9339686|Contrast Media|C0009924|1477|MH|||RC
9339686|Dilatation, Pathologic|C0012359|1134|MH|||RC
9339686|Hydrogen-Ion Concentration|C0020283|647|MH|||RC
9339686|Prognosis|C0033325|620|MH|||RC
9339686|Age Factors|C0001783|519|MH|||RC
9339686|Kinetics|C0022702|304|MH|||RC
9339686|Autoregulation|C0019868|218|ET|Entry Term Replacement for "Homeostasis";RtM via: Homeostasis|AB|MM
------
9339686|Child|C0008059|1000|CT|Developmental Disabilities;Child Behavior Disorders||RC
9339686|Humans|C0086418|1000|CT|Child Development;Infant, Premature, Diseases;CT Text Lookup: adult;CT Text Lookup: infant;CT Text Lookup: newborn;CT Text Lookup: newborn infant;CT Text Lookup: newborn infants|CT Text Lookup: adult;CT Text Lookup: infant;CT Text Lookup: newborn;CT Text Lookup: newborn infant;CT Text Lookup: newborn infants|MM;RC
9339686|Infant, Newborn|C0021289|1000|CT|Infant, Premature, Diseases;CT Text Lookup: newborn;CT Text Lookup: newborn infant;CT Text Lookup: newborn infants|CT Text Lookup: newborn infants|MM;RC
9339686|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9339686|Infant|C0021270|1000|CT|CT Text Lookup: infant|CT Text Lookup: infant|MM
9339686|radionuclide imaging|C0034607|11766|SH1|RtM via: CEREBRAL BLOOD FLOW IMAGING;Radionuclide Imaging (C0034606)|TI;AB|MM
9339686|surgery|C0038895|543|SH1|RtM via: CEREBRAL BLOOD FLOW IMAGING;Surgical Procedures, Operative (C0543467)|TI;AB|MM
9339686|blood|C0005768|205|SH1|RtM via: In Blood;blood (C0005768);RtM via: Blood|AB|MM
9339686|injuries|C1510467|20|SH|Wounds and Injuries|AB|MM
9339686|methods|C0025664|4|SH|Methods|AB|MM
9339686|radiography|C0034571|1111|SH|E01.370.350.700.700.810 (Tomography, X-Ray Computed)||MM
9357896|*Bupivacaine|C0006400|556104|MH|RtM via: Bupivacaine|TI;AB|MM;RC
9357896|*Heart Ventricles|C0018827|181341|MH|RtM via: Heart Ventricle;RtM via: Ventricular|TI;AB|MM;RC
9357896|*Calcium|C0006675|96609|MH|RtM via: Calcium;RtM via: Calcium ion|TI;AB|MM;RC
9357896|Anesthetics, Local|C0002934|88124|MH|RtM via: Local Anesthetics|AB|MM;RC
9357896|*Cardiomyocytes|C0225828|70263|ET|Entry Term Replacement for "Myocytes, Cardiac";RtM via: Myocytes, Cardiac|TI;AB|MM
9357896|Heart|C0018787|62940|MH|RtM via: Heart;RtM via: Cardiac|AB|MM;RC
9357896|Calcium Channels, L-Type|C0288263|53367|MH|||RC
9357896|Calcium Channel Blockers|C0006684|28990|MH|||RC
9357896|Calcium Channels, T-Type|C0752118|19572|MH|||RC
9357896|*Calcium, Dietary|C0006726|18594|MH|RtM via: Calcium, Dietary|TI|MM
9357896|Anesthesia, Local|C0002921|17928|MH|RtM via: Local anesthesia|AB|MM;RC
9357896|Patch-Clamp Techniques|C0242625|17826|MH|||RC
9357896|Myocardium|C0027061|17328|MH|||RC
9357896|Ion Channel Gating|C0022008|13368|MH|||RC
9357896|Membrane Potentials|C0025251|10050|MH|||RC
9357896|Kv Channel-Interacting Proteins|C1566012|10002|MH|||RC
9357896|Shal Potassium Channels|C0378533|8734|MH|||RC
9357896|Anesthetics, Intravenous|C0242904|7244|MH|||RC
9357896|Anesthetics, Inhalation|C0242903|4509|MH|||RC
9357896|Adenosine Triphosphate|C0001480|4274|MH|||RC
9357896|Electrophysiology|C0013865|2713|MH|||RC
9357896|Cells, Cultured|C0007635|1877|MH|||RC
9357896|Cell Separation|C0007616|1699|MH|||RC
9357896|*Physical Processes|C0597237|1644|MH|RtM via: Electrical Current;RtM via: Affinity|TI;AB|MM
9357896|Muscle Proteins|C0026832|1643|MH|||RC
9357896|Dose-Response Relationship, Drug|C0013059|1254|MH|||RC
9357896|Drug Interactions|C0687133|1182|MH|||RC
9357896|Kinetics|C0022702|1166|MH|||RC
9357896|Rats, Sprague-Dawley|C0034715|933|MH|||RC
9357896|Animals, Newborn|C0003065|667|MH|||RC
9357896|Time Factors|C0040225|448|MH|||RC
9357896|Oxidative Stress|C0242606|402|MH|||RC
9357896|Mutagenesis, Site-Directed|C0079870|269|MH|||RC
9357896|CHO Cells|C0085080|214|MH|||RC
9357896|Algorithms|C0002045|203|MH|||RC
------
9357896|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;Animals, Newborn;CHO Cells;CT Text Lookup: hamster|CT Text Lookup: hamster|MM;RC
9357896|Rats|C0034721|1000|CT|Rats, Sprague-Dawley||RC
9357896|Cricetinae|C0018557|1000|CT|CHO Cells;CT Text Lookup: hamster|CT Text Lookup: hamster|MM;RC
9357896|metabolism|C0025520|681|SH1|RtM via: Metabolic Inhibition;Metabolism (C0025519);RtM via: Inhibited;Metabolism (C0025519)|TI;AB|MM
9357896|blood supply|C0005839|86|SH|Blood Circulation|AB|MM
9298188|*Hydrogen|C0020275|357666|MH|RtM via: Hydrogen;RtM via: Hydrogen, Homeopathic preparation|TI|MM;RC
9298188|formic acid|C0016576|173773|NM|RtM via: formate|TI;AB|MM
9298188|*Formic Acids|C0016578|173772|HM|RtM via: formate|TI;AB|MM;RC
9298188|*Formates|C0016572|154974|MH|RtM via: Formates|TI;AB|MM;RC
9298188|*Carbon|C0007009|120489|MH|RtM via: Carbon|TI;AB|MM;RC
9298188|Fermentation|C0015852|105377|MH|RtM via: Fermentation|AB|MM;RC
9298188|Carbon Dioxide|C0007012|54254|MH|RtM via: Carbon Dioxide;RtM via: Carbon dioxide content measurement|AB|MM;RC
9298188|FD 1|C0060122|30571|NM|RtM via: FD 1;Forced Lookup:fd-1|TI;AB|MM
9298188|*Tegafur|C0016778|30570|HM|RtM via: FD 1|TI;AB|MM
9298188|Anaerobiosis|C0002750|30171|MH|||RC
9298188|Acetates|C0000979|27558|MH|RtM via: Acetates|AB|MM;RC
9298188|Pyruvates|C0034354|19633|MH|RtM via: Pyruvates|AB|MM;RC
9298188|Cellobiose|C0007630|14830|MH|RtM via: Cellobiose|AB|MM;RC
9298188|Cellulose|C0007648|11969|MH|RtM via: Cellulose|AB|MM;RC
9298188|*Ruminococcus|C0318074|11682|MH|RtM via: Ruminococcus flavefaciens|TI;AB|MM
9298188|Lactate|C0376261|10624|ET|Entry Term Replacement for "Lactic Acid";RtM via: Lactate|AB|MM;RC
9298188|Phosphoenolpyruvate|C0031642|8877|MH|RtM via: Phosphoenolpyruvate|AB|MM;RC
9298188|Hydrogen-Ion Concentration|C0020283|8011|MH|||RC
9298188|Bioelectric Energy Sources|C0005485|6213|MH|||RC
9298188|Glucose|C0017725|6154|MH|||RC
9298188|Energy Metabolism|C0014272|4861|MH|||RC
9298188|Bioreactors|C0376432|4358|MH|||RC
9298188|Culture Media|C0010454|3240|MH|||RC
9298188|Succinates|C0038617|3047|MH|RtM via: Succinates|AB|MM;RC
9298188|Refuse Disposal|C0034962|2312|MH|||RC
9298188|Carbon Radioisotopes|C0007021|2036|MH|||RC
9298188|*Physical Processes|C0597237|1695|MH|RtM via: Flux|TI|MM
9298188|Temperature|C0039476|1526|MH|||RC
9298188|Manometry|C0024751|1146|MH|||RC
9298188|Hydrogenase|C0020284|1128|MH|RtM via: Hydrogenase|AB|MM
9298188|Equipment Design|C0014677|739|MH|||RC
9298188|Escherichia coli|C0014834|721|MH|||RC
9298188|Acetate Kinase|C0000977|717|MH|RtM via: Acetate Kinase|AB|MM
9298188|Equipment Failure Analysis|C0376694|683|MH|||RC
9298188|Pyruvate|C0244104|591|ET|Entry Term Replacement for "Pyruvic Acid";RtM via: Pyruvate|AB|MM
9298188|Succinate|C0220918|300|ET|Entry Term Replacement for "Succinic Acid";RtM via: succinate|AB|MM
9298188|Time Factors|C0040225|270|MH|||RC
9298188|Species Specificity|C0037783|241|MH|||RC
9298188|Phosphoenolpyruvate Carboxykinase (ATP)|C0251211|226|MH|RtM via: ATP-Dependent Phosphoenolpyruvate Carboxykinase|AB|MM
------
9298188|metabolism|C0025520|4086|SH1|RtM via: Anabolism;Metabolism (C0025519);RtM via: Biochemical Pathway;Metabolism (C0025519);RtM via: Metabolic;Metabolism (C0025519)|TI;AB|MM
9298188|growth & development|C1457898|345|SH1|RtM via: Growth & development aspects;growth & development (C1457898);RtM via: growth aspects;growth & development (C1457898)|AB|MM
9298188|methods|C0025664|30|SH|Methods|AB|MM
9263049|*Confidence Intervals|C0009667|291237|MH|RtM via: Confidence Intervals|TI;AB|MM;RC
9263049|Models, Genetic|C0026343|27722|MH|||RC
9263049|Pedigree|C0030761|21828|MH|RtM via: genetic pedigree|AB|MM;RC
9263049|Models, Statistical|C0026348|15967|MH|||RC
9263049|Selection, Genetic|C0036576|12639|MH|||RC
9263049|Phenotype|C0031437|11570|MH|RtM via: trait|AB|MM;RC
9263049|Computer Simulation|C0009609|7318|MH|||RC
9263049|Genetics, Population|C0017404|6630|MH|||RC
9263049|Genetic Variation|C0042333|4827|MH|||RC
9263049|Models, Biological|C0026339|2712|MH|||RC
9263049|Animal Husbandry|C0003052|2547|MH|||RC
9263049|Algorithms|C0002045|1896|MH|||RC
9263049|Genomic Imprinting|C0242614|1222|MH|||RC
9263049|Animal Model|C0599779|68|ET|Entry Term Replacement for "Models, Animal";RtM via: Animal Model|AB|MM
------
9263049|Animals|C0003062|1000|CT|Animal Model|AB|MM
9263049|methods|C0025664|2343|SH1|RtM via: Methodology;methods (C0025664)|TI;AB|MM
9263049|genetics|C0017399|1111|SH1|RtM via: cell transformation;Genetics (C0017398)|AB|MM;RC
9263049|instrumentation|C0021632|1|SH|Equipment and Supplies|AB|MM
9308130|DNASE1 protein, human|C1144786|879334|NM|RtM via: Dornase Alfa|TI|MM
9308130|*Deoxyribonuclease I|C0011519|879333|HM|RtM via: Dornase Alfa|TI|MM;RC
9308130|*Recurrence|C0034897|29757|MH|RtM via: Recurrence|TI;AB|MM;RC
9308130|Biometry|C0005544|15270|MH|RtM via: Science of Statistics|AB|MM;RC
9308130|Treatment Outcome|C0085415|13844|MH|RtM via: Treatment outcome|AB|MM;RC
9308130|Models, Statistical|C0026348|7355|MH|||RC
9308130|Clinical Trials as Topic|C0008976|6557|MH|RtM via: Clinical Trials|AB|MM;RC
9308130|Randomized Controlled Trials as Topic|C0282440|6223|MH|||RC
9308130|Mucociliary Clearance|C0026687|6164|MH|||RC
9308130|Administration, Inhalation|C0001559|4090|MH|||RC
9308130|Forced Expiratory Volume|C0016529|3213|MH|||RC
9308130|Drug Administration Schedule|C0013154|2430|MH|||RC
9308130|Time Factors|C0040225|1940|MH|||RC
9308130|*Research|C0035168|1806|MH|RtM via: Analysis of substances|TI;AB|MM
9308130|Exercise Tolerance|C0162521|964|MH|||RC
9308130|*Laboratory Techniques and Procedures|C0600201|945|MH|RtM via: Analysis of substances|TI;AB|MM
9308130|Risk Factors|C0035648|581|MH|||RC
------
9308130|analysis|C1524024|900|SH1|RtM via: analysis aspect|TI;AB|MM
9308130|therapy|C0039798|2061|SH|Therapeutics|TI;AB|MM
9308130|organization & administration|C0029236|1206|SH|Organization and Administration|TI;AB|MM
9308130|drug therapy|C0013217|9999|SH|new SH add rule - Administration, Inhalation [E02.319.267.050] (E02.319)||MM
9317033|*Entamoeba histolytica|C0014323|1214322|MH|RtM via: Entamoeba histolytica|TI;AB|MM;RC
9317033|Amoebic Dysentery|C0013370|254875|ET|Entry Term Replacement for "Dysentery, Amebic";RtM via: Amebic colitis|AB|MM;RC
9317033|*Phagocytosis|C0031308|246318|MH|RtM via: Phagocytosis|TI;AB|MM;RC
9317033|Entamoebiasis|C0014324|159241|MH|||RC
9317033|*Amoeba|C0002642|106299|MH|RtM via: Amoeba genus|TI;AB|MM
9317033|*Vacuolar ATPase|C0379099|69768|ET|Entry Term Replacement for "Vacuolar Proton-Translocating ATPases";RtM via: vacuolar H+-ATPase|TI|MM;RC
9317033|*Erythrocytes|C0014792|64029|MH|RtM via: Erythrocytes|TI;AB|MM;RC
9317033|Amebiasis|C0002438|38096|MH|||RC
9317033|Phagosomes|C0031310|21290|MH|||RC
9317033|Protozoan Proteins|C0033742|18713|MH|||RC
9317033|DNA, Protozoan|C0079250|10422|MH|||RC
9317033|Cell Adhesion|C0007577|9539|MH|||RC
9317033|Lectins|C0023206|9281|MH|RtM via: Lectin|AB|MM;RC
9317033|Escherichia coli Infections|C0014836|6690|MH|||RC
9317033|Epithelial Cells|C0014597|6470|MH|RtM via: Epithelial Cells|AB|MM;RC
9317033|Host-Parasite Interactions|C0020034|5515|MH|||RC
9317033|Cell Survival|C0007620|5441|MH|||RC
9317033|*Evolution|C0015219|5337|MH|RtM via: Evolution|TI;AB|MM
9317033|Apoptosis|C0162638|5237|MH|||RC
9317033|Cell Line|C0007600|5172|MH|||RC
9317033|Cysteine Proteinase Inhibitors|C0010658|4642|MH|||RC
9317033|Escherichia coli|C0014834|4620|MH|||RC
9317033|RNA, Protozoan|C0080126|4498|MH|||RC
9317033|*Bacteria|C0004611|4431|MH|RtM via: Bacteria;RtM via: Bacterial|TI;AB|MM
9317033|Mucin|C0026682|3838|ET|Entry Term Replacement for "Mucins";RtM via: Mucins;RtM via: Mucin 1 protein|AB|MM;RC
9317033|rac GTP-Binding Proteins|C0539241|3478|MH|||RC
9317033|Molecular Sequence Data|C0026382|2818|MH|||RC
9317033|Membrane Proteins|C0025252|2809|MH|||RC
9317033|Amino Acid Sequence|C0002518|2715|MH|||RC
9317033|Cytotoxicity, Immunologic|C0010864|2578|MH|||RC
9317033|Protein Kinases|C0033640|2349|MH|||RC
9317033|Cloning, Molecular|C0009017|1961|MH|||RC
9317033|Hydrogen-Ion Concentration|C0020283|1936|MH|||RC
9317033|Trophozoites|C0686882|1935|MH|RtM via: Trophozoite|AB|MM
9317033|Cricetulus|C0010320|1786|MH|||RC
9317033|Microscopy, Fluorescence|C0026022|1577|MH|||RC
9317033|Microscopy, Confocal|C0242842|1436|MH|||RC
9317033|Phylogeny|C0031797|1391|MH|||RC
9317033|Saccharomyces cerevisiae|C0036025|1197|MH|||RC
9317033|Gene Expression Profiling|C0752248|962|MH|||RC
9317033|Electrophoresis, Polyacrylamide Gel|C0013862|950|MH|||RC
9317033|RNA, Small Interfering|C1099354|923|MH|||RC
9317033|Dextrans|C0011806|843|MH|RtM via: Dextrans|AB|MM;RC
9317033|Kinetics|C0022702|787|MH|||RC
9317033|Mice, Inbred CBA|C0025922|739|MH|||RC
9317033|Swine|C0039005|691|MH|||RC
9317033|Macrophages|C0024432|510|MH|RtM via: macrophage;RtM via: Specimen Type - Macrophages|AB|MM
9317033|Adhesiveness|C0001515|320|MH|||RC
9317033|Cytokinesis|C0010813|317|MH|RtM via: Cytokinesis|AB|MM
9317033|Disease Models, Animal|C0012644|314|MH|||RC
------
9317033|Animals|C0003062|1000|CT|Trophozoites;Cricetulus;Mice, Inbred CBA;Swine;Disease Models, Animal|AB|MM;RC
9317033|Cricetinae|C0018557|1000|CT|Cricetulus||RC
9317033|Mice|C0026809|1000|CT|Mice, Inbred CBA||RC
9317033|microbiology|C0025953|819|SH1|RtM via: bacteria aspects;microbiology (C0025953);RtM via: Fungal;microbiology (C0025953)|TI;AB|MM
9317033|pathogenicity|C0030657|17936|SH|Pathogenicity|AB|MM;RC
9317033|immunology|C1522005|1111|SH|G12.450.575.809 (Phagocytosis)|TI;AB|MM
9317033|genetics|C0017399|1111|SH|G05.355.265 (Evolution)|TI;AB|MM
9331038|Bupivacaine|C0006400|1277821|MH|RtM via: Bupivacaine|AB|MM;RC
9331038|*Injection, Intra-Articular|C0021488|634559|ET|Entry Term Replacement for "Injections, Intra-Articular";RtM via: Intra-articular route;RtM via: Intra-Articular Injections;Forced Lookup:intra-articular injection|TI;AB|MM;RC
9331038|*Pain|C0030193|400050|MH|RtM via: Pain;RtM via: Actual Pain;RtM via: Hip pain|TI;AB|MM;RC
9331038|Anesthetics, Local|C0002934|336725|MH|||RC
9331038|*Anesthesia, Local|C0002921|207114|MH|RtM via: Local anesthesia|TI|MM
9331038|Pain, Postoperative|C0030201|182583|MH|||RC
9331038|Pain Measurement|C0030198|135671|MH|||RC
9331038|Arthroscopy|C0003904|55111|MH|||RC
9331038|Nerve Block|C0027741|38008|MH|||RC
9331038|Analgesics, Opioid|C0002772|32840|MH|||RC
9331038|Brachial Plexus|C0006090|17733|MH|||RC
9331038|Hip Joint|C0019558|15525|MH|||RC
9331038|Arthroplasty, Replacement, Hip|C0392806|13749|MH|RtM via: Total Hip Replacement (procedure)|AB|MM;RC
9331038|Shoulder Joint|C0037009|12391|MH|||RC
9331038|Vasoconstrictor Agents|C0042397|12100|MH|||RC
9331038|*Joints|C0022417|11910|MH|RtM via: Repair of hip|TI;AB|MM
9331038|Anesthetics, Dissociative|C0002933|11440|MH|||RC
9331038|Osteoarthritis, Hip|C0029410|8702|MH|||RC
9331038|*Arthroplasty, Replacement|C0185317|7887|MH|RtM via: Repair of hip|TI;AB|MM
9331038|Hip Prosthesis|C0019560|5275|MH|||RC
9331038|Ankle Joint|C0003087|4672|MH|||RC
9331038|Treatment Outcome|C0085415|779|MH|||RC
9331038|Time Factors|C0040225|491|MH|||RC
9331038|Diagnosis, Differential|C0011906|452|MH|||RC
9331038|Arthroplasties|C0003893|304|ET|Entry Term Replacement for "Arthroplasty";RtM via: Arthroplasty|AB|MM
------
9331038|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9331038|surgery|C0038895|1111|SH1|RtM via: Repair of hip;surgery (C0038895);RtM via: Reattachment - action;Surgical Procedures, Operative (C0543467);RtM via: Surgical revision;Surgical Procedures, Operative (C0543467)|TI;AB|MM
9382160|*Renal Dialysis|C0917873|1845357|MH|RtM via: Initial hemodialysis;RtM via: Hemodialysis|TI;AB|MM;RC
9382160|Arteriovenous Shunt, Surgical|C0684204|552050|MH|||RC
9382160|Renal Disease, End-Stage|C0022661|476859|ET|Entry Term Replacement for "Kidney Failure, Chronic";RtM via: Kidney Failure, Chronic;Forced Lookup:end-stage renal disease|AB|MM;RC
9382160|Catheters, Indwelling|C0007439|159572|MH|||RC
9382160|Polytetrafluoroethylene|C0032611|114582|MH|RtM via: Polytetrafluoroethylene|AB|MM;RC
9382160|Vascular Patency|C0042377|67623|MH|||RC
9382160|Thrombosis|C0040053|47472|MH|RtM via: Thrombosis|AB|MM;RC
9382160|Graft Occlusion, Vascular|C0018128|45560|MH|||RC
9382160|Blood Vessel Prosthesis|C0005846|28886|MH|||RC
9382160|Catheterization, Central Venous|C0007435|20674|MH|||RC
9382160|Anticoagulants|C0003280|7094|MH|||RC
9382160|Treatment Outcome|C0085415|5410|MH|||RC
9382160|Age Factors|C0001783|4557|MH|||RC
9382160|Anastomosis, Surgical|C0002805|3873|MH|||RC
9382160|Sex Factors|C0036881|3230|MH|||RC
9382160|Serum Albumin|C0036773|3098|MH|||RC
9382160|Platelet Aggregation Inhibitors|C0032177|2645|MH|||RC
9382160|Equipment Failure|C0014678|2561|MH|||RC
9382160|Blacks|C0005680|2160|ET|Entry Term Replacement for "African Continental Ancestry Group";RtM via: Black race|AB|MM;RC
9382160|Prognosis|C0033325|2158|MH|||RC
9382160|Graft Survival|C0018131|2089|MH|||RC
9382160|Outcome Assessment (Health Care)|C0085565|1989|MH|||RC
9382160|Risk Factors|C0035648|1984|MH|||RC
9382160|Blood Flow Velocity|C0005798|1851|MH|||RC
9382160|Patient Care Team|C0030679|1413|MH|||RC
9382160|Body Mass Index|C0005893|1016|MH|||RC
9382160|Interdisciplinary Communication|C0079631|878|MH|||RC
9382160|Time Factors|C0040225|807|MH|||RC
9382160|Patient Participation|C0030699|683|MH|||RC
9382160|Kidney|C0022646|551|MH|RtM via: Kidney|AB|MM
9382160|Forearm|C0016536|445|MH|RtM via: Forearm|AB|MM
9382160|Program Evaluation|C0033336|440|MH|||RC
9382160|Arm|C0446516|372|MH|RtM via: Upper arm;RtM via: Entire upper arm|AB|MM
9382160|Databases, Factual|C0079199|204|MH|||RC
------
9382160|Humans|C0086418|1000|CT|Blacks;Patient Participation;CT Text Lookup: aged;CT Text Lookup: men;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: women|AB;CT Text Lookup: aged;CT Text Lookup: men;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: women|MM;RC
9382160|Male|C0024554|1000|CT|CT Text Lookup: men|CT Text Lookup: men|MM
9382160|Female|C0015780|1000|CT|CT Text Lookup: women|CT Text Lookup: women|MM
9382160|surgery|C0038895|1467|SH1|RtM via: Surgical aspects;surgery (C0038895);RtM via: Operative Surgical Procedures;Surgical Procedures, Operative (C0543467)|AB|MM
9382160|methods|C0025664|29|SH|Methods|AB|MM
9301125|*U937 Cells|C0600531|315883|MH|RtM via: U937 Cells;Forced Lookup:u937 cell|TI;AB|MM;RC
9301125|N,N-dimethylpradimicin FA-2|C0083556|300773|NM|RtM via: BMY 28864;Forced Lookup:bmy-28864|AB|MM
9301125|Anthracyclines|C0282564|300772|HM|RtM via: BMY 28864|AB|MM;RC
9301125|*Apoptosis|C0162638|65070|MH|RtM via: Apoptosis|TI;AB|MM;RC
9301125|Antifungal Agents|C0003308|43405|MH|RtM via: Antibiotics, Antifungal|AB|MM;RC
9301125|*Anti-Bacterial Agents|C0279516|35124|MH|RtM via: Antibiotics|TI|MM
9301125|1-Deoxynojirimycin|C0089267|22440|MH|Forced Lookup:1-deoxymannojirimycin||MM;RC
9301125|*Carbohydrates|C0007004|21564|MH|RtM via: Carbohydrates|TI|MM;RC
9301125|Mannose|C0024742|19947|MH|RtM via: Mannose|AB|MM;RC
9301125|Microbial Sensitivity Tests|C0025948|13936|MH|||RC
9301125|DNA Fragmentation|C0376669|11607|MH|RtM via: DNA Fragmentation|AB|MM;RC
9301125|Calcium|C0006675|9832|MH|RtM via: Calcium|AB|MM;RC
9301125|Mannosides|C0024747|6469|MH|RtM via: Mannosides|AB|MM;RC
9301125|Drug Therapy, Combination|C0013218|4251|MH|||RC
9301125|Hela Cells|C0018873|3886|MH|||RC
9301125|G2 Phase|C0079396|2912|MH|||RC
9301125|Antineoplastic Agents, Phytogenic|C0003394|2656|MH|||RC
9301125|Antimetabolites, Antineoplastic|C0003377|1961|MH|||RC
9301125|Free Radical Scavengers|C0079381|1894|MH|||RC
9301125|Membrane Potentials|C0025251|1673|MH|||RC
9301125|Saccharomyces cerevisiae|C0036025|1643|MH|||RC
9301125|Binding Sites|C0005456|1642|MH|||RC
9301125|Nuclear Proteins|C0028589|1597|MH|||RC
9301125|Potassium|C0032821|1488|MH|||RC
9301125|Tumor Suppressor Proteins|C0597611|1455|MH|||RC
9301125|*Biophysical Processes|C1511162|1305|MH|RtM via: mannose binding;RtM via: Binding (Molecular Function)|TI;AB|MM
9301125|Viral Proteins|C0042736|1142|MH|||RC
9301125|Structure-Activity Relationship|C0038477|1054|MH|||RC
9301125|Gene Expression Regulation, Neoplastic|C0017268|1025|MH|||RC
9301125|Flow Cytometry|C0016263|955|MH|||RC
9301125|Spectrophotometry, Ultraviolet|C0037808|864|MH|||RC
9301125|Drug Interactions|C0687133|829|MH|||RC
9301125|Molecular Structure|C0026383|829|MH|||RC
9301125|Fluorescein-5-isothiocyanate|C0085216|809|MH|||RC
9301125|Kinetics|C0022702|564|MH|||RC
9301125|Cell Fusion|C0007594|502|MH|||RC
9301125|RNA, Messenger|C0035696|341|MH|||RC
9301125|Molecular Sequence Data|C0026382|214|MH|||RC
------
9301125|Humans|C0086418|1000|CT|U937 Cells;Hela Cells|TI;AB|MM;RC
9301125|methods|C0025664|3|SH|Methods|AB|MM
9301125|genetics|C0017399|1111|SH|G05.355.180.230 (DNA Fragmentation)|AB|MM
9378488|*alpha-beta T-Cell Receptor|C0085247|1440018|ET|Entry Term Replacement for "Receptors, Antigen, T-Cell, alpha-beta";RtM via: alpha-beta T-Cell Receptor|TI;AB|MM;RC
9378488|*Listeria Infections|C0023860|948240|MH|RtM via: Listeriosis|TI|MM;RC
9378488|*Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|C0065344|430461|MH|RtM via: Lymphocyte Specific Protein Tyrosine Kinase p56(lck);RtM via: LCK non-membrane spanning protein tyrosine kinase activity|TI|MM;RC
9378488|*Antigens, CD8|C0085358|264750|MH|RtM via: CD4+CD8+|TI;AB|MM;RC
9378488|*CD8-Positive T-Lymphocytes|C0242629|248211|MH|RtM via: CD8-Positive T-Lymphocytes|TI;AB|MM
9378488|*CD4-Positive T-Lymphocytes|C0039215|229224|MH|RtM via: CD4 Positive T Lymphocytes|TI|MM
9378488|Interleukin-2|C0021756|197777|MH|RtM via: Interleukin-2;RtM via: Recombinant Interleukin-2;Forced Lookup:il-2;Forced Lookup:interleukin-2|AB|MM
9378488|Granulocyte-Macrophage Colony-Stimulating Factor|C0079460|196982|MH|RtM via: Granulocyte-Macrophage Colony-Stimulating Factor;Forced Lookup:gm-csf;Forced Lookup:granulocyte-macrophage colony-stimulating factor|AB|MM
9378488|Receptors, Antigen, T-Cell, gamma-delta|C0085246|176683|MH|||RC
9378488|Interferon-gamma|C0021745|154499|MH|RtM via: Interferon Type II;Forced Lookup:interferon-gamma|AB|MM;RC
9378488|T-Lymphocyte Subsets|C0080202|153024|MH|||RC
9378488|*Antigens, CD4|C0003323|110724|MH|RtM via: CD4+CD8+|TI;AB|MM;RC
9378488|Interleukin-4|C0021758|108255|MH|Forced Lookup:il-4||MM;RC
9378488|Listeria monocytogenes|C0023861|106823|MH|RtM via: Listeria monocytogenes|AB|MM;RC
9378488|T-Cells|C0039194|104100|ET|Entry Term Replacement for "T-Lymphocytes";RtM via: T-Lymphocyte|AB|MM;RC
9378488|RT-PCR|C0599161|98688|ET|Entry Term Replacement for "Reverse Transcriptase Polymerase Chain Reaction";RtM via: Reverse Transcriptase Polymerase Chain Reaction;Forced Lookup:rt-pcr|AB|MM
9378488|Colony-Stimulating Factors|C0009392|98232|MH|Forced Lookup:colony-stimulating factor||MM
9378488|Interleukin-10|C0085295|98232|MH|Forced Lookup:il-10||MM
9378488|Macrophage Colony-Stimulating Factor|C0079784|98232|MH|Forced Lookup:macrophage colony-stimulating factor||MM
9378488|*Cell Differentiation|C0007589|84687|MH|RtM via: Cell Differentiation process|TI|MM;RC
9378488|Mice, Inbred BALB C|C0025919|40120|MH|||RC
9378488|Mice, Inbred C3H|C0025920|39439|MH|||RC
9378488|Cytokines|C0079189|34892|MH|RtM via: cytokine|AB|MM;RC
9378488|visilizumab|C1134691|30581|NM|RtM via: Monoclonal Antibody HuM291|AB|MM
9378488|Antibodies, Monoclonal|C0003250|30580|HM|RtM via: Monoclonal Antibody HuM291|AB|MM;RC
9378488|Lymphocyte Activation|C0024262|27579|MH|||RC
9378488|Mice, Inbred C57BL|C0025921|25913|MH|||RC
9378488|Genes|C0017337|22617|MH|RtM via: Genes;RtM via: CSF2 gene;RtM via: IL2 gene|AB|MM;RC
9378488|Flow Cytometry|C0016263|9310|MH|||RC
9378488|Immunity, Innate|C0020969|6279|MH|||RC
9378488|Receptors, IgG|C0123263|5228|MH|||RC
9378488|Peritoneal Cavity|C1704247|4731|MH|RtM via: Peritoneal Cavity;RtM via: Entire peritoneal cavity|AB|MM;RC
9378488|Receptors, IgE|C0123242|4275|MH|||RC
9378488|Molecular Sequence Data|C0026382|3711|MH|||RC
9378488|*Cell|C0007634|2988|ET|Entry Term Replacement for "Cells";RtM via: Cells;RtM via: Receptor Cell|TI;AB|MM
9378488|*Cellular Structures|C0243092|2730|MH|RtM via: Entire cell|TI;AB|MM
9378488|Heat-Shock Proteins|C0018850|2715|MH|||RC
9378488|*Biological Processes|C0277784|2670|MH|RtM via: interferon-gamma production|TI|MM
9378488|Intestinal Mucosa|C0021839|2562|MH|||RC
9378488|Mice, Knockout|C0206745|2250|MH|||RC
9378488|Mycobacterium tuberculosis|C0026926|2115|MH|||RC
9378488|*Blood Cell Count|C0005771|1770|MH|RtM via: CD4+CD8+|TI;AB|MM
9378488|Cells, Cultured|C0007635|1673|MH|||RC
9378488|RNA, Messenger|C0035696|1162|MH|||RC
9378488|Organ Culture Techniques|C0029205|1057|MH|||RC
9378488|Aging|C0001811|784|MH|||RC
9378488|Macrophages|C0024432|646|MH|RtM via: macrophage;RtM via: Specimen Type - Macrophages|AB|MM
9378488|Chemokine CCL2|C0128897|278|MH|RtM via: Monocyte Chemoattractant Protein-1|AB|MM
------
9378488|Mice|C0026809|200|CT||AB|MM
9378488|Animals|C0003062|1000|CT|Mice, Inbred BALB C;Mice, Inbred C3H;Mice, Inbred C57BL;Mice, Knockout;CT Text Lookup: mice|CT Text Lookup: mice|MM;RC
9378488|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9378488|Humans|C0086418|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9378488|enzymology|C0014445|939|SH1|RtM via: LCK non-membrane spanning protein tyrosine kinase activity;enzymology (C0014445)|TI|MM
9378488|immunology|C1522005|1111|SH|D23.050.301.264.035.109 (Antigens, CD8)|TI;AB|MM
9378488|genetics|C0017399|1111|SH|G05.360.340.024.340 (Genes)|AB|MM
9298438|*Personality Inventory|C0031213|452826|MH|RtM via: Beck depression inventory|TI;AB|MM;RC
9298438|*Psychiatric Status Rating Scales|C0033871|248481|MH|RtM via: Beck depression inventory|TI;AB|MM;RC
9298438|Depressive Disorder|C0011581|119626|MH|RtM via: Depressive disorder;RtM via: Unipolar Depression|AB|MM;RC
9298438|*Multiple Sclerosis|C0026769|96132|MH|RtM via: Multiple Sclerosis|TI;AB|MM;RC
9298438|Depression|C0011570|95754|MH|RtM via: Mental Depression;RtM via: Depressed mood;RtM via: Depressive episode, unspecified|AB|MM;RC
9298438|Major Depressive Disorder|C1269683|62393|ET|Entry Term Replacement for "Depressive Disorder, Major";RtM via: Major Depressive Disorder|AB|MM;RC
9298438|Psychometrics|C0033920|46499|MH|||RC
9298438|Questionnaires|C0034394|10455|MH|||RC
9298438|Cross-Cultural Comparison|C0010358|5488|MH|||RC
9298438|Affect|C0001721|5362|MH|||RC
9298438|Self Concept|C0036594|3792|MH|||RC
9298438|Pain Measurement|C0030198|2208|MH|||RC
9298438|Patient Admission|C0030673|1412|MH|||RC
9298438|Diagnosis, Differential|C0011906|1142|MH|||RC
9298438|Fatigue|C0015672|720|MH|RtM via: Fatigue;RtM via: Actual Fatigue;RtM via: Cardiovascular surgery result: fatigue|AB|MM
------
9298438|Humans|C0086418|1000|CT|Patient Admission;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM;RC
9298438|instrumentation|C0021632|28|SH|Inventory|AB|MM
9279722|Hepatitis A Vaccine|C0170300|431600|ET|Entry Term Replacement for "Hepatitis A Vaccines";RtM via: Hepatitis A Vaccines|AB|MM;RC
9279722|*Vaccines, Inactivated|C0042212|291618|MH|RtM via: Hepatitis A Vaccine, Inactivated|TI;AB|MM;RC
9279722|Hepatitis A Antibodies|C0062524|239658|MH|||RC
9279722|Hepatitis A Virus, Human|C0206437|173687|MH|||RC
9279722|*Vaccination|C0042196|97362|MH|RtM via: Vaccination|TI;AB|MM;RC
9279722|Antibodies, Neutralizing|C0475463|68638|MH|RtM via: Neutralizing antibody;Forced New Lookup:neutralizing antibodies;Forced New Lookup:neutralizing antibody|AB|MM
9279722|Vaccines|C0042210|17674|MH|RtM via: Vaccines;RtM via: Vaccine - EntityCode|AB|MM;RC
9279722|*Viral Vaccines|C0042742|17436|MH|RtM via: Hepatitis A Vaccine, Inactivated|TI;AB|MM
9279722|Immunization, Secondary|C0020975|9666|MH|||RC
9279722|Radioimmunoassay|C0034580|4649|MH|RtM via: Radioimmunoassay|AB|MM;RC
9279722|Preparation H|C0071888|3763|NM|RtM via: Hepatitis A Vaccine, Inactivated|TI;AB|MM
9279722|*Phenylmercury Compounds|C0031489|3762|HM|RtM via: Hepatitis A Vaccine, Inactivated|TI;AB|MM
9279722|Neutralization Tests|C0027944|3747|MH|||RC
9279722|*Yeasts|C0043393|3165|HM|RtM via: Hepatitis A Vaccine, Inactivated|TI;AB|MM
9279722|*Fish Oils|C0016157|3150|HM|RtM via: Hepatitis A Vaccine, Inactivated|TI;AB|MM
9279722|*Drug Combinations|C0013162|1845|HM|RtM via: Hepatitis A Vaccine, Inactivated|TI;AB|MM
9279722|Immunoglobulins|C0021027|1580|MH|RtM via: Immunoglobulins|AB|MM;RC
9279722|Immunoglobulin M|C0020861|1187|MH|||RC
9279722|Travel|C0040802|1125|MH|||RC
9279722|Drug Administration Schedule|C0013154|641|MH|||RC
9279722|Consumer Product Safety|C0009826|549|MH|||RC
9279722|Antibodies|C0003241|485|MH|RtM via: Antibodies|AB|MM
9279722|Military Personnel|C0026126|366|MH|||RC
9279722|Immunization|C0020971|346|MH|RtM via: Booster|AB|MM
------
9279722|methods|C0025664|903|SH|Methods|TI;AB|MM
9279722|therapy|C0039798|26|SH|Therapeutics|AB|MM
9279722|drug therapy|C0013217|9999|SH|new SH add rule - Drug Administration Schedule [E02.319.283] (E02.319)||MM
9366534|*Carcinoma, Hepatocellular|C0019204|2966859|MH|RtM via: Primary carcinoma of the liver cells|TI;AB|MM;RC
9366534|*Spinal Cord Compression|C0037926|590184|MH|RtM via: Compression of spinal cord|TI;AB|MM;RC
9366534|*Tomography, X-Ray Computed|C0040405|523347|MH|RtM via: X-Ray Computed Tomography;RtM via: Radiologic Technologist - Computed Tomography|TI;AB|MM;RC
9366534|Magnetic Resonance Imaging|C0024485|103966|MH|RtM via: Magnetic Resonance Imaging|AB|MM;RC
9366534|Spinal Neoplasms|C0037939|91174|MH|||RC
9366534|*Diagnostic Imaging|C0011923|57381|MH|RtM via: Diagnostic Imaging|TI|MM
9366534|Thoracic Vertebrae|C0039987|27699|MH|||RC
9366534|*Neoplasms|C0027651|23982|MH|RtM via: Hepatocellular Carcinoma of the Mouse|TI;AB|MM
9366534|*Magnetic|C0024488|9774|ET|Entry Term Replacement for "Magnetics";RtM via: Study of magnetics|TI|MM
9366534|Cervical Vertebrae|C0728985|7972|MH|||RC
9366534|Spinal Fractures|C0080179|7967|MH|||RC
9366534|Soft Tissue Neoplasms|C0037579|7917|MH|||RC
9366534|Radiotherapy Planning, Computer-Assisted|C0034621|7573|MH|||RC
9366534|Breast Neoplasms|C1458155|6981|MH|||RC
9366534|Lumbar Vertebrae|C0024091|6267|MH|||RC
9366534|Radiotherapy Dosage|C0034620|4375|MH|||RC
9366534|Brain Neoplasms|C0006118|4199|MH|||RC
9366534|*Vibration|C0459800|4080|MH|RtM via: Vibration - physical agent;RtM via: Pulmonary resonance|TI|MM
9366534|Lung Neoplasms|C0024121|3143|MH|||RC
9366534|Combined Modality Therapy|C0009429|2840|MH|||RC
9366534|Palliative Care|C0030231|2673|MH|||RC
9366534|Diagnosis, Differential|C0011906|1615|MH|||RC
9366534|*Physical Processes|C0597237|1524|MH|RtM via: Magnetism|TI|MM
9366534|Decision Support Techniques|C0011113|1316|MH|||RC
9366534|Practice Guidelines as Topic|C0162793|1024|MH|||RC
9366534|Interdisciplinary Communication|C0079631|889|MH|||RC
9366534|Treatment Outcome|C0085415|726|MH|||RC
9366534|Patient Care Team|C0030679|655|MH|||RC
------
9366534|Humans|C0086418|1000|CT|Breast Neoplasms;Palliative Care;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM;RC
9366534|secondary|C1522484|122553|SH1|RtM via: metastatic qualifier;secondary (C1522484)|TI;AB|MM
9366534|diagnosis|C1704338|462|SH1|RtM via: diagnosis aspect;RtM via: Diagnosis;RtM via: Diagnosis Study;RtM via: Diagnosis Study;diagnosis (C1704338)|AB|MM
9366534|therapy|C0039798|236|SH1|RtM via: therapeutic aspects;therapy (C0039798)|AB|MM
9366534|methods|C0025664|408|SH1|RtM via: Methodology;methods (C0025664)|AB|MM
9366534|organization & administration|C0029236|666|SH|Organization and Administration|TI;AB|MM
9366534|radiography|C0034571|1111|SH|E01.370.350.700.700.810 (Tomography, X-Ray Computed)|TI;AB|MM
9366534|radiotherapy|C1522449|1111|SH|E02.815.639 (Radiotherapy Dosage)||MM
9293364|*Thoracic Aorta|C1522460|613074|ET|Entry Term Replacement for "Aorta, Thoracic";RtM via: Thoracic aorta;RtM via: Entire thoracic aorta|TI|MM;RC
9293364|Aortic Rupture|C0003496|268475|MH|RtM via: Aortic Rupture|AB|MM;RC
9293364|Thoracic Injuries|C0039980|152674|MH|||RC
9293364|*Incidence|C0021149|77055|MH|RtM via: Incidence|TI;AB|MM;RC
9293364|Aortic Aneurysm, Thoracic|C0162872|22742|MH|||RC
9293364|Accidents, Traffic|C0000932|22016|MH|||RC
9293364|Blood Vessel Prosthesis Implantation|C0525022|11650|MH|||RC
9293364|Age Distribution|C0001782|9061|MH|||RC
9293364|*Aging|C0001811|8997|MH|RtM via: Aging|TI|MM;RC
9293364|Automobile Driving|C0004379|7043|MH|||RC
9293364|Prognosis|C0033325|4837|MH|||RC
9293364|Age Factors|C0001783|4459|MH|||RC
9293364|Stents|C0038257|4225|MH|||RC
9293364|Accidents, Aviation|C0000928|3996|MH|||RC
9293364|Treatment Outcome|C0085415|3739|MH|||RC
9293364|Aorta|C0003483|3277|MH|RtM via: Aorta;RtM via: Entire aorta|AB|MM
9293364|Sex Factors|C0036881|1475|MH|||RC
9293364|Emergency Medical Services|C0013961|1414|MH|||RC
9293364|Time Factors|C0040225|1338|MH|||RC
9293364|Postoperative Complications|C0032787|1191|MH|||RC
9293364|Risk Assessment|C0086930|1150|MH|||RC
9293364|Emergency Service, Hospital|C0013967|963|MH|||RC
9293364|Registries|C0034975|863|MH|||RC
9293364|Biomechanics|C0005537|801|MH|||RC
9293364|Stress, Mechanical|C0038442|764|MH|||RC
9293364|Population Surveillance|C0032687|573|MH|||RC
9293364|Severity of Illness Index|C0036859|528|MH|||RC
9293364|Regional Blood Flow|C0034965|523|MH|||RC
------
9293364|North Carolina|C0028407|13|MH-S|RtM via: North Carolina|AB|MM
9293364|epidemiology|C0014508|846|SH1|RtM via: incidence of cases;epidemiology (C0014508)|TI;AB|MM
9293364|surgery|C0038895|1111|SH1|RtM via: Transected;Surgical Procedures, Operative (C0543467)|TI|MM
9293364|injuries|C1510467|6909|SH|Wounds and Injuries|TI|MM
9293364|methods|C0025664|22|SH|Methods|AB|MM
9377289|*Thalamus|C0039729|373770|MH|RtM via: Thalamic structure;RtM via: Entire thalamus|TI;AB|MM;RC
9377289|*Infarction|C0021308|31464|MH|RtM via: Infarction|TI;AB|MM
9377289|Tomography, X-Ray Computed|C0040405|23827|MH|||RC
9377289|*Psychomotor Disorders|C0033922|20829|MH|RtM via: Clinical variability|TI|MM;RC
9377289|Cerebellum|C0007765|9406|MH|RtM via: Cerebellum|AB|MM;RC
9377289|Brain|C0006104|6921|MH|||RC
9377289|Brain Mapping|C0006117|6749|MH|||RC
9377289|Brain Ischemia|C0007786|6327|MH|||RC
9377289|Memory Disorders|C0025261|5617|MH|RtM via: Memory Disorders|AB|MM;RC
9377289|*Duane Retraction Syndrome|C0013261|4791|MH|RtM via: Clinical variability|TI|MM
9377289|*Neuroacanthocytosis|C0393576|3861|MH|RtM via: Clinical variability|TI|MM
9377289|Functional Laterality|C1720777|3078|MH|||RC
9377289|Neuropsychological Tests|C0027902|2528|MH|||RC
9377289|Cognition Disorders|C0009241|2411|MH|||RC
9377289|*Microcephaly|C0025958|2205|MH|RtM via: Clinical variability|TI|MM
9377289|Risk Factors|C0035648|1116|MH|||RC
9377289|Severity of Illness Index|C0036859|720|MH|||RC
9377289|Leg|C1140621|678|MH|||RC
9377289|Diagnosis, Differential|C0011906|556|MH|||RC
9377289|Syndrome|C0039082|552|MH|||RC
9377289|Abnormal Movements|C0013384|345|ET|Entry Term Replacement for "Dyskinesias";RtM via: Dyskinetic syndrome|AB|MM
------
9377289|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9377289|radiography|C0034571|1111|SH|E01.370.350.700.700.810 (Tomography, X-Ray Computed)||MM
9379299|*Nematoda|C1704319|870528|MH|RtM via: Nematodes|TI|MM;RC
9379299|*Spiruroidea|C0037988|201432|MH|RtM via: Cystidicolidae;RtM via: Ascarophis;RtM via: Cystidicola|TI;AB|MM;RC
9379299|*Fishes|C0016163|172602|MH|RtM via: Fishes|TI|MM;RC
9379299|*Helminths|C0018893|147042|MH|RtM via: Nematoda|TI|MM
9379299|*Perciformes|C0030983|137562|MH|RtM via: Carangidae;RtM via: Parona signata|TI;AB|MM;RC
9379299|Fish Diseases|C0016154|37718|MH|||RC
9379299|Spirurida Infections|C0162636|10240|MH|||RC
9379299|Fresh Water|C0016710|4767|MH|||RC
9379299|Tuna|C0041382|3978|MH|||RC
9379299|Host-Parasite Interactions|C0020034|3425|MH|||RC
9379299|Seawater|C0036499|2878|MH|||RC
9379299|Egg|C0029974|1498|ET|Entry Term Replacement for "Ovum";RtM via: Ovum|AB|MM;RC
9379299|Marine Biology|C0024811|1471|MH|||RC
9379299|Microscopy, Electron, Scanning|C0026020|743|MH|||RC
9379299|Species Specificity|C0037783|249|MH|||RC
------
9379299|Animals|C0003062|1000|CT|Nematoda;Spiruroidea;Fishes;Helminths;Perciformes;Fish Diseases;Tuna|TI;AB|MM;RC
9379299|Female|C0015780|1000|CT|CT Text Lookup: female|CT Text Lookup: female|MM
9379299|Male|C0024554|1000|CT|CT Text Lookup: male|CT Text Lookup: male|MM
9379299|methods|C0025664|0|SH|Methods|AB|MM
9314714|*Veterans|C0042610|753696|MH|RtM via: Veterans|TI;AB|MM;RC
9314714|*Mental Disorders|C0004936|701652|MH|RtM via: Mental disorders|TI|MM;RC
9314714|Hospitals, Veterans|C0020030|102823|MH|||RC
9314714|United States Department of Veterans Affairs|C0041735|97095|MH|||RC
9314714|Substance Abuse|C0740858|91381|ET|Entry Term Replacement for "Substance-Related Disorders";RtM via: Actual Substance Abuse;RtM via: Substance abuse problem|AB|MM;RC
9314714|Comorbidities|C0009488|69210|ET|Entry Term Replacement for "Comorbidity";RtM via: Comorbidity|AB|MM;RC
9314714|Community Mental Health Services|C0009475|59544|MH|||RC
9314714|Health Services Accessibility|C0018748|50903|MH|||RC
9314714|Combat Disorders|C0009426|24989|MH|||RC
9314714|Substance Abuse Treatment Centers|C0079256|19255|MH|||RC
9314714|Delivery of Health Care|C0011211|19196|MH|RtM via: follow-up|AB|MM;RC
9314714|Schizophrenia|C0036341|18345|MH|RtM via: Schizophrenia|AB|MM;RC
9314714|Outpatient Clinics, Hospital|C0029916|17709|MH|||RC
9314714|Alcoholism|C0001973|16058|MH|||RC
9314714|Health Expenditures|C0015318|15495|MH|RtM via: payment|AB|MM;RC
9314714|Patient Acceptance of Health Care|C0030672|15452|MH|||RC
9314714|Clinic, Outpatient|C0002424|14692|ET|Entry Term Replacement for "Ambulatory Care Facilities";RtM via: Ambulatory Care Facilities|AB|MM;RC
9314714|Psychiatric Status Rating Scales|C0033871|13051|MH|||RC
9314714|Disability Evaluation|C0012605|8348|MH|||RC
9314714|Outcome Assessment (Health Care)|C0085565|7666|MH|||RC
9314714|Patient Admission|C0030673|7298|MH|||RC
9314714|Urban Population|C0041935|5755|MH|||RC
9314714|Continuity of Patient Care|C0009853|5615|MH|||RC
9314714|Health Surveys|C0018762|5069|MH|||RC
9314714|Activities of Daily Living|C0001288|5064|MH|||RC
9314714|Length of Stay|C0023303|3896|MH|||RC
9314714|Socioeconomic Factors|C0037464|3324|MH|||RC
9314714|Patient Care Planning|C0030678|2376|MH|||RC
9314714|Risk Factors|C0035648|2055|MH|||RC
9314714|Age Distribution|C0001782|1694|MH|||RC
9314714|Mentally Ill|C0025360|1170|ET|Entry Term Replacement for "Mentally Ill Persons";RtM via: Mentally Ill Persons|AB|MM
9314714|Mental Health|C0025353|1086|MH|RtM via: mental health|AB|MM
9314714|Patient Discharge|C0030685|1043|MH|RtM via: Patient Discharge|AB|MM
9314714|Outpatient|C0029921|809|ET|Entry Term Replacement for "Outpatients";RtM via: Outpatients|AB|MM
9314714|Posttraumatic Stress Disorder|C0038436|722|ET|Entry Term Replacement for "Stress Disorders, Post-Traumatic";RtM via: Stress Disorders, Post-Traumatic|AB|MM
9314714|Geography|C0017447|595|MH|||RC
------
9314714|United States|C0041703|1000|MH+|United States Department of Veterans Affairs||MM
9314714|Humans|C0086418|1000|CT|Community Mental Health Services;Patient Admission;Activities of Daily Living;Length of Stay;Patient Discharge|AB|MM;RC
9314714|utilization|C0042153|27735|SH1|RtM via: utilization qualifier|TI;AB|MM
9314714|therapy|C0039798|5694|SH|Therapeutics|TI;AB|MM
9314714|methods|C0025664|5|SH|Methods|AB|MM
9314714|economics|C0013557|1111|SH|N03.219.151.450 (Health Expenditures)|AB|MM
9314714|rehabilitation|C0034992|1111|SH|E02.831.067 (Activities of Daily Living)||MM
9293538|*Odontogenic Tumors|C0028880|1393671|MH|RtM via: Ameloblastic fibrosarcoma|TI;AB|MM;RC
9293538|*Maxilla|C0024947|184617|MH|RtM via: Maxilla;RtM via: Entire maxilla;RtM via: Right maxilla|TI;AB|MM;RC
9293538|Maxillary Neoplasms|C0024954|132996|MH|||RC
9293538|*Fibrosarcoma|C0016057|30651|MH|RtM via: Ameloblastic fibrosarcoma;RtM via: fibrosarcoma|TI;AB|MM;RC
9293538|Mandibular Neoplasms|C0024694|13272|MH|||RC
9293538|Fibroma|C0016045|4697|MH|||RC
9293538|*Mouth Neoplasms|C0026640|4269|MH|RtM via: Ameloblastic fibrosarcoma|TI;AB|MM
9293538|Keratin|C0022564|1929|ET|Entry Term Replacement for "Keratins";RtM via: Cytokeratin;RtM via: Keratin|AB|MM;RC
9293538|Tooth, Impacted|C0040456|1929|MH|||RC
9293538|Vimentin|C0042666|1651|MH|RtM via: Vimentin|AB|MM;RC
9293538|Epithelial Cells|C0014597|750|MH|||RC
9293538|Neoplasm Recurrence, Local|C0027643|523|MH|||RC
9293538|Cell Transformation, Neoplastic|C0007621|436|MH|||RC
9293538|Radiotherapy, Adjuvant|C0242939|381|MH|||RC
9293538|Diagnosis, Differential|C0011906|253|MH|||RC
9293538|Ameloblast|C0002449|217|ET|Entry Term Replacement for "Ameloblasts";RtM via: Ameloblasts|AB|MM
------
9293538|Male|C0024554|1000|CT|CT Text Lookup: male|CT Text Lookup: male|MM
9293538|methods|C0025664|2|SH|Methods|AB|MM
9293538|instrumentation|C0021632|0|SH|Equipment and Supplies|AB|MM
9293538|organization & administration|C0029236|0|SH|Organization and Administration|AB|MM
9293538|radiotherapy|C1522449|1111|SH|E02.815.600 (Radiotherapy, Adjuvant)||MM
9346183|*Solitary Fibrous Tumor|C1266119|90276|ET|Entry Term Replacement for "Solitary Fibrous Tumors";RtM via: Solitary fibrous tumor|TI;AB|MM
9346183|Fibroma|C0016045|55790|MH|||RC
9346183|Soft Tissue Neoplasms|C0037579|50622|MH|||RC
9346183|Tumor Markers, Biological|C0041366|11612|MH|||RC
9346183|S100 Proteins|C0027758|11564|MH|Forced Lookup:s-100 protein||MM;RC
9346183|Buttock|C0006497|5536|ET|Entry Term Replacement for "Buttocks";RtM via: Buttocks|AB|MM;RC
9346183|Retroperitoneal Neoplasms|C0035358|5343|MH|||RC
9346183|Neoplasm Recurrence, Local|C0027643|5174|MH|||RC
9346183|Hyalin|C0020191|4366|MH|||RC
9346183|Head and Neck Neoplasms|C0018671|4143|MH|||RC
9346183|Fibroblast|C0016030|3959|ET|Entry Term Replacement for "Fibroblasts";RtM via: Fibroblasts|AB|MM;RC
9346183|Neoplasm Proteins|C0027642|3919|MH|||RC
9346183|*Microscopy|C0026018|3330|MH|RtM via: Light microscopy|TI|MM
9346183|Desmin|C0011696|3236|MH|RtM via: Desmin|AB|MM;RC
9346183|Orbital Neoplasms|C0029185|2617|MH|||RC
9346183|Prognosis|C0033325|2515|MH|||RC
9346183|Sarcomas, Spindle Cell|C0205945|1660|ET|Entry Term Replacement for "Sarcoma";RtM via: Sarcoma, Spindle Cell|AB|MM
9346183|Actin|C0001271|1627|ET|Entry Term Replacement for "Actins";RtM via: Actins|AB|MM;RC
9346183|Stromal Cells|C0162597|1367|MH|||RC
9346183|Cytokeratin|C0010803|1090|ET|Entry Term Replacement for "Keratins";RtM via: Cytokeratin;RtM via: Keratin|AB|MM
9346183|Diagnosis, Differential|C0011906|1083|MH|||RC
9346183|*Musculoskeletal System|C0026860|867|MH|RtM via: soft tissue|TI;AB|MM
9346183|Microscopy, Electron, Transmission|C0678118|825|MH|||RC
9346183|Epithelial Membrane Antigen|C0006611|739|ET|Entry Term Replacement for "Mucin-1";RtM via: Mucin-1 Antigen|AB|MM
9346183|Treatment Outcome|C0085415|686|MH|||RC
9346183|*Drug Administration Routes|C0013153|666|MH|RtM via: Drug Administration into Soft Tissue|TI;AB|MM
9346183|Vimentin|C0042666|292|MH|RtM via: Vimentin|AB|MM
9346183|Terminology as Topic|C1956183|277|MH|||RC
------
9346183|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9346183|Female|C0015780|1000|CT|CT Text Lookup: vulva|CT Text Lookup: vulva|MM
9346183|ultrastructure|C0041623|2985|SH1|RtM via: Ultrastructure;ultrastructure (C0041623)|TI;AB|MM
9346183|methods|C0025664|477|SH|Methods|TI;AB|MM
9346183|organization & administration|C0029236|57|SH|Organization and Administration|TI;AB|MM
9346183|immunology|C1522005|1111|SH|D23.050.285.050.300 (Epithelial Membrane Antigen)|AB|MM
9325071|*Polymorphonuclear Leukocytes|C0027950|374019|ET|Entry Term Replacement for "Neutrophils";RtM via: neutrophil|TI;AB|MM;RC
9325071|Phagocytosis|C0031308|191673|MH|RtM via: Phagocytosis|AB|MM;RC
9325071|*Hydrogen Peroxide|C0020281|91142|MH|RtM via: Hydrogen Peroxide;Forced Lookup:h2o2|TI;AB|MM;RC
9325071|Phorbol Myristate Acetate|C0039654|20599|ET|Entry Term Replacement for "Tetradecanoylphorbol Acetate";RtM via: Tetradecanoylphorbol Acetate|AB|MM;RC
9325071|Peroxidase|C0027021|11974|MH|||RC
9325071|Cytometries, Flow|C0016263|10779|ET|Entry Term Replacement for "Flow Cytometry";RtM via: Flow Cytometry|AB|MM;RC
9325071|Chemotaxis, Leukocyte|C0008019|10121|MH|||RC
9325071|Apoptosis|C0162638|2314|MH|||RC
9325071|Kidney Failure, Chronic|C0022661|1890|MH|||RC
9325071|Fluorescent Dyes|C0016320|621|MH|||RC
9325071|Cells, Cultured|C0007635|521|MH|||RC
9325071|Infant, Premature|C0021294|450|MH|||RC
9325071|Oxygen Consumption|C0030055|294|MH|||RC
9325071|Severity of Illness Index|C0036859|231|MH|||RC
------
9325071|Humans|C0086418|1000|CT|Infant, Premature;CT Text Lookup: adult;CT Text Lookup: neonate;CT Text Lookup: newborn|CT Text Lookup: adult;CT Text Lookup: neonate;CT Text Lookup: newborn|MM;RC
9325071|Infant, Newborn|C0021289|1000|CT|Infant, Premature;CT Text Lookup: neonate;CT Text Lookup: newborn|CT Text Lookup: neonate;CT Text Lookup: newborn|MM;RC
9325071|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9325071|methods|C0025664|0|SH|Methods|AB|MM
9325071|immunology|C1522005|1111|SH|G12.450.575.809 (Phagocytosis)|AB|MM
9379259|*Muscle, Skeletal|C0242692|558669|MH|RtM via: Structure of muscle of forearm;RtM via: Structure of extensor carpi radialis brevis muscle;RtM via: Entire extensor carpi radialis brevis muscle|TI;AB|MM;RC
9379259|Muscle Fatigue|C0242979|374865|MH|RtM via: Muscle Fatigue|AB|MM;RC
9379259|Isometric Contraction|C0022205|369770|MH|RtM via: Isometric Contraction|AB|MM;RC
9379259|*Forearm|C0016536|361587|MH|RtM via: Structure of muscle of forearm;RtM via: Forearm;RtM via: Structure of extensor carpi radialis brevis muscle;RtM via: Entire extensor carpi radialis brevis muscle;RtM via: Structure of right forearm;RtM via: Entire right forearm|TI;AB|MM;RC
9379259|Muscle Contraction|C0026820|328880|MH|RtM via: Muscle Contraction|AB|MM;RC
9379259|Oxygen Consumption|C0030055|105647|MH|||RC
9379259|Electromyography|C0013839|90649|MH|||RC
9379259|Spectroscopy, Near-Infrared|C0376519|85324|MH|RtM via: Spectroscopy, Near-Infrared|AB|MM;RC
9379259|Physical Exertion|C0031807|47885|MH|||RC
9379259|Oxygen|C0030054|47283|MH|RtM via: Oxygen|AB|MM;RC
9379259|Physical Endurance|C0031808|44249|MH|||RC
9379259|Muscle Strength|C0517349|29819|MH|||RC
9379259|Exercise|C0015259|23953|MH|||RC
9379259|Mitochondria, Muscle|C0026240|23819|MH|||RC
9379259|Arm|C0446516|20993|MH|RtM via: Entire right upper arm;RtM via: Right upper arm structure|AB|MM;RC
9379259|Hand Strength|C0242959|20989|MH|||RC
9379259|Ischemia|C0022116|18313|MH|RtM via: Ischemic|AB|MM;RC
9379259|Rest|C0035253|18147|MH|RtM via: Rest|AB|MM;RC
9379259|Physical Fitness|C0031812|13400|MH|||RC
9379259|Leg|C1140621|11279|MH|||RC
9379259|Sympathetic Nervous System|C0039044|9141|MH|||RC
9379259|Blood Pressure|C0005823|5968|MH|||RC
9379259|Compartment Syndromes|C0009492|5876|MH|||RC
9379259|Task Performance and Analysis|C0039334|5658|MH|||RC
9379259|Regional Blood Flow|C0034965|5581|MH|||RC
9379259|Pressure|C0033095|5363|MH|||RC
9379259|Motor Activity|C0026606|4486|MH|||RC
9379259|Vasoconstriction|C0042396|4197|MH|||RC
9379259|Carbon Dioxide|C0007012|4057|MH|||RC
9379259|Blood Flow Velocity|C0005798|3525|MH|||RC
9379259|Electrophysiology|C0013865|2983|MH|||RC
9379259|Spectrophotometry, Infrared|C0037807|2638|MH|||RC
9379259|Potassium|C0032821|2343|MH|||RC
9379259|Lumbar Vertebrae|C0024091|1472|MH|||RC
9379259|*Behavior|C0004927|939|MH|RtM via: Voluntary|TI;AB|MM
9379259|Spectroscopy, Fourier Transform Infrared|C0206055|922|MH|||RC
9379259|Wrist Joint|C1322271|683|MH|RtM via: Wrist joint;RtM via: Entire wrist region|AB|MM
9379259|Elbow Joint|C0013770|599|MH|RtM via: Elbow joint structure|AB|MM
9379259|*Urinary Bladder Diseases|C0005686|441|MH|RtM via: Contraction (finding)|TI;AB|MM
------
9379259|methods|C0025664|102|SH|Methods|TI;AB|MM
9085387|*Pesticides|C0031253|670938|MH|RtM via: Pesticides|TI;AB|MM;RC
9085387|*Risks|C0035647|127311|ET|Entry Term Replacement for "Risk";RtM via: Risk|TI|MM;RC
9085387|Agriculture|C0001829|64096|MH|RtM via: Agriculture;RtM via: Farmer, unspecified|AB|MM;RC
9085387|Agricultural Workers' Diseases|C0001828|61554|MH|||RC
9085387|Pest Control|C0031249|30472|MH|RtM via: Pest Control|AB|MM;RC
9085387|Occupational Exposure|C0028798|28275|MH|||RC
9085387|Occupational Diseases|C0028797|20788|MH|||RC
9085387|Environmental Exposure|C0014412|19394|MH|||RC
9085387|Risk Factors|C0035648|13991|MH|||RC
9085387|Risk Assessment|C0086930|10405|MH|||RC
9085387|Iowa|C0022037|10288|MH|RtM via: Iowa|AB|MM;RC
9085387|Michigan|C0025939|9326|MH|RtM via: Michigan (geographic location)|AB|MM;RC
9085387|2,4-Dichlorophenoxyacetic Acid|C0000220|7642|MH|||RC
9085387|Poison Control Centers|C0032340|6785|MH|||RC
9085387|Accidents, Occupational|C0000931|6682|MH|||RC
9085387|Population Surveillance|C0032687|5749|MH|||RC
------
9085387|New York|C0027976|4548|MH-S|RtM via: New York (geographic location)|AB|MM;RC
9085387|California|C0006754|4234|MH-S|RtM via: California|AB|MM;RC
9085387|Wisconsin|C0043193|4060|MH-S|RtM via: Wisconsin|AB|MM;RC
9085387|New Jersey|C0027971|2499|MH-S|RtM via: New Jersey|AB|MM;RC
9085387|Illinois|C0020898|291|MH-S|RtM via: Illinois (geographic location)|AB|MM
9085387|Florida|C0016253|286|MH-S|RtM via: Florida|AB|MM
9085387|Missouri|C0026222|253|MH-S|RtM via: Missouri|AB|MM
9085387|Nebraska|C0027523|253|MH-S|RtM via: Nebraska (geographic location)|AB|MM
9085387|Texas|C0039711|94|MH-S|RtM via: Texas|AB|MM
9085387|Washington|C0043038|94|MH-S|RtM via: Washington state|AB|MM
9085387|United States|C0041703|1000|MH+|CT Text Lookup: american medical association||MM
9085387|poisoning|C0032344|600|SH1|Poisoning (C0032343)||RC
9085387|injuries|C1510467|41|SH|Wounds and Injuries|AB|MM
9376959|*Gastrointestinal Hemorrhage|C0017181|1228713|MH|RtM via: Upper gastrointestinal hemorrhage;RtM via: Gastrointestinal Hemorrhage|TI;AB|MM;RC
9376959|*Arteriography|C0003844|417150|ET|Entry Term Replacement for "Angiography";RtM via: angiogram;RtM via: Angiogram - Consent Type;RtM via: Arteriography|TI;AB|MM;RC
9376959|Esophageal and Gastric Varices|C0014849|385151|MH|||RC
9376959|Embolization, Therapeutic|C0013931|32127|MH|||RC
9376959|Hemostatic Techniques|C0019119|18156|MH|||RC
9376959|Endoscopy|C0014245|11791|MH|RtM via: endoscopy;RtM via: Clinic / Center - Endoscopy|AB|MM;RC
9376959|Hemostatics|C0019120|8327|MH|||RC
9376959|Radiography, Interventional|C0034578|8055|MH|||RC
9376959|Varicose Veins|C0042345|7926|MH|||RC
9376959|Tomography, X-Ray Computed|C0040405|5519|MH|||RC
9376959|Diverticulitis, Colonic|C0012814|5353|MH|||RC
9376959|Vasoconstrictor Agents|C0042397|3686|MH|||RC
9376959|Gastric Mucosa|C0017136|1886|MH|||RC
9376959|Injections, Intravenous|C0021494|614|MH|||RC
------
9376959|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9376959|organization & administration|C0029236|3|SH|Organization and Administration|TI|MM
9376959|methods|C0025664|0|SH|Methods|AB|MM
9376959|drug therapy|C0013217|9999|SH|new SH add rule - Injections, Intra-Arterial [E02.319.267.530.370] (E02.319)||MM
9376959|radiography|C0034571|1111|SH|E01.370.350.700.060 (Arteriography)|TI;AB|MM
9327223|*HIV Infections|C0019693|245769|MH|RtM via: HIV Infections|TI;AB|MM;RC
9327223|Lymphoma, Non-Hodgkin's|C0024305|138773|ET|Entry Term Replacement for "Lymphoma, Non-Hodgkin";RtM via: Lymphoma, Non-Hodgkin's;RtM via: Primary central nervous system lymphoma;Forced Lookup:non-hodgkin's lymphoma|AB|MM;RC
9327223|*Lymphomas|C0024299|95493|ET|Entry Term Replacement for "Lymphoma";RtM via: Lymphoma|TI;AB|MM
9327223|Disease, Hodgkin|C0019829|92472|ET|Entry Term Replacement for "Hodgkin Disease";RtM via: Hodgkins Disease|AB|MM;RC
9327223|Central Nervous System Neoplasms|C0085136|72180|MH|RtM via: Primary central nervous system lymphoma|AB|MM;RC
9327223|B-Lymphocytes|C0004561|24152|MH|RtM via: B-Lymphocytes;Forced Lookup:b-cell|AB|MM
9327223|Brain Neoplasms|C0006118|7799|MH|||RC
9327223|Incidence|C0021149|6882|MH|RtM via: Incidence|AB|MM;RC
9327223|Combined Modality Therapy|C0009429|4929|MH|||RC
9327223|Antineoplastic Combined Chemotherapy Protocols|C0003393|3950|MH|||RC
9327223|Meningeal Neoplasms|C0025284|3382|MH|||RC
9327223|Prognosis|C0033325|3340|MH|||RC
9327223|Developing Countries|C0011750|2341|MH|||RC
9327223|Treatment Outcome|C0085415|1796|MH|||RC
------
9327223|therapy|C0039798|281|SH1|RtM via: therapeutic aspects;therapy (C0039798)|AB|MM
9327223|methods|C0025664|19|SH|Methods|AB|MM
9327223|drug therapy|C0013217|9999|SH|new SH add rule - Antiretroviral Therapy, Highly Active [E02.319.310.075] (E02.319)||MM
9339895|*Peptides|C0030956|283725|MH|RtM via: Peptides|TI;AB|MM;RC
9339895|*Anti-Bacterial Agents|C0279516|167922|MH|RtM via: Anti-Bacterial Agents|TI;AB|MM;RC
9339895|Amino Acid Sequence|C0002518|99096|MH|RtM via: Amino Acid Sequence|AB|MM;RC
9339895|Antimicrobial Cationic Peptides|C0066510|95981|MH|||RC
9339895|Gram-Negative Bacteria|C0018150|67373|MH|RtM via: Gram-Negative Bacteria|AB|MM;RC
9339895|Hemolymph|C0019051|66719|MH|RtM via: Hemolymph|AB|MM;RC
9339895|*Butterflies|C0006496|57564|MH|RtM via: Pieris brassicae;RtM via: Artogeia rapae|TI;AB|MM;RC
9339895|Molecular Sequence Data|C0026382|54855|MH|||RC
9339895|Gram-Positive Bacteria|C0018154|54706|MH|RtM via: Gram-Positive Bacteria|AB|MM;RC
9339895|Microbial Sensitivity Tests|C0025948|47918|MH|||RC
9339895|Larvae|C0023047|26010|ET|Entry Term Replacement for "Larva";RtM via: Larva|AB|MM;RC
9339895|Bombyx|C0037119|20435|MH|||RC
9339895|Molecular Weight|C0026385|12906|MH|RtM via: Molecular Mass|AB|MM;RC
9339895|Sequence Homology, Amino Acid|C0162777|10521|MH|||RC
9339895|Mass Spectrometry|C0037813|7469|MH|RtM via: Spectrometers, Mass|AB|MM;RC
9339895|Muramidase|C0026794|7433|MH|RtM via: Muramidase|AB|MM;RC
9339895|Peptide Fragments|C0030935|6794|MH|||RC
9339895|Escherichia coli|C0014834|6218|MH|||RC
9339895|Moths|C0026593|5325|MH|||RC
9339895|Chromatography, High Pressure Liquid|C0008562|5051|MH|||RC
9339895|Cloning, Molecular|C0009017|3780|MH|||RC
9339895|Drosophila Proteins|C0949989|2947|MH|||RC
9339895|Cell Membrane Permeability|C0007605|2447|MH|||RC
9339895|Protein Conformation|C0033625|2207|MH|||RC
9339895|Sequence Alignment|C0080143|1896|MH|||RC
9339895|Electrophoresis, Polyacrylamide Gel|C0013862|1448|MH|||RC
9339895|Phylogeny|C0031797|919|MH|||RC
9339895|Swine|C0039005|890|MH|||RC
9339895|Amino Acids|C0002520|407|MH|RtM via: Amino Acids|AB|MM
9339895|Reverse Transcriptase Polymerase Chain Reaction|C0599161|288|MH|||RC
9339895|Hydrophobicity|C0598629|237|MH|RtM via: Hydrophobicity|AB|MM
------
9339895|Animals|C0003062|1000|CT|Hemolymph;Butterflies;Larvae;Bombyx;Moths;Swine|TI;AB|MM;RC
9339895|injuries|C1510467|5|SH|Wounds and Injuries|AB|MM
9339895|genetics|C0017399|1111|SH|G05.810.200 (Sequence Homology, Amino Acid)||MM
9307842|*DNA Adducts|C0242958|851715|MH|RtM via: DNA Adducts|TI;AB|MM;RC
9307842|O(6)-Methylguanine-DNA Methyltransferase|C0069197|193371|MH|RtM via: O(6)-Methylguanine-DNA Methyltransferase|AB|MM;RC
9307842|Nitrosodimethylamine|C0012431|144188|ET|Entry Term Replacement for "Dimethylnitrosamine";RtM via: Dimethylnitrosamine;Forced Lookup:n-nitrosodimethylamine|AB|MM;RC
9307842|Nitrosamines|C0028197|134238|MH|RtM via: Nitrosamines|AB|MM;RC
9307842|DNA Damage|C0012860|125027|MH|RtM via: adduct;RtM via: genotoxicity|AB|MM;RC
9307842|Carcinogens|C0007090|94956|MH|RtM via: Carcinogens|AB|MM;RC
9307842|DNA|C0012854|75069|MH|RtM via: DNA|AB|MM;RC
9307842|DNA Repair|C0012899|67234|MH|||RC
9307842|*Antineoplastic Agents|C0003392|52674|MH|RtM via: Agent;RtM via: Protocol Agent;RtM via: Cytotoxic agent|TI;AB|MM;RC
9307842|Procarbazine|C0033223|50799|MH|RtM via: Procarbazine|AB|MM;RC
9307842|Methyltransferases|C0025831|17440|MH|||RC
9307842|Dacarbazine|C0010927|16639|MH|RtM via: Dacarbazine|AB|MM;RC
9307842|Liver Neoplasms, Experimental|C0023904|7268|MH|||RC
9307842|Fetal Tissues|C0242291|6011|ET|Entry Term Replacement for "Fetus";RtM via: Fetal Tissue|AB|MM;RC
------
9307842|Animals|C0003062|1000|CT|Liver Neoplasms, Experimental||RC
9307842|Humans|C0086418|1000|CT|CT Text Lookup: human|CT Text Lookup: human|MM
9307842|injuries|C1510467|2331|SH|Wounds and Injuries|TI;AB|MM
9307842|genetics|C0017399|1111|SH|G05.355.180.104 (DNA Adducts)|TI;AB|MM
9385099|Confidence Intervals|C0009667|180470|MH|RtM via: Confidence Intervals|AB|MM;RC
9385099|Life Table Methods|C0023681|32248|ET|Entry Term Replacement for "Life Tables";RtM via: Life Table Methods|AB|MM;RC
9385099|Models, Statistical|C0026348|31394|MH|||RC
9385099|Biometry|C0005544|27262|MH|||RC
9385099|Cluster Analysis|C0009085|16146|MH|RtM via: Cluster|AB|MM;RC
9385099|Randomized Controlled Trials as Topic|C0282440|6415|MH|||RC
9385099|Computer Simulation|C0009609|3821|MH|||RC
9385099|Research Design|C0035171|3112|MH|||RC
9385099|Software|C0037585|1389|MH|||RC
9385099|Treatment Outcome|C0085415|1141|MH|||RC
9385099|Alveolar Bone Loss|C0002382|816|MH|||RC
9385099|Dental Implants|C0011373|441|MH|||RC
9385099|Antimetabolites, Antineoplastic|C0003377|371|MH|||RC
9385099|Diet Surveys|C0012158|295|MH|||RC
9385099|Health Care Costs|C0085552|270|MH|||RC
9385099|Observation|C0302523|264|MH|RtM via: Observation in research;RtM via: Examination and observation for unspecified reason|AB|MM
9385099|Breast Neoplasms|C1458155|216|MH|||RC
------
9385099|Humans|C0086418|1000|CT|Breast Neoplasms||RC
9385099|mortality|C0026566|630|SH1|RtM via: survival aspects;mortality (C0026566)|TI;AB|MM
9385099|methods|C0025664|57|SH|Methods|AB|MM
9385099|economics|C0013557|1111|SH|N03.219.151.400 (Health Care Costs)||MM
9350074|*Minimal Residual Disease|C0242596|793626|ET|Entry Term Replacement for "Neoplasm, Residual";RtM via: Neoplasm, Residual|TI;AB|MM;RC
9350074|Heavy Chain, Immunoglobulin|C0021034|307449|ET|Entry Term Replacement for "Immunoglobulin Heavy Chains";RtM via: Immunoglobulin Heavy Chains|AB|MM;RC
9350074|*Precursor Cell Lymphoblastic Leukemia-Lymphoma|C1961102|307131|MH|RtM via: In complete remission|TI|MM;RC
9350074|*PCR|C0032520|157932|ET|Entry Term Replacement for "Polymerase Chain Reaction";RtM via: Polymerase Chain Reaction;RtM via: In complete remission|TI|MM;RC
9350074|Gene Rearrangement|C0017287|118306|MH|||RC
9350074|Blotting, Southern|C0005862|110883|MH|RtM via: Southern blot assay (procedure)|AB|MM;RC
9350074|Molecular Sequence Data|C0026382|62759|MH|||RC
9350074|Base Sequence|C0004793|56195|MH|RtM via: Base Sequence;RtM via: DNA Sequence|AB|MM;RC
9350074|Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor|C0017293|49671|MH|||RC
9350074|Immunoglobulin Variable Region|C0877857|48450|MH|||RC
9350074|*Remission Induction|C0035052|37893|MH|RtM via: In complete remission|TI|MM;RC
9350074|*Lymphoproliferative Disorders|C0024314|21840|MH|RtM via: Lymphoproliferative Disorders|TI|MM
9350074|Clone|C0009013|21022|ET|Entry Term Replacement for "Clone Cells";RtM via: Clone Cells|AB|MM;RC
9350074|DNA|C0012854|10943|MH|RtM via: DNA|AB|MM;RC
9350074|Receptors, Antigen, T-Cell, gamma-delta|C0085246|10467|MH|||RC
9350074|Gene Amplification|C0017256|5699|MH|||RC
9350074|Transplantation Conditioning|C0376450|4821|MH|||RC
9350074|Fluorescent Dyes|C0016320|4797|MH|||RC
9350074|Hematopoietic Stem Cell Transplantation|C0472699|4545|MH|||RC
9350074|Nucleic Acid Conformation|C0028599|3833|MH|||RC
9350074|Neoplasm Recurrence, Local|C0027643|2187|MH|||RC
9350074|Transplantation, Homologous|C0040739|2108|MH|||RC
9350074|Basic Helix-Loop-Helix Transcription Factors|C0288972|1634|MH|||RC
9350074|Prognosis|C0033325|621|MH|||RC
9350074|Time Factors|C0040225|561|MH|||RC
9350074|Leukemia|C0023418|433|MH|RtM via: leukemia|AB|MM
9350074|Aging|C0001811|267|MH|||RC
------
9350074|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9350074|surgery|C0038895|1111|SH1|RtM via: Application procedure;Surgical Procedures, Operative (C0543467);RtM via: Extraction;Surgical Procedures, Operative (C0543467)|AB|MM
9350074|organization & administration|C0029236|9|SH|Organization and Administration|TI;AB|MM
9350074|genetics|C0017399|1111|SH|G05.355.330 (Gene Rearrangement)||MM
9350074|transplantation|C0029216|1111|SH|E04.936.225.687.500 (Hematopoietic Stem Cell Transplantation)||MM
9342465|*Amniotic Fluid Index|C0552315|993261|ET|Entry Term Replacement for "Amniotic Fluid";RtM via: Amniotic Fluid Index|TI;AB|MM;RC
9342465|Oligohydramnios|C0079924|545449|MH|RtM via: Oligohydramnios|AB|MM;RC
9342465|*Amniocentesis|C0002627|356124|MH|RtM via: Amniocentesis|TI;AB|MM;RC
9342465|Hydramnios|C0020224|202929|ET|Entry Term Replacement for "Polyhydramnios";RtM via: Polyhydramnios|AB|MM;RC
9342465|Amnion|C0002630|50754|MH|RtM via: Structure of amnion|AB|MM;RC
9342465|Fetal Membranes, Premature Rupture|C0015944|48897|MH|||RC
9342465|*Delivery, Obstetric|C0011209|40503|MH|RtM via: Amnioinfusion|TI;AB|MM;RC
9342465|Gestational Age|C0017504|15265|MH|||RC
9342465|Ultrasonography, Prenatal|C0080265|7855|MH|||RC
9342465|Fluid Therapy|C0016286|5784|MH|RtM via: Fluid Therapy|AB|MM;RC
9342465|Heart Rate, Fetal|C0018811|4185|MH|||RC
9342465|Cardiotocography|C0007208|3290|MH|||RC
9342465|Infusions, Intravenous|C0021440|1383|MH|||RC
9342465|Regression Analysis|C0034980|1379|MH|RtM via: Regression Analysis|AB|MM;RC
9342465|Treatment Outcome|C0085415|821|MH|||RC
9342465|Blood Flow Velocity|C0005798|687|MH|||RC
9342465|Pressure|C0033095|563|MH|||RC
9342465|Transducers|C0040661|510|MH|||RC
9342465|Time Factors|C0040225|284|MH|||RC
------
9342465|Pregnancy|C0032961|1000|CT|Oligohydramnios;Amniocentesis;Hydramnios;Fetal Membranes, Premature Rupture;Delivery, Obstetric;Ultrasonography, Prenatal;Cardiotocography;CT Text Lookup: oligohydramnios;CT Text Lookup: pregnancy|TI;AB;CT Text Lookup: oligohydramnios;CT Text Lookup: pregnancy|MM;RC
9342465|Female|C0015780|1000|CT|Oligohydramnios;Amniocentesis;Hydramnios;Fetal Membranes, Premature Rupture;Delivery, Obstetric;Ultrasonography, Prenatal;Cardiotocography;CT Text Lookup: oligohydramnios;CT Text Lookup: pregnancy;CT Text Lookup: women|TI;AB;CT Text Lookup: oligohydramnios;CT Text Lookup: pregnancy;CT Text Lookup: women|MM;RC
9342465|Humans|C0086418|1000|CT|Amniocentesis;Ultrasonography, Prenatal;Cardiotocography;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: women|TI;AB;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: women|MM;RC
9342465|ultrasonography|C0175676|1111|SH1|RtM via: Ultrasonography;RtM via: use of ultrasonography|AB|MM
9342465|surgery|C0038895|1111|SH1|RtM via: Surgical aspects;surgery (C0038895);RtM via: Extraction;Surgical Procedures, Operative (C0543467)|AB|MM
9304708|*Hematologic Neoplasms|C0376545|126156|MH|RtM via: Hematologic Neoplasms|TI;AB|MM;RC
9304708|Genetic Vectors|C0017397|41244|MH|RtM via: Cloning Vectors|AB|MM;RC
9304708|Gene Transfer Techniques|C0886519|35108|MH|||RC
9304708|Gene Therapy|C0017296|26015|MH|||RC
9304708|Cell, Hematopoietic Stem|C0018956|17194|ET|Entry Term Replacement for "Hematopoietic Stem Cells";RtM via: Hematopoietic stem cells|AB|MM;RC
9304708|Cancer|C0006826|6512|ET|Entry Term Replacement for "Neoplasms";RtM via: Malignant Neoplasms;RtM via: Neoplasm;RtM via: Primary malignant neoplasm|AB|MM;RC
9304708|Hematopoietic Stem Cell Transplantation|C0472699|6234|MH|||RC
9304708|Cancer Vaccines|C0376659|4777|MH|||RC
9304708|Transplantation Conditioning|C0376450|3304|MH|||RC
9304708|Prodrugs|C0033262|3200|MH|RtM via: Prodrugs|AB|MM;RC
9304708|*Clinical Protocols|C0008971|2046|MH|RtM via: Application dose|TI;AB|MM
9304708|Genetic Engineering|C0017387|1619|MH|||RC
9304708|Combined Modality Therapy|C0009429|1424|MH|||RC
9304708|Drug Resistance, Neoplasm|C0282588|1236|MH|||RC
------
9304708|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9304708|administration & dosage|C0001555|369|SH1|RtM via: Application dose;administration & dosage (C0001555)|TI;AB|MM
9304708|genetics|C0017399|1111|SH|G05.360.337 (Genetic Vectors)|AB|MM
9304708|transplantation|C0029216|1111|SH|E04.936.225.687.500 (Hematopoietic Stem Cell Transplantation)||MM
9365353|*Torque|C0376590|1349196|MH|RtM via: Torque|TI;AB|MM;RC
9365353|*Knee Joint|C0022745|1247904|MH|RtM via: Knee joint|TI;AB|MM;RC
9365353|*Ankle Joints|C0003087|1109730|ET|Entry Term Replacement for "Ankle Joint";RtM via: Ankle joint structure;RtM via: Entire ankle region|TI;AB|MM;RC
9365353|*Knee|C0022742|637623|MH|RtM via: Knee;RtM via: Entire knee region|TI;AB|MM;RC
9365353|Range of Motion, Articular|C0080078|133670|MH|||RC
9365353|Muscle Contraction|C0026820|100390|MH|||RC
9365353|Hip Joint|C0019558|99593|MH|||RC
9365353|Muscle, Skeletal|C0242692|48084|MH|||RC
9365353|Muscle Fatigue|C0242979|38607|MH|||RC
9365353|Joint Instability|C0022410|30558|MH|||RC
9365353|Muscle Strength|C0517349|26174|MH|||RC
9365353|Knee Injuries|C0022744|22990|MH|||RC
9365353|Exercise|C0015259|20956|MH|||RC
9365353|Leg|C1140621|19782|MH|||RC
9365353|Biomechanics|C0005537|17647|MH|||RC
9365353|Osteoarthritis, Knee|C0409959|15757|MH|||RC
9365353|Flexor Dental Liner|C0175090|14494|NM|RtM via: Flexor;SuppChem Update Replacement for "Flexor"|TI;AB|MM
9365353|*Dimethylpolysiloxanes|C0012436|14493|HM|RtM via: Flexor|TI;AB|MM
9365353|Exercise Therapy|C0452240|13378|MH|||RC
9365353|Movement|C0026649|12242|MH|||RC
9365353|Weight-Bearing|C1318107|11869|MH|||RC
9365353|Posture|C1262869|11396|MH|||RC
9365353|Ankle Injuries|C0085111|10860|MH|||RC
9365353|Exercise Test|C0015260|10040|MH|||RC
9365353|Exercise Tolerance|C0162521|7711|MH|||RC
9365353|Orthopedic Procedures|C0524852|5149|MH|||RC
9365353|Kinetics|C0022702|4635|MH|||RC
9365353|Psychomotor Performance|C0033923|3951|MH|||RC
9365353|Statistics as Topic|C1956348|3759|MH|RtM via: Correlation Study|AB|MM;RC
9365353|Activities of Daily Living|C0001288|3060|MH|||RC
9365353|Reconstructive Surgical Procedures|C0524865|2733|MH|||RC
9365353|*Population Groups|C1257890|2607|MH|RtM via: Population Group;RtM via: User Group|TI;AB|MM
9365353|Aging|C0001811|2190|MH|||RC
9365353|Treatment Outcome|C0085415|1350|MH|||RC
9365353|Pain Measurement|C0030198|1100|MH|||RC
9365353|Reference Values|C0034926|780|MH|||RC
9365353|Time Factors|C0040225|581|MH|||RC
------
9365353|*Polymethacrylic Acids|C0032522|14355|HM|RtM via: Flexor|TI;AB|MM
9365353|Humans|C0086418|1000|CT|Exercise Therapy;Activities of Daily Living;Population Groups|TI;AB|MM;RC
9365353|Female|C0015780|1000|CT|CT Text Lookup: female|CT Text Lookup: female|MM
9365353|Male|C0024554|1000|CT|CT Text Lookup: male|CT Text Lookup: male|MM
9365353|rehabilitation|C0034992|1111|SH1|RtM via: Rehabilitation therapy;RtM via: Rehabilitation aspects;rehabilitation (C0034992);RtM via: Rehabilitation - specialty|AB|MM
9365353|methods|C0025664|19|SH|Methods|AB|MM
9365353|surgery|C0038895|1111|SH|E04.555 (Orthopedic Procedures)||MM
9327207|*Renal Failure, Acute|C0022660|519357|ET|Entry Term Replacement for "Kidney Failure, Acute";RtM via: Kidney Failure, Acute|TI|MM;RC
9327207|*Atrial Natriuretic Factor|C0027481|432846|MH|RtM via: Atrial Natriuretic Factor|TI;AB|MM;RC
9327207|Kidney Tubular Necrosis, Acute|C0022672|105162|MH|RtM via: Kidney Tubular Necrosis, Acute|AB|MM;RC
9327207|Natriuresis|C0027477|36964|MH|RtM via: Natriuresis|AB|MM;RC
9327207|Kidney Function Tests|C0022662|31137|MH|RtM via: Kidney Function Tests;RtM via: Creatinine clearance|AB|MM;RC
9327207|Renal Dialysis|C0917873|28410|MH|RtM via: dialysis device|AB|MM;RC
9327207|Glomerular Filtration Rate|C0017654|23076|MH|RtM via: Glomerular Filtration Rate|AB|MM;RC
9327207|Creatinine|C0010294|21274|MH|RtM via: Creatinine clearance|AB|MM;RC
9327207|Peptide Fragments|C0030935|16409|MH|||RC
9327207|Ischemia|C0022116|10361|MH|RtM via: Ischemic|AB|MM;RC
9327207|Blood Pressure|C0005823|6343|MH|||RC
9327207|Treatment Outcome|C0085415|4423|MH|||RC
9327207|Postoperative Complications|C0032787|4350|MH|||RC
9327207|Metabolic Clearance Rate|C0025515|4021|MH|||RC
------
9327207|Humans|C0086418|1000|CT|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|MM
9327207|diagnosis|C1704338|1035|SH1|RtM via: Falls;Diagnosis (C0011900)|TI|MM
9327207|injuries|C1510467|894|SH|Injury|TI;AB|MM
9324068|*Naltrexone|C0027360|321714|MH|RtM via: Naltrexone|TI;AB|MM;RC
9324068|Narcotic Antagonists|C0027410|70695|MH|RtM via: Narcotic Antagonists|AB|MM;RC
9324068|Fetus|C0015965|43383|MH|RtM via: Fetus;RtM via: Entire fetus;RtM via: Fetal Tissue|AB|MM;RC
9324068|Maternal-Fetal Exchange|C0024929|40907|MH|||RC
9324068|Placenta|C0032043|37015|MH|RtM via: Placenta;RtM via: Entire placenta;RtM via: Placenta Specimen|AB|MM;RC
9324068|Rats, Sprague-Dawley|C0034715|14868|MH|||RC
9324068|Heart|C0018787|5776|MH|RtM via: Heart;RtM via: Entire heart|AB|MM;RC
9324068|Animals, Newborn|C0003065|5139|MH|||RC
9324068|Gestational Age|C0017504|4000|MH|||RC
9324068|Spectrophotometry, Ultraviolet|C0037808|3776|MH|||RC
9324068|*Drug Administration Routes|C0013153|3147|MH|RtM via: Transplacental Route of Drug Administration;RtM via: Enteral Route of Drug Administration|TI;AB|MM
9324068|Tissue Distribution|C0040287|2948|MH|||RC
9324068|Liver|C0023884|2821|MH|RtM via: Liver;RtM via: Entire liver;RtM via: Liver Flavor|AB|MM;RC
9324068|Pregnancy, Animal|C0032986|2720|MH|||RC
9324068|Brain|C0006104|2429|MH|RtM via: Brain;RtM via: Entire brain|AB|MM;RC
9324068|Chromatography, High Performance Liquid|C0008562|2363|ET|Entry Term Replacement for "Chromatography, High Pressure Liquid";RtM via: High pressure liquid chromatography procedure;RtM via: Chromatography Systems, Liquid, Packed Column, High-Pressure;RtM via: Observation Method - High performance liquid chromatography|AB|MM;RC
9324068|Myocardium|C0027061|2301|MH|||RC
9324068|Maternal Exposure|C0243033|2235|MH|||RC
9324068|Organ Size|C1450569|1726|MH|||RC
9324068|Insecticides|C0021576|1664|MH|||RC
9324068|Prenatal Exposure Delayed Effects|C0033054|1292|MH|||RC
9324068|Endocrine Disruptors|C1568245|958|MH|||RC
9324068|Lactation|C0022925|573|MH|||RC
9324068|Aging|C0001811|515|MH|||RC
9324068|Species Specificity|C0037783|403|MH|||RC
9324068|Area Under Curve|C0376690|393|MH|||RC
9324068|Kinetics|C0022702|365|MH|||RC
9324068|Time Factors|C0040225|325|MH|||RC
9324068|Injections, Intravenous|C0021494|236|MH|||RC
------
9324068|Rats|C0034721|75447|CT||TI;AB|MM
9324068|Female|C0015780|1000|CT|Maternal-Fetal Exchange;Placenta;Pregnancy, Animal;Maternal Exposure;Prenatal Exposure Delayed Effects;Lactation;CT Text Lookup: placenta;CT Text Lookup: pregnant|AB;CT Text Lookup: placenta;CT Text Lookup: pregnant|MM;RC
9324068|Pregnancy|C0032961|1000|CT|Maternal-Fetal Exchange;Placenta;Pregnancy, Animal;Prenatal Exposure Delayed Effects;CT Text Lookup: placenta;CT Text Lookup: pregnant|AB;CT Text Lookup: placenta;CT Text Lookup: pregnant|MM;RC
9324068|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;Animals, Newborn;Pregnancy, Animal;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9324068|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9324068|Humans|C0086418|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9324068|methods|C0025664|903|SH|Methods|TI;AB|MM
9322764|adhesin, Staphylococcus aureus|C0164452|1489105|NM|RtM via: adhesin, Staphylococcus aureus|TI|MM
9322764|*Adhesins, Bacterial|C0243040|1489104|MH|RtM via: adhesin, Staphylococcus aureus;RtM via: Adhesins, Bacterial|TI;AB|MM;RC
9322764|Staphylococcus aureus|C0038172|515572|MH|RtM via: Staphylococcus aureus|AB|MM;RC
9322764|Staphylococcal Infections|C0038160|421896|MH|RtM via: Staphylococcus aureus infection|AB|MM;RC
9322764|Methicillin Resistance|C0079830|118179|MH|||RC
9322764|Genes, Bacterial|C0017339|73116|MH|||RC
9322764|Electrophoresis, Gel, Pulsed-Field|C0085117|69754|MH|RtM via: Electrophoresis, Gel, Pulsed-Field;Forced Lookup:pulsed-field gel electrophoresis|AB|MM
9322764|Bacterial Proteins|C0004627|64892|MH|||RC
9322764|Bacterial Adhesion|C0004614|42798|MH|||RC
9322764|*Genes|C0017337|40464|MH|RtM via: Genes|TI;AB|MM
9322764|Methicillin-Resistant Staphylococcus aureus|C1265292|35658|MH|||RC
9322764|*Chromosomes|C0008633|29772|MH|RtM via: Chromosomes|TI;AB|MM
9322764|Virulence Factors|C1136170|29411|MH|||RC
9322764|Genome, Bacterial|C0085238|22756|MH|||RC
9322764|*Prevalence|C0033105|22677|MH|RtM via: Statistical Prevalence|TI;AB|MM
9322764|DNA, Bacterial|C0012924|22379|MH|||RC
9322764|Carrier State|C0560175|19338|MH|||RC
9322764|Bacterial Typing Techniques|C0004631|16437|MH|||RC
9322764|Hemolysin Proteins|C0019053|16267|MH|||RC
9322764|Gene Expression Regulation, Bacterial|C0017264|14054|MH|||RC
9322764|Molecular Sequence Data|C0026382|13818|MH|||RC
9322764|DNA Fingerprinting|C0079247|13324|MH|||RC
9322764|Blotting, Southern|C0005862|13179|MH|RtM via: Southern blot assay (procedure)|AB|MM;RC
9322764|Cross Infection|C0010356|11833|MH|||RC
9322764|Drug Resistance, Multiple, Bacterial|C0949671|8623|MH|||RC
9322764|Prosthesis-Related Infections|C0085073|7568|MH|||RC
9322764|Molecular Epidemiology|C0206173|7098|MH|||RC
9322764|Surgical Wound Infection|C0038941|5246|MH|||RC
9322764|Repetitive Sequences, Amino Acid|C0600626|3130|MH|||RC
9322764|Electrophoresis, Polyacrylamide Gel|C0013862|2780|MH|||RC
9322764|Sequence Analysis, DNA|C0162802|2529|MH|||RC
9322764|Species Specificity|C0037783|2395|MH|||RC
9322764|Genotype|C0017431|2006|MH|||RC
9322764|Recombinant Fusion Proteins|C0034857|1851|MH|||RC
9322764|Evolution, Molecular|C0282688|1718|MH|||RC
9322764|Chickens|C0008051|1224|MH|||RC
9322764|Phenotype|C0031437|1107|MH|||RC
------
9322764|Animals|C0003062|1000|CT|Chickens||RC
9322764|epidemiology|C0014508|2088|SH1|RtM via: Prevalence aspects;epidemiology (C0014508)|TI;AB|MM
9322764|immunology|C1522005|1111|SH|D23.050.161.050 (Adhesins, Bacterial)|TI;AB|MM
9322764|genetics|C0017399|1111|SH|G05.360.340.024.340.210 (Genes, Bacterial)||MM
9237552|*Alzheimer's Disease|C0002395|628896|ET|Entry Term Replacement for "Alzheimer Disease";RtM via: Alzheimer's Disease|TI;AB|MM;RC
9237552|*Multiple Sclerosis|C0026769|255045|MH|RtM via: Multiple Sclerosis|TI;AB|MM;RC
9237552|*Iron|C0302583|189633|MH|RtM via: Iron|TI;AB|MM;RC
9237552|*Brains|C0006104|155376|ET|Entry Term Replacement for "Brain";RtM via: Brain|TI;AB|MM;RC
9237552|protease nexins|C0072334|92281|NM|RtM via: APP protein, human|AB|MM
9237552|Amyloid beta-Protein Precursor|C0085151|92280|HM|RtM via: APP protein, human|AB|MM;RC
9237552|Amyloid beta-Protein|C0078939|67944|MH|||RC
9237552|Triton X-100|C0146951|36280|ET|Entry Term Replacement for "Octoxynol";RtM via: Triton X-100;Forced Lookup:triton x-100|AB|MM
9237552|Myelin|C0026969|27497|ET|Entry Term Replacement for "Myelin Sheath";RtM via: Myelin;RtM via: Myelin Sheath|AB|MM;RC
9237552|Amyloid|C0002716|15292|MH|RtM via: Amyloid|AB|MM;RC
9237552|Microglia|C0206116|14851|MH|RtM via: Microglia|AB|MM;RC
9237552|Histocytochemistry|C0019635|10770|MH|RtM via: Histocytochemistry|AB|MM;RC
9237552|Staining|C0487602|6610|ET|Entry Term Replacement for "Staining and Labeling";RtM via: Staining method|AB|MM;RC
9237552|Lipofuscin|C0023789|6336|MH|RtM via: Lipofuscin|AB|MM;RC
9237552|Tissue Fixation|C0085254|5110|MH|||RC
9237552|Peptide Fragments|C0030935|4747|MH|||RC
9237552|Mice, Transgenic|C0025936|3057|MH|||RC
9237552|Brain Disease|C0006111|2923|ET|Entry Term Replacement for "Brain Diseases";RtM via: Brain Diseases|AB|MM
9237552|Microscopy, Electron, Transmission|C0678118|1558|MH|||RC
9237552|Microtubule-Associated Proteins|C0026045|1552|MH|||RC
9237552|RNA, Messenger|C0035696|1181|MH|||RC
9237552|Chemotaxis, Leukocyte|C0008019|1013|MH|||RC
9237552|Reference Values|C0034926|879|MH|||RC
9237552|Ubiquitin-Protein Ligases|C0077678|627|MH|||RC
9237552|Oligodendrocytes|C0028944|410|ET|Entry Term Replacement for "Oligodendroglia";RtM via: Oligodendroglia|AB|MM
9237552|Mitochondria|C0026237|266|MH|RtM via: Mitochondria|AB|MM
9237552|Proteinase K|C0059256|235|ET|Entry Term Replacement for "Endopeptidase K";RtM via: Endopeptidase K|AB|MM
9237552|Neurons|C0027882|215|MH|RtM via: Neurons|AB|MM
9237552|Cell Line, Tumor|C0085983|211|MH|||RC
------
9237552|Receptors, Cell Surface|C0034800|-1|HM|RtM via: APP protein, human|AB|MM
9237552|Animals|C0003062|1000|CT|Mice, Transgenic||RC
9237552|Mice|C0026809|1000|CT|Mice, Transgenic||RC
9344613|*Prostaglandin H Synthase|C0033551|3207258|ET|Entry Term Replacement for "Prostaglandin-Endoperoxide Synthases";RtM via: Prostaglandin-Endoperoxide Synthase|TI;AB|MM;RC
9344613|PTGS2 protein, human|C1565860|1059527|NM|RtM via: prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human|AB|MM
9344613|Prostaglandin H Synthase-2|C0387583|1059526|ET|Entry Term Replacement for "Cyclooxygenase 2";RtM via: cyclooxygenase 2;RtM via: prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human;Forced Lookup:prostaglandin h synthase-2|AB|MM;RC
9344613|N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide|C0950855|949399|NM|RtM via: NS398|AB|MM
9344613|Nitrobenzenes|C0028145|949398|HM|RtM via: NS398|AB|MM;RC
9344613|Sulfonamides|C0038760|376500|HM|RtM via: NS398|AB|MM;RC
9344613|Prostaglandin H Synthase-1|C0389003|327809|ET|Entry Term Replacement for "Cyclooxygenase 1";RtM via: cyclooxygenase 1;Forced Lookup:prostaglandin h synthase-1|AB|MM;RC
9344613|*Adenocarcinoma|C0001418|162141|MH|RtM via: Adenocarcinoma|TI;AB|MM;RC
9344613|PGE2|C0012472|135985|ET|Entry Term Replacement for "Dinoprostone";RtM via: Dinoprostone|AB|MM;RC
9344613|*Colorectal Neoplasms|C0009404|82782|MH|RtM via: Adenocarcinoma of large intestine|TI;AB|MM;RC
9344613|Gene Expression Regulation, Enzymologic|C0017265|57857|MH|||RC
9344613|mRNA|C0035696|48305|ET|Entry Term Replacement for "RNA, Messenger";RtM via: RNA, Messenger|AB|MM;RC
9344613|Gene Expression Regulation, Neoplastic|C0017268|40031|MH|||RC
9344613|Aspirin|C0004057|37103|MH|RtM via: Aspirin|AB|MM;RC
9344613|Reverse Transcriptase Polymerase Chain Reaction|C0599161|26827|MH|||RC
9344613|Membrane Proteins|C0025252|21066|MH|||RC
9344613|Colonic Neoplasms|C0009375|19954|MH|RtM via: Adenocarcinoma of colon|AB|MM;RC
9344613|Cell Line, Tumor|C0085983|19402|MH|||RC
9344613|Receptors, Prostaglandin E|C0072301|19360|MH|||RC
9344613|6-Ketoprostaglandin F1 alpha|C0000617|14641|MH|||RC
9344613|Cell Proliferation|C0596290|13531|MH|||RC
9344613|1-Phosphatidylinositol 3-Kinase|C0044602|13042|MH|||RC
9344613|Intramolecular Oxidoreductases|C0524934|12316|MH|||RC
9344613|Apoptosis|C0162638|11874|MH|||RC
9344613|*Cell Lines|C0007600|11259|ET|Entry Term Replacement for "Cell Line";RtM via: Human Cell Line;RtM via: Cell Line|TI;AB|MM
9344613|Brain Neoplasms|C0006118|9164|MH|||RC
9344613|NF-kappa B|C0079904|8867|MH|||RC
9344613|Carcinoma, Papillary|C0007133|8352|MH|||RC
9344613|Tumor Suppressor Proteins|C0597611|7617|MH|||RC
9344613|Caco-2 Cells|C0282560|6252|MH|||RC
9344613|Signal Transduction|C0037083|5834|MH|||RC
9344613|Antimetabolites, Antineoplastic|C0003377|5647|MH|||RC
9344613|Cell Movement|C1621968|5416|MH|||RC
9344613|Protein Synthesis Inhibitors|C0033671|5389|MH|||RC
9344613|Cell Differentiation|C0007589|5387|MH|||RC
9344613|Extracellular Matrix|C0015350|5209|MH|RtM via: Extracellular Matrix|AB|MM;RC
9344613|Thyroid Neoplasms|C0040136|5029|MH|||RC
9344613|Matrix Metalloproteinase 2|C0172537|4990|MH|||RC
9344613|Cells, Cultured|C0007635|4783|MH|||RC
9344613|MAP Kinase Signaling System|C0752321|4727|MH|||RC
9344613|Mutation|C0026882|3820|MH|||RC
9344613|Transfection|C0040669|3667|MH|||RC
9344613|Flow Cytometry|C0016263|3227|MH|||RC
9344613|Platelet Aggregation Inhibitors|C0032177|3182|MH|||RC
9344613|Neurons|C0027882|3174|MH|||RC
9344613|Mice, SCID|C0085112|2437|MH|||RC
9344613|Dose-Response Relationship, Drug|C0013059|2108|MH|||RC
9344613|Brain|C0006104|1999|MH|||RC
9344613|Antibodies, Monoclonal|C0003250|1721|MH|||RC
9344613|Cell Cycle|C0007586|845|MH|RtM via: Cell Cycle;RtM via: Mitotic Cell Cycle|AB|MM
------
9344613|Humans|C0086418|1000|CT|Caco-2 Cells;CT Text Lookup: human;CT Text Lookup: man|CT Text Lookup: human;CT Text Lookup: man|MM;RC
9344613|Animals|C0003062|1000|CT|Mice, SCID||RC
9344613|Mice|C0026809|1000|CT|Mice, SCID||RC
9344613|Male|C0024554|1000|CT|CT Text Lookup: man|CT Text Lookup: man|MM
9344613|surgery|C0038895|2844|SH1|RtM via: Expression procedure;Surgical Procedures, Operative (C0543467)|TI;AB|MM
9344613|enzymology|C0014445|13443|SH|Enzymes||RC
9344613|genetics|C0017399|1111|SH|G05.355.315.320 (Gene Expression Regulation, Enzymologic)||MM
9345238|*PTFE|C0032611|1665321|ET|Entry Term Replacement for "Polytetrafluoroethylene";RtM via: Polytetrafluoroethylene|TI;AB|MM;RC
9345238|*Ischemia|C0022116|887781|MH|RtM via: Ischemia|TI;AB|MM;RC
9345238|*Vein|C0042449|714948|ET|Entry Term Replacement for "Veins";RtM via: Veins;RtM via: Entire vein|TI;AB|MM;RC
9345238|Popliteal Artery|C0032649|333189|MH|||RC
9345238|Femoral Artery|C0015801|193785|MH|||RC
9345238|Blood Vessel Prosthesis|C0005846|184509|MH|||RC
9345238|Leg|C1140621|183371|MH|||RC
9345238|Blood Vessel Prosthesis Implantation|C0525022|137555|MH|||RC
9345238|Vascular Patency|C0042377|98702|MH|||RC
9345238|Graft Occlusion, Vascular|C0018128|64771|MH|||RC
9345238|Arteriovenous Shunt, Surgical|C0684204|45103|MH|||RC
9345238|Anastomosis, Surgical|C0002805|29260|MH|||RC
9345238|Prosthesis Design|C0033585|14319|MH|||RC
9345238|Prosthesis Failure|C0033586|13397|MH|||RC
9345238|Postoperative Complications|C0032787|8126|MH|||RC
9345238|Brachial Artery|C0006087|8093|MH|||RC
9345238|*Raynaud Disease|C0034734|4164|MH|RtM via: Critical limb ischemia|TI;AB|MM
9345238|Treatment Outcome|C0085415|3567|MH|||RC
9345238|Transplantation, Autologous|C0040736|2294|MH|||RC
9345238|Anticoagulants|C0003280|2106|MH|||RC
9345238|Risk Factors|C0035648|1160|MH|RtM via: risk factors|AB|MM;RC
9345238|Time Factors|C0040225|976|MH|||RC
9345238|Patient Selection|C0242802|814|MH|||RC
9345238|Graft Survival|C0018131|720|MH|||RC
9345238|Blood Pressure|C0005823|613|MH|||RC
------
9345238|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9345238|transplantation|C0029216|1111|SH1|RtM via: grafting qualifier;transplantation (C0040733)|AB|MM
9345238|surgery|C0038895|1111|SH|E04.100.814.200 (Blood Vessel Prosthesis Implantation)||MM
9336588|Ketosis|C0022638|521672|MH|RtM via: Ketosis|AB|MM;RC
9336588|*Ketogenic Diet|C0259972|234459|MH|RtM via: Ketogenic Diet|TI;AB|MM
9336588|Ketones|C0022634|61869|MH|RtM via: Ketones;RtM via: Urine ketone test|AB|MM;RC
9336588|Dietary Fats|C0012171|39662|MH|||RC
9336588|Dietary Carbohydrates|C0012170|24122|MH|||RC
9336588|Dietary Proteins|C0012177|7792|MH|||RC
9336588|Eating|C0013470|4765|MH|||RC
9336588|Electroencephalography|C0013819|4327|MH|||RC
9336588|Rats, Wistar|C0034716|2317|MH|||RC
9336588|Rats, Long-Evans|C0324537|2193|MH|||RC
9336588|Breath Tests|C0006153|2075|MH|||RC
9336588|Patient Compliance|C1321605|1916|MH|||RC
9336588|Rats, Sprague-Dawley|C0034715|1890|MH|||RC
9336588|Blood Glucose|C0005802|1623|MH|||RC
9336588|Patient Satisfaction|C0030702|1521|MH|||RC
9336588|Questionnaires|C0034394|1474|MH|||RC
9336588|Spatial Behavior|C0037774|1389|MH|||RC
9336588|Disease Models, Animal|C0012644|1364|MH|||RC
9336588|Maze Learning|C0242996|1360|MH|||RC
9336588|Exploratory Behavior|C0015328|1199|MH|||RC
9336588|Quality of Life|C0034380|1076|MH|||RC
9336588|Treatment Outcome|C0085415|1049|MH|||RC
9336588|Patient Acceptance of Health Care|C0030672|982|MH|||RC
9336588|Age Factors|C0001783|972|MH|||RC
9336588|Behavior, Animal|C0004935|929|MH|||RC
9336588|Time Factors|C0040225|654|MH|||RC
9336588|Dehydration|C0011175|224|MH|RtM via: Dehydration|AB|MM
------
9336588|Animals|C0003062|1000|CT|Rats, Wistar;Rats, Long-Evans;Rats, Sprague-Dawley;Disease Models, Animal;Behavior, Animal||RC
9336588|Rats|C0034721|1000|CT|Rats, Wistar;Rats, Long-Evans;Rats, Sprague-Dawley||RC
9336588|diet therapy|C0012160|4866|SH1|RtM via: High fat diet NOS;Diet Therapy (C0012159)|AB|MM;RC
9336588|therapy|C0039798|253|SH1|RtM via: therapeutic aspects;therapy (C0039798)|AB|MM
9336588|blood supply|C0005839|12|SH|Blood Circulation|AB|MM
9336566|*Dietetics|C0012180|458622|MH|RtM via: Dietetics|TI;AB|MM;RC
9336566|*Curricula|C0010478|340158|ET|Entry Term Replacement for "Curriculum";RtM via: Educational Curriculum|TI|MM;RC
9336566|Competency-Based Education|C0009494|29954|MH|||RC
9336566|*Research|C0035168|24366|MH|RtM via: Research Activities;RtM via: research|TI;AB|MM
9336566|Teaching|C0039401|21349|MH|RtM via: Educational process of instructing;RtM via: educator|AB|MM;RC
9336566|Clinical Competence|C0008956|16200|MH|||RC
9336566|Inservice Training|C0021599|15339|MH|||RC
9336566|Food Service, Hospital|C0016489|14055|MH|||RC
9336566|Educational Measurement|C0013656|13287|MH|||RC
9336566|Health Education|C0018701|9476|MH|||RC
9336566|Educational Status|C0013658|8969|MH|RtM via: Educational Status|AB|MM;RC
9336566|Internship, Nonmedical|C0021796|8151|MH|||RC
9336566|Internship and Residency|C0021794|7030|MH|||RC
9336566|Quality of Health Care|C0034379|6805|MH|||RC
9336566|Questionnaires|C0034394|6192|MH|||RC
9336566|Employee Performance Appraisal|C0014001|5926|MH|||RC
9336566|Nutrition Policy|C0242888|5707|MH|||RC
9336566|Professional Competence|C0033278|5035|MH|||RC
9336566|Allied Health Personnel|C0002122|4474|MH|||RC
9336566|Chronic Diseases|C0008679|4348|ET|Entry Term Replacement for "Chronic Disease";RtM via: Chronic disease|AB|MM;RC
9336566|Universities|C0041740|4289|MH|||RC
9336566|Learning|C0023185|3848|MH|RtM via: Learning|AB|MM;RC
9336566|Patient Care Team|C0030679|3769|MH|||RC
9336566|Health Promotion|C0018738|3637|MH|||RC
9336566|Quality Assurance, Health Care|C0034377|2881|MH|||RC
9336566|Health Behavior|C0018687|2764|MH|||RC
9336566|Patient Satisfaction|C0030702|2403|MH|||RC
9336566|Delivery of Health Care, Integrated|C0282600|2207|MH|||RC
9336566|Congresses as Topic|C1956345|2201|MH|||RC
9336566|Health Policy|C0018735|2165|MH|||RC
9336566|Outcome Assessment (Health Care)|C0085565|1587|MH|||RC
9336566|Social Values|C0037439|1193|MH|||RC
9336566|Exercise|C0015259|1082|MH|||RC
9336566|Dietary Services|C0012179|804|MH|RtM via: Dietary Services|AB|MM
9336566|Health Care Reform|C0206597|379|MH|RtM via: Health Care Reform|AB|MM
9336566|Food Service|C0016490|329|ET|Entry Term Replacement for "Food Services";RtM via: Food Services|AB|MM
------
9336566|Humans|C0086418|1000|CT|Health Education||RC
9336566|education|C0013621|1067|SH1|RtM via: Educational aspects;education (C0013622);RtM via: Knowledge acquisition;Education (C0013621);RtM via: Teaching aspects;education (C0013622)|AB|MM
9323515|*Thyroid|C0040132|882735|ET|Entry Term Replacement for "Thyroid Gland";RtM via: Thyroid Gland|TI;AB|MM;RC
9323515|Graves Disease|C0018213|387879|MH|RtM via: Graves' Disease|AB|MM;RC
9323515|Antithyroid Agents|C0040125|176690|MH|||RC
9323515|Thyroxin|C0040165|114447|ET|Entry Term Replacement for "Thyroxine";RtM via: Thyroxine|AB|MM;RC
9323515|*Recurrence|C0034897|37740|MH|RtM via: Recurrence|TI;AB|MM;RC
9323515|Triiodothyronine|C0041014|27996|MH|RtM via: Tri-iodothyronine measurement|AB|MM;RC
9323515|Iodine Radioisotopes|C0021970|17750|MH|||RC
9323515|Iodide Peroxidase|C0021965|14775|MH|||RC
9323515|*Ophthalmoparesis|C0751401|9978|ET|Entry Term Replacement for "Ophthalmoplegia";RtM via: Ophthalmoparesis|TI;AB|MM
9323515|Treatment Outcome|C0085415|4457|MH|||RC
9323515|Prognosis|C0033325|2459|MH|||RC
9323515|Symporters|C0598849|1964|MH|||RC
9323515|Organ Size|C1450569|1352|MH|||RC
9323515|Tissue Distribution|C0040287|1054|MH|||RC
9323515|Ultrasonography, Doppler, Color|C0242844|1037|MH|||RC
9323515|Radiation Injuries|C0034530|841|MH|||RC
9323515|Drug Administration Schedule|C0013154|597|MH|||RC
9323515|Embolization, Therapeutic|C0013931|582|MH|||RC
9323515|Combined Modality Therapy|C0009429|498|MH|||RC
9323515|Diagnosis, Differential|C0011906|444|MH|||RC
9323515|Risk Factors|C0035648|404|MH|||RC
9323515|Regional Blood Flow|C0034965|384|MH|||RC
9323515|Postoperative Complications|C0032787|320|MH|||RC
9323515|Smoking|C0037369|255|MH|||RC
------
9323515|Humans|C0086418|1000|CT|CT Text Lookup: patient|CT Text Lookup: patient|MM
9323515|drug therapy|C0013217|1149|SH1|RtM via: Endocrine therapy;Drug Therapy (C0013216);RtM via: Replacement therapy;Drug Therapy (C0013216)|TI;AB|MM
9323515|methods|C0025664|6|SH|Methods|AB|MM
9323515|ultrasonography|C0175676|1111|SH|E01.370.350.850.850.850.850 (Ultrasonography, Doppler, Color)||MM
9380370|Color Perception Tests|C0009396|564219|MH|||RC
9380370|Color Vision Defects|C0009398|346644|MH|RtM via: Color Blindness, Red|AB|MM;RC
9380370|*Reproducibility of Results|C0035149|56004|MH|RtM via: Validity (characteristic)|TI;AB|MM;RC
9380370|Color Perception|C0009395|28673|MH|||RC
9380370|Vision Screening|C0042792|25985|MH|RtM via: Vision Screening|AB|MM;RC
9380370|Color|C0009393|10739|MH|RtM via: Color;RtM via: Color quantity;RtM via: color additive|AB|MM
9380370|Color Vision|C0086032|1148|MH|RtM via: Color Vision|AB|MM
9380370|*Eye Diseases|C0015397|1023|MH|RtM via: Color vision examination (procedure)|TI|MM
9380370|Fixation, Ocular|C0016183|979|MH|||RC
9380370|Disability Evaluation|C0012605|675|MH|||RC
9380370|Aerospace Medicine|C0001713|648|MH|||RC
9380370|Reference Values|C0034926|510|MH|||RC
9380370|School Health Services|C0036371|509|MH|||RC
9380370|Diagnostic Errors|C0011922|321|MH|||RC
9380370|*Ear Diseases|C0013447|306|MH|RtM via: Color vision examination (procedure)|TI|MM
9380370|African Americans|C0085756|298|MH|RtM via: African American|AB|MM
9380370|Severity of Illness Index|C0036859|231|MH|||RC
------
9380370|Humans|C0086418|1000|CT|School Health Services;Diagnostic Errors;African Americans;CT Text Lookup: adult;CT Text Lookup: aged;CT Text Lookup: children|AB;CT Text Lookup: adult;CT Text Lookup: aged;CT Text Lookup: children|MM;RC
9380370|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9380370|Child|C0008059|1000|CT|CT Text Lookup: children|CT Text Lookup: children|MM
9380370|diagnosis|C1704338|366|SH1|RtM via: Color vision examination (procedure);diagnosis (C1704338);RtM via: diagnosis aspect;RtM via: Diagnosis;RtM via: Diagnosis Study;RtM via: Diagnosis Study;diagnosis (C1704338)|TI;AB|MM
9380370|therapy|C0039798|279|SH1|RtM via: Color vision examination (procedure);therapy (C0039798)|TI|MM
9380370|utilization|C0042153|245|SH1|RtM via: utilization qualifier|AB|MM
9380370|classification|C0008903|70|SH|Classification|AB|MM
9380370|instrumentation|C0021632|2|SH|Equipment and Supplies|AB|MM
9333208|*Hepatic Encephalopathy|C0019151|690891|MH|RtM via: Hepatic Encephalopathy;RtM via: Encephalopathies|TI;AB|MM;RC
9333208|Thiacetamid|C0039872|307224|ET|Entry Term Replacement for "Thioacetamide";RtM via: Thioacetamide|AB|MM;RC
9333208|Aminotransferase, Aspartate|C0004002|76775|ET|Entry Term Replacement for "Aspartate Aminotransferases";RtM via: Aspartate Transaminase|AB|MM;RC
9333208|Alanine Aminotransferase|C0001899|68405|ET|Entry Term Replacement for "Alanine Transaminase";RtM via: Alanine Transaminase|AB|MM;RC
9333208|Liver|C0023884|61976|MH|RtM via: Hepatic|AB|MM;RC
9333208|Rats, Sprague-Dawley|C0034715|55671|MH|||RC
9333208|NG-Nitroarginine Methyl Ester|C0083536|39858|MH|||RC
9333208|*Animal Model|C0599779|17016|ET|Entry Term Replacement for "Models, Animal";RtM via: Animal Model|TI;AB|MM
9333208|Bilirubin|C0005437|15824|MH|RtM via: Bilirubin;RtM via: Bilirubin, total measurement;RtM via: Bilirubin.total|AB|MM;RC
9333208|*Behavior|C0004927|12009|MH|RtM via: Behavior;RtM via: Performance;RtM via: performance - action|TI;AB|MM
9333208|Disease Models, Animal|C0012644|10411|MH|||RC
9333208|Injections, Intraperitoneal|C0021493|8590|MH|RtM via: Intraperitoneal route|AB|MM;RC
9333208|Rats, Wistar|C0034716|8578|MH|||RC
9333208|Motor Activity|C0026606|6406|MH|||RC
9333208|Nitric Oxide|C0028128|6132|MH|||RC
9333208|*Sex Differences|C0036866|5928|ET|Entry Term Replacement for "Sex Characteristics";RtM via: Sex Characteristics|TI;AB|MM
9333208|Endotoxins|C0014264|3702|MH|||RC
9333208|Free Radical Scavengers|C0079381|3442|MH|||RC
9333208|Brain|C0006104|2909|MH|||RC
9333208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|C0360714|2526|MH|||RC
9333208|Severity of Illness Index|C0036859|1182|MH|||RC
9333208|Drug Administration Schedule|C0013154|971|MH|||RC
9333208|6-Ketoprostaglandin F1 alpha|C0000617|966|MH|||RC
9333208|Treatment Outcome|C0085415|742|MH|||RC
9333208|Narcotic Antagonists|C0027410|738|MH|||RC
9333208|Time Factors|C0040225|608|MH|||RC
9333208|Dose-Response Relationship, Drug|C0013059|544|MH|||RC
9333208|Anti-Bacterial Agents|C0279516|498|MH|||RC
9333208|Alkaline Phosphatase|C0002059|305|MH|RtM via: Alkaline Phosphatase|AB|MM
------
9333208|Rats|C0034721|188487|CT||TI;AB|MM
9333208|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;Animal Model;Disease Models, Animal;Rats, Wistar;CT Text Lookup: rat|TI;AB;CT Text Lookup: rat|MM;RC
9333208|Female|C0015780|1000|CT|CT Text Lookup: female;CT Text Lookup: females|CT Text Lookup: females|MM
9333208|Male|C0024554|1000|CT|CT Text Lookup: male|CT Text Lookup: male|MM
9333208|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9297630|*Corticotropin-Releasing Hormone|C0010132|1346607|MH|RtM via: Corticotropin-Releasing Hormone;Forced Lookup:corticotropin-releasing factor|TI;AB|MM;RC
9297630|*Paraventricular Nucleus|C0030532|1210377|ET|Entry Term Replacement for "Paraventricular Hypothalamic Nucleus";RtM via: Structure of paraventricular nucleus;RtM via: Entire paraventricular nucleus|TI;AB|MM;RC
9297630|*Gene Expression|C0017262|182181|MH|RtM via: Gene Expression|TI|MM;RC
9297630|NR3C1 protein, human|C1370369|134923|NM|RtM via: NR3C1 protein, human|TI;AB|MM
9297630|*Glucocorticoid Receptor|C0034809|134922|ET|Entry Term Replacement for "Receptors, Glucocorticoid";RtM via: Glucocorticoid Receptor;RtM via: NR3C1 protein, human|TI;AB|MM
9297630|Hypothalamus|C0020663|108076|MH|RtM via: Hypothalamic structure|AB|MM;RC
9297630|mRNA|C0035696|85813|ET|Entry Term Replacement for "RNA, Messenger";RtM via: RNA, Messenger|AB|MM;RC
9297630|Brains|C0006104|58357|ET|Entry Term Replacement for "Brain";RtM via: Brain|AB|MM;RC
9297630|Proto-Oncogene Proteins c-fos|C0085301|53845|MH|||RC
9297630|In Situ Hybridization|C0162788|49750|MH|||RC
9297630|Corticotrophin|C0001655|48022|ET|Entry Term Replacement for "Adrenocorticotropic Hormone";RtM via: Corticotropin;RtM via: Recombinant Corticotropin|AB|MM;RC
9297630|Rats, Sprague-Dawley|C0034715|46349|MH|||RC
9297630|*Ribonucleic Acid|C0035668|40755|ET|Entry Term Replacement for "RNA";RtM via: RNA|TI|MM
9297630|*Mice, Transgenic|C0025936|39342|MH|RtM via: Mice, Transgenic|TI;AB|MM
9297630|Neurons|C0027882|36053|MH|RtM via: Neurons;RtM via: Neuronal|AB|MM;RC
9297630|Lipopolysaccharides|C0023810|33972|MH|RtM via: Lipopolysaccharides|AB|MM;RC
9297630|Amygdala|C0002708|25121|MH|RtM via: Amygdaloid structure|AB|MM;RC
9297630|Hypothalamo-Hypophyseal System|C0020662|22918|MH|||RC
9297630|Pituitary-Adrenal System|C0032022|21814|MH|||RC
9297630|Immunocytochemistry|C0242349|17356|ET|Entry Term Replacement for "Immunohistochemistry";RtM via: Immunocytochemistry|AB|MM;RC
9297630|Transcription Factor|C0040648|17285|ET|Entry Term Replacement for "Transcription Factors";RtM via: TRANSCRIPTION FACTOR|AB|MM;RC
9297630|Brain Mapping|C0006117|11346|MH|||RC
9297630|Endotoxins|C0014264|9234|MH|RtM via: Endotoxins|AB|MM;RC
9297630|Histocytochemistry|C0019635|6443|MH|RtM via: Histocytochemistry|AB|MM;RC
9297630|Stress, Physiological|C0449430|6316|MH|||RC
9297630|Gene Expression Regulation, Enzymologic|C0017265|3968|MH|||RC
9297630|Injections, Intraventricular|C0021495|3936|MH|||RC
9297630|Dinoprostone|C0012472|3803|MH|||RC
9297630|Cell Nucleus|C0007610|3802|MH|RtM via: Cell Nucleus|AB|MM
9297630|Time Factors|C0040225|3707|MH|||RC
9297630|Stress, Psychological|C0038443|3080|MH|||RC
9297630|Serotonin Agonists|C0162757|3036|MH|||RC
9297630|Tissue Distribution|C0040287|2954|MH|||RC
9297630|Sulfur Radioisotopes|C0038783|2898|MH|||RC
9297630|Body Temperature|C0005903|2533|MH|||RC
9297630|Antisense RNA|C0080124|2152|ET|Entry Term Replacement for "RNA, Antisense";RtM via: Antisense RNA|AB|MM
9297630|Restraint, Physical|C0035260|2081|MH|||RC
9297630|Cerebellar Nuclei|C0007763|1107|MH|RtM via: Cerebellar Nuclei|AB|MM
9297630|Blood Pressure|C0005823|884|MH|||RC
9297630|Carcinoembryonic Antigen|C0007082|445|MH|RtM via: Carcinoembryonic Antigen|AB|MM
9297630|Kinetics|C0022702|440|MH|||RC
9297630|Injections, Intravenous|C0021494|391|MH|||RC
9297630|Dose-Response Relationship, Drug|C0013059|318|MH|||RC
9297630|Neurosecretory Systems|C0027912|260|MH|RtM via: Neurosecretory Systems|AB|MM
9297630|Reference Values|C0034926|259|MH|||RC
9297630|Animals, Transgenic|C0003069|242|ET|Entry Term Replacement for "Animals, Genetically Modified";RtM via: Animals, Transgenic|AB|MM
------
9297630|Mice|C0026809|1461|CT||AB|MM
9297630|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;Mice, Transgenic;Animals, Transgenic;CT Text Lookup: animals;CT Text Lookup: mice;CT Text Lookup: transgenic mice|TI;AB;CT Text Lookup: animals;CT Text Lookup: mice;CT Text Lookup: transgenic mice|MM;RC
9297630|Rats|C0034721|1000|CT|Rats, Sprague-Dawley||RC
9297630|genetics|C0017399|1111|SH|G05.355.310 (Gene Expression)|TI|MM
9297630|immunology|C1522005|1111|SH|D23.050.161.616.525 (Lipopolysaccharides)|AB|MM
9378611|*Cerebellum|C0007765|907410|MH|RtM via: Cerebellum;RtM via: Entire cerebellum|TI;AB|MM;RC
9378611|Cerebellar Nuclei|C0007763|214607|MH|RtM via: Cerebellar Nuclei|AB|MM;RC
9378611|Motor Cortex|C0026607|212193|MH|RtM via: Motor Cortex|AB|MM;RC
9378611|Thalamus|C0039729|177401|MH|RtM via: Thalamic structure;RtM via: Entire thalamus|AB|MM;RC
9378611|Prefrontal Cortex|C0162783|151983|MH|RtM via: Prefrontal Cortex|AB|MM;RC
9378611|Neural Pathways|C0027792|96870|MH|||RC
9378611|Cerebral Cortex|C0007776|90728|MH|RtM via: Cerebral cortex|AB|MM;RC
9378611|Brain Mapping|C0006117|86059|MH|||RC
9378611|Neuron|C0027882|52801|ET|Entry Term Replacement for "Neurons";RtM via: Neurons|AB|MM;RC
9378611|Image Processing, Computer-Assisted|C0020911|9756|MH|||RC
9378611|Action Potentials|C0001272|8347|MH|||RC
9378611|Electric Stimulation|C0013786|4619|MH|||RC
9378611|Cognition|C0009240|4545|MH|||RC
9378611|Rabies virus|C0034497|3896|MH|||RC
------
9378611|Humans|C0086418|1000|CT|CT Text Lookup: human|CT Text Lookup: human|MM
9378611|methods|C0025664|45|SH|Methods|AB|MM
9348568|*Leucovorin|C0023413|5204304|MH|RtM via: Leucovorin|TI;AB|MM;RC
9348568|*Fluorouracil|C0016360|1953394|MH|RtM via: Fluorouracil;Forced Lookup:5-fu|TI;AB|MM;RC
9348568|Tegafur|C0016778|630277|MH|RtM via: Tegafur|AB|MM;RC
9348568|Uracil|C0041917|394089|MH|RtM via: Uracil|AB|MM;RC
9348568|Colorectal Neoplasms|C0009404|196545|MH|RtM via: Colorectal cancer metastatic|AB|MM;RC
9348568|Patient Preference|C0376409|170736|MH|RtM via: Patient Preference;Forced New Lookup:patient preference|AB|MM
9348568|Antineoplastic Combined Chemotherapy Protocols|C0003393|85375|MH|||RC
9348568|Antimetabolites, Antineoplastic|C0003377|36562|MH|||RC
9348568|Administration, Oral|C0001563|27170|MH|||RC
9348568|Drug Therapy, Combination|C0013218|13069|MH|||RC
9348568|Clinical Trials, Phase III as Topic|C0282461|11842|MH|RtM via: Phase 3 Clinical Trials|AB|MM;RC
9348568|Neoplasm Recurrence, Local|C0027643|7203|MH|||RC
9348568|Antidotes|C0003295|5954|MH|||RC
9348568|Area Under Curve|C0376690|5871|MH|||RC
9348568|Quality of Life|C0034380|3280|MH|||RC
9348568|Dose-Response Relationship, Drug|C0013059|3000|MH|||RC
9348568|Questionnaires|C0034394|1988|MH|||RC
9348568|Randomized Controlled Trials as Topic|C0282440|1513|MH|||RC
9348568|Patient Satisfaction|C0030702|1285|MH|||RC
9348568|Health Care Costs|C0085552|920|MH|||RC
9348568|Food|C0016452|827|MH|RtM via: Liver Flavor|AB|MM;RC
9348568|Injections, Intravenous|C0021494|665|MH|||RC
9348568|Sex Factors|C0036881|385|MH|||RC
9348568|Chromatography, High Pressure Liquid|C0008562|268|MH|||RC
9348568|Time Factors|C0040225|211|MH|||RC
------
9348568|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9348568|secondary|C1522484|19623|SH1|RtM via: metastatic qualifier;secondary (C1522484)|TI|MM
9348568|organization & administration|C0029236|9|SH|Administration|AB|MM
9348568|methods|C0025664|8|SH|Methods|AB|MM
9348568|drug therapy|C0013217|9999|SH|new SH add rule - Antineoplastic Combined Chemotherapy Protocols [E02.319.077.500] (E02.319)||MM
9348568|injuries|C1510467|5|SH|Wounds and Injuries|AB|MM
9348568|economics|C0013557|1111|SH|N03.219.151.400 (Health Care Costs)||MM
9313184|*Hysterectomy|C0020699|500460|MH|RtM via: Hysterectomy;RtM via: Consent Type - Hysterectomy|TI;AB|MM;RC
9313184|*Personal Satisfaction|C0031206|199125|MH|RtM via: Personal Satisfaction;RtM via: Psychological Well Being|TI;AB|MM;RC
9313184|Questionnaire|C0034394|73645|ET|Entry Term Replacement for "Questionnaires";RtM via: Questionnaires|AB|MM;RC
9313184|Treatment Outcome|C0085415|46440|MH|RtM via: Treatment outcome|AB|MM;RC
9313184|Quality of Life|C0034380|43799|MH|||RC
9313184|Patient Satisfaction|C0030702|35967|MH|||RC
9313184|Outcome Measures|C0086749|23245|ET|Entry Term Replacement for "Outcome Assessment (Health Care)";RtM via: Outcome Measures|AB|MM;RC
9313184|Depression|C0011570|22714|MH|RtM via: Mental Depression;RtM via: Depressed mood;RtM via: Depressive episode, unspecified|AB|MM;RC
9313184|Women's Health|C0080339|20410|MH|||RC
9313184|Sexual Dysfunction, Physiological|C0237873|20025|MH|||RC
9313184|Health Status|C0018759|18647|MH|RtM via: Health Status|AB|MM;RC
9313184|Ovariectomy|C0029936|17010|MH|||RC
9313184|Libido|C0023618|14879|MH|||RC
9313184|Pelvic Pain|C0030794|9436|MH|||RC
9313184|Depressive Disorder|C0011581|8005|MH|RtM via: Depressive disorder|AB|MM;RC
9313184|Activities of Daily Living|C0001288|6246|MH|||RC
9313184|Patient Education as Topic|C0030688|6122|MH|||RC
9313184|Adaptation, Psychological|C0683269|5653|MH|||RC
9313184|Body Image|C0005891|4924|MH|||RC
9313184|Self Concept|C0036594|4851|MH|||RC
9313184|Counseling|C0010210|4789|MH|RtM via: preoperative counseling|AB|MM;RC
9313184|Choice Behavior|C0008300|4590|MH|||RC
9313184|Attitude to Health|C0004275|4293|MH|||RC
9313184|Social Support|C0037438|3678|MH|||RC
9313184|Socioeconomic Factors|C0037464|2342|MH|||RC
9313184|Medroxyprogesterone Acetate|C0065864|1738|MH|||RC
9313184|Age Factors|C0001783|1547|MH|||RC
9313184|Postoperative Complications|C0032787|1145|MH|||RC
9313184|Surgical Wound Infection|C0038941|890|MH|||RC
9313184|Health Survey|C0018762|710|ET|Entry Term Replacement for "Health Surveys";RtM via: Health Surveys|AB|MM
9313184|Medical Record|C0025102|235|ET|Entry Term Replacement for "Medical Records";RtM via: Medical Records|AB|MM
------
9313184|Texas|C0039711|0|MH-S|RtM via: Texas|AB|MM
9313184|Female|C0015780|1000|CT|Hysterectomy;Ovariectomy;CT Text Lookup: hysterectomy;CT Text Lookup: women|TI;AB;CT Text Lookup: hysterectomy;CT Text Lookup: women|MM;RC
9313184|Humans|C0086418|1000|CT|Activities of Daily Living;Patient Education as Topic;Counseling;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: women|AB;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: women|MM;RC
9313184|surgery|C0038895|1111|SH1|RtM via: Surgical aspects;surgery (C0038895);RtM via: Operative Surgical Procedures;Surgical Procedures, Operative (C0543467);RtM via: Extraction;Surgical Procedures, Operative (C0543467)|AB|MM
9313184|methods|C0025664|21|SH|Methods|AB|MM
9313184|rehabilitation|C0034992|1111|SH|E02.831.067 (Activities of Daily Living)||MM
9298185|*Yeasts|C0043393|433479|MH|RtM via: Yeasts|TI;AB|MM;RC
9298185|*Saccharomyces cerevisiae|C0036025|87087|MH|RtM via: Saccharomyces cerevisiae|TI;AB|MM;RC
9298185|*River|C0337050|54588|ET|Entry Term Replacement for "Rivers";RtM via: Rivers|TI;AB|MM
9298185|Basidiomycota|C0004810|44717|MH|RtM via: Cystofilobasidium capitatum|AB|MM;RC
9298185|Ascomycota|C0003965|35658|MH|RtM via: Aureobasidium pullulans|AB|MM;RC
9298185|Cryptococcus|C0010415|29968|MH|RtM via: Cryptococcus albidus|AB|MM;RC
9298185|Candida|C0006836|29213|MH|RtM via: Candida krusei;RtM via: Candida maltosa|AB|MM;RC
9298185|Water Microbiology|C0043051|19070|MH|||RC
9298185|Killer Factors, Yeast|C2350482|17553|MH|||RC
9298185|Mitosporic Fungi|C0011746|14976|MH|RtM via: Aureobasidium pullulans|AB|MM;RC
9298185|Colony Count, Microbial|C0009380|14199|MH|||RC
9298185|Ecosystem|C0162358|13637|MH|||RC
9298185|Rhodotorula|C2587210|12747|MH|RtM via: Rhodotorula glutinis|AB|MM;RC
9298185|Soil Microbiology|C0037593|11593|MH|||RC
9298185|Fresh Water|C0016710|10073|MH|||RC
9298185|Fungal Proteins|C0016829|9102|MH|||RC
9298185|Mycological Typing Techniques|C0085127|8602|MH|||RC
9298185|Bathing Beaches|C0004834|7893|MH|||RC
9298185|DNA, Fungal|C0012927|6670|MH|||RC
9298185|Geologic Sediments|C0282590|6099|MH|||RC
9298185|Industrial Microbiology|C0021262|4832|MH|||RC
9298185|Geotrichum|C0017456|4597|MH|RtM via: Galactomyces geotrichum;RtM via: Geotrichum candidum antigen|AB|MM;RC
9298185|Food Microbiology|C0016477|3677|MH|||RC
9298185|Environmental Monitoring|C0014416|2625|MH|||RC
9298185|Crops, Agricultural|C0242775|2414|MH|||RC
9298185|Bacteriological Techniques|C0004642|2343|MH|||RC
9298185|Agriculture|C0001829|2276|MH|||RC
9298185|Microbial Sensitivity Tests|C0025948|2181|MH|||RC
9298185|Temperature|C0039476|1251|MH|||RC
9298185|Molecular Sequence Data|C0026382|1141|MH|||RC
9298185|Hydrogen-Ion Concentration|C0020283|789|MH|||RC
9298185|Genetic Variation|C0042333|686|MH|||RC
9298185|Reagent Kits, Diagnostic|C0034758|559|MH|||RC
9298185|Sequence Analysis, DNA|C0162802|544|MH|||RC
9298185|Species Specificity|C0037783|485|MH|||RC
9298185|Antibodies, Fungal|C0003245|244|MH|RtM via: Aureobasidium pullulans antigen|AB|MM
------
9298185|genetics|C0017399|1111|SH|G05.365 (Genetic Variation)||MM
9346625|*Prostaglandin E1|C0002335|202104|ET|Entry Term Replacement for "Alprostadil";RtM via: Alprostadil|TI;AB|MM;RC
9346625|Reperfusion Injury|C0035126|137080|MH|RtM via: Reperfusion Injury|AB|MM;RC
9346625|Organ Preservation|C0029209|93852|MH|||RC
9346625|Liver|C0023884|78638|MH|RtM via: Liver;RtM via: Entire liver;RtM via: Liver Flavor;RtM via: Injury to liver, NOS|AB|MM;RC
9346625|*Platelet|C0005821|67815|ET|Entry Term Replacement for "Blood Platelets";RtM via: Blood Platelets|TI;AB|MM;RC
9346625|Reperfusion|C0035124|50234|MH|RtM via: Reperfusion Therapy;RtM via: Physiological reperfusion|AB|MM;RC
9346625|Bile|C0005388|41192|MH|RtM via: Bile fluid|AB|MM;RC
9346625|Organ Preservation Solutions|C0182061|33963|MH|||RC
9346625|Krebs-Henseleit solution|C0167250|25732|NM|RtM via: Krebs-Henseleit solution;Forced Lookup:krebs-henseleit solution|AB|MM
9346625|Glucose|C0017725|25731|HM|RtM via: Krebs-Henseleit solution|AB|MM
9346625|Tromethamine|C0041175|25553|HM|RtM via: Krebs-Henseleit solution|AB|MM
9346625|Liver Circulation|C0023889|20116|MH|||RC
9346625|Platelet Adhesiveness|C0032175|18729|MH|RtM via: Platelet adhesion, function|AB|MM;RC
9346625|Cold|C0009264|16582|ET|Entry Term Replacement for "Cold Temperature";RtM via: Cold Temperature|AB|MM;RC
9346625|Rats, Wistar|C0034716|11797|MH|||RC
9346625|Cryopreservation|C0010405|8797|MH|RtM via: Cryopreservation|AB|MM;RC
9346625|P-Selectin|C0134835|6783|MH|||RC
9346625|Rats, Sprague-Dawley|C0034715|6639|MH|||RC
9346625|Platelet Aggregation|C0032176|6145|MH|||RC
9346625|Transplantation, Homologous|C0040739|5342|MH|||RC
9346625|Endothelium|C0014257|3882|MH|RtM via: Endothelium of sinusoid|AB|MM;RC
9346625|Graft Survival|C0018131|3623|MH|||RC
9346625|Adenosine|C0001443|3470|MH|||RC
9346625|Prostaglandins|C0033554|3012|MH|RtM via: Prostaglandins|AB|MM
9346625|Hot Temperature|C2350229|2975|MH|||RC
9346625|Guanine Deaminase|C0018324|2624|MH|||RC
9346625|Peroxidase|C0027021|2224|MH|||RC
9346625|Immunosuppressive Agents|C0021081|2111|MH|||RC
9346625|Cell Adhesion|C0007577|2019|MH|||RC
9346625|Rats, Inbred Lew|C0034704|1840|MH|||RC
9346625|Warm Ischemia|C1567664|1488|MH|RtM via: Warm Ischemia|AB|MM
9346625|Cell Separation|C0007616|1406|MH|||RC
9346625|Endothelium, Vascular|C0014261|1304|MH|||RC
9346625|Flow Cytometry|C0016263|1215|MH|||RC
9346625|Antibodies, Monoclonal|C0003250|767|MH|||RC
9346625|Time Factors|C0040225|739|MH|||RC
9346625|Oxygen Consumption|C0030055|642|MH|||RC
9346625|Transaminases|C0002594|609|MH|RtM via: Transaminases|AB|MM
9346625|Microscopy, Fluorescence|C0026022|515|MH|||RC
9346625|Platelet Function Tests|C0032184|450|MH|RtM via: Platelet adhesiveness test|AB|MM
9346625|Mucins|C0026682|341|MH|||RC
9346625|Adenosine Diphosphate|C0001459|292|MH|RtM via: Adenosine Diphosphate|AB|MM
9346625|paraform|C0070066|271|NM|RtM via: paraform|AB|MM
9346625|Formaldehyde|C0016564|270|HM|RtM via: paraform|AB|MM
9346625|Protease Inhibitors|C0033607|264|MH|||RC
9346625|Liver Function Tests|C0023901|235|MH|RtM via: Transaminase Assay|AB|MM
------
9346625|Polymers|C0032521|174|HM|RtM via: paraform|AB|MM
9346625|Wisconsin|C0043193|0|MH-S|RtM via: Wisconsin|AB|MM
9346625|Rats|C0034721|42846|CT||TI;AB|MM
9346625|Animals|C0003062|1000|CT|Rats, Wistar;Rats, Sprague-Dawley;Rats, Inbred Lew;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9346625|methods|C0025664|51|SH|Methods|AB|MM
9346625|surgery|C0038895|1111|SH|E04.100.700 (Reperfusion)|AB|MM
9346625|immunology|C1522005|1111|SH|D23.050.301.264.035.914 (P-Selectin)||MM
9346625|transplantation|C0029216|1111|SH|E04.936.864 (Transplantation, Homologous)||MM
9237858|Ophthalmology|C0029087|87814|MH|RtM via: Ophthalmology specialty;RtM via: Physicians - Ophthalmology|AB|MM;RC
9237858|Vision|C0042789|39810|ET|Entry Term Replacement for "Vision, Ocular";RtM via: Vision;RtM via: Vision attachment:Finding:Point in time:^Patient:Document|AB|MM;RC
9237858|Eye|C0015392|35205|MH|RtM via: Eye|AB|MM;RC
9237858|Visual Perception|C0042830|4129|MH|||RC
9237858|Symbolism|C0039034|3794|MH|||RC
9237858|Mythology|C0027143|3768|MH|||RC
9237858|Metaphor|C0302829|1541|MH|||RC
9237858|Optics and Photonics|C2350273|1432|MH|||RC
9237858|Nerve Block|C0027741|1408|MH|||RC
9237858|Color Perception|C0009395|1256|MH|||RC
9237858|Anesthetics, Local|C0002934|1188|MH|||RC
9237858|*Anxiety|C0003467|684|MH|RtM via: Nervousness|TI;AB|MM
9237858|Medicine, Ayurvedic|C0025122|341|MH|||RC
9237858|Universities|C0041740|304|MH|||RC
------
9237858|Humans|C0086418|1000|CT|CT Text Lookup: human;CT Text Lookup: man|CT Text Lookup: human;CT Text Lookup: man|MM
9237858|Male|C0024554|1000|CT|CT Text Lookup: man|CT Text Lookup: man|MM
9237858|physiology|C0031843|1170|SH1|RtM via: physiological aspects;physiology (C0031843)|TI;AB|MM
9237858|innervation|C1619351|909|SH1|RtM via: innervation aspect|TI;AB|MM
9237858|history|C0019665|1618|SH1|RtM via: Historical aspects qualifier;history (C0019665)|AB|MM
9237858|instrumentation|C0021632|72|SH|Supplies|AB|MM
9237858|surgery|C0038895|1111|SH|E04.525.210.550 (Nerve Block)||MM
9343384|*alpha-Factor Receptor|C1566953|5084334|ET|Entry Term Replacement for "Receptors, Mating Factor";RtM via: Mating Factor Receptor Ste2|TI;AB|MM;RC
9343384|Saccharomyces cerevisiae|C0036025|633132|MH|RtM via: Saccharomyces cerevisiae|AB|MM;RC
9343384|Saccharomyces cerevisiae Proteins|C0949987|327170|MH|||RC
9343384|Fungal Proteins|C0016829|234001|MH|||RC
9343384|Half-Life|C0018517|172554|MH|RtM via: Half-Life;Forced Lookup:half-life|AB|MM
9343384|*Biological Transport|C0005528|172506|MH|RtM via: Elimination outcomes;RtM via: Excretory function|TI;AB|MM;RC
9343384|mating factor|C0065743|169822|NM|RtM via: pheromone alpha-factor|TI;AB|MM
9343384|*Peptides|C0030956|169821|HM|RtM via: pheromone alpha-factor|TI;AB|MM;RC
9343384|Vacuoles|C0042219|158722|MH|RtM via: Vacuole|AB|MM;RC
9343384|Plasma Membrane|C0007603|154473|ET|Entry Term Replacement for "Cell Membrane";RtM via: Cell membrane;RtM via: Cell surface|AB|MM;RC
9343384|*Carrier Proteins|C0007292|127698|MH|RtM via: receptor|TI;AB|MM;RC
9343384|Membrane Protein|C0025252|95987|ET|Entry Term Replacement for "Membrane Proteins";RtM via: Membrane Proteins;RtM via: Plasma membrane protein|AB|MM;RC
9343384|Signal Transduction|C0037083|92031|MH|RtM via: Signal|AB|MM;RC
9343384|GTP-Binding Protein alpha Subunits|C0887847|89582|MH|||RC
9343384|Endocytosis|C0014139|81130|MH|||RC
9343384|Gene Expression Regulation, Fungal|C0017266|75251|MH|||RC
9343384|Mutation|C0026882|64027|MH|RtM via: Mutation|AB|MM;RC
9343384|Pheromones|C0031516|57909|MH|RtM via: Pheromone|AB|MM;RC
9343384|GTP-Binding Protein beta Subunits|C0887848|44981|MH|||RC
9343384|Receptors, Pheromone|C0031515|37409|MH|||RC
9343384|GTP-Binding Protein alpha Subunits, Gq-G11|C1257828|28210|MH|||RC
9343384|Vesicular Transport Proteins|C1135986|25894|MH|||RC
9343384|Membrane Transport Proteins|C0596902|24631|MH|||RC
9343384|GTP-Binding Protein gamma Subunits|C0887849|23682|MH|||RC
9343384|Two-Hybrid System Techniques|C0752172|19281|MH|||RC
9343384|Genetic Complementation Test|C0017381|17465|MH|||RC
9343384|Cell Polarity|C0085304|15057|MH|||RC
9343384|Sequence Homology, Amino Acid|C0162777|14056|MH|||RC
9343384|Protein Binding|C0033618|13220|MH|||RC
9343384|Molecular Sequence Data|C0026382|12788|MH|||RC
9343384|Amino Acid Substitution|C0525038|12708|MH|||RC
9343384|ATP-Binding Cassette Transporters|C0242738|11660|MH|||RC
9343384|Transcriptional Activation|C0162493|10791|MH|||RC
9343384|Recombinant Fusion Proteins|C0034857|10503|MH|||RC
9343384|Cloning, Molecular|C0009017|10269|MH|||RC
9343384|Protein Folding|C0162847|9039|MH|||RC
9343384|Amino Acid Transport Systems, Basic|C0949774|8861|MH|||RC
9343384|Amino Acid Sequence|C0002518|8445|MH|||RC
9343384|Cell Differentiation|C0007589|5871|MH|||RC
9343384|Models, Biological|C0026339|5463|MH|||RC
9343384|Gene Deletion|C0017260|5145|MH|||RC
9343384|Phenotype|C0031437|4006|MH|||RC
9343384|Microscopy, Fluorescence|C0026022|3002|MH|||RC
9343384|Sex Attractants|C0036863|2980|MH|||RC
9343384|Kinetics|C0022702|2223|MH|||RC
9343384|Cells, Cultured|C0007635|2143|MH|||RC
9343384|Pyridinium Compounds|C0034256|2069|MH|||RC
9343384|Temperature|C0039476|1841|MH|||RC
9343384|Centrifugation, Density Gradient|C0007704|1336|MH|||RC
9343384|Glycosylation|C0017982|1304|MH|RtM via: Protein Glycosylation;RtM via: glycosylation|AB|MM
------
9343384|genetics|C0017399|1111|SH|G05.355.315.330 (Gene Expression Regulation, Fungal)||MM
9259380|*Gilles de la Tourette Syndrome|C0040517|1070280|ET|Entry Term Replacement for "Tourette Syndrome";RtM via: Gilles de la Tourette syndrome|TI;AB|MM;RC
9259380|*Obsessive-Compulsive Disorder|C0028768|559104|MH|RtM via: Obsessive-Compulsive Disorder|TI;AB|MM;RC
9259380|Compulsive Behavior|C0600104|119891|MH|RtM via: Obsessive compulsive behavior|AB|MM;RC
9259380|Psychiatric Status Rating Scales|C0033871|17700|MH|||RC
9259380|Personality Inventory|C0031213|6316|MH|||RC
9259380|Impulsive Behavior|C0021125|4394|MH|||RC
9259380|Psychometrics|C0033920|2097|MH|||RC
9259380|Cognition Disorders|C0009241|1276|MH|||RC
9259380|Severity of Illness Index|C0036859|1149|MH|||RC
9259380|Organotechnetium Compounds|C0029256|1045|MH|||RC
9259380|Diagnosis, Differential|C0011906|533|MH|||RC
9259380|Cerebrovascular Circulation|C0007818|453|MH|||RC
9259380|Phenotype|C0031437|393|MH|||RC
9259380|Sex Characteristics|C0036866|186|MH|||RC
------
9259380|diagnosis|C1704338|14598|SH1|RtM via: diagnosis aspect;RtM via: Diagnosis;RtM via: Diagnosis Study;RtM via: Diagnosis Study;diagnosis (C1704338);RtM via: Symptoms aspect;diagnosis (C1704338);RtM via: Symptoms;Diagnosis (C0011900)|TI;AB|MM
9259380|etiology|C0015127|309|SH1|RtM via: Etiology;Causality (C1314792);RtM via: Etiology aspects;etiology (C0015127);RtM via: Pathogenesis;Causality (C1314792);RtM via: pathogenic aspects;etiology (C0015127)|AB|MM
9259380|genetics|C0017399|1111|SH|G05.695 (Phenotype)||MM
9379007|*Antigens, CD28|C0075747|3050949|MH|RtM via: CD28 Antigens|TI;AB|MM;RC
9379007|*T Lymphocytes|C0039194|1101072|ET|Entry Term Replacement for "T-Lymphocytes";RtM via: T-Lymphocyte|TI;AB|MM;RC
9379007|Receptors, Antigen, T-Cell|C0034790|376631|MH|RtM via: T-Cell Receptor|AB|MM;RC
9379007|Lymphocyte Activation|C0024262|374023|MH|RtM via: T cell differentiation|AB|MM;RC
9379007|IL2|C0021756|274552|ET|Entry Term Replacement for "Interleukin-2";RtM via: Interleukin-2;Forced Lookup:il-2|AB|MM;RC
9379007|Interleukin-4|C0021758|172520|MH|Forced Lookup:il-4||MM;RC
9379007|Chemokines, CC|C0282552|137566|MH|Forced Lookup:c-c chemokines||MM;RC
9379007|Mice, Knock-out|C0206745|137023|ET|Entry Term Replacement for "Mice, Knockout";RtM via: Mice, Knockout;Forced Lookup:knock-out mice|AB|MM;RC
9379007|Chemokine CCL3|C0128546|136981|MH|Forced Lookup:mip-1alpha||MM;RC
9379007|Signal Transduction|C0037083|61132|MH|RtM via: Signal|AB|MM;RC
9379007|visilizumab|C1134691|50657|NM|RtM via: Monoclonal Antibody HuM291|AB|MM
9379007|Antibodies, Monoclonal|C0003250|50656|MH|RtM via: Monoclonal Antibodies;RtM via: galiximab;RtM via: Monoclonal Antibody HuM291|AB|MM;RC
9379007|Mice, Inbred BALB C|C0025919|38331|MH|||RC
9379007|Mice, Transgenic|C0025936|36708|MH|RtM via: Mice, Transgenic|AB|MM;RC
9379007|Interferon-gamma|C0021745|35000|MH|||RC
9379007|Macrophage Inflammatory Proteins|C0376579|33284|MH|RtM via: Macrophage Inflammatory Proteins|AB|MM;RC
9379007|CD4-Positive T-Lymphocytes|C0039215|29532|MH|||RC
9379007|CD8-Positive T-Lymphocytes|C0242629|27236|MH|||RC
9379007|Th1 Cells|C0242632|26884|MH|||RC
9379007|Receptors, Antigen, T-Cell, gamma-delta|C0085246|26834|MH|||RC
9379007|Mice, Inbred C57BL|C0025921|26559|MH|||RC
9379007|galiximab|C1098262|25305|NM|RtM via: galiximab|AB|MM
9379007|T-Lymphocyte Subsets|C0080202|18014|MH|||RC
9379007|Th2 Cells|C0242633|16163|MH|||RC
9379007|Immunologic Memory|C0021055|14288|MH|||RC
9379007|Antigen Presentation|C0206431|10631|MH|||RC
9379007|Cytotoxicity, Immunologic|C0010864|10262|MH|||RC
9379007|Cells, Cultured|C0007635|9305|MH|||RC
9379007|Calcineurin|C0054450|8089|MH|||RC
9379007|Recombinant Fusion Proteins|C0034857|7862|MH|||RC
9379007|GATA3 Transcription Factor|C0118891|7808|MH|||RC
9379007|NF-kappa B|C0079904|7468|MH|||RC
9379007|Cell Survival|C0007620|6493|MH|||RC
9379007|Immunosuppressive Agents|C0021081|6203|MH|||RC
9379007|Immunization, Secondary|C0020975|5603|MH|||RC
9379007|Adjuvants, Immunologic|C0001551|5214|MH|||RC
9379007|JNK Mitogen-Activated Protein Kinases|C0248813|5026|MH|||RC
9379007|Cell Differentiation|C0007589|4914|MH|||RC
9379007|Proto-Oncogene Proteins c-jun|C0085296|4524|MH|||RC
9379007|Calcium Signaling|C0600431|4110|MH|||RC
9379007|p38 Mitogen-Activated Protein Kinases|C1120843|3830|MH|||RC
9379007|Proto-Oncogene Proteins c-bcl-2|C0107696|3758|MH|||RC
9379007|mRNA|C0035696|3365|ET|Entry Term Replacement for "RNA, Messenger";RtM via: RNA, Messenger|AB|MM;RC
9379007|Protein Binding|C0033618|3050|MH|||RC
9379007|Immunoglobulin G|C0020852|2977|MH|||RC
9379007|CHO Cells|C0085080|2553|MH|||RC
9379007|Amino Acid Substitution|C0525038|2193|MH|||RC
9379007|STAT6 protein, human|C0297890|2129|NM|RtM via: STAT6 protein, human|AB|MM
9379007|STAT6 Transcription Factor|C0297893|2128|HM|RtM via: STAT6 protein, human|AB|MM
9379007|Peptide Fragments|C0030935|1904|MH|||RC
------
9379007|Mice|C0026809|34029|CT||TI;AB|MM
9379007|Animals|C0003062|1000|CT|Mice, Knock-out;Mice, Inbred BALB C;Mice, Transgenic;Mice, Inbred C57BL;CHO Cells;CT Text Lookup: knock-out mice;CT Text Lookup: mice;CT Text Lookup: transgenic mice|AB;CT Text Lookup: knock-out mice;CT Text Lookup: mice;CT Text Lookup: transgenic mice|MM;RC
9379007|Cricetinae|C0018557|1000|CT|CHO Cells||RC
9379007|immunology|C1522005|1111|SH|D23.050.301.264.035.128 (Antigens, CD28)|TI;AB|MM
9379007|genetics|C0017399|1111|SH|G05.355.600.109 (Amino Acid Substitution)||MM
9376099|*HIV Seroprevalence|C0019700|2153700|MH|RtM via: HIV Seroprevalence|TI;AB|MM;RC
9376099|*Risk Behavior|C0086931|513450|ET|Entry Term Replacement for "Risk-Taking";RtM via: Risk Behavior|TI;AB|MM;RC
9376099|Needle Sharing|C0085091|375834|MH|RtM via: Needle Sharing;Forced Lookup:needle-sharing|AB|MM;RC
9376099|Substance Abuse, Intravenous|C0038579|227221|MH|||RC
9376099|HIV Infections|C0019693|166316|MH|RtM via: HIV Infections;RtM via: AIDS risk behavior|AB|MM;RC
9376099|HIV Seropositivity|C0019699|121783|MH|RtM via: HIV Seropositivity|AB|MM;RC
9376099|Sexual Behavior|C0036864|113616|MH|RtM via: Sex Behavior|AB|MM;RC
9376099|HIV-1|C0019704|73664|MH|||RC
9376099|*Drug Users|C0338666|57291|MH|RtM via: Injecting drug user|TI;AB|MM
9376099|Homosexuality, Male|C0242658|47368|MH|||RC
9376099|Risk Factors|C0035648|36744|MH|||RC
9376099|Hepatitis C|C0019196|14608|MH|||RC
9376099|Seroprevalence|C0600367|14277|ET|Entry Term Replacement for "Seroepidemiologic Studies";RtM via: Seroprevalence|AB|MM;RC
9376099|Herpes Genitalis|C0019342|11021|MH|||RC
9376099|Health Knowledge, Attitudes, Practice|C0022758|8767|MH|||RC
9376099|HTLV-I Infections|C0020097|8092|MH|||RC
9376099|Brazil|C0006137|7431|MH|RtM via: Brazil|TI;AB|MM;RC
9376099|Urban Population|C0041935|5045|MH|||RC
9376099|Socioeconomic Factors|C0037464|4902|MH|||RC
9376099|Population Surveillance|C0032687|4219|MH|||RC
9376099|Health Surveys|C0018762|3213|MH|||RC
9376099|Age Factors|C0001783|2811|MH|||RC
9376099|Questionnaires|C0034394|1359|MH|||RC
9376099|Genotype|C0017431|786|MH|||RC
9376099|Disinfection|C0012683|487|MH|||RC
9376099|Poverty|C0032854|479|MH|RtM via: Poverty|AB|MM
9376099|World Health Organization|C0043237|204|MH|RtM via: World Health Organization|AB|MM
------
9376099|Male|C0024554|1000|CT|Homosexuality, Male||RC
9376099|genetics|C0017399|1111|SH|G05.380 (Genotype)||MM
9332329|liposomal amphotericin B|C0771887|3451588|NM|Forced Lookup:l-amb||MM
9332329|*Amphotericin B|C0002679|3451587|MH|RtM via: Amphotericin B;RtM via: Amphotericin B lipid complex|TI;AB|MM;RC
9332329|liposomal amphotericin B|C1145701|3236232|NM|RtM via: Amphotericin B lipid complex|AB|MM
9332329|Mycoses|C0026946|497038|MH|RtM via: Mycoses;RtM via: Systemic mycosis|AB|MM;RC
9332329|*Pyrexia|C0015967|383469|ET|Entry Term Replacement for "Fever";RtM via: Fever|TI;AB|MM;RC
9332329|Antifungal Agents|C0003308|376806|MH|RtM via: Antifungal Agents|AB|MM;RC
9332329|Neutropenia|C0027947|282020|MH|RtM via: Neutropenia|AB|MM;RC
9332329|*Liposomes|C0023828|104145|MH|RtM via: Liposomes|TI;AB|MM;RC
9332329|Fever of Unknown Origin|C0015970|84312|MH|RtM via: [D]Persistent fever|AB|MM;RC
9332329|Drug Resistance, Fungal|C0949686|21569|MH|||RC
9332329|Candidiasis|C0006840|16676|MH|||RC
9332329|Drug Carriers|C0013161|5742|MH|||RC
9332329|Treatment Outcome|C0085415|3485|MH|||RC
9332329|Hypokalemia|C0020621|3342|MH|RtM via: Hypokalemia|AB|MM;RC
9332329|Drug Therapy, Combination|C0013218|2488|MH|||RC
9332329|Combined Modality Therapy|C0009429|2446|MH|||RC
9332329|Incidence|C0021149|2316|MH|RtM via: Incidence|AB|MM;RC
9332329|Drug Administration Schedule|C0013154|1907|MH|||RC
9332329|Infusions, Intravenous|C0021440|1763|MH|||RC
9332329|Antibiotic Prophylaxis|C0282638|1639|MH|||RC
9332329|Antineoplastic Combined Chemotherapy Protocols|C0003393|1270|MH|||RC
9332329|Administration, Oral|C0001563|1199|MH|||RC
9332329|Anti-Bacterial Agents|C0279516|520|MH|RtM via: Antibiotics|AB|MM
------
9332329|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9332329|Humans|C0086418|1000|CT|CT Text Lookup: adult;CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: adult;CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients|MM
9332329|Child|C0008059|1000|CT|CT Text Lookup: children;CT Text Lookup: paediatric|CT Text Lookup: children;CT Text Lookup: paediatric|MM
9332329|therapy|C0039798|14031|SH1|RtM via: therapeutic aspects;therapy (C0039798)|TI;AB|MM
9332329|drug therapy|C0013217|9999|SH|new SH add rule - Drug Carriers [E02.319.300.380] (E02.319)||MM
9332329|methods|C0025664|579|SH|Methods|TI;AB|MM
9332329|injuries|C1510467|4|SH|Wounds and Injuries|AB|MM
9377966|*Fracture Fixation|C0016641|640458|MH|RtM via: External skeletal fixation procedure|TI;AB|MM;RC
9377966|*Fractures, Bone|C0016658|506511|MH|RtM via: Fracture;RtM via: Fracture of metacarpal bone|TI;AB|MM;RC
9377966|Fractures, Open|C0016662|368477|MH|RtM via: Fractures, Open|AB|MM;RC
9377966|Metacarpal Bones|C0025526|141924|MH|RtM via: Metacarpal bone;RtM via: Entire metacarpal|AB|MM;RC
9377966|Fracture Healing|C0162542|66941|MH|||RC
9377966|Fracture Fixation, Internal|C0016642|63523|MH|||RC
9377966|Finger Injuries|C0016124|62270|MH|||RC
9377966|*Hand|C0018563|36150|MH|RtM via: Hand;RtM via: Entire hand|TI;AB|MM
9377966|Hand Injuries|C0018571|32373|MH|RtM via: Fracture of metacarpal bone|AB|MM;RC
9377966|Ankle Injuries|C0085111|27935|MH|||RC
9377966|Tendon Injuries|C0039504|19164|MH|||RC
9377966|Finger Joint|C0016125|16458|MH|||RC
9377966|Treatment Outcome|C0085415|15486|MH|||RC
9377966|Range of Motion, Articular|C0080078|9249|MH|||RC
9377966|Osteogenesis, Distraction|C0524975|8612|MH|||RC
9377966|Surgical Wound Infection|C0038941|8529|MH|||RC
9377966|Tendons|C0039508|7773|MH|RtM via: Tendon structure|AB|MM;RC
9377966|Knee Injuries|C0022744|7253|MH|||RC
9377966|Postoperative Complications|C0032787|5547|MH|||RC
9377966|Equipment Design|C0014677|3380|MH|||RC
9377966|Wound Healing|C0043240|3247|MH|||RC
9377966|Prognosis|C0033325|2638|MH|||RC
9377966|Miniaturization|C0026164|2492|MH|||RC
9377966|Patient Satisfaction|C0030702|1705|MH|||RC
9377966|Equipment Failure|C0014678|1481|MH|||RC
9377966|Recovery of Function|C0599766|1148|MH|||RC
9377966|Risk Factors|C0035648|1073|MH|||RC
9377966|Risk Assessment|C0086930|748|MH|||RC
9377966|Tomography, X-Ray Computed|C0040405|533|MH|||RC
------
9377966|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9377966|therapy|C0039798|7539|SH1|RtM via: therapeutic aspects;therapy (C0039798)|TI;AB|MM
9377966|surgery|C0038895|1111|SH1|RtM via: Surgical construction;Surgical Procedures, Operative (C0543467)|AB|MM
9377966|methods|C0025664|1422|SH|Methods|TI;AB|MM
9377966|radiography|C0034571|1111|SH|E01.370.350.700.700.810 (Tomography, X-Ray Computed)||MM
9303406|RU 64004|C0537900|8500543|NM|RtM via: RU 64004;RtM via: HMR 3004|TI;AB|MM
9303406|*Ketolides|C1449860|8500542|MH|RtM via: Ketolides;RtM via: RU 64004;RtM via: HMR 3004;RtM via: RU 66647;RtM via: HMR 3647|TI;AB|MM;RC
9303406|telithromycin|C0907410|8410867|NM|RtM via: RU 66647;RtM via: HMR 3647|TI;AB|MM
9303406|Erythromycin|C0014806|522152|MH|RtM via: Erythromycin|AB|MM;RC
9303406|Roxithromycin|C0035891|434434|MH|RtM via: Roxithromycin|AB|MM;RC
9303406|Azithromycin|C0052796|434368|MH|RtM via: Azithromycin|AB|MM;RC
9303406|Clarithromycin|C0055856|372502|MH|RtM via: Clarithromycin|AB|MM;RC
9303406|Microbial Sensitivity Tests|C0025948|283162|MH|RtM via: Minimum Inhibitory Concentration measurement|AB|MM;RC
9303406|Anti-Bacterial Agents|C0279516|106816|MH|||RC
9303406|Bacteria, Anaerobic|C0004613|98880|MH|RtM via: Bacteria, Anaerobic|AB|MM;RC
9303406|Drug Therapy, Combination|C0013218|14782|MH|||RC
9303406|beta-Lactamases|C0597979|8692|MH|||RC
9303406|Bites, Human|C0005660|3217|MH|||RC
9303406|Drug Evaluation, Preclinical|C0013206|1956|MH|||RC
9303406|Carbon Dioxide|C0007012|220|MH|||RC
------
9303406|Humans|C0086418|1000|CT|Bites, Human||RC
9303406|injuries|C1510467|302|SH|Wounds and Injuries||RC
9357967|*kit Ligand|C0143630|382898|ET|Entry Term Replacement for "Stem Cell Factor";RtM via: Stem Cell Factor;Forced Lookup:c-kit ligand|TI|MM;RC
9357967|*Marrow|C0376152|337317|ET|Entry Term Replacement for "Bone Marrow";RtM via: Marrow|TI;AB|MM;RC
9357967|Granulocyte Colony-Stimulating Factor|C0079459|200913|MH|RtM via: Granulocyte Colony-Stimulating Factor;RtM via: Recombinant human granulocyte colony stimulating factor;Forced Lookup:g-csf;Forced Lookup:granulocyte colony-stimulating factor|AB|MM;RC
9357967|Bone Marrow Transplantation|C0005961|127464|MH|RtM via: Bone Marrow Transplantation|AB|MM;RC
9357967|Total Body Irradiation|C0043162|61480|ET|Entry Term Replacement for "Whole-Body Irradiation";RtM via: Whole-Body Irradiation|AB|MM;RC
9357967|Colony-Stimulating Factors|C0009392|50570|MH|Forced Lookup:colony-stimulating factor||MM;RC
9357967|*Leukocytes|C0023516|29052|MH|RtM via: Leukocytes|TI;AB|MM
9357967|Hematopoietic Stem Cell Transplantation|C0472699|26573|MH|||RC
9357967|Transplantation, Homologous|C0040739|23102|MH|||RC
9357967|Leukocyte Count|C0023508|20279|MH|RtM via: Absolute neutrophil count|AB|MM;RC
9357967|Graft Survival|C0018131|17916|MH|||RC
9357967|Hematopoietic Stem Cell Mobilization|C0524864|17562|MH|||RC
9357967|Bone Marrow Cells|C0005955|14792|MH|||RC
9357967|Recombinant Proteins|C0034861|12710|MH|RtM via: Recombinant human granulocyte colony stimulating factor|AB|MM;RC
9357967|Graft Rejection|C0018129|10541|MH|||RC
9357967|Neutrophils|C0027950|9479|MH|RtM via: neutrophil|AB|MM;RC
9357967|Histocompatibility Antigens Class I|C0019629|6809|MH|||RC
9357967|Platelet Count|C0032181|5653|MH|RtM via: Platelet Count measurement|AB|MM;RC
9357967|*Antigen|C0003320|4656|ET|Entry Term Replacement for "Antigens";RtM via: Antigens|TI;AB|MM
9357967|Skin Transplantation|C0037297|3121|MH|||RC
9357967|Incidence|C0021149|2569|MH|RtM via: Incidence|AB|MM;RC
9357967|T-Lymphocytes, Regulatory|C0039198|1460|MH|||RC
9357967|T-Lymphocyte Subsets|C0080202|1423|MH|||RC
9357967|Antibodies, Monoclonal|C0003250|1356|MH|||RC
9357967|Monocytes|C0026473|1192|MH|RtM via: monocyte;RtM via: Monocyte count procedure|AB|MM
9357967|Treatment Outcome|C0085415|816|MH|||RC
9357967|Cross Reactions|C0010357|734|MH|||RC
9357967|Antifungal Agents|C0003308|488|MH|||RC
9357967|Drug Evaluation, Preclinical|C0013206|299|MH|||RC
9357967|Time Factors|C0040225|282|MH|||RC
9357967|Platelets|C0005821|218|ET|Entry Term Replacement for "Blood Platelets";RtM via: Blood Platelets|AB|MM
------
9357967|Dogs|C0012984|6099|CT||TI;AB|MM
9357967|Animals|C0003062|1000|CT|CT Text Lookup: animals;CT Text Lookup: dog|CT Text Lookup: animals;CT Text Lookup: dog|MM
9357967|Humans|C0086418|1000|CT|CT Text Lookup: human|CT Text Lookup: human|MM
9357967|transplantation|C0029216|1870|SH1|RtM via: Organ Transplantation;RtM via: transplantation aspects;RtM via: Transplantation|AB|MM
9357967|methods|C0025664|50|SH|Methods|AB|MM
9357967|injuries|C1510467|12|SH|Wounds and Injuries|AB|MM
9357967|radiotherapy|C1522449|1111|SH|E02.815.814 (Total Body Irradiation)|AB|MM
9357967|surgery|C0038895|1111|SH|E04.936.225.687.500 (Hematopoietic Stem Cell Transplantation)||MM
9357967|immunology|C1522005|1111|SH|D23.050.301.500.400 (Histocompatibility Antigens Class I)||MM
9326217|*Cytotoxic T-Lymphocytes|C0039195|754917|ET|Entry Term Replacement for "T-Lymphocytes, Cytotoxic";RtM via: Cytotoxic T-Lymphocytes|TI;AB|MM;RC
9326217|HLA-A2.1|C0086414|370675|ET|Entry Term Replacement for "HLA-A2 Antigen";RtM via: HLA-A2.1;Forced Lookup:hla-a2;Forced Lookup:hla-a2.1|AB|MM;RC
9326217|*Proteinase 3|C0067033|314349|ET|Entry Term Replacement for "Myeloblastin";RtM via: Proteinase 3|TI;AB|MM;RC
9326217|*Leukemia, Myelogenous, Chronic, BCR-ABL Positive|C0023473|301773|MH|RtM via: Myeloid Leukemia, Chronic|TI;AB|MM;RC
9326217|Cytotoxicity, Immunologic|C0010864|94986|MH|||RC
9326217|*Colony Forming Units|C0439156|94612|ET|Entry Term Replacement for "Stem Cells";RtM via: CFU unit of measurement;Forced Lookup:colony-forming unit;Forced Lookup:colony-forming units|TI|MM
9326217|Adoptive Immunotherapy|C0079613|60057|ET|Entry Term Replacement for "Immunotherapy, Adoptive";RtM via: Adoptive Immunotherapy|AB|MM;RC
9326217|Granulocyte-Macrophage Progenitor Cells|C2350243|44740|MH|RtM via: Granulocyte-Macrophage Colony Forming Units;Forced Lookup:cfu-gm|AB|MM
9326217|Myeloid Leukemias|C0023470|41532|ET|Entry Term Replacement for "Leukemia, Myeloid";RtM via: Myeloid Leukemia|AB|MM;RC
9326217|HLA-A Antigens|C0019728|36484|MH|||RC
9326217|Serine Endopeptidases|C0036734|29138|MH|||RC
9326217|Fusion Proteins, bcr-abl|C0004891|25444|MH|||RC
9326217|Leukemia|C0023418|23252|MH|RtM via: leukemia|AB|MM;RC
9326217|*Peptides|C0030956|14733|MH|RtM via: Peptides|TI;AB|MM
9326217|CD8-Positive T-Lymphocytes|C0242629|12686|MH|||RC
9326217|Peptide Fragments|C0030935|12050|MH|||RC
9326217|CD4-Positive T-Lymphocytes|C0039215|10171|MH|||RC
9326217|Antigen Presentation|C0206431|10138|MH|||RC
9326217|Amino Acid Sequence|C0002518|9586|MH|||RC
9326217|Histocompatibility Antigens Class I|C0019629|7974|MH|||RC
9326217|Molecular Sequence Data|C0026382|7872|MH|||RC
9326217|WT1 Proteins|C0148873|6436|MH|||RC
9326217|T-Lymphocyte Subsets|C0080202|6420|MH|||RC
9326217|Lymphocyte Activation|C0024262|6080|MH|||RC
9326217|Neoplasm Proteins|C0027642|5971|MH|||RC
9326217|Flow Cytometry|C0016263|5768|MH|RtM via: Flow Cytometry|AB|MM;RC
9326217|Neoplastic Stem Cells|C1956421|5414|MH|||RC
9326217|Bone Marrow Cells|C0005955|3340|MH|||RC
9326217|Interferon-gamma|C0021745|2994|MH|||RC
9326217|Exon|C0015295|2595|ET|Entry Term Replacement for "Exons";RtM via: Exons|AB|MM;RC
9326217|Cell Line|C0007600|2544|MH|||RC
9326217|Cell Line, Transformed|C0007601|2418|MH|||RC
9326217|Cells, Cultured|C0007635|2190|MH|||RC
9326217|Leukocytes, Mononuclear|C0023517|2146|MH|||RC
9326217|Cell Differentiation|C0007589|1791|MH|||RC
9326217|Cell Culture Techniques|C0007585|1482|MH|||RC
9326217|Apoptosis|C0162638|1379|MH|||RC
9326217|Transfection|C0040669|1261|MH|||RC
9326217|proteinase T|C0084212|1031|NM|RtM via: proteinase T|AB|MM
9326217|Subtilisins|C0038601|1030|HM|RtM via: proteinase T|AB|MM
9326217|Sequence Homology, Amino Acid|C0162777|1016|MH|||RC
9326217|RNA, Messenger|C0035696|1008|MH|||RC
9326217|Phenotype|C0031437|860|MH|||RC
9326217|Bone Marrow|C0005953|643|MH|RtM via: Bone Marrow;RtM via: Marrow|AB|MM
9326217|Granulocyte|C0018183|260|ET|Entry Term Replacement for "Granulocytes";RtM via: granulocyte|AB|MM
------
9326217|metabolism|C0025520|2742|SH1|RtM via: Inhibited;Metabolism (C0025519);RtM via: Metabolic Inhibition;Metabolism (C0025519);RtM via: Anabolism;Metabolism (C0025519)|TI;AB|MM
9326217|blood supply|C0005839|134|SH|Blood Circulation||RC
9326217|immunology|C1522005|1111|SH|D23.050.301.500.400.370.374 (HLA-A2.1)|AB|MM
9326217|genetics|C0017399|1111|SH|G05.360.340.024.340.137.232 (Exon)|AB|MM
9382507|*Carcinoma|C0007097|98094|MH|RtM via: Carcinoma|TI;AB|MM;RC
9382507|Pancreatic Neoplasms|C0030297|95712|MH|||RC
9382507|*Pancreas|C0030274|74250|MH|RtM via: Pancreas;RtM via: Entire pancreas;RtM via: Pancreas extract|TI;AB|MM
9382507|Carcinoma, Pancreatic Ductal|C0887833|55676|MH|||RC
9382507|Radiotherapy, Adjuvant|C0242939|37009|MH|||RC
9382507|Combined Modality Therapy|C0009429|31537|MH|||RC
9382507|Radiotherapy Dosage|C0034620|16554|MH|||RC
9382507|Chemotherapy, Adjuvant|C0085533|15830|MH|||RC
9382507|Prognosis|C0033325|15563|MH|RtM via: Forecast of outcome|AB|MM;RC
9382507|Cumulative Survival Rate|C0010456|8773|ET|Entry Term Replacement for "Survival Rate";RtM via: Cumulative Survival Rate|AB|MM;RC
9382507|Neoplasm Staging|C0027646|8376|MH|||RC
9382507|Antimetabolites, Antineoplastic|C0003377|7793|MH|||RC
9382507|Neoplasm Recurrence, Local|C0027643|4451|MH|||RC
9382507|Intraoperative Period|C0021891|3486|MH|||RC
9382507|Palliative Care|C0030231|2536|MH|||RC
9382507|Treatment Outcome|C0085415|1601|MH|||RC
9382507|Postoperative Complications|C0032787|425|MH|||RC
9382507|Patient Care Team|C0030679|228|MH|||RC
------
9382507|Humans|C0086418|1000|CT|Palliative Care;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM;RC
9382507|Animals|C0003062|1000|CT|CT Text Lookup: tail|CT Text Lookup: tail|MM
9382507|radiotherapy|C1522449|20082|SH1|RtM via: Intraoperative radiation therapy;Radiotherapy (C1522449);RtM via: radiotherapeutic;radiotherapy (C0034619);RtM via: Therapeutic radiology procedure;Radiotherapy (C1522449);RtM via: Radiotherapy (finding);RtM via: Radiotherapy (finding);radiotherapy (C0034619)|TI;AB|MM
9382507|surgery|C0038895|1111|SH1|RtM via: Excision;Surgical Procedures, Operative (C0543467)|AB|MM
9382507|methods|C0025664|4|SH|Methods|AB|MM
9382507|drug therapy|C0013217|9999|SH|new SH add rule - Chemotherapy, Adjuvant [E02.319.170] (E02.319)||MM
9325342|2-N-((3'-iodo-4'-azidophenyl)propionyl)tetrabenazine|C0666969|1345586|NM|Forced Lookup:tbz-aipp||MM
9325342|*Tetrabenazine|C0039623|1345585|HM|RtM via: Tetrabenazine|TI;AB|MM;RC
9325342|Azides|C0004492|607472|HM|||MM;RC
9325342|*Monoamine Vesicular Transporter|C1529240|547578|ET|Entry Term Replacement for "Vesicular Monoamine Transport Proteins";RtM via: Vesicular Monoamine Transport Proteins|TI|MM;RC
9325342|azidoiodoketanserin|C0081685|206649|NM|Forced Lookup:7-azido-8-iodoketanserin||MM
9325342|Membrane Transport Proteins|C0596902|118651|MH|RtM via: Membrane Transport Proteins|AB|MM;RC
9325342|Ketanserin|C0022616|106245|HM|||MM;RC
9325342|7-aminoketanserin|C0049837|57702|NM|Forced Lookup:7-aminoketanserin||MM
9325342|*Binding Sites|C0005456|57234|MH|RtM via: Binding Sites|TI|MM;RC
9325342|Serotonin|C0036751|32627|MH|RtM via: Serotonin|AB|MM;RC
9325342|Synaptic Vesicle|C0039065|19985|ET|Entry Term Replacement for "Synaptic Vesicles";RtM via: Synaptic Vesicles|AB|MM;RC
9325342|Norepinephrine|C0028351|9407|MH|RtM via: Norepinephrine|AB|MM;RC
9325342|*Peptide Mapping|C0030944|8847|MH|RtM via: Peptide Mapping|TI|MM
9325342|Baculovirus|C0935640|7048|ET|Entry Term Replacement for "Baculoviridae";RtM via: Baculoviridae;RtM via: Baculovirus|AB|MM;RC
9325342|Amines|C0002508|6741|MH|RtM via: Amines;RtM via: monoamine|AB|MM;RC
9325342|Radioligand Assay|C0034596|4703|MH|||RC
9325342|Spodoptera frugiperda|C0242626|4222|ET|Entry Term Replacement for "Spodoptera";RtM via: Spodoptera frugiperda|AB|MM;RC
9325342|Transfection|C0040669|3998|MH|||RC
9325342|Molecular Structure|C0026383|3793|MH|||RC
9325342|Electrophoresis, Polyacrylamide Gel|C0013862|3720|MH|RtM via: SDS-PAGE|AB|MM;RC
9325342|Amino Acid Sequence|C0002518|3537|MH|||RC
9325342|Cloning, Molecular|C0009017|3437|MH|||RC
9325342|Iodine Radioisotopes|C0021970|3380|MH|||RC
9325342|Binding, Competitive|C0005458|2873|MH|||RC
9325342|Indicators and Reagents|C0021213|1854|MH|RtM via: Radiolabeled|AB|MM;RC
9325342|Mutagenesis, Site-Directed|C0079870|1752|MH|||RC
9325342|DNA|C0012854|1598|MH|RtM via: DNA|AB|MM;RC
9325342|Brain|C0006104|1424|MH|||RC
9325342|Molecular Sequence Data|C0026382|1202|MH|||RC
9325342|Cell Line|C0007600|1085|MH|||RC
9325342|Kinetics|C0022702|1042|MH|||RC
9325342|Isotope Labeling|C0022261|1022|MH|||RC
9325342|In Situ Hybridization|C0162788|911|MH|||RC
9325342|Photochemistry|C0031739|880|MH|||RC
9325342|Dopamine Transporter|C0114838|782|ET|Entry Term Replacement for "Dopamine Plasma Membrane Transport Proteins";RtM via: dopamine transporter|AB|MM
9325342|RNA, Messenger|C0035696|666|MH|||RC
9325342|Protein Conformation|C0033625|493|MH|||RC
9325342|Species Specificity|C0037783|445|MH|||RC
9325342|Cercopithecus aethiops|C0026438|384|MH|||RC
9325342|cDNA|C0006556|305|ET|Entry Term Replacement for "DNA, Complementary";RtM via: DNA, Complementary|AB|MM
9325342|Chromatography, High Pressure Liquid|C0008562|254|MH|||RC
------
9325342|Rats|C0034721|308|CT||AB|MM
9325342|Animals|C0003062|1000|CT|Spodoptera frugiperda;Cercopithecus aethiops;CT Text Lookup: rat|AB;CT Text Lookup: rat|MM;RC
9325342|genetics|C0017399|1111|SH|G05.355.760.860 (Transfection)||MM
9301342|*Chronic Fatigue Syndrome|C0015674|625446|ET|Entry Term Replacement for "Fatigue Syndrome, Chronic";RtM via: Chronic Fatigue Syndrome|TI;AB|MM;RC
9301342|Comorbidity|C0009488|74613|MH|RtM via: Comorbidity|AB|MM;RC
9301342|Mental Disorders|C0004936|71828|MH|RtM via: Mental disorders|AB|MM;RC
9301342|Diagnosis, Differential|C0011906|16216|MH|||RC
9301342|Prevalence|C0033105|9554|MH|RtM via: High Prevalence|AB|MM;RC
9301342|Psychiatric Status Rating Scales|C0033871|7954|MH|||RC
9301342|Illness Behavior|C2350572|5916|MH|||RC
9301342|Questionnaires|C0034394|4873|MH|||RC
9301342|*Politics|C0032382|3897|MH|RtM via: Politics|TI|MM
9301342|Health Surveys|C0018762|3439|MH|||RC
9301342|Severity of Illness Index|C0036859|3362|MH|||RC
9301342|Adaptation, Psychological|C0683269|3153|MH|||RC
9301342|Research|C0035168|2890|MH|RtM via: Research Activities;RtM via: research|AB|MM;RC
9301342|Terminology as Topic|C1956183|2311|MH|||RC
9301342|Attitude to Health|C0004275|1682|MH|||RC
9301342|Sex Factors|C0036881|1494|MH|||RC
9301342|Patient Care Team|C0030679|1266|MH|||RC
9301342|Outcome Assessment (Health Care)|C0085565|1188|MH|||RC
9301342|Syndrome|C0039082|1090|MH|RtM via: Syndrome|AB|MM
9301342|Reference Values|C0034926|813|MH|||RC
9301342|Temporomandibular Joint Disorders|C0039494|752|MH|||RC
9301342|Socioeconomic Factors|C0037464|729|MH|||RC
9301342|Physical Exertion|C0031807|509|MH|||RC
9301342|Time Factors|C0040225|245|MH|||RC
------
9301342|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9301342|therapy|C0039798|205|SH1|RtM via: therapeutic aspects;therapy (C0039798)|AB|MM
9301342|methods|C0025664|29|SH|Methods|AB|MM
9353195|*Hydrogen Bonding|C0020276|463173|MH|RtM via: Hydrogen Bonding|TI;AB|MM;RC
9353195|*Proteases, Serine|C2717971|271762|ET|Entry Term Replacement for "Serine Endopeptidases";RtM via: Serine Protease;Forced New Lookup:serine protease;Forced New Lookup:serine proteases|TI;AB|MM;RC
9353195|*Catalysis|C0007382|223134|MH|RtM via: Catalysis|TI;AB|MM;RC
9353195|Aspartic Acid|C0004015|88621|MH|RtM via: Aspartic Acid|AB|MM;RC
9353195|Histidine|C0019602|66321|MH|RtM via: Histidine|AB|MM;RC
9353195|Active Sites|C0205681|18897|ET|Entry Term Replacement for "Catalytic Domain";RtM via: Active Site|AB|MM;RC
9353195|Binding Sites|C0005456|14931|MH|||RC
9353195|Hydrogen-Ion Concentration|C0020283|11647|MH|||RC
9353195|Models, Molecular|C0026344|11556|MH|||RC
9353195|Serine|C0036720|10320|MH|||RC
9353195|Molecular Structure|C0026383|8749|MH|||RC
9353195|Models, Chemical|C0026341|6589|MH|||RC
9353195|Hydrogen|C0020275|4782|MH|RtM via: Hydrogen;RtM via: Hydrogen, Homeopathic preparation|AB|MM;RC
9353195|Kinetics|C0022702|4056|MH|||RC
9353195|Mutagenesis, Site-Directed|C0079870|3720|MH|||RC
9353195|Amino Acid Sequence|C0002518|3657|MH|||RC
9353195|Protein Conformation|C0033625|2928|MH|||RC
9353195|Crystallography, X-Ray|C0206755|2598|MH|||RC
9353195|Nuclear Magnetic Resonance, Biomolecular|C0525018|2479|MH|||RC
9353195|Thermodynamics|C0039808|2391|MH|||RC
9353195|Spectroscopy, Fourier Transform Infrared|C0206055|1454|MH|||RC
9353195|Temperature|C0039476|1416|MH|||RC
9353195|Scattering, Radiation|C0036289|642|MH|||RC
9353195|Cold Temperature|C0009264|577|MH|||RC
9353195|*Sarcolemma|C0036208|528|MH|RtM via: Transverse tubule of muscle cell|TI;AB|MM
------
9353195|methods|C0025664|15|SH|Methods|AB|MM
9315221|*Aeromonas|C0001705|1165371|MH|RtM via: Aeromonas eucrenophilia|TI|MM;RC
9315221|*Anti-Bacterial Agents|C0279516|122844|MH|RtM via: Antibiotics|TI;AB|MM;RC
9315221|*Fishes|C0016163|121290|MH|RtM via: Fishes|TI;AB|MM;RC
9315221|Microbial Sensitivity Tests|C0025948|57265|MH|||RC
9315221|Fish Diseases|C0016154|29270|MH|||RC
9315221|*Hemolysis|C0019054|27738|MH|RtM via: Hemolytic|TI;AB|MM;RC
9315221|Water Microbiology|C0043051|21318|MH|||RC
9315221|*Water|C0043047|20043|MH|RtM via: Water;RtM via: Water Specimen|TI|MM
9315221|Hemolysin Proteins|C0019053|15048|MH|RtM via: Hemolysin|AB|MM;RC
9315221|Aquaculture|C0206225|12345|MH|||RC
9315221|Drug Resistance, Multiple, Bacterial|C0949671|11049|MH|||RC
9315221|Seafood|C0206208|8873|MH|||RC
9315221|Fresh Water|C0016710|8861|MH|RtM via: Fresh Water|AB|MM;RC
9315221|Food Microbiology|C0016477|8755|MH|||RC
9315221|Ampicillin|C0002680|4814|MH|RtM via: Ampicillin|AB|MM
9315221|Food Contamination|C0016462|4334|MH|||RC
9315221|Gastrointestinal Tract|C0017189|4255|MH|RtM via: Gastrointestinal tract structure|AB|MM;RC
9315221|Consumer Product Safety|C0009826|1839|MH|||RC
------
9315221|Animals|C0003062|1000|CT|Fishes;Fish Diseases|TI;AB|MM;RC
9315221|therapy|C0039798|39|SH|Therapeutics|AB|MM
9315221|organization & administration|C0029236|5|SH|Organization and Administration|AB|MM
9335460|*Immunologic Surveillance|C0021059|51900|MH|RtM via: Immunologic Surveillance|TI;AB|MM;RC
9335460|*T Lymphocytes|C0039194|42633|ET|Entry Term Replacement for "T-Lymphocytes";RtM via: T-Lymphocyte|TI;AB|MM;RC
9335460|*Epithelial Cells|C0014597|20688|MH|RtM via: Intercalated cell of collecting duct of renal tubule|TI;AB|MM;RC
9335460|Vestibule|C0042606|20492|ET|Entry Term Replacement for "Vestibule, Labyrinth";RtM via: Vestibular Labyrinth|AB|MM;RC
9335460|Gap Junctions|C0206117|14830|MH|||RC
9335460|*Immune System|C0020962|14421|MH|RtM via: Immune system;RtM via: Entire immune system|TI;AB|MM
9335460|Ear, Inner|C0022889|14042|MH|RtM via: Entire vestibule|AB|MM;RC
9335460|Melanocytes|C0025201|13015|MH|RtM via: melanocyte|AB|MM;RC
9335460|Macrophages|C0024432|10128|MH|RtM via: macrophage;RtM via: Specimen Type - Macrophages|AB|MM;RC
9335460|Schwannoma, Vestibular|C0027859|6765|ET|Entry Term Replacement for "Neuroma, Acoustic";RtM via: Acoustic Neuroma|AB|MM;RC
9335460|Microscopy, Electron, Scanning|C0026020|6549|MH|||RC
9335460|Antigens, CD45|C0054961|5992|MH|RtM via: CD45 Antigens|AB|MM;RC
9335460|Lymphocytes|C0024264|4973|MH|RtM via: Lymphocyte|AB|MM;RC
9335460|Vestibular Diseases|C0042594|4708|MH|||RC
9335460|Phagocytoses|C0031308|4349|ET|Entry Term Replacement for "Phagocytosis";RtM via: Phagocytosis|AB|MM;RC
9335460|Melanins|C0025196|3521|MH|||RC
9335460|Leukocytes|C0023516|3247|MH|RtM via: Mononuclear cells|AB|MM;RC
9335460|CD8-Positive T-Lymphocytes|C0242629|1473|MH|||RC
9335460|Cell Adhesion|C0007577|1243|MH|||RC
9335460|*Cardiovascular System|C0007226|1140|MH|RtM via: Capillary vessel|TI;AB|MM
9335460|Melanosomes|C0025213|1066|MH|RtM via: Melanosomes|AB|MM
9335460|Leukocytes, Mononuclear|C0023517|955|MH|||RC
9335460|Histocytochemistry|C0019635|856|MH|||RC
9335460|Cell Differentiation|C0007589|799|MH|||RC
9335460|Glutaraldehyde|C0017814|789|ET|Entry Term Replacement for "Glutaral";RtM via: Glutaral|AB|MM;RC
9335460|Fixatives|C0016184|762|MH|||RC
9335460|Cell Count|C0007584|690|MH|||RC
9335460|von Willebrand Factor|C0042971|579|MH|RtM via: von Willebrand Factor|AB|MM;RC
9335460|Abortion, Induced|C0392535|529|MH|||RC
9335460|*Pneumocystis|C0597258|489|MH|RtM via: Immunohistochemical|TI|MM
9335460|Semicircular Canals|C0036622|464|MH|RtM via: Semicircular canal structure|AB|MM
9335460|Microscopy|C0026018|424|MH|RtM via: Microscopes, Light;RtM via: Microscope Device Component;RtM via: Transmission Electron Microscopes|AB|MM
9335460|Abortion, Spontaneous|C0000786|326|MH|||RC
9335460|Swine|C0039005|305|MH|||RC
9335460|Pericytes|C0598800|207|MH|RtM via: Pericytes|AB|MM
------
9335460|Female|C0015780|1000|CT|Abortion, Induced;Abortion, Spontaneous||RC
9335460|Pregnancy|C0032961|1000|CT|Abortion, Induced;Abortion, Spontaneous||RC
9335460|Humans|C0086418|1000|CT|Abortion, Spontaneous;CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|MM;RC
9335460|Animals|C0003062|1000|CT|Swine||RC
9335460|ultrastructure|C0041623|4014|SH1|RtM via: Ultrastructure;ultrastructure (C0041623)|TI|MM
9335460|instrumentation|C0021632|324|SH|Equipment and Supplies|TI;AB|MM
9335460|methods|C0025664|35|SH|Methods|AB|MM
9335460|immunology|C1522005|1111|SH|G12.450.050.400.412 (Immunologic Surveillance)|TI;AB|MM
9335460|surgery|C0038895|1111|SH|E04.520.050 (Abortion, Induced)||MM
9331078|*Epidermodysplasia Verruciformis|C0014522|4504887|MH|RtM via: Epidermodysplasia Verruciformis|TI;AB|MM;RC
9331078|*Papillomaviridae|C0949793|2121999|MH|RtM via: Human Papillomavirus|TI;AB|MM;RC
9331078|Papillomavirus Infections|C0950124|261131|MH|||RC
9331078|*Skin|C1123023|158157|MH|RtM via: Cutaneous;RtM via: Skin;RtM via: Transplanted skin;RtM via: Entire skin;RtM via: Skin Specimen|TI;AB|MM;RC
9331078|Skin Cancers|C0007114|129188|ET|Entry Term Replacement for "Skin Neoplasms";RtM via: Malignant neoplasm of skin|AB|MM;RC
9331078|DNA, Viral|C0012939|98805|MH|||RC
9331078|Precancerous Conditions|C0032927|38183|MH|||RC
9331078|Sunlight|C0038817|22234|MH|RtM via: Sunlight|AB|MM;RC
9331078|Cell Transformation, Neoplastic|C0007621|15109|MH|RtM via: Carcinogenesis;RtM via: Skin Carcinogenesis|AB|MM;RC
9331078|*Grafting, Skin|C0037297|10032|ET|Entry Term Replacement for "Skin Transplantation";RtM via: Skin autograft;RtM via: Skin Transplantation|TI;AB|MM
9331078|Cell Transformation, Viral|C0007622|6730|MH|||RC
9331078|Molecular Sequence Data|C0026382|4899|MH|||RC
9331078|Kidney Transplantation|C0022671|4558|MH|||RC
9331078|Immunocompetence|C0020987|3825|MH|||RC
9331078|Cloning, Molecular|C0009017|2981|MH|||RC
9331078|Mice, Nude|C0025932|2705|MH|||RC
9331078|Neoplasm Transplantation|C0027648|2284|MH|||RC
9331078|Papillomavirus Vaccines|C1721102|1729|MH|RtM via: Human Papilloma Virus Vaccine|AB|MM
9331078|Risk Factors|C0035648|1521|MH|||RC
9331078|Genotype|C0017431|1249|MH|||RC
9331078|Age Distribution|C0001782|1215|MH|||RC
9331078|Amino Acid Sequence|C0002518|719|MH|||RC
9331078|Risk Assessment|C0086930|623|MH|||RC
9331078|Disease Models, Animal|C0012644|551|MH|||RC
9331078|Phylogeny|C0031797|429|MH|||RC
9331078|Time Factors|C0040225|414|MH|||RC
9331078|Severity of Illness Index|C0036859|308|MH|||RC
------
9331078|Animals|C0003062|1000|CT|Mice, Nude;Disease Models, Animal||RC
9331078|Mice|C0026809|1000|CT|Mice, Nude||RC
9331078|Humans|C0086418|1000|CT|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|MM
9331078|transplantation|C0029216|1111|SH1|RtM via: Organ Transplantation;RtM via: transplantation aspects;RtM via: Transplantation;RtM via: grafting qualifier;transplantation (C0040733)|AB|MM
9331078|surgery|C0038895|1111|SH1|RtM via: Surgical aspects;surgery (C0038895);RtM via: Operative Surgical Procedures;Surgical Procedures, Operative (C0543467)|AB|MM
9331078|virology|C0205466|1111|SH|G06.920.875.210 (Cell Transformation, Viral)||MM
9331078|genetics|C0017399|1111|SH|G05.380 (Genotype)||MM
9325282|*Cystic Fibrosis Transmembrane Conductance Regulator|C0056889|1050420|MH|RtM via: Cystic Fibrosis Transmembrane Conductance Regulator|TI;AB|MM;RC
9325282|Ion Channel Gating|C0022008|54850|MH|||RC
9325282|Phosphorylation|C0031715|45647|MH|RtM via: Phosphorylation|AB|MM;RC
9325282|Ethylmaleimide|C0015101|45645|MH|RtM via: Ethylmaleimide;Forced Lookup:n-ethylmaleimide|AB|MM;RC
9325282|Patch-Clamp Techniques|C0242625|36008|MH|||RC
9325282|Mutagenesis, Site-Directed|C0079870|26051|MH|||RC
9325282|Membrane Potentials|C0025251|23080|MH|||RC
9325282|Adenosine Triphosphate|C0001480|18179|MH|||RC
9325282|Chloride Channels|C0055363|14908|MH|||RC
9325282|Serine|C0036720|13804|MH|RtM via: Serine|AB|MM;RC
9325282|*Biophysical Processes|C1511162|12894|MH|RtM via: Covalent Interaction;RtM via: nucleotide binding|TI;AB|MM
9325282|Cysteine|C0010654|12613|MH|RtM via: Cysteine|AB|MM;RC
9325282|Transfection|C0040669|12018|MH|||RC
9325282|Amino Acid Sequence|C0002518|10393|MH|||RC
9325282|Binding Sites|C0005456|10205|MH|||RC
9325282|Protein Structure, Tertiary|C0162808|9891|MH|||RC
9325282|Sulfhydryl Reagents|C0038738|9281|MH|RtM via: Sulfhydryl Reagents|AB|MM;RC
9325282|Cell Line|C0007600|8992|MH|||RC
9325282|Oocytes|C0029045|7895|MH|||RC
9325282|Cloning, Molecular|C0009017|6376|MH|||RC
9325282|Alanine|C0001898|6151|MH|RtM via: Alanine|AB|MM;RC
9325282|Hela Cells|C0018873|6116|MH|||RC
9325282|Structure-Activity Relationship|C0038477|5975|MH|||RC
9325282|Xenopus laevis|C0043343|5843|MH|||RC
9325282|Protein Binding|C0033618|5752|MH|||RC
9325282|Cyclic AMP|C0001455|5253|MH|||RC
9325282|Kinetics|C0022702|4804|MH|||RC
9325282|Chlorides|C0008203|4384|MH|||RC
9325282|Mutation|C0026882|3690|MH|RtM via: Mutation|AB|MM;RC
9325282|Protein Kinases|C0033640|3629|MH|||RC
9325282|Models, Biological|C0026339|3038|MH|||RC
9325282|Mutagenesis, Insertional|C0079868|2921|MH|||RC
9325282|Dimerization|C0376525|2897|MH|||RC
9325282|Recombinant Fusion Proteins|C0034857|2670|MH|||RC
9325282|Molecular Sequence Data|C0026382|2641|MH|||RC
9325282|Membrane Proteins|C0025252|2288|MH|||RC
9325282|Models, Molecular|C0026344|2183|MH|||RC
9325282|Sulfur Radioisotopes|C0038783|2008|MH|||RC
9325282|Sequence Homology, Amino Acid|C0162777|1714|MH|||RC
9325282|P-Glycoprotein|C0242643|1512|MH|||RC
9325282|Escherichia coli|C0014834|1495|MH|||RC
9325282|Circular Dichroism|C0008813|1359|MH|||RC
9325282|Myocardium|C0027061|1228|MH|||RC
9325282|Gene Deletion|C0017260|1017|MH|||RC
9325282|Phosphodiesterase Inhibitors|C0031638|565|MH|||RC
9325282|Time Factors|C0040225|522|MH|||RC
9325282|Maleimides|C0024579|297|MH|RtM via: Maleimides|AB|MM
9325282|Cytoplasm|C0010834|208|MH|RtM via: Protoplasm|AB|MM
------
9325282|Humans|C0086418|1000|CT|Hela Cells||RC
9325282|Animals|C0003062|1000|CT|Xenopus laevis||RC
9325282|enzymology|C0014445|1602|SH1|RtM via: Cytochrome p450 CYP4A11 enzyme activity;enzymology (C0014445)|TI;AB|MM
9325282|genetics|C0017399|1111|SH|G05.355.760.860 (Transfection)||MM
9382073|*AIDS|C0001175|842382|ET|Entry Term Replacement for "Acquired Immunodeficiency Syndrome";RtM via: Acquired Immunodeficiency Syndrome|TI|MM;RC
9382073|Sarcoma, Kaposi|C0036220|642565|MH|RtM via: Kaposi's sarcoma of skin|AB|MM;RC
9382073|Skin Neoplasms|C0037286|43701|MH|RtM via: Kaposi's sarcoma of skin|AB|MM;RC
9382073|HIV Infections|C0019693|40153|MH|RtM via: HIV Infections|AB|MM;RC
9382073|HIV Seropositivity|C0019699|39491|MH|RtM via: HIV Seropositivity|AB|MM;RC
9382073|AIDS-Related Opportunistic Infections|C0162526|15788|MH|||RC
9382073|Tomography, X-Ray Computed|C0040405|8372|MH|||RC
9382073|Anti-HIV Agents|C0376565|7092|MH|||RC
9382073|Splenic Neoplasms|C0037999|5433|MH|||RC
9382073|Neoplasm Staging|C0027646|5041|MH|||RC
9382073|Liver|C0023884|4787|MH|RtM via: Liver;RtM via: Entire liver;RtM via: Liver Flavor|AB|MM;RC
9382073|Substance Abuse, Intravenous|C0038579|4651|MH|||RC
9382073|Homosexuality, Male|C0242658|4338|MH|||RC
9382073|Parotid Neoplasms|C0030581|4004|MH|||RC
9382073|Chylous Ascites|C0008732|3709|MH|||RC
9382073|Lymphatic Metastasis|C0024232|3632|MH|||RC
9382073|Lung Neoplasms|C0024121|3455|MH|||RC
9382073|Peritoneal Neoplasms|C0031149|2347|MH|||RC
9382073|Skin|C1123023|2278|MH|||RC
9382073|*Gastrointestinal Diseases|C0017178|1806|MH|RtM via: Lesion of liver|TI;AB|MM
9382073|Diagnosis, Differential|C0011906|1706|MH|||RC
9382073|Injections, Intravenous|C0021494|1120|MH|||RC
9382073|Treatment Outcome|C0085415|359|MH|||RC
9382073|*Lipid Metabolism Disorders|C0154251|330|MH|RtM via: Fatty degeneration|TI|MM
9382073|Liver Function Tests|C0023901|208|MH|RtM via: Liver Function Tests|AB|MM
------
9382073|Male|C0024554|1000|CT|Homosexuality, Male||RC
9382073|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9382073|secondary|C1522484|565|SH1|RtM via: metastatic qualifier;secondary (C1522484)|AB|MM
9382073|organization & administration|C0029236|97|SH|Organization and Administration|AB|MM
9382073|methods|C0025664|5|SH|Methods|AB|MM
9382073|radiography|C0034571|1111|SH|E01.370.350.700.700.810 (Tomography, X-Ray Computed)||MM
9377881|Positive-Pressure Respiration, Intrinsic|C0242676|308386|MH|RtM via: Positive-Pressure Respiration, Intrinsic|AB|MM;RC
9377881|Tidal Volume|C0040210|227195|MH|RtM via: Tidal Volume|AB|MM;RC
9377881|Positive-Pressure Respiration|C0032740|191321|MH|Forced Lookup:positive end-expiratory pressure||MM;RC
9377881|Respiration, Artificial|C0035205|115310|MH|||RC
9377881|Intermittent Positive-Pressure Ventilation|C0021778|70840|MH|RtM via: Volume controlled ventilation|AB|MM;RC
9377881|*Ventilator|C0087153|32520|ET|Entry Term Replacement for "Ventilators, Mechanical";RtM via: Ventilator - respiratory equipment|TI;AB|MM
9377881|*Pressure|C0033095|23070|MH|RtM via: Pressure- physical agent|TI;AB|MM;RC
9377881|Respiratory Mechanics|C0035230|21107|MH|||RC
9377881|Ventilatory Muscles|C0035231|17040|ET|Entry Term Replacement for "Respiratory Muscles";RtM via: Respiratory Muscles|AB|MM;RC
9377881|Respiration|C0035203|13131|MH|RtM via: Ventilated|AB|MM;RC
9377881|*Respiratory System|C0035237|12786|MH|RtM via: Breath|TI;AB|MM
9377881|Pulmonary Ventilation|C0035213|11611|MH|||RC
9377881|Intubation, Intratracheal|C0021932|8794|MH|||RC
9377881|Intensive Care Unit|C0021708|6245|ET|Entry Term Replacement for "Intensive Care Units";RtM via: intensive care unit;RtM via: Room type - Intensive care unit|AB|MM;RC
9377881|Manometry|C0024751|2358|MH|||RC
9377881|Respiratory Rate|C0231832|1496|MH|||RC
9377881|*Physical Processes|C0597237|1059|MH|RtM via: Flow|TI;AB|MM
9377881|Severity of Illness Index|C0036859|625|MH|||RC
9377881|Equipment Design|C0014677|609|MH|||RC
------
9377881|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9377881|methods|C0025664|49|SH|Methods|AB|MM
9315229|transcription factor PEA3|C0084827|1469585|NM|RtM via: transcription factor PEA3;Forced Lookup:pea-3|AB|MM
9315229|Transcription Factors|C0040648|1469584|MH|RtM via: transcription factor PEA3;RtM via: ETS Family Protein|AB|MM;RC
9315229|DNA-Binding Proteins|C0012940|446584|MH|RtM via: Sequence-Specific DNA Binding Protein|AB|MM;RC
9315229|*Oncogenes|C0029016|308007|MH|RtM via: Oncogene ETS|TI|MM;RC
9315229|Proto-Oncogene Proteins c-ets|C0072461|229864|MH|||RC
9315229|Repressor Proteins|C0035147|98602|MH|||RC
9315229|Molecular Sequence Data|C0026382|67825|MH|||RC
9315229|Proto-Oncogene Protein c-ets-1|C0377914|64268|MH|||RC
9315229|Proto-Oncogene Proteins c-myb|C0072473|51499|MH|||RC
9315229|Proto-Oncogene Protein c-ets-2|C0072462|43023|MH|||RC
9315229|Transcriptional Activation|C0162493|42343|MH|||RC
9315229|Amino Acid Sequence|C0002518|39433|MH|||RC
9315229|Multigene Family|C0017363|32322|MH|||RC
9315229|Binding Sites|C0005456|29314|MH|||RC
------
9315229|Humans|C0086418|1000|CT|CT Text Lookup: human;CT Text Lookup: man;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: human;CT Text Lookup: man;CT Text Lookup: patient;CT Text Lookup: patients|MM
9315229|Male|C0024554|1000|CT|CT Text Lookup: man|CT Text Lookup: man|MM
9315229|genetics|C0017399|1111|SH|G05.360.340.024.340.375.500 (Oncogenes)|TI|MM
9261855|*Histoplasmosis|C0019655|1799628|MH|RtM via: Histoplasmosis|TI|MM;RC
9261855|Histoplasma capsulatum|C0319941|495423|ET|Entry Term Replacement for "Histoplasma";RtM via: Histoplasma capsulatum|AB|MM;RC
9261855|Lung Diseases, Fungal|C0024116|125957|MH|||RC
9261855|Antifungal Agents|C0003308|73346|MH|||RC
9261855|*Hemoptysis|C0019079|61458|MH|RtM via: coughing up massive amount of blood;RtM via: Hemoptysis|TI;AB|MM;RC
9261855|Dermatomycoses|C0011630|34094|MH|||RC
9261855|Antigens, Fungal|C0003330|4086|MH|||RC
9261855|Lymphatic Diseases|C0024228|3102|MH|RtM via: HILAR ADENOPATHY|AB|MM;RC
9261855|Bronchoscopy|C0006290|2214|MH|RtM via: Bronchoscopy|AB|MM;RC
9261855|HIV Infections|C0019693|1151|MH|||RC
9261855|Travel|C0040802|954|MH|||RC
9261855|Transplantation, Homologous|C0040739|927|MH|||RC
9261855|Kidney Transplantation|C0022671|863|MH|||RC
9261855|Drug Interactions|C0687133|690|MH|||RC
9261855|Adoption|C0001593|598|MH|||RC
------
9261855|Male|C0024554|1000|CT|CT Text Lookup: boy|CT Text Lookup: boy|MM
9261855|Child|C0008059|1000|CT|CT Text Lookup: child|CT Text Lookup: child|MM
9261855|Humans|C0086418|1000|CT|CT Text Lookup: child|CT Text Lookup: child|MM
9261855|surgery|C0038895|1111|SH1|RtM via: Excision;Surgical Procedures, Operative (C0543467)|AB|MM
9261855|immunology|C1522005|1111|SH|D23.050.202 (Antigens, Fungal)||MM
9261855|transplantation|C0029216|1111|SH|E04.936.864 (Transplantation, Homologous)||MM
9336559|*Self Efficacy|C0600564|670944|MH|RtM via: Self Efficacy|TI;AB|MM;RC
9336559|Health Behavior|C0018687|225397|MH|RtM via: Health behavior;RtM via: Health behavior outcomes|AB|MM;RC
9336559|Internal-External Control|C0021783|88075|MH|||RC
9336559|Self Esteem|C0036597|80983|ET|Entry Term Replacement for "Self Concept";RtM via: Self Esteem|AB|MM;RC
9336559|Adaptation, Psychological|C0683269|54764|MH|||RC
9336559|Attitude to Health|C0004275|47157|MH|||RC
9336559|Diet|C0012155|31060|MH|RtM via: Diet|AB|MM;RC
9336559|Models, Psychological|C0026347|25920|MH|||RC
9336559|*Behavior|C0004927|23031|MH|RtM via: Health-related behavior;RtM via: Behavior|TI;AB|MM
9336559|Questionnaires|C0034394|17598|MH|||RC
9336559|Health Status|C0018759|17544|MH|||RC
9336559|Social Support|C0037438|16626|MH|||RC
9336559|Health|C0018684|13971|MH|RtM via: Health|AB|MM;RC
9336559|Health Knowledge, Attitudes, Practice|C0022758|12421|MH|||RC
------
9336559|Humans|C0086418|1000|CT|CT Text Lookup: human|CT Text Lookup: human|MM
9336559|prevention & control|C0033107|3669|SH1|RtM via: control aspects;prevention & control (C0033107)|TI;AB|MM
9336559|methods|C0025664|3123|SH|Methods|TI;AB|MM
9281438|*Myocardium|C0027061|490737|MH|RtM via: Myocardium|TI|MM;RC
9281438|Stunned Myocardium|C0206145|368447|ET|Entry Term Replacement for "Myocardial Stunning";RtM via: Stunned Myocardium|AB|MM;RC
9281438|Hearts|C0018787|130829|ET|Entry Term Replacement for "Heart";RtM via: Heart|AB|MM;RC
9281438|Systole|C0039155|126312|MH|RtM via: Systole|AB|MM;RC
9281438|Myocardial Contraction|C0027045|89411|MH|||RC
9281438|Cardiotonic Agents|C0007209|80535|MH|||RC
9281438|*Calcium|C0006675|63432|MH|RtM via: Calcium ion|TI;AB|MM;RC
9281438|Myocardial Reperfusion Injury|C0027055|59180|MH|||RC
9281438|Oxygen Consumption|C0030055|43960|MH|||RC
9281438|Pyridazines|C0034250|38345|MH|||RC
9281438|Ischemic Preconditioning, Myocardial|C0376442|21902|MH|||RC
9281438|Coronary Circulation|C0010067|18142|MH|||RC
9281438|Ventricular Dysfunction, Left|C0242698|16646|MH|||RC
9281438|Heart Rate|C0018810|15760|MH|RtM via: heart rate|AB|MM;RC
9281438|Stroke Volume|C0038455|10893|MH|||RC
9281438|Phosphodiesterase Inhibitors|C0031638|8277|MH|||RC
9281438|Energy Metabolism|C0014272|6722|MH|||RC
9281438|Vasodilator Agents|C0042402|5275|MH|||RC
9281438|Vasoconstrictor Agents|C0042397|5095|MH|||RC
9281438|Blood Pressure|C0005823|5052|MH|||RC
9281438|*Ischemia|C0022116|4785|MH|RtM via: Ischemic;RtM via: Ischemia|TI;AB|MM
9281438|Muscle, Skeletal|C0242692|4403|MH|||RC
9281438|Oxygen|C0030054|4011|MH|||RC
9281438|Tissue Distribution|C0040287|2473|MH|||RC
9281438|Cyclic AMP|C0001455|1979|MH|||RC
9281438|Ventricular Function|C0080309|1921|MH|RtM via: Ventricular Function|AB|MM
9281438|*Ions|C0022023|1710|MH|RtM via: Calcium ion|TI;AB|MM
9281438|Brain|C0006104|1215|MH|||RC
9281438|Swine|C0039005|1034|MH|||RC
9281438|Drug Evaluation, Preclinical|C0013206|501|MH|||RC
------
9281438|Animals|C0003062|1000|CT|Swine;CT Text Lookup: rabbit|CT Text Lookup: rabbit|MM;RC
9281438|Rabbits|C0034493|1000|CT|CT Text Lookup: rabbit|CT Text Lookup: rabbit|MM
9313157|Rumen|C0035946|560530|MH|RtM via: Rumen|AB|MM;RC
9313157|*Starch|C0038179|496632|MH|RtM via: Starch|TI;AB|MM;RC
9313157|Digestion|C0012238|150652|MH|||RC
9313157|*Leucine|C0023401|144438|MH|RtM via: Leucine|TI;AB|MM;RC
9313157|Lactation|C0022925|98896|MH|||RC
9313157|Maize|C1138842|75652|ET|Entry Term Replacement for "Zea mays";RtM via: Maize;RtM via: Zea mays|AB|MM;RC
9313157|Animal Nutritional Physiological Phenomena|C1720746|70603|MH|||RC
9313157|*Glutamine|C0017797|57420|MH|RtM via: Glutamine|TI;AB|MM
9313157|*Bioavailability|C0005508|56247|ET|Entry Term Replacement for "Biological Availability";RtM via: Biological Availability|TI;AB|MM;RC
9313157|Amino Acids|C0002520|55759|MH|RtM via: Amino Acids|AB|MM;RC
9313157|Half-Life|C0018517|51861|MH|RtM via: Half-Life;Forced Lookup:half-life|AB|MM
9313157|Duodenum|C0013303|43524|MH|RtM via: Duodenum;RtM via: Entire duodenum|AB|MM;RC
9313157|Dietary Proteins|C0012177|42653|MH|||RC
9313157|Fermentation|C0015852|37139|MH|||RC
9313157|Animal Feed|C0003050|33853|MH|||RC
9313157|Gastrointestinal Contents|C0017177|21397|MH|||RC
9313157|Nutritional Requirements|C0028719|20228|MH|||RC
9313157|Dairying|C0010948|18420|MH|||RC
9313157|Glucose|C0017725|17307|MH|||RC
9313157|Eating|C0013470|14116|MH|||RC
9313157|Dietary Carbohydrates|C0012170|11845|MH|||RC
9313157|Kinetics|C0022702|7778|MH|RtM via: Kinetics|AB|MM;RC
9313157|Intestinal Absorption|C0021826|5475|MH|||RC
9313157|Energy Metabolism|C0014272|5372|MH|||RC
9313157|Blood Glucose|C0005802|5328|MH|||RC
9313157|Nitrogen Isotopes|C0028162|4574|MH|||RC
9313157|Gastrointestinal Transit|C0017191|3475|MH|||RC
9313157|Sweetening Agents|C0038998|2972|MH|||RC
9313157|Propionic Acids|C0033482|1613|MH|||RC
9313157|Hydrogen-Ion Concentration|C0020283|1168|MH|||RC
9313157|Dose-Response Relationship, Drug|C0013059|849|MH|||RC
9313157|Absorption|C0000854|278|MH|RtM via: Process of absorption|AB|MM
------
9313157|Cattle|C0007452|175260|CT||TI;AB|MM
9313157|Animals|C0003062|1000|CT|Rumen;Animal Nutritional Physiological Phenomena;CT Text Lookup: rumen|AB;CT Text Lookup: rumen|MM;RC
9313157|Female|C0015780|1000|CT|Lactation||RC
9344581|retinoic acid receptor beta|C0140280|1359008|NM|RtM via: retinoic acid receptor beta;Forced Lookup:retinoic acid receptor-beta|AB|MM
9344581|*Retinoic Acid Receptor|C0140278|1359007|ET|Entry Term Replacement for "Receptors, Retinoic Acid";RtM via: Retinoic Acid Receptor;RtM via: retinoic acid receptor alpha;RtM via: retinoic acid receptor beta|TI;AB|MM;RC
9344581|retinoic acid receptor alpha|C0140279|1226798|NM|RtM via: retinoic acid receptor alpha|AB|MM
9344581|trans-Retinoic Acid|C0040845|330335|ET|Entry Term Replacement for "Tretinoin";RtM via: Tretinoin;Forced Lookup:all-trans-retinoic acid;Forced Lookup:trans-retinoic acid|AB|MM;RC
9344581|*Epithelial Cells|C0014597|305952|MH|RtM via: Epithelial Cells|TI|MM;RC
9344581|*Epithelium|C0014609|155229|MH|RtM via: Epithelium|TI|MM;RC
9344581|*Cellular Proliferation|C0596290|130701|ET|Entry Term Replacement for "Cell Proliferation";RtM via: Cell Proliferation|TI|MM
9344581|*Mammary Glands, Human|C0929301|130329|MH|RtM via: Mammary gland|TI;AB|MM
9344581|Breast Cancer|C0006142|48374|ET|Entry Term Replacement for "Breast Neoplasms";RtM via: Breast Carcinoma;RtM via: Malignant neoplasm of breast|AB|MM;RC
9344581|Cultured Cells|C0007635|41478|ET|Entry Term Replacement for "Cells, Cultured";RtM via: Cultured Cells|AB|MM;RC
9344581|Nuclear Proteins|C0028589|34702|MH|||RC
9344581|mRNA|C0035696|31485|ET|Entry Term Replacement for "RNA, Messenger";RtM via: RNA, Messenger|AB|MM;RC
9344581|Apoptosis|C0162638|27068|MH|||RC
9344581|*Hyperplasia|C0020507|27021|MH|RtM via: Hyperplasia|TI|MM
9344581|Cell Differentiation|C0007589|23483|MH|RtM via: Cell Differentiation process|AB|MM;RC
9344581|G0 Phase|C0079394|17689|MH|||RC
9344581|Transfection|C0040669|13837|MH|||RC
9344581|Repressor Proteins|C0035147|11944|MH|||RC
9344581|Cell Cycle Proteins|C0243021|11188|MH|||RC
9344581|Cyclin-Dependent Kinase Inhibitor p21|C0288472|10648|MH|||RC
9344581|Tumor Suppressor Proteins|C0597611|9818|MH|||RC
9344581|Cell Aging|C0007581|9236|MH|||RC
9344581|Cell Line|C0007600|9126|MH|||RC
9344581|Transcriptional Activation|C0162493|8860|MH|||RC
9344581|*Cell Count|C0007584|6591|MH|RtM via: Epithelial cell count (procedure)|TI|MM
9344581|Gene Expression Regulation, Neoplastic|C0017268|6062|MH|||RC
9344581|Cyclin-Dependent Kinase Inhibitor p16|C0249880|6045|MH|||RC
9344581|Transduction, Genetic|C0040667|5938|MH|||RC
9344581|Signal Transduction|C0037083|5914|MH|||RC
9344581|Genetic Vectors|C0017397|5567|MH|||RC
9344581|CREB-Binding Protein|C0256079|5137|MH|||RC
9344581|Cell Transformation, Viral|C0007622|4793|MH|||RC
9344581|Cyclin-Dependent Kinase Inhibitor p15|C0258920|4665|MH|||RC
9344581|Flow Cytometry|C0016263|4314|MH|||RC
9344581|Proteasome Endopeptidase Complex|C0208355|4168|MH|||RC
9344581|Homeostasis|C0019868|3139|MH|||RC
9344581|Molecular Sequence Data|C0026382|2846|MH|||RC
9344581|Mutagenesis, Insertional|C0079868|1731|MH|||RC
9344581|Recombinant Fusion Proteins|C0034857|1620|MH|||RC
9344581|Antigens, Viral|C0003342|1420|MH|||RC
9344581|Models, Biological|C0026339|1342|MH|||RC
9344581|Substrate Specificity|C0038592|897|MH|||RC
9344581|Extracellular Matrix|C0015350|783|MH|RtM via: Extracellular Matrix|AB|MM
9344581|Cell Culture Techniques|C0007585|263|MH|RtM via: Cell Culture Techniques|AB|MM
------
9344581|Humans|C0086418|1000|CT|Mammary Glands, Human;Breast Cancer;CT Text Lookup: human|TI;AB;CT Text Lookup: human|MM;RC
9344581|metabolism|C0025520|29832|SH1|RtM via: Anabolism;Metabolism (C0025519);RtM via: Inhibited;Metabolism (C0025519);RtM via: Metabolic Inhibition;Metabolism (C0025519)|TI;AB|MM
9344581|physiology|C0031843|22725|SH1|RtM via: physiological aspects;physiology (C0031843)|TI;AB|MM
9344581|genetics|C0017399|1111|SH|G05.355.760.860 (Transfection)||MM
9344581|virology|C0205466|1111|SH|G06.920.875.210 (Cell Transformation, Viral)||MM
9344581|immunology|C1522005|1111|SH|D23.050.327 (Antigens, Viral)||MM
9380472|cefuroxime axetil|C0055015|1364214|NM|RtM via: cefuroxime axetil|AB|MM
9380472|*Cefuroxime|C0007562|1364213|MH|RtM via: Cefuroxime;RtM via: cefuroxime axetil|TI;AB|MM;RC
9380472|*Middle Ear Effusion|C0029883|325356|ET|Entry Term Replacement for "Otitis Media with Effusion";RtM via: Otitis Media with Effusion|TI;AB|MM;RC
9380472|*Otitis Media|C0029882|229260|MH|RtM via: Acute otitis media|TI;AB|MM;RC
9380472|beta-Lactams|C0282215|46798|MH|Forced Lookup:beta-lactams||MM
9380472|Haemophilus influenzae|C0018483|28372|MH|RtM via: Haemophilus influenzae|AB|MM;RC
9380472|Streptococcus pneumoniae|C0038410|21028|MH|RtM via: Streptococcus pneumoniae|AB|MM;RC
9380472|Minimum Inhibitory Concentration|C0427978|19974|ET|Entry Term Replacement for "Microbial Sensitivity Tests";RtM via: Minimum Inhibitory Concentration measurement|AB|MM;RC
9380472|Haemophilus Infections|C0018482|18055|MH|||RC
9380472|Middle Ear|C0013455|17810|ET|Entry Term Replacement for "Ear, Middle";RtM via: middle ear;RtM via: Entire middle ear|AB|MM;RC
9380472|Drug Therapy, Combination|C0013218|17793|MH|||RC
9380472|Pneumococcal Infections|C0032269|13443|MH|||RC
9380472|Anti-Bacterial Agents|C0279516|13357|MH|RtM via: Antibiotic concentrations|AB|MM;RC
9380472|Administration, Oral|C0001563|6549|MH|RtM via: Administration, Oral|AB|MM;RC
9380472|Exudates and Transudates|C0015389|4779|MH|RtM via: effusion|AB|MM;RC
9380472|beta-Lactamases|C0597979|2548|MH|||RC
9380472|Drug Administration Schedule|C0013154|2316|MH|||RC
9380472|Moraxella catarrhalis|C0006132|1242|ET|Entry Term Replacement for "Moraxella (Branhamella) catarrhalis";RtM via: Moraxella (Branhamella) catarrhalis|AB|MM
9380472|Pharmaceutical Preparations|C0013227|1228|MH|||RC
9380472|Suspensions|C0038960|1148|MH|RtM via: Suspensions;RtM via: Suspension substance|AB|MM;RC
9380472|Treatment Outcome|C0085415|917|MH|||RC
9380472|Colony Count, Microbial|C0009380|654|MH|||RC
9380472|Dose-Response Relationship, Drug|C0013059|601|MH|||RC
9380472|Drug Monitoring|C0085421|560|MH|||RC
9380472|Disease Models, Animal|C0012644|270|MH|||RC
9380472|Chromatography, High Pressure Liquid|C0008562|250|MH|||RC
------
9380472|Animals|C0003062|1000|CT|Disease Models, Animal||RC
9380472|Child|C0008059|1000|CT|CT Text Lookup: children;CT Text Lookup: pediatric|CT Text Lookup: children;CT Text Lookup: pediatric|MM
9380472|Humans|C0086418|1000|CT|CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: pediatric|CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: pediatric|MM
9357761|Chloride Channels|C0055363|76112|MH|||RC
9357761|Reverse Transcriptase Polymerase Chain Reaction|C0599161|75889|MH|RtM via: Reverse Transcriptase Polymerase Chain Reaction;Forced Lookup:rt-pcr|AB|MM;RC
9357761|cDNA|C0006556|71562|ET|Entry Term Replacement for "DNA, Complementary";RtM via: DNA, Complementary|AB|MM;RC
9357761|4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid|C0057911|62560|MH|Forced Lookup:4,4'-diisothiocyanostilbene-2,2'-disulfonic acid||MM;RC
9357761|*Cell Line|C0007600|55860|MH|RtM via: Cell Line|TI|MM;RC
9357761|Amino Acid Sequences|C0002518|45110|ET|Entry Term Replacement for "Amino Acid Sequence";RtM via: Amino Acid Sequence|AB|MM;RC
9357761|Xenopus laevis|C0043343|41953|MH|RtM via: Xenopus laevis|AB|MM;RC
9357761|*Kidney|C0022646|35658|MH|RtM via: Kidney;RtM via: Epithelial cell of renal tubule;RtM via: Entire kidney|TI;AB|MM;RC
9357761|Molecular Sequence Data|C0026382|35303|MH|||RC
9357761|Cloning, Molecular|C0009017|34565|MH|||RC
9357761|mRNA|C0035696|33873|ET|Entry Term Replacement for "RNA, Messenger";RtM via: RNA, Messenger|AB|MM;RC
9357761|Chlorides|C0008203|33320|MH|||RC
9357761|Patch-Clamp Techniques|C0242625|30517|MH|||RC
9357761|DNA Primers|C0206416|27898|MH|RtM via: Oligonucleotide Primers|AB|MM;RC
9357761|Base Sequence|C0004793|26121|MH|RtM via: DNA Sequence;RtM via: Base Sequence|AB|MM;RC
9357761|Ion Transport|C0162585|24663|MH|RtM via: Ion Transport|AB|MM;RC
9357761|Oocytes|C0029045|21202|MH|RtM via: Oocytes|AB|MM;RC
9357761|*Epithelial Cells|C0014597|19929|MH|RtM via: Epithelial cell of renal tubule|TI;AB|MM;RC
9357761|cardiotrophin-like cytokine|C0908711|16309|NM|RtM via: cardiotrophin-like cytokine|TI;AB|MM
9357761|*Cytokines|C0079189|16308|HM|RtM via: cardiotrophin-like cytokine|TI;AB|MM
9357761|Membrane Potentials|C0025251|12938|MH|||RC
9357761|Anions|C0003075|12716|MH|RtM via: Anions|AB|MM;RC
9357761|Cell Volume|C0596292|9202|ET|Entry Term Replacement for "Cell Size";RtM via: Cell Volume|AB|MM;RC
9357761|Anion Transport Proteins|C0051913|8049|MH|||RC
9357761|Transfection|C0040669|7918|MH|||RC
9357761|Sequence Homology, Amino Acid|C0162777|7282|MH|||RC
9357761|Xenopus Proteins|C0950056|6686|MH|||RC
9357761|Kidney Tubules, Collecting|C0022675|5807|MH|||RC
9357761|Ion Channel Gating|C0022008|4891|MH|||RC
9357761|In Situ Hybridization|C0162788|4726|MH|||RC
9357761|Sequence Alignment|C0080143|4323|MH|||RC
9357761|Gene Expression Profiling|C0752248|3979|MH|||RC
9357761|Water-Electrolyte Balance|C0043064|3873|MH|||RC
9357761|Cell Polarity|C0085304|2961|MH|||RC
9357761|Hela Cells|C0018873|2711|MH|||RC
9357761|Electrophysiology|C0013865|2498|MH|||RC
9357761|Recombinant Fusion Proteins|C0034857|2400|MH|||RC
9357761|Nerve Tissue Proteins|C0027759|2341|MH|||RC
9357761|Membrane Proteins|C0025252|2209|MH|||RC
9357761|Sequence Analysis, DNA|C0162802|2163|MH|||RC
9357761|Mutagenesis, Site-Directed|C0079870|2109|MH|||RC
9357761|Cells, Cultured|C0007635|2067|MH|||RC
9357761|Species Specificity|C0037783|1946|MH|||RC
9357761|Pigment Epithelium of Eye|C0031907|1929|MH|||RC
9357761|Brain|C0006104|1806|MH|RtM via: Brain;RtM via: Entire brain|AB|MM;RC
9357761|Homeostasis|C0019868|1802|MH|||RC
9357761|Cell Line, Transformed|C0007601|1796|MH|||RC
9357761|Hydrogen-Ion Concentration|C0020283|1711|MH|||RC
9357761|Cyclic AMP|C0001455|1558|MH|||RC
9357761|Body Water|C0005909|1449|MH|||RC
------
9357761|Animals|C0003062|1000|CT|Xenopus laevis;CT Text Lookup: rat;CT Text Lookup: stomach|AB;CT Text Lookup: rat;CT Text Lookup: stomach|MM;RC
9357761|Humans|C0086418|1000|CT|Hela Cells;CT Text Lookup: human|CT Text Lookup: human|MM;RC
9357761|Rats|C0034721|1000|CT|CT Text Lookup: rat|CT Text Lookup: rat|MM
9357761|genetics|C0017399|1111|SH|G05.360.080 (Base Sequence)|AB|MM
9285033|*Williams Syndrome|C0175702|1093632|MH|RtM via: Williams Syndrome|TI;AB|MM;RC
9285033|Elastin|C0013765|77764|MH|RtM via: Elastin;RtM via: Elastin activity|AB|MM;RC
9285033|Chromosome Deletion|C0008628|41514|MH|||RC
9285033|Karyotyping|C0022526|34335|MH|RtM via: Karyotype determination procedure|AB|MM;RC
9285033|In Situ Hybridization, Fluorescence|C0162789|31714|MH|||RC
9285033|Gene Deletion|C0017260|20575|MH|||RC
9285033|Chromosomes, Human, Pair 22|C0008665|13092|MH|||RC
9285033|Facies|C0282631|11271|MH|RtM via: Facies|AB|MM;RC
9285033|Supravalvular Aortic Stenosis|C0003499|7131|ET|Entry Term Replacement for "Aortic Stenosis, Supravalvular";RtM via: Supravalvular aortic stenosis|AB|MM
9285033|Chromosomes, Human, Pair 11|C0008653|7069|MH|||RC
9285033|Abnormalities, Multiple|C0000772|6920|MH|||RC
9285033|Syndrome|C0039082|6188|MH|||RC
9285033|In Situ Hybridization|C0162788|5578|MH|||RC
9285033|Phenotype|C0031437|5049|MH|||RC
9285033|Genotype|C0017431|3092|MH|||RC
9285033|Face|C0015450|2498|MH|RtM via: Face|AB|MM;RC
9285033|Chromosome Mapping|C0008630|2226|MH|||RC
9285033|Growth Disorders|C0018273|1993|MH|||RC
9285033|Genetic Variation|C0042333|1781|MH|||RC
9285033|Ultrasonography, Prenatal|C0080265|1699|MH|||RC
9285033|Singapore|C0037173|1080|MH|RtM via: Singapore|TI|MM
9285033|Sequence Deletion|C0162773|849|MH|RtM via: Deletion Mutation;RtM via: Deletion (action)|AB|MM
9285033|Mental Deficiency|C0917816|441|ET|Entry Term Replacement for "Mental Retardation";RtM via: Mental deficiency|AB|MM
9285033|Hypercalcemia|C0020437|403|MH|RtM via: Hypercalcemia|AB|MM
9285033|Mitral Valve Prolapse|C0026267|358|MH|RtM via: Mitral Valve Prolapse|AB|MM
9285033|Mitral Regurgitation|C0026266|223|ET|Entry Term Replacement for "Mitral Valve Insufficiency";RtM via: Mitral Valve Insufficiency|AB|MM
------
9285033|Humans|C0086418|1000|CT|Chromosomes, Human, Pair 22;Chromosomes, Human, Pair 11;Ultrasonography, Prenatal;CT Text Lookup: aged;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: aged;CT Text Lookup: patient;CT Text Lookup: patients|MM;RC
9285033|Female|C0015780|1000|CT|Ultrasonography, Prenatal;CT Text Lookup: girl;CT Text Lookup: girls|CT Text Lookup: girls|MM;RC
9285033|Pregnancy|C0032961|1000|CT|Ultrasonography, Prenatal||RC
9285033|methods|C0025664|1|SH|Methods|AB|MM
9285033|genetics|C0017399|1111|SH|G05.355.600.800.180 (Chromosome Deletion)||MM
9285033|ultrasonography|C0175676|1111|SH|E01.370.350.850.865 (Ultrasonography, Prenatal)||MM
9287109|*Schizosaccharomyces pombe|C0178453|1874922|ET|Entry Term Replacement for "Schizosaccharomyces";RtM via: Schizosaccharomyces pombe|TI;AB|MM;RC
9287109|*Arabidopsis thaliana|C0162740|523677|ET|Entry Term Replacement for "Arabidopsis";RtM via: Arabidopsis thaliana|TI;AB|MM;RC
9287109|*cDNA|C0006556|311142|ET|Entry Term Replacement for "DNA, Complementary";RtM via: DNA, Complementary|TI;AB|MM;RC
9287109|Schizosaccharomyces pombe Proteins|C0949988|266007|MH|||RC
9287109|*Pheromone Receptors|C0031515|110634|ET|Entry Term Replacement for "Receptors, Pheromone";RtM via: Pheromone Receptors|TI;AB|MM
9287109|Amino Acid Sequence|C0002518|108380|MH|||RC
9287109|Molecular Sequence Data|C0026382|103049|MH|||RC
9287109|Meiosis|C0025186|96549|MH|RtM via: Meiosis|AB|MM;RC
9287109|Fungal Proteins|C0016829|67091|MH|||RC
9287109|DNA, Fungal|C0012927|62121|MH|||RC
9287109|Gene Expression Regulation, Fungal|C0017266|55542|MH|||RC
9287109|*Proteins|C0033684|51981|MH|RtM via: Proteins;RtM via: Protein measurement|TI;AB|MM
9287109|Sequence Homology, Amino Acid|C0162777|48048|MH|||RC
9287109|Genetic Complementation Test|C0017381|44051|MH|||RC
9287109|Arabidopsis Proteins|C0969730|43973|MH|||RC
9287109|Cloning, Molecular|C0009017|41239|MH|||RC
9287109|Genes, Plant|C0162728|33013|MH|||RC
9287109|Sequence Alignment|C0080143|31849|MH|||RC
9287109|Conserved Sequence|C0009802|29690|MH|||RC
9287109|Plant Proteins|C0032089|25489|MH|||RC
9287109|Saccharomyces cerevisiae|C0036025|25091|MH|||RC
9287109|Sequence Analysis, DNA|C0162802|22425|MH|||RC
9287109|Blotting, Northern|C0005861|21863|MH|RtM via: Northern Blotting|AB|MM;RC
9287109|Saccharomyces cerevisiae Proteins|C0949987|20990|MH|||RC
9287109|Gene Expression Regulation, Plant|C0242717|19188|MH|||RC
9287109|Spores, Fungal|C0038029|15690|MH|||RC
9287109|Genome, Plant|C0242965|15463|MH|||RC
9287109|RNA, Messenger|C0035696|13050|MH|||RC
9287109|Proto-Oncogene Proteins c-myb|C0072473|12896|MH|||RC
9287109|Mutation|C0026882|12866|MH|||RC
9287109|Cell Cycle Proteins|C0243021|12032|MH|||RC
9287109|DNA, Plant|C0242964|10006|MH|||RC
9287109|Two-Hybrid System Techniques|C0752172|9681|MH|||RC
9287109|Binding Sites|C0005456|8618|MH|||RC
9287109|Signal Transduction|C0037083|8572|MH|RtM via: Signal|AB|MM;RC
9287109|RNA Helicases|C0084378|7835|MH|||RC
9287109|In Situ Hybridization|C0162788|7519|MH|||RC
9287109|Gene Duplication|C0017261|6240|MH|||RC
9287109|Alternative Splicing|C0002345|6025|MH|||RC
9287109|Recombinant Fusion Proteins|C0034857|5933|MH|||RC
9287109|Models, Genetic|C0026343|5228|MH|||RC
9287109|Gene Expression Regulation, Developmental|C0242718|5077|MH|||RC
9287109|Protein Binding|C0033618|4971|MH|||RC
9287109|DEAD-box RNA Helicases|C1720998|4495|MH|||RC
9287109|Genetic Variation|C0042333|3489|MH|||RC
9287109|Mutagenesis, Site-Directed|C0079870|3236|MH|||RC
9287109|Phylogeny|C0031797|3195|MH|||RC
9287109|Evolution|C0015219|2364|MH|||RC
9287109|Species Specificity|C0037783|2262|MH|||RC
9287109|Cyclic AMP|C0001455|2255|MH|||RC
------
9287109|genetics|C0017399|1111|SH|G05.355.105.220.687 (Meiosis)|AB|MM
9381776|*Heart Defects, Congenital|C0018798|742053|MH|RtM via: Holt-Oram syndrome;RtM via: Congenital Heart Defects;RtM via: Congenital heart disease;RtM via: Reported family history of congenital heart disease|TI;AB|MM;RC
9381776|*Abnormalities, Multiple|C0000772|347724|MH|RtM via: Holt-Oram syndrome|TI;AB|MM;RC
9381776|*Syndrome|C0039082|333639|MH|RtM via: Holt-Oram syndrome;RtM via: Syndrome|TI;AB|MM;RC
9381776|Hand Deformities, Congenital|C0018566|205029|MH|RtM via: Talipomanus|AB|MM;RC
9381776|Ventricular Septal Defects|C0018818|184091|ET|Entry Term Replacement for "Heart Septal Defects, Ventricular";RtM via: Ventricular Septal Defects|AB|MM;RC
9381776|*Chromosome Disorders|C0008626|138966|MH|RtM via: Holt-Oram syndrome|TI;AB|MM;RC
9381776|Ectromelia|C0013589|104848|MH|RtM via: Talipomanus|AB|MM;RC
9381776|Thumb|C0040067|59126|MH|RtM via: Thumb structure;RtM via: Entire thumb|AB|MM;RC
9381776|Fingers|C0016129|38638|MH|RtM via: Index finger|AB|MM;RC
9381776|Pedigree|C0030761|17146|MH|||RC
9381776|*Cardiomyopathies|C0878544|14757|MH|RtM via: Holt-Oram syndrome|TI;AB|MM
9381776|Arm|C0446516|11823|MH|RtM via: Talipomanus|AB|MM;RC
9381776|Fetal Heart|C0015935|10732|MH|||RC
9381776|T-Box Domain Proteins|C0752212|6604|MH|||RC
------
9381776|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9381776|therapy|C0039798|5904|SH1|RtM via: therapeutic aspects;therapy (C0039798)|TI;AB|MM
9381776|methods|C0025664|2274|SH1|RtM via: Methodology;methods (C0025664)|AB|MM
9306153|CD69 antigen|C0108800|2118280|NM|RtM via: CD69 antigen|TI;AB|MM
9306153|*Antigens, Differentiation, T-Lymphocyte|C0003329|2118279|HM|RtM via: CD69 antigen|TI;AB|MM;RC
9306153|*Antigens, CD|C0003322|846456|HM|RtM via: CD69 antigen|TI;AB|MM;RC
9306153|*Ouabain|C0029904|137556|MH|RtM via: Ouabain|TI;AB|MM;RC
9306153|*Lymphocytes|C0024264|129330|MH|RtM via: Activated Lymphocyte;RtM via: Peripheral Blood Lymphocyte|TI;AB|MM;RC
9306153|Lymphocyte Activation|C0024262|117721|MH|||RC
9306153|Interleukin-2|C0021756|66118|MH|RtM via: Interleukin-2;RtM via: Recombinant Interleukin-2|AB|MM;RC
9306153|CD4-Positive T-Lymphocytes|C0039215|26644|MH|||RC
9306153|Interleukin-2 Receptor alpha Subunit|C1101536|23112|MH|||RC
9306153|Cell Cycle|C0007586|19450|MH|RtM via: Cell Cycle;RtM via: Mitotic Cell Cycle|AB|MM;RC
9306153|Immunosuppressive Agents|C0021081|16472|MH|||RC
9306153|T-Lymphocyte Subsets|C0080202|16283|MH|||RC
9306153|CD8-Positive T-Lymphocytes|C0242629|14823|MH|||RC
9306153|Flow Cytometry|C0016263|13992|MH|||RC
9306153|Leukocytes, Mononuclear|C0023517|11378|MH|||RC
9306153|Tetradecanoylphorbol Acetate|C0039654|9104|MH|||RC
9306153|Cell Survival|C0007620|9048|MH|||RC
9306153|Apoptosis|C0162638|8395|MH|RtM via: Apoptosis|AB|MM;RC
9306153|Phorbol Esters|C0031586|8063|MH|RtM via: Phorbol Esters|AB|MM;RC
9306153|Cell Proliferation|C0596290|8037|MH|||RC
9306153|Cell Differentiation|C0007589|7699|MH|RtM via: induction activity|AB|MM;RC
9306153|Cells, Cultured|C0007635|6300|MH|||RC
9306153|*Cells|C0007634|5166|MH|RtM via: Cells|TI;AB|MM
9306153|Cell Separation|C0007616|4776|MH|||RC
9306153|Histocompatibility Antigens Class I|C0019629|4422|MH|||RC
9306153|Signal Transduction|C0037083|4185|MH|||RC
9306153|Antibodies, Monoclonal|C0003250|4077|MH|||RC
9306153|Gangliosides|C0017082|3314|MH|||RC
9306153|Membrane Proteins|C0025252|2784|MH|||RC
9306153|Sodium-Potassium-Exchanging ATPase|C0001479|2527|MH|||RC
9306153|Sarcoplasmic Reticulum Calcium-Transporting ATPases|C0916181|2360|MH|||RC
9306153|Binding, Competitive|C0005458|1288|MH|||RC
9306153|Calcium|C0006675|1241|MH|||RC
9306153|RNA, Messenger|C0035696|1157|MH|||RC
9306153|Phenotype|C0031437|756|MH|||RC
9306153|Kinetics|C0022702|646|MH|||RC
9306153|Dose-Response Relationship, Drug|C0013059|620|MH|||RC
9306153|Mice, Inbred BALB C|C0025919|551|MH|||RC
9306153|Time Factors|C0040225|236|MH|||RC
------
9306153|Animals|C0003062|1000|CT|Mice, Inbred BALB C||RC
9306153|Mice|C0026809|1000|CT|Mice, Inbred BALB C||RC
9306153|methods|C0025664|11|SH|Methods|AB|MM
9306153|immunology|C1522005|1111|SH|D23.050.301.264.894 (Antigens, Differentiation, T-Lymphocyte)|TI;AB|MM
9306153|genetics|C0017399|1111|SH|G05.695 (Phenotype)||MM
9337957|*Electroconvulsive Therapy|C0013806|1382994|MH|RtM via: Electroconvulsive Therapy|TI;AB|MM;RC
9337957|*Depressive Disorder|C0011581|411735|MH|RtM via: Depressive disorder;RtM via: Unipolar Depression|TI;AB|MM;RC
9337957|*Norepinephrine|C0028351|349866|MH|RtM via: Norepinephrine;RtM via: noradrenergic|TI;AB|MM;RC
9337957|Cortisol|C0020268|91201|ET|Entry Term Replacement for "Hydrocortisone";RtM via: Hydrocortisone|AB|MM;RC
9337957|Diagnostic and Statistical Manual of Mental Disorders|C1136324|62913|MH|RtM via: DSM III-R;Forced Lookup:dsm-iii|AB|MM;RC
9337957|Bipolar Disorder|C0005586|54531|MH|RtM via: Severe major depression with psychotic features|AB|MM;RC
9337957|Major Depressive Disorder|C1269683|34489|ET|Entry Term Replacement for "Depressive Disorder, Major";RtM via: Major Depressive Disorder;RtM via: Severe major depression with psychotic features|AB|MM;RC
9337957|Psychotic Disorders|C0033975|19329|MH|RtM via: Psychotic Disorders;RtM via: Psychotic symptom present;RtM via: Severe major depression with psychotic features|AB|MM;RC
9337957|Methoxyhydroxyphenylglycol|C0025691|12170|MH|||RC
9337957|Receptors, Adrenergic, alpha-2|C0001639|5629|MH|||RC
9337957|Brain|C0006104|2690|MH|||RC
9337957|Brain-Derived Neurotrophic Factor|C0107103|2199|MH|||RC
9337957|Electroencephalography|C0013819|2160|MH|||RC
9337957|Neuropsychological Tests|C0027902|2046|MH|||RC
9337957|Dysthymic Disorder|C0013415|1931|MH|RtM via: Dysthymic Disorder|AB|MM
9337957|Circadian Rhythm|C0008810|1816|MH|||RC
9337957|Depression|C0011570|1815|MH|RtM via: Depressed mood;RtM via: Mental Depression;RtM via: Depressive episode, unspecified|AB|MM
9337957|Receptors, Adrenergic, beta-2|C0001643|1466|MH|||RC
9337957|Treatment Outcome|C0085415|1385|MH|||RC
9337957|Synaptic Transmission|C0027793|1262|MH|||RC
9337957|Time Factors|C0040225|1226|MH|||RC
9337957|Sex Factors|C0036881|1103|MH|||RC
9337957|Age Factors|C0001783|938|MH|||RC
9337957|Radioligand Assay|C0034596|917|MH|||RC
9337957|Biological Markers|C0005516|677|MH|RtM via: Biological Markers|AB|MM;RC
9337957|Cold Temperature|C0009264|621|MH|||RC
9337957|Severity of Illness Index|C0036859|531|MH|||RC
9337957|Reference Values|C0034926|430|MH|||RC
9337957|Suffering|C0683278|250|ET|Entry Term Replacement for "Stress, Psychological";RtM via: Mental Suffering|AB|MM
------
9337957|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9337957|organization & administration|C0029236|1002|SH|Organization and Administration|TI;AB|MM
9337957|injuries|C1510467|12|SH|Wounds and Injuries|AB|MM
9351726|*beta-Adrenergic Blocking Agents|C0001645|545946|ET|Entry Term Replacement for "Adrenergic beta-Antagonists";RtM via: Adrenergic beta-Antagonists|TI;AB|MM;RC
9351726|*Myocardial Infarction|C0027051|316257|MH|RtM via: Myocardial Infarction|TI;AB|MM;RC
9351726|Angioplasty, Transluminal, Percutaneous Coronary|C0002997|53421|MH|||RC
9351726|Coronary Angiography|C0085532|16727|MH|RtM via: Coronary angiography;RtM via: Consent Type - Coronary Angiography|AB|MM;RC
9351726|*HMO|C0018720|14955|ET|Entry Term Replacement for "Health Maintenance Organizations";RtM via: Health Maintenance Organizations|TI|MM
9351726|Antihypertensive Agents|C0003364|10849|MH|||RC
9351726|Treatment Outcome|C0085415|7863|MH|||RC
9351726|Analyses, Multivariate|C0026777|7379|ET|Entry Term Replacement for "Multivariate Analysis";RtM via: Multivariate Analysis|AB|MM;RC
9351726|Relative Risk|C0242492|7253|ET|Entry Term Replacement for "Risk";RtM via: Relative Risk|AB|MM;RC
9351726|Stroke Volume|C0038455|4444|MH|||RC
9351726|Risk Assessment|C0086930|4424|MH|||RC
9351726|Physician's Practice Patterns|C0031828|4073|MH|||RC
9351726|Drug Utilization|C0013223|4018|MH|||RC
9351726|Risk Factors|C0035648|3315|MH|||RC
9351726|Guideline Adherence|C0525059|2671|MH|||RC
9351726|Randomized Controlled Trials as Topic|C0282440|2607|MH|||RC
9351726|Outcome Assessment (Health Care)|C0085565|2414|MH|||RC
9351726|Patient Selection|C0242802|2003|MH|||RC
9351726|Practice Guidelines as Topic|C0162793|1940|MH|||RC
9351726|Survivors|C0206194|1818|MH|RtM via: Survivors|AB|MM;RC
9351726|Age Distribution|C0001782|1306|MH|||RC
9351726|Dose-Response Relationship, Drug|C0013059|1133|MH|||RC
9351726|Preoperative Care|C0033061|1038|MH|||RC
9351726|Recovery of Function|C0599766|968|MH|||RC
9351726|Chemotherapy, Adjuvant|C0085533|625|MH|||RC
9351726|Drug Therapy, Combination|C0013218|480|MH|||RC
9351726|Cardiology|C0007189|313|MH|RtM via: cardiology discipline|AB|MM
9351726|Infusions, Intravenous|C0021440|252|MH|||RC
9351726|American Heart Association|C0002458|211|MH|RtM via: American Heart Association|AB|MM
------
9351726|United States|C0041703|1000|MH+|CT Text Lookup: american heart association||MM
9351726|Humans|C0086418|1000|CT|Preoperative Care;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM;RC
9351726|mortality|C0026566|192780|SH1|RtM via: Death Rate;Mortality (C0026565);RtM via: Mortality Vital Statistics;RtM via: survival aspects;mortality (C0026566)|TI;AB|MM
9351726|methods|C0025664|4|SH|Methods|AB|MM
9351726|surgery|C0038895|1111|SH|E04.100.376.719.100 (Angioplasty, Transluminal, Percutaneous Coronary)||MM
9351726|radiography|C0034571|1111|SH|E01.370.350.700.060.200 (Coronary Angiography)|AB|MM
9351726|economics|C0013557|1111|SH|N03.219.521.576.343.800.400 (HMO)|TI|MM
9302538|*Sex Offenses|C0036888|98283|MH|RtM via: Sexual assault|TI;AB|MM;RC
9302538|Child Abuse, Sexual|C0008062|67479|MH|||RC
9302538|Child Abuse|C0008060|12532|MH|||RC
9302538|Stress Disorders, Post-Traumatic|C0038436|9898|MH|||RC
9302538|Depression|C0011570|9290|MH|RtM via: Mental Depression;RtM via: Depressed mood;RtM via: Depressive episode, unspecified|AB|MM;RC
9302538|Odds Ratio|C0028873|7068|MH|RtM via: Odds Ratio|AB|MM;RC
9302538|Spouse|C0162409|6417|ET|Entry Term Replacement for "Spouses";RtM via: spouse|AB|MM;RC
9302538|*Population Groups|C1257890|5919|MH|RtM via: Study Population (group);RtM via: Population Group|TI;AB|MM
9302538|Mental Disorders|C0004936|5276|MH|RtM via: Actual Depression|AB|MM;RC
9302538|Risk Factors|C0035648|5257|MH|||RC
9302538|Social Support|C0037438|5196|MH|||RC
9302538|Ethnic Groups|C0015031|5101|MH|RtM via: Ethnic group|AB|MM;RC
9302538|*Perceptions|C0030971|4656|ET|Entry Term Replacement for "Perception";RtM via: Perception|TI;AB|MM
9302538|Depressive Disorder|C0011581|4586|MH|RtM via: Depressive disorder|AB|MM;RC
9302538|Gender|C0079399|4116|ET|Entry Term Replacement for "Gender Identity";RtM via: Gender|AB|MM;RC
9302538|Risk-Taking|C0035651|4093|MH|||RC
9302538|Life Change Events|C0023670|3519|MH|||RC
9302538|Confidence Interval|C0009667|2612|ET|Entry Term Replacement for "Confidence Intervals";RtM via: Confidence Intervals|AB|MM;RC
9302538|Psychiatric Status Rating Scales|C0033871|2564|MH|||RC
9302538|Adaptation, Psychological|C0683269|2478|MH|||RC
9302538|Health Surveys|C0018762|2274|MH|||RC
9302538|Sex Factors|C0036881|2176|MH|||RC
9302538|Health Status|C0018759|2161|MH|||RC
9302538|Attitude to Health|C0004275|1699|MH|||RC
9302538|Age Factors|C0001783|1650|MH|||RC
9302538|Military Personnel|C0026126|1614|MH|||RC
9302538|Socioeconomic Factors|C0037464|1553|MH|||RC
9302538|Community Networks|C0282623|1505|MH|||RC
9302538|United States Department of Veterans Affairs|C0041735|1416|MH|||RC
9302538|Patient Admission|C0030673|949|MH|||RC
9302538|Health Care Costs|C0085552|878|MH|||RC
9302538|Research Design|C0035171|812|MH|||RC
9302538|HIV Infections|C0019693|696|MH|||RC
------
9302538|United States|C0041703|1000|MH+|United States Department of Veterans Affairs||MM
9302538|Child|C0008059|1000|CT|Child Abuse, Sexual||RC
9302538|Humans|C0086418|1000|CT|Population Groups;Ethnic Groups;Community Networks;Patient Admission;CT Text Lookup: men;CT Text Lookup: women|TI;AB;CT Text Lookup: men;CT Text Lookup: women|MM;RC
9302538|Male|C0024554|1000|CT|CT Text Lookup: men|CT Text Lookup: men|MM
9302538|Female|C0015780|1000|CT|CT Text Lookup: women|CT Text Lookup: women|MM
9302538|history|C0019665|3048|SH1|RtM via: Historical aspects qualifier;history (C0019665)|TI;AB|MM
9302538|injuries|C1510467|4986|SH|Wounds and Injuries|TI;AB|MM
9302538|economics|C0013557|1111|SH|N03.219.151.400 (Health Care Costs)||MM
9259208|PTCA|C0002997|663461|ET|Entry Term Replacement for "Angioplasty, Transluminal, Percutaneous Coronary";RtM via: Angioplasty, Transluminal, Percutaneous Coronary;RtM via: Drug Delivery Catheters|AB|MM;RC
9259208|Stents|C0038257|313489|MH|RtM via: Stent, device|AB|MM;RC
9259208|Coronary Angiography|C0085532|164943|MH|||RC
9259208|Coronary Restenosis|C0948480|63159|MH|||RC
9259208|Drug-Eluting Stents|C1322815|35135|MH|||RC
9259208|Fibrinolytic Agents|C0016018|34564|MH|||RC
9259208|Blood Vessel Prosthesis Implantation|C0525022|22538|MH|||RC
9259208|Treatment Outcome|C0085415|20758|MH|||RC
9259208|Drug Delivery Systems|C0085104|17548|MH|||RC
9259208|*Drug Administration Routes|C0013153|17262|MH|RtM via: Intracoronary route;RtM via: Intravascular|TI;AB|MM
9259208|Heart Catheterization|C0018795|14033|MH|||RC
9259208|Tunica Intima|C0162864|11610|MH|||RC
9259208|Anticoagulants|C0003280|9409|MH|||RC
9259208|Catheterization, Peripheral|C0007436|7850|MH|||RC
9259208|Electrocardiography|C1623258|7334|MH|||RC
9259208|Prosthesis Failure|C0033586|4655|MH|||RC
9259208|Coronary Occlusion|C0151814|3693|MH|RtM via: Coronary Occlusion|AB|MM
9259208|Infusions, Intra-Arterial|C0021439|2890|MH|||RC
9259208|Antineoplastic Agents, Phytogenic|C0003394|2663|MH|||RC
9259208|Endothelium, Vascular|C0014261|2556|MH|||RC
9259208|Postoperative Complications|C0032787|2437|MH|||RC
9259208|Blood Flow Velocity|C0005798|2370|MH|||RC
9259208|Preoperative Care|C0033061|2108|MH|||RC
9259208|Muscle, Smooth, Vascular|C0026844|1912|MH|||RC
9259208|Equipment Design|C0014677|1790|MH|||RC
9259208|Endosonography|C0376444|1599|MH|||RC
9259208|Time Factors|C0040225|1167|MH|||RC
9259208|Age Factors|C0001783|1164|MH|||RC
9259208|Risk Factors|C0035648|998|MH|||RC
9259208|Cell Proliferation|C0596290|716|MH|||RC
9259208|Femoral Arteries|C0015801|655|ET|Entry Term Replacement for "Femoral Artery";RtM via: Structure of femoral artery|AB|MM
9259208|*Genital Diseases, Female|C0017411|246|MH|RtM via: Delivery finding|TI;AB|MM
------
9259208|Humans|C0086418|1000|CT|Preoperative Care;CT Text Lookup: adult|CT Text Lookup: adult|MM;RC
9259208|Female|C0015780|1000|CT|Genital Diseases, Female|TI;AB|MM
9259208|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9259208|ultrasonography|C0175676|4848|SH1|RtM via: Ultrasonic;ultrasonography (C0175676);RtM via: Ultrasonography;RtM via: ultrasound device;Ultrasonography (C0041618);RtM via: ultrasound device;ultrasonography (C0175676)|AB|MM;RC
9259208|growth & development|C1457898|345|SH1|RtM via: Biologic Development;Growth and Development (C0018271);RtM via: development aspects;growth & development (C1457898)|TI|MM
9259208|methods|C0025664|1779|SH1|RtM via: Methodology;methods (C0025664)|AB|MM
9259208|surgery|C0038895|1111|SH|E04.100.376.719.100 (PTCA)|AB|MM
9259208|radiography|C0034571|1111|SH|E01.370.350.700.060.200 (Coronary Angiography)||MM
9325340|neurexin Ibeta|C0254165|1223515|NM|RtM via: neurexin Ibeta|TI;AB|MM
9325340|*Nerve Tissue Proteins|C0027759|1223514|MH|RtM via: neuroligin 1;RtM via: neurexin Ibeta|TI;AB|MM;RC
9325340|neuroligin 1|C0297241|1187257|NM|RtM via: neuroligin 1|TI;AB|MM
9325340|*Membrane Proteins|C0025252|755208|MH|RtM via: neuroligin 1;RtM via: Plasma membrane protein|TI;AB|MM;RC
9325340|*Cell Adhesion Molecules|C0007578|151713|MH|RtM via: Cell Adhesion Molecules|TI;AB|MM;RC
9325340|Protein Binding|C0033618|109218|MH|RtM via: neuroligin|AB|MM;RC
9325340|Alternative Splicing|C0002345|96713|MH|RtM via: Alternative Splicing|AB|MM;RC
9325340|*Cell Adhesion|C0007577|88446|MH|RtM via: heterophilic cell adhesion|TI;AB|MM;RC
9325340|Neurons|C0027882|79845|MH|RtM via: Neuronal|AB|MM;RC
9325340|Recombinant Proteins|C0034861|56838|MH|RtM via: Fusion protein|AB|MM;RC
9325340|Cell Membrane|C0007603|39629|MH|RtM via: Cell surface|AB|MM;RC
9325340|Calcium|C0006675|29031|MH|RtM via: Calcium ion|AB|MM;RC
9325340|Molecular Sequence Data|C0026382|26104|MH|||RC
9325340|Amino Acid Sequence|C0002518|24934|MH|||RC
9325340|*Ions|C0022023|23202|MH|RtM via: Molecule;RtM via: Calcium ion|TI;AB|MM;RC
9325340|Cells, Cultured|C0007635|22945|MH|||RC
9325340|Binding Sites|C0005456|18042|MH|||RC
9325340|Cell Lines|C0007600|17816|ET|Entry Term Replacement for "Cell Line";RtM via: Cell Line|AB|MM;RC
9325340|Protein Structure, Tertiary|C0162808|17235|MH|||RC
9325340|Protein Folding|C0162847|16665|MH|||RC
9325340|*Biophysical Processes|C1511162|13515|MH|RtM via: Binding (Molecular Function)|TI;AB|MM
9325340|Protein Conformation|C0033625|12712|MH|||RC
9325340|Models, Molecular|C0026344|10338|MH|||RC
9325340|Sequence Homology, Amino Acid|C0162777|8961|MH|||RC
9325340|Transfection|C0040669|8081|MH|||RC
9325340|Microtubule-Associated Proteins|C0026045|7707|MH|||RC
9325340|Protein Multimerization|C2350405|6153|MH|||RC
9325340|Structure-Activity Relationship|C0038477|4820|MH|||RC
9325340|Dimerization|C0376525|4351|MH|||RC
9325340|Brain|C0006104|4319|MH|||RC
9325340|Substrate Specificity|C0038592|4306|MH|||RC
9325340|Cercopithecus aethiops|C0026438|4084|MH|||RC
9325340|Models, Biological|C0026339|3911|MH|||RC
9325340|Electrophysiology|C0013865|3887|MH|||RC
9325340|Surface Plasmon Resonance|C0597731|3746|MH|||RC
9325340|Crystallography, X-Ray|C0206755|3738|MH|||RC
9325340|RNA, Messenger|C0035696|3699|MH|||RC
9325340|Autistic Disorder|C0004352|3034|MH|||RC
9325340|Electrophoresis, Polyacrylamide Gel|C0013862|2976|MH|||RC
9325340|Animals, Newborn|C0003065|2867|MH|||RC
9325340|Tissue Distribution|C0040287|2307|MH|||RC
9325340|RNA Splicing|C0035687|1670|MH|RtM via: RNA Splicing|AB|MM
9325340|Dose-Response Relationship, Drug|C0013059|1068|MH|||RC
9325340|Time Factors|C0040225|866|MH|||RC
9325340|Detergent|C0011740|404|ET|Entry Term Replacement for "Detergents";RtM via: Detergents|AB|MM
------
9325340|Animals|C0003062|1000|CT|Cercopithecus aethiops;Animals, Newborn||RC
9325340|physiology|C0031843|26535|SH1|RtM via: physiological aspects;physiology (C0031843)|TI;AB|MM
9325340|metabolism|C0025520|8340|SH1|RtM via: Binding action;Metabolism (C0025519);RtM via: Binding action;metabolism (C0025520);RtM via: Inhibited;Metabolism (C0025519)|TI;AB|MM
9325340|pharmacokinetics|C0031328|990|SH1|RtM via: Binding aspects;pharmacokinetics (C0031328)|TI;AB|MM
9325340|immunology|C1522005|1111|SH|D23.050.301.350 (Cell Adhesion Molecules)|TI;AB|MM
9325340|genetics|C0017399|1111|SH|G05.355.315.700.700.100 (Alternative Splicing)|AB|MM
9378512|*Heart|C0018787|1017981|MH|RtM via: Heart;RtM via: Entire heart|TI;AB|MM;RC
9378512|*Calcium|C0006675|395373|MH|RtM via: Calcium;RtM via: Calcium ion|TI;AB|MM;RC
9378512|Myocardium|C0027061|172639|MH|||RC
9378512|Myocardial Contraction|C0027045|140001|MH|||RC
9378512|EGTA|C0013714|94665|ET|Entry Term Replacement for "Egtazic Acid";RtM via: Egtazic Acid|AB|MM;RC
9378512|*Chelators|C0007974|80727|ET|Entry Term Replacement for "Chelating Agents";RtM via: Chelating Agents|TI;AB|MM;RC
9378512|Heart Ventricles|C0018827|60058|MH|RtM via: Heart Ventricle;RtM via: Ventricular|AB|MM;RC
9378512|*Myocytes|C0596981|57447|ET|Entry Term Replacement for "Muscle Cells";RtM via: Muscle Cells|TI;AB|MM
9378512|*Calcium, Dietary|C0006726|54546|MH|RtM via: Calcium, Dietary|TI|MM
9378512|Sarcolemma|C0036208|43194|MH|RtM via: Sarcolemma|AB|MM;RC
9378512|Calcium Channels, L-Type|C0288263|25138|MH|||RC
9378512|Calcium Signaling|C0600431|19396|MH|||RC
9378512|Calcium Channel Blockers|C0006684|14409|MH|||RC
9378512|Myocardial Reperfusion Injury|C0027055|13452|MH|||RC
9378512|Extracellular Space|C0015352|9698|MH|RtM via: Extracellular|AB|MM;RC
9378512|Membrane Potentials|C0025251|9625|MH|||RC
9378512|Action Potentials|C0001272|9551|MH|||RC
9378512|Sodium|C0037473|9095|MH|||RC
9378512|Perfusion|C0031001|8041|MH|RtM via: Perfusion (procedure)|AB|MM;RC
9378512|Cells, Cultured|C0007635|6351|MH|||RC
9378512|Patch-Clamp Techniques|C0242625|6112|MH|||RC
9378512|Electrophysiology|C0013865|4682|MH|||RC
9378512|Cardiomyocyte|C0225828|4215|ET|Entry Term Replacement for "Myocytes, Cardiac";RtM via: Myocytes, Cardiac|AB|MM
9378512|Microscopy, Confocal|C0242842|3378|MH|||RC
9378512|Rats, Wistar|C0034716|2651|MH|||RC
9378512|Electric Conductivity|C0013777|2624|MH|||RC
9378512|Cell Survival|C0007620|2521|MH|||RC
9378512|Cell Separation|C0007616|2415|MH|||RC
9378512|Cell Aging|C0007581|2180|MH|||RC
9378512|Phosphodiesterase Inhibitors|C0031638|2143|MH|||RC
9378512|Aging|C0001811|2096|MH|||RC
9378512|Electric Stimulation|C0013786|2032|MH|||RC
9378512|Fluorescent Dyes|C0016320|2003|MH|||RC
9378512|Animals, Newborn|C0003065|1857|MH|||RC
9378512|Kinetics|C0022702|1769|MH|||RC
9378512|Radioligand Assay|C0034596|1460|MH|||RC
9378512|Temperature|C0039476|965|MH|||RC
9378512|Mesocricetus|C0025484|799|MH|||RC
9378512|Rats, Sprague-Dawley|C0034715|720|MH|||RC
9378512|Surface Properties|C0038884|720|MH|||RC
9378512|Reaction Time|C0034746|661|MH|||RC
9378512|Mice, Inbred C57BL|C0025921|503|MH|||RC
9378512|Tissue Fixation|C0085254|468|MH|||RC
9378512|Taurine|C0039350|334|MH|RtM via: Taurine|AB|MM
------
9378512|Animals|C0003062|1000|CT|Rats, Wistar;Animals, Newborn;Mesocricetus;Rats, Sprague-Dawley;Mice, Inbred C57BL;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9378512|Rats|C0034721|1000|CT|Rats, Wistar;Rats, Sprague-Dawley;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9378512|Cricetinae|C0018557|1000|CT|Mesocricetus||RC
9378512|Mice|C0026809|1000|CT|Mice, Inbred C57BL||RC
9378512|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9378512|Humans|C0086418|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9300300|*Isoprenaline|C0022245|1585524|ET|Entry Term Replacement for "Isoproterenol";RtM via: Isoproterenol|TI;AB|MM;RC
9300300|Calcium Channel|C0006685|191166|ET|Entry Term Replacement for "Calcium Channels";RtM via: Calcium Channel|AB|MM;RC
9300300|Agonist, beta-Adrenergic|C0001644|186892|ET|Entry Term Replacement for "Adrenergic beta-Agonists";RtM via: Adrenergic beta-Agonists|AB|MM;RC
9300300|beta Adrenergic Receptors|C0034785|124798|ET|Entry Term Replacement for "Receptors, Adrenergic, beta";RtM via: beta-adrenergic receptor;Forced Lookup:beta-adrenergic receptors|AB|MM;RC
9300300|Myocardium|C0027061|96716|MH|||RC
9300300|Calcium Channels, L-Type|C0288263|85642|MH|Forced Lookup:l-type calcium channel||MM;RC
9300300|Patch-Clamp Techniques|C0242625|58346|MH|||RC
9300300|Carnitine|C0007258|56886|MH|RtM via: Carnitine;Forced Lookup:l-carnitine|AB|MM
9300300|Membrane Potentials|C0025251|53995|MH|||RC
9300300|*Myocytes|C0596981|45900|ET|Entry Term Replacement for "Muscle Cells";RtM via: Muscle Cells|TI;AB|MM
9300300|Myocardial Contraction|C0027045|40725|MH|||RC
9300300|Calcium|C0006675|35430|MH|||RC
9300300|Receptors, Adrenergic, beta-2|C0001643|13862|MH|||RC
9300300|Ion Channel Gating|C0022008|12672|MH|||RC
9300300|Action Potentials|C0001272|12572|MH|||RC
9300300|Calcium Signaling|C0600431|12147|MH|||RC
9300300|Cells, Cultured|C0007635|9790|MH|||RC
9300300|Calcium Channel Blockers|C0006684|7723|MH|||RC
9300300|Electrophysiology|C0013865|5688|MH|||RC
9300300|Bucladesine|C0012054|5275|MH|||RC
9300300|Cyclic AMP|C0001455|3753|MH|||RC
9300300|Electric Conductivity|C0013777|3639|MH|||RC
9300300|Electric Stimulation|C0013786|3346|MH|||RC
9300300|Kinetics|C0022702|3188|MH|||RC
9300300|Triiodothyronine|C0041014|2521|MH|||RC
9300300|Rats, Wistar|C0034716|2307|MH|||RC
9300300|Animals, Newborn|C0003065|2299|MH|||RC
9300300|Signal Transduction|C0037083|2022|MH|||RC
9300300|Phosphodiesterase Inhibitors|C0031638|1619|MH|||RC
9300300|Microscopy, Confocal|C0242842|1341|MH|||RC
9300300|Endotoxins|C0014264|1118|MH|||RC
9300300|Culture Media|C0010454|884|MH|RtM via: Culture Media|AB|MM;RC
9300300|Mice, Transgenic|C0025936|776|MH|||RC
9300300|Sex Characteristics|C0036866|754|MH|||RC
9300300|*Laboratory Techniques and Procedures|C0600201|648|MH|RtM via: Laboratory culture;RtM via: Microbial culture (procedure);RtM via: Preservation Technique|TI;AB|MM
9300300|*Research|C0035168|570|MH|RtM via: Laboratory culture;RtM via: Microbial culture (procedure)|TI;AB|MM
9300300|Rats, Sprague-Dawley|C0034715|560|MH|||RC
9300300|*Culture|C0010453|474|MH|RtM via: Anthropological Culture|TI;AB|MM
9300300|Myocytes, Cardiac|C0225828|340|MH|RtM via: Regular ventricular cardiac myocyte|AB|MM
9300300|Electric Capacitance|C0242264|337|MH|RtM via: Electric Capacitance|AB|MM
9300300|*Dosage Forms|C0013058|267|MH|RtM via: Culture Dose Form|TI;AB|MM
9300300|Escherichia coli|C0014834|267|MH|||RC
9300300|Taurine|C0039350|260|MH|RtM via: Taurine|AB|MM
9300300|Creatine|C0010286|206|MH|RtM via: Creatine|AB|MM
------
9300300|Animals|C0003062|1000|CT|Rats, Wistar;Animals, Newborn;Mice, Transgenic;Rats, Sprague-Dawley;CT Text Lookup: rabbit|CT Text Lookup: rabbit|MM;RC
9300300|Rats|C0034721|1000|CT|Rats, Wistar;Rats, Sprague-Dawley||RC
9300300|Mice|C0026809|1000|CT|Mice, Transgenic||RC
9300300|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9300300|Humans|C0086418|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9300300|Rabbits|C0034493|1000|CT|CT Text Lookup: rabbit|CT Text Lookup: rabbit|MM
9300300|organization & administration|C0029236|1242|SH|Organization and Administration|TI;AB|MM
9300300|methods|C0025664|60|SH|Methods|AB|MM
9326653|*Leukemia, Lymphoblastic, Acute|C1961102|246564|ET|Entry Term Replacement for "Precursor Cell Lymphoblastic Leukemia-Lymphoma";RtM via: In complete remission;RtM via: Precursor Cell Lymphoblastic Leukemia Lymphoma|TI;AB|MM;RC
9326653|Myeloid-Lymphoid Leukemia Protein|C1571619|226145|MH|||RC
9326653|*PCR|C0032520|186288|ET|Entry Term Replacement for "Polymerase Chain Reaction";RtM via: Polymerase Chain Reaction;RtM via: In complete remission|TI;AB|MM;RC
9326653|Chromosomes, Human, Pair 11|C0008653|183303|MH|||RC
9326653|*Leukemia|C0023418|151176|MH|RtM via: leukemia|TI;AB|MM;RC
9326653|Base Sequence|C0004793|83847|MH|RtM via: DNA Sequence;RtM via: Base Sequence;RtM via: Translocation Breakpoint|AB|MM;RC
9326653|*Genome|C0017428|82584|MH|RtM via: Genome|TI;AB|MM;RC
9326653|Nuclear Proteins|C0028589|76763|MH|||RC
9326653|Blotting, Southern|C0005862|61647|MH|RtM via: Southern blot assay (procedure)|AB|MM;RC
9326653|Chromosome Breakage|C0376628|61264|MH|||RC
9326653|Molecular Sequence Data|C0026382|56036|MH|||RC
9326653|Oncogene Proteins, Fusion|C0029014|41135|MH|||RC
9326653|Intron|C0021920|31195|ET|Entry Term Replacement for "Introns";RtM via: Introns|AB|MM;RC
9326653|Leukemia, Myeloid, Acute|C0023467|30854|MH|RtM via: Treatment related acute myeloid leukaemia|AB|MM;RC
9326653|Gene Rearrangement|C0017287|27984|MH|||RC
9326653|Cloning, Molecular|C0009017|26824|MH|||RC
9326653|Cell Cycle Proteins|C0243021|17405|MH|||RC
9326653|Reverse Transcriptase Polymerase Chain Reaction|C0599161|15532|MH|RtM via: Reverse Transcriptase Polymerase Chain Reaction|AB|MM;RC
9326653|Karyotyping|C0022526|15527|MH|RtM via: Karyotype determination procedure|AB|MM;RC
9326653|DNA|C0012854|15489|MH|RtM via: DNA|AB|MM;RC
9326653|Chromosomes, Human, Pair 22|C0008665|13711|MH|||RC
9326653|Chromosome Inversion|C0021943|13346|MH|||RC
9326653|In Situ Hybridization, Fluorescence|C0162789|11607|MH|||RC
9326653|Chromosome Mapping|C0008630|10164|MH|||RC
9326653|Chromosome Deletion|C0008628|9484|MH|||RC
9326653|Bacterial Proteins|C0004627|8050|MH|||RC
9326653|Amino Acid Sequence|C0002518|7415|MH|||RC
9326653|Cell Hybrid, Somatic|C0020200|6035|ET|Entry Term Replacement for "Hybrid Cells";RtM via: Hybrid Cells|AB|MM;RC
9326653|Abnormalities, Multiple|C0000772|5955|MH|||RC
9326653|Acute Disease|C0001314|5114|MH|RtM via: Acute lymphocytic leukemia|AB|MM;RC
9326653|Gene Deletion|C0017260|4703|MH|||RC
9326653|Models, Genetic|C0026343|4603|MH|||RC
9326653|Alternative Splicing|C0002345|4283|MH|||RC
9326653|Genome, Human|C0017429|3558|MH|||RC
9326653|*Remission Induction|C0035052|3489|MH|RtM via: In complete remission|TI;AB|MM
9326653|Diseases in Twins|C0012675|3416|MH|||RC
9326653|Computational Biology|C0376528|2026|MH|||RC
9326653|Cell Line, Tumor|C0085983|1708|MH|||RC
9326653|Syndrome|C0039082|1681|MH|||RC
9326653|Models, Biological|C0026339|785|MH|||RC
9326653|Hybrid, Radiation|C0887811|578|ET|Entry Term Replacement for "Radiation Hybrid Mapping";RtM via: Radiation Hybrids|AB|MM
9326653|Neoplasm Recurrence, Local|C0027643|418|MH|||RC
9326653|Age Factors|C0001783|313|MH|||RC
9326653|Clone|C0009013|282|ET|Entry Term Replacement for "Clone Cells";RtM via: Clone Cells|AB|MM
------
9326653|Humans|C0086418|1000|CT|Chromosomes, Human, Pair 11;Chromosomes, Human, Pair 22;Genome, Human;CT Text Lookup: adult;CT Text Lookup: pediatric|CT Text Lookup: adult;CT Text Lookup: pediatric|MM;RC
9326653|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9326653|Child|C0008059|1000|CT|CT Text Lookup: pediatric|CT Text Lookup: pediatric|MM
9326653|therapy|C0039798|6087|SH1|RtM via: therapeutic aspects;therapy (C0039798)|TI;AB|MM
9326653|analysis|C1524024|250|SH1|RtM via: analysis aspect|AB|MM
9326653|genetics|C0017399|1111|SH|G05.360.162.520.300.325.355 (Chromosomes, Human, Pair 11)||MM
9322741|*Homeobox|C0242303|1322457|ET|Entry Term Replacement for "Genes, Homeobox";RtM via: Homeo Box Sequence|TI;AB|MM;RC
9322741|*Sunflower|C0087040|612978|ET|Entry Term Replacement for "Helianthus";RtM via: Helianthus annuus;RtM via: Helianthus species|TI;AB|MM;RC
9322741|*cDNA|C0006556|587586|ET|Entry Term Replacement for "DNA, Complementary";RtM via: DNA, Complementary|TI;AB|MM;RC
9322741|Gene Expression Regulation, Plant|C0242717|185720|MH|||RC
9322741|Homeodomain Proteins|C0242617|176900|MH|RtM via: Homeodomain Proteins|AB|MM;RC
9322741|Amino Acid Sequence|C0002518|123718|MH|RtM via: Amino Acid Sequence|AB|MM;RC
9322741|Plant Proteins|C0032089|122735|MH|||RC
9322741|Arabidopsis Proteins|C0969730|105007|MH|||RC
9322741|Molecular Sequence Data|C0026382|100846|MH|||RC
9322741|Flowers|C0330090|88934|MH|RtM via: Flowers|AB|MM;RC
9322741|Base Sequence|C0004793|78126|MH|RtM via: Base Sequence;RtM via: DNA Sequence|AB|MM;RC
9322741|Genes, Plant|C0162728|68417|MH|||RC
9322741|Seeds|C0036563|53190|MH|RtM via: Plant seeds|AB|MM;RC
9322741|Cloning, Molecular|C0009017|51208|MH|||RC
9322741|MADS Domain Proteins|C0949739|47188|MH|||RC
9322741|Gene Library|C0017272|43185|MH|RtM via: DNA Library;RtM via: cDNA Library|AB|MM;RC
9322741|Plant Roots|C0242726|39977|MH|RtM via: Plant Roots|AB|MM;RC
9322741|Sequence Homology, Amino Acid|C0162777|38544|MH|||RC
9322741|Gene Expression Regulation, Developmental|C0242718|33309|MH|||RC
9322741|Sequence Analysis, DNA|C0162802|32715|MH|||RC
9322741|Sequence Alignment|C0080143|26503|MH|||RC
9322741|DNA, Plant|C0242964|25936|MH|||RC
9322741|Antigens, Plant|C1567994|13942|MH|||RC
9322741|Plants, Genetically Modified|C0950153|13779|MH|||RC
9322741|Plant Shoots|C0242729|13719|MH|||RC
9322741|Recombinant Fusion Proteins|C0034857|13231|MH|||RC
9322741|Cell Differentiation|C0007589|11815|MH|RtM via: epidermal cell differentiation|AB|MM;RC
9322741|Polymerase Chain Reaction|C0032520|10413|MH|RtM via: Polymerase Chain Reaction|AB|MM;RC
9322741|RNA, Messenger|C0035696|8910|MH|||RC
9322741|Multigene Family|C0017363|8577|MH|||RC
9322741|Nucleic Acid Amplification Techniques|C0887813|7273|MH|||RC
9322741|Plant Stems|C0242767|6861|MH|||RC
9322741|Two-Hybrid System Techniques|C0752172|6735|MH|||RC
9322741|Restriction Fragment Length Polymorphism|C0035268|6030|ET|Entry Term Replacement for "Polymorphism, Restriction Fragment Length";RtM via: Restriction fragment length polymorphism|AB|MM;RC
9322741|Phylogeny|C0031797|5888|MH|||RC
9322741|Binding Sites|C0005456|5760|MH|||RC
9322741|Protein Binding|C0033618|5660|MH|||RC
9322741|In Situ Hybridization|C0162788|4866|MH|||RC
9322741|Selection, Genetic|C0036576|4639|MH|||RC
9322741|Species Specificity|C0037783|4259|MH|||RC
9322741|Mutation|C0026882|4175|MH|||RC
9322741|Muscle Proteins|C0026832|4161|MH|||RC
9322741|Crosses, Genetic|C0010364|3853|MH|||RC
9322741|Gene Dosage|C0178655|3397|MH|||RC
9322741|Mitotic Spindle Apparatus|C0026258|3207|MH|||RC
9322741|Phenotype|C0031437|2817|MH|||RC
9322741|Hypocotyls|C0242766|2274|ET|Entry Term Replacement for "Hypocotyl";RtM via: Hypocotyl|AB|MM
9322741|Saccharomyces cerevisiae|C0036025|2144|MH|||RC
9322741|Dimerization|C0376525|1744|MH|||RC
9322741|Tissue Distribution|C0040287|1476|MH|||RC
------
9322741|genetics|C0017399|1111|SH|G05.360.340.024.340.230.500 (Homeobox)|TI;AB|MM
9322741|immunology|C1522005|1111|SH|D23.050.291 (Antigens, Plant)||MM
9376223|*Phosphorylation|C0031715|836259|MH|RtM via: Tyrosine Phosphorylation|TI;AB|MM;RC
9376223|SHC1 protein, human|C1312062|740986|NM|RtM via: SHC1 protein, human|TI;AB|MM
9376223|*Shc Signaling Adaptor Proteins|C2350555|740985|HM|RtM via: SHC1 protein, human|TI;AB|MM;RC
9376223|*Proteins|C0033684|541920|MH|RtM via: Proteins|TI;AB|MM;RC
9376223|Pertussis Toxin|C0020731|235895|MH|RtM via: Pertussis Toxin|AB|MM;RC
9376223|Calcium-Calmodulin-Dependent Protein Kinases|C0006776|179863|MH|RtM via: MAPK3 protein, human|AB|MM;RC
9376223|*Opioid Receptor, delta|C0140057|153843|ET|Entry Term Replacement for "Receptors, Opioid, delta";RtM via: Receptors, Opioid, delta|TI;AB|MM;RC
9376223|Adaptor Proteins, Signal Transducing|C1449886|144642|MH|||RC
9376223|*Isoforms|C0597298|115191|ET|Entry Term Replacement for "Protein Isoforms";RtM via: Protein Isoforms|TI|MM;RC
9376223|Mitogen-Activated Protein Kinase 3|C0082529|90173|MH|RtM via: MAPK3 protein, human|AB|MM;RC
9376223|Signal Transduction|C0037083|85475|MH|||RC
9376223|Mitogen-Activated Protein Kinase 1|C0170168|76670|MH|||RC
9376223|Protein Binding|C0033618|59981|MH|RtM via: epidermal growth factor activity|AB|MM;RC
9376223|ras Proteins|C0242853|48421|MH|||RC
9376223|Cell Line|C0007600|34980|MH|RtM via: Rat-1|AB|MM;RC
9376223|Tyrosine|C0041485|32325|MH|RtM via: Tyrosine|AB|MM;RC
9376223|1-Phosphatidylinositol 3-Kinase|C0044602|29881|MH|||RC
9376223|Receptor, Epidermal Growth Factor|C0034802|24796|MH|||RC
9376223|Epidermal Growth Factor|C0242275|24526|MH|RtM via: Epidermal Growth Factor|AB|MM;RC
9376223|Protein Kinases|C0033640|16688|MH|||RC
9376223|Clone|C0009013|15213|ET|Entry Term Replacement for "Clone Cells";RtM via: Clone Cells|AB|MM;RC
9376223|Tetradecanoylphorbol Acetate|C0039654|14717|MH|||RC
9376223|Amino Acid Sequence|C0002518|11951|MH|||RC
9376223|Insulin Receptor Substrate Proteins|C2350409|9997|MH|||RC
9376223|ras GTPase-Activating Proteins|C0245355|9162|MH|||RC
9376223|Kinetics|C0022702|9076|MH|||RC
9376223|Phosphatidylinositol Phosphates|C0071655|8670|MH|||RC
9376223|Transfection|C0040669|8050|MH|||RC
9376223|Seminal Plasma Proteins|C0074312|7399|MH|||RC
9376223|Fibroblasts|C0016030|6753|MH|RtM via: Fibroblasts|AB|MM;RC
9376223|CHO Cells|C0085080|6436|MH|||RC
9376223|Protein Kinase C-epsilon|C0257694|5661|MH|||RC
9376223|Cell Movement|C1621968|5155|MH|||RC
9376223|Phosphotransferases (Alcohol Group Acceptor)|C0206338|5030|MH|||RC
9376223|Bucladesine|C0012054|4679|MH|||RC
9376223|Protein Transport|C0599895|4491|MH|||RC
9376223|Transcriptional Activation|C0162493|4205|MH|||RC
9376223|Molecular Sequence Data|C0026382|3056|MH|||RC
9376223|Gene Expression Regulation, Enzymologic|C0017265|2963|MH|||RC
9376223|Calcium Signaling|C0600431|2733|MH|||RC
9376223|Proto-Oncogene Proteins c-fos|C0085301|2634|MH|||RC
9376223|Recombinant Fusion Proteins|C0034857|2615|MH|||RC
9376223|Models, Biological|C0026339|2575|MH|||RC
9376223|Receptors, Adrenergic, alpha-2|C0001639|2296|MH|||RC
9376223|Cytoplasmic Vesicles|C0887884|2279|MH|||RC
9376223|Cricetulus|C0010320|2162|MH|||RC
9376223|RNA, Messenger|C0035696|1877|MH|||RC
9376223|Carcinogens|C0007090|1468|MH|||RC
9376223|Bromodeoxyuridine|C0006233|1230|MH|||RC
9376223|Microscopy, Confocal|C0242842|1037|MH|||RC
------
9376223|Cricetinae|C0018557|1000|CT|CHO Cells;Cricetulus||RC
9376223|Animals|C0003062|1000|CT|CHO Cells;Cricetulus;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9376223|Rats|C0034721|1000|CT|CT Text Lookup: rat|CT Text Lookup: rat|MM
9376223|agonists|C0243192|4512|SH1|RtM via: agonists|TI|MM
9376223|genetics|C0017399|1111|SH|G05.355.760.860 (Transfection)||MM
9352845|*Gastrointestinal Hemorrhage|C0017181|240723|MH|RtM via: Acute upper gastrointestinal hemorrhage;RtM via: Upper gastrointestinal hemorrhage|TI;AB|MM;RC
9352845|Hospitalization|C0019993|63804|MH|RtM via: Hospitalization|AB|MM;RC
9352845|*Acute Disease|C0001314|54858|MH|RtM via: Acute upper gastrointestinal hemorrhage|TI;AB|MM;RC
9352845|*Medicine|C0025118|50994|MH|RtM via: Medical Specialities|TI|MM;RC
9352845|Length of Stay|C0023303|49852|MH|||RC
9352845|Patient Discharge|C0030685|28918|MH|RtM via: Patient Discharge|AB|MM;RC
9352845|Esophageal and Gastric Varices|C0014849|23448|MH|||RC
9352845|Gastroenterology|C0017163|14460|MH|||RC
9352845|Retrospective Study|C0035363|12669|ET|Entry Term Replacement for "Retrospective Studies";RtM via: Retrospective Studies|AB|MM;RC
9352845|Patient Care|C0017313|9007|MH|RtM via: Admission activity;RtM via: Admitting - Provider role|AB|MM;RC
9352845|*Cost|C0010186|5994|ET|Entry Term Replacement for "Costs and Cost Analysis";RtM via: Financial cost|TI;AB|MM
9352845|Emergency Service, Hospital|C0013967|5067|MH|||RC
9352845|Specialization|C0037776|4889|MH|||RC
9352845|Health Care Costs|C0085552|4839|MH|||RC
9352845|Critical Pathways|C0282655|4705|MH|||RC
9352845|Endoscopy|C0014245|4472|MH|RtM via: endoscopy;RtM via: Clinic / Center - Endoscopy|AB|MM;RC
9352845|Treatment Outcome|C0085415|4259|MH|||RC
9352845|Physicians|C0031831|3989|MH|RtM via: Gastroenterologist;RtM via: Internist;RtM via: Surgeon;RtM via: Physicians|AB|MM;RC
9352845|Quality Assurance, Health Care|C0034377|3626|MH|||RC
9352845|Quality of Health Care|C0034379|2825|MH|||RC
9352845|Outcome Assessment (Health Care)|C0085565|2545|MH|||RC
9352845|Prognosis|C0033325|2065|MH|||RC
9352845|Patient Care Team|C0030679|1636|MH|||RC
9352845|Time Factors|C0040225|1602|MH|||RC
9352845|Risk Factors|C0035648|1288|MH|||RC
9352845|Severity of Illness Index|C0036859|1168|MH|||RC
9352845|Interdepartmental Relations|C0021726|1164|MH|||RC
9352845|Evidence-Based Medicine|C0376537|1026|MH|||RC
9352845|Patient Selection|C0242802|893|MH|||RC
9352845|Diagnosis, Differential|C0011906|801|MH|||RC
9352845|Hospital Costs|C0206174|664|MH|RtM via: Hospital Costs|AB|MM
9352845|Hospital, Teaching|C0020027|230|ET|Entry Term Replacement for "Hospitals, Teaching";RtM via: Teaching Hospitals|AB|MM
9352845|Hospital, Urban|C0020029|224|ET|Entry Term Replacement for "Hospitals, Urban";RtM via: Hospitals, Urban|AB|MM
------
9352845|Humans|C0086418|1000|CT|Hospitalization;Length of Stay;Patient Discharge;Patient Care;CT Text Lookup: patient;CT Text Lookup: patients|AB;CT Text Lookup: patient;CT Text Lookup: patients|MM;RC
9352845|economics|C0013557|2439|SH1|RtM via: Cost aspects;economics (C0013557)|TI;AB|MM
9352845|surgery|C0038895|2349|SH|General Surgery||RC
9312208|*Hemoglobin, Sickle|C0019043|1367355|MH|RtM via: Sickle Hemoglobin|TI;AB|MM;RC
9312208|*Red Blood Cells|C0014792|384087|ET|Entry Term Replacement for "Erythrocytes";RtM via: Erythrocytes;RtM via: Red blood cells, blood product|TI;AB|MM;RC
9312208|K+ Channels, Ca2+-Activated|C0949653|86244|ET|Entry Term Replacement for "Potassium Channels, Calcium-Activated";RtM via: Calcium-Activated Potassium Channel;Forced Lookup:ca2+-activated k+ channels|AB|MM;RC
9312208|*Cations|C0007447|79776|MH|RtM via: Cations|TI;AB|MM;RC
9312208|Potassium|C0032821|73013|MH|||RC
9312208|Erythrocytes, Abnormal|C0014793|62242|MH|RtM via: Drepanocyte|AB|MM;RC
9312208|Calcium|C0006675|58987|MH|RtM via: Calcium ion|AB|MM;RC
9312208|A23187|C0878412|53193|ET|Entry Term Replacement for "Calcimycin";RtM via: A-23187|AB|MM;RC
9312208|Ca2+ ATPase|C0001476|40223|ET|Entry Term Replacement for "Calcium-Transporting ATPases";RtM via: Ca(2+)-Transporting ATPase|AB|MM;RC
9312208|Erythrocyte Membrane|C0014780|37324|MH|||RC
9312208|Sodium|C0037473|35245|MH|||RC
9312208|Charybdotoxin|C0109278|30037|MH|RtM via: Charybdotoxin|AB|MM;RC
9312208|Cytoplasm|C0010834|26102|MH|RtM via: Protoplasm|AB|MM;RC
9312208|Calmodulin|C0006772|23795|MH|RtM via: Calmodulin;RtM via: Calmodulin 1|AB|MM;RC
9312208|*Mouse, Transgenic|C0025936|21636|ET|Entry Term Replacement for "Mice, Transgenic";RtM via: Mice, Transgenic|TI;AB|MM;RC
9312208|Ionophores|C0022022|17388|MH|RtM via: Ionophores|AB|MM;RC
9312208|Cytosol|C1383501|16074|MH|RtM via: Cytoplasmic matrix|AB|MM;RC
9312208|Chlorides|C0008203|13297|MH|||RC
9312208|Oxygen|C0030054|12508|MH|||RC
9312208|Biological Transport|C0005528|10490|MH|RtM via: Biological Transport;RtM via: Ionophore activity|AB|MM;RC
9312208|Hydrogen-Ion Concentration|C0020283|9464|MH|||RC
9312208|Ions|C0022023|7607|MH|RtM via: Calcium ion|AB|MM;RC
9312208|Membrane Potentials|C0025251|5655|MH|||RC
9312208|Sodium-Potassium-Exchanging ATPase|C0001479|5615|MH|||RC
9312208|Cell Membrane Permeability|C0007605|4441|MH|||RC
9312208|Kinetics|C0022702|3653|MH|||RC
9312208|Scorpion Venoms|C0036450|3565|MH|||RC
9312208|Water-Electrolyte Balance|C0043064|2926|MH|||RC
9312208|*Physical Processes|C0597237|2469|MH|RtM via: Flux|TI;AB|MM
9312208|Cell Hypoxia|C0007598|2288|MH|||RC
9312208|Tetradecanoylphorbol Acetate|C0039654|1581|MH|||RC
9312208|Cell Separation|C0007616|1495|MH|||RC
9312208|Reference Values|C0034926|1119|MH|||RC
9312208|Irritants|C0022108|991|MH|||RC
9312208|Cells, Cultured|C0007635|960|MH|||RC
9312208|Mice, Inbred C57BL|C0025921|952|MH|RtM via: Mice, Inbred C57BL|AB|MM;RC
9312208|Energy Metabolism|C0014272|911|MH|||RC
9312208|Spectrometry, Fluorescence|C0037802|798|MH|||RC
9312208|Models, Chemical|C0026341|625|MH|||RC
9312208|Dose-Response Relationship, Drug|C0013059|386|MH|||RC
9312208|Animals, Genetically Modified|C0969757|384|MH|RtM via: Animals, Transgenic|AB|MM
9312208|Calcium, Dietary|C0006726|342|MH|RtM via: Calcium, Dietary|AB|MM
9312208|Cell Membrane|C0007603|264|MH|RtM via: Cell membrane|AB|MM
------
9312208|Mice|C0026809|1872|CT||AB|MM
9312208|Animals|C0003062|1000|CT|Mouse, Transgenic;Mice, Inbred C57BL;Animals, Genetically Modified;CT Text Lookup: mice;CT Text Lookup: mouse;CT Text Lookup: transgenic mice;CT Text Lookup: transgenic mouse|TI;AB;CT Text Lookup: mice;CT Text Lookup: mouse;CT Text Lookup: transgenic mice;CT Text Lookup: transgenic mouse|MM;RC
9312208|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9312208|Humans|C0086418|1000|CT|CT Text Lookup: adult;CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: adult;CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|MM
9312208|methods|C0025664|7|SH|Methods|AB|MM
9298159|*Dizygotic Twin|C0041429|4178445|ET|Entry Term Replacement for "Twins, Dizygotic";RtM via: Twins, Dizygotic|TI;AB|MM;RC
9298159|Monozygotic Twins|C0041432|779849|ET|Entry Term Replacement for "Twins, Monozygotic";RtM via: Monozygotic twins|AB|MM;RC
9298159|Social Environment|C0037414|6007|MH|||RC
9298159|Family|C0015576|3711|MH|RtM via: Offspring|AB|MM;RC
9298159|Cognition|C0009240|3520|MH|||RC
9298159|Interpersonal Relations|C0021797|1973|MH|||RC
9298159|Self Concept|C0036594|1898|MH|||RC
9298159|Verbal Behavior|C0042530|1531|MH|||RC
9298159|Models, Psychological|C0026347|1434|MH|||RC
9298159|Cognition Disorders|C0009241|1187|MH|||RC
9298159|Phenotype|C0031437|1130|MH|||RC
9298159|Mental Recall|C0034770|974|MH|||RC
9298159|Functional Laterality|C1720777|892|MH|||RC
9298159|Questionnaires|C0034394|618|MH|||RC
9298159|Sex Factors|C0036881|573|MH|||RC
9298159|Anthropometry|C0003188|555|MH|||RC
9298159|Genetic Variation|C0042333|426|MH|||RC
9298159|Brothers|C0337527|379|ET|Entry Term Replacement for "Siblings";RtM via: Brothers|AB|MM
------
9298159|Female|C0015780|1000|CT|Dizygotic Twin;Monozygotic Twins|TI;AB|MM;RC
9298159|Child|C0008059|1000|CT|CT Text Lookup: children|CT Text Lookup: children|MM
9298159|Humans|C0086418|1000|CT|CT Text Lookup: children|CT Text Lookup: children|MM
9298159|classification|C0008903|5|SH|Classification|AB|MM
9298159|organization & administration|C0029236|3|SH|Organization and Administration|AB|MM
9298159|therapy|C0039798|2|SH|Therapeutics|AB|MM
9298159|genetics|C0017399|1111|SH|G05.695 (Phenotype)||MM
9338089|*Exercise Test|C0015260|397968|MH|RtM via: Treadmill, device|TI;AB|MM;RC
9338089|Carbon Dioxide|C0007012|182603|MH|RtM via: Carbon Dioxide;RtM via: Calculation|AB|MM;RC
9338089|*Exercise|C0015259|134646|MH|RtM via: Exercise|TI;AB|MM;RC
9338089|Oxygen|C0030054|101281|MH|RtM via: Oxygen|AB|MM;RC
9338089|Oxygen Consumption|C0030055|80056|MH|||RC
9338089|Pulmonary Ventilation|C0035213|58789|MH|||RC
9338089|Running|C0035953|38554|MH|RtM via: Running (physical activity)|AB|MM;RC
9338089|Physical Endurance|C0031808|13211|MH|||RC
9338089|Water|C0043047|12777|MH|RtM via: Water;RtM via: Water Specimen|AB|MM;RC
9338089|Temperature|C0039476|10796|MH|RtM via: Temperature|AB|MM;RC
9338089|Physical Conditioning, Animal|C0031802|5275|MH|||RC
9338089|Breath Tests|C0006153|5116|MH|||RC
9338089|Pressure|C0033095|4864|MH|RtM via: Pressure- physical agent|AB|MM;RC
9338089|Respiration, Artificial|C0035205|4099|MH|||RC
9338089|Electrodes|C0013812|3003|MH|RtM via: Electrode Grid|AB|MM;RC
9338089|Refuse Disposal|C0034962|2509|MH|||RC
9338089|Rheology|C0035423|2343|MH|||RC
9338089|Body Water|C0005909|2204|MH|||RC
9338089|*Research|C0035168|2070|MH|RtM via: Study;RtM via: Analysis;RtM via: Analysis of substances|TI;AB|MM
9338089|Equipment Design|C0014677|1837|MH|||RC
9338089|Air Pollutants|C0001869|1822|MH|||RC
9338089|Equipment Failure Analysis|C0376694|1266|MH|||RC
9338089|Biometry|C0005544|1240|MH|||RC
9338089|Rest|C0035253|943|MH|RtM via: Rest|AB|MM
9338089|Time Factors|C0040225|939|MH|||RC
9338089|Atmosphere|C0004178|897|MH|RtM via: Atmosphere, planetary|AB|MM
9338089|Administration, Inhalation|C0001559|881|MH|||RC
9338089|Reference Values|C0034926|783|MH|||RC
9338089|Gases|C0017110|726|MH|RtM via: Gases|AB|MM
9338089|Air|C0001861|678|MH|RtM via: Air|AB|MM
------
9338089|Rats|C0034721|17529|CT||TI;AB|MM
9338089|Animals|C0003062|1000|CT|Physical Conditioning, Animal;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9338089|instrumentation|C0021632|855|SH1|RtM via: Treadmill, device;instrumentation (C0021632)|TI;AB|MM
9338089|methods|C0025664|3687|SH|Methods|AB|MM;RC
9338089|therapy|C0039798|1836|SH|Therapeutics|TI;AB|MM
9338089|drug therapy|C0013217|9999|SH|new SH add rule - Administration, Inhalation [E02.319.267.050] (E02.319)||MM
9338089|toxicity|C0040539|423|SH|Toxicology||RC
9334930|*Hantaviruses|C0019092|3249855|ET|Entry Term Replacement for "Hantavirus";RtM via: Tula virus;RtM via: Hantavirus|TI;AB|MM;RC
9334930|*Puumala virus|C0205790|1134714|MH|RtM via: Puumala virus|TI;AB|MM;RC
9334930|*Rodents|C0035804|236406|ET|Entry Term Replacement for "Rodentia";RtM via: Rodent|TI;AB|MM;RC
9334930|RT-PCR|C0599161|145275|ET|Entry Term Replacement for "Reverse Transcriptase Polymerase Chain Reaction";RtM via: Reverse Transcriptase Polymerase Chain Reaction;Forced Lookup:rt-pcr|AB|MM;RC
9334930|Arvicolinae|C0010318|131904|MH|RtM via: Microtus arvalis;RtM via: Clethrionomys glariolus|AB|MM;RC
9334930|Nephropathia Epidemica|C0242993|82414|ET|Entry Term Replacement for "Hemorrhagic Fever with Renal Syndrome";RtM via: Nephropathia Epidemica|AB|MM;RC
9334930|Rodent Diseases|C0035801|51818|MH|||RC
9334930|Base Sequence|C0004793|36669|MH|RtM via: DNA Sequence;RtM via: Base Sequence|AB|MM;RC
9334930|Antibodies, Viral|C0003253|33378|MH|||RC
9334930|Neutralization Tests|C0027944|26570|MH|||RC
9334930|Molecular Sequence Data|C0026382|22376|MH|||RC
9334930|RNA, Viral|C0035736|21189|MH|||RC
9334930|Antigens, Viral|C0003342|19116|MH|||RC
9334930|Disease Reservoirs|C0012653|13882|MH|||RC
9334930|Phylogeny|C0031797|13166|MH|||RC
9334930|DNA, Viral|C0012939|13010|MH|||RC
9334930|Europe|C0015176|7268|MH|RtM via: Europe|AB|MM;RC
9334930|Genetic Variation|C0042333|6085|MH|||RC
9334930|Amino Acid Sequence|C0002518|5551|MH|||RC
9334930|RNA|C0035668|5062|MH|RtM via: RNA|AB|MM;RC
9334930|Immunoglobulin M|C0020861|4866|MH|||RC
9334930|Sequence Analysis, DNA|C0162802|4561|MH|||RC
9334930|DNA, Mitochondrial|C0012929|4469|MH|||RC
9334930|*Genes|C0017337|4182|MH|RtM via: Genetic|TI;AB|MM
9334930|Serotyping|C0036759|3887|MH|||RC
9334930|Immunoglobulin G|C0020852|2968|MH|||RC
9334930|Transcription, Genetic|C0040649|2748|MH|RtM via: reverse transcription polymerase chain reaction|AB|MM;RC
9334930|Viral Proteins|C0042736|2578|MH|||RC
9334930|Species Specificity|C0037783|2264|MH|||RC
9334930|Genotype|C0017431|2229|MH|||RC
9334930|Cross Reactions|C0010357|2175|MH|||RC
9334930|Austria|C0004348|1886|MH|RtM via: Austria|AB|MM;RC
9334930|Mice, Inbred BALB C|C0025919|1776|MH|||RC
9334930|Czech Republic|C0206578|1732|MH|RtM via: Czech Republic|AB|MM;RC
9334930|Antibodies, Monoclonal|C0003250|1698|MH|||RC
9334930|Vero Cells|C0042542|919|MH|||RC
9334930|Cercopithecus aethiops|C0026438|770|MH|||RC
9334930|Antibodies|C0003241|393|MH|RtM via: Antibodies|AB|MM
9334930|Time Factors|C0040225|218|MH|||RC
------
9334930|Slovakia|C0206579|75|MH-S|RtM via: Slovakia|AB|MM
9334930|Animals|C0003062|1000|CT|Rodents;Arvicolinae;Rodent Diseases;Mice, Inbred BALB C;Vero Cells;Cercopithecus aethiops|TI;AB|MM;RC
9334930|Mice|C0026809|1000|CT|Mice, Inbred BALB C||RC
9334930|Humans|C0086418|1000|CT|CT Text Lookup: human|CT Text Lookup: human|MM
9334930|methods|C0025664|6|SH|Methods|AB|MM
9334930|genetics|C0017399|1111|SH|G05.360.080 (Base Sequence)|AB|MM
9334930|immunology|C1522005|1111|SH|D23.050.327 (Antigens, Viral)||MM
9342232|*Cloning, Molecular|C0009017|263502|MH|RtM via: Cloning, Molecular|TI|MM;RC
9342232|leukotriene-C4 synthase|C0244579|260416|NM|RtM via: leukotriene-C4 synthase;RtM via: LTC4S gene;Forced Lookup:leukotriene-c4 synthase|TI;AB|MM
9342232|*Glutathione S-Transferase|C0017837|260415|ET|Entry Term Replacement for "Glutathione Transferase";RtM via: leukotriene-C4 synthase;RtM via: LTC4S gene;RtM via: Glutathione S-Transferase;Forced Lookup:glutathione s-transferase|TI;AB|MM;RC
9342232|5-lipoxygenase-activating protein|C0049275|110221|NM|Forced Lookup:5-lipoxygenase-activating protein||MM
9342232|Integral Membrane Protein|C0021699|110220|ET|Entry Term Replacement for "Membrane Proteins";RtM via: Integral Membrane Proteins|AB|MM;RC
9342232|Carrier Proteins|C0007292|91586|HM|||MM;RC
9342232|Molecular Sequence Data|C0026382|63974|MH|||RC
9342232|Base Sequence|C0004793|51924|MH|RtM via: Base Sequence|AB|MM;RC
9342232|*Leukotriene C4|C0023542|49491|MH|RtM via: LTC4S gene|TI;AB|MM;RC
9342232|cysteinyl-leukotriene|C0675175|40749|NM|RtM via: cysteinyl-leukotriene|AB|MM
9342232|Leukotrienes|C0023545|40748|MH|RtM via: Leukotrienes;RtM via: cysteinyl-leukotriene|AB|MM;RC
9342232|Amino Acid Sequence|C0002518|23264|MH|||RC
9342232|Arachidonate 5-Lipoxygenase|C0003693|19292|MH|Forced Lookup:5-lipoxygenase||MM
9342232|Colony-Stimulating Factors|C0009392|19292|MH|Forced Lookup:colony-stimulating factor||MM
9342232|Chromosome Mapping|C0008630|13836|MH|||RC
9342232|Gene Library|C0017272|13492|MH|RtM via: DNA Library;RtM via: cDNA Library|AB|MM;RC
9342232|Cysteine|C0010654|12196|HM|RtM via: cysteinyl-leukotriene|AB|MM;RC
9342232|Sequence Homology, Amino Acid|C0162777|11968|MH|||RC
9342232|Intron|C0021920|11878|ET|Entry Term Replacement for "Introns";RtM via: Introns|AB|MM;RC
9342232|Exons|C0015295|10856|MH|RtM via: Exons|AB|MM;RC
9342232|Leukotriene A4|C0125631|10350|MH|RtM via: Leukotriene A4|AB|MM;RC
9342232|Reduced Glutathione|C0034917|8420|ET|Entry Term Replacement for "Glutathione";RtM via: Reduced Glutathione|AB|MM;RC
9342232|Sequence Alignment|C0080143|3922|MH|||RC
9342232|Hybrid Cells|C0020200|3390|MH|||RC
9342232|Cell Line|C0007600|2933|MH|||RC
9342232|Bronchial Hyperreactivity|C0085129|2585|MH|||RC
9342232|Catalysis|C0007382|2494|MH|RtM via: Catalysis|AB|MM;RC
9342232|Mutagenesis, Site-Directed|C0079870|2168|MH|||RC
9342232|Binding Sites|C0005456|2163|MH|||RC
9342232|In Situ Hybridization, Fluorescence|C0162789|2098|MH|||RC
9342232|Cell Compartmentation|C0007583|2093|MH|RtM via: chromosome localization|AB|MM;RC
9342232|Molecular Structure|C0026383|1695|MH|||RC
9342232|Multigene Family|C0017363|1445|MH|||RC
9342232|Immune System|C0020962|1419|MH|RtM via: Clone|AB|MM;RC
9342232|Kinetics|C0022702|1177|MH|||RC
9342232|Genetic Predisposition to Disease|C0314657|1162|MH|||RC
9342232|Protein Conformation|C0033625|959|MH|||RC
9342232|Lipoxygenase Inhibitors|C0085385|913|MH|||RC
9342232|RNA, Messenger|C0035696|842|MH|||RC
9342232|Phenotype|C0031437|800|MH|||RC
9342232|Mast Cells|C0024880|785|MH|||RC
9342232|Gene Expression Regulation, Enzymologic|C0017265|757|MH|||RC
9342232|Databases, Factual|C0079199|474|MH|||RC
9342232|Tissue Distribution|C0040287|434|MH|||RC
9342232|Mice, Inbred BALB C|C0025919|426|MH|||RC
9342232|Transcription Initiation Site|C0949639|346|MH|RtM via: Transcription Initiation Site|AB|MM
9342232|Nucleotides|C0028630|321|MH|RtM via: Nucleotides|AB|MM
9342232|Chromosome 11|C0008653|248|ET|Entry Term Replacement for "Chromosomes, Human, Pair 11";RtM via: Chromosomes, Human, Pair 11|AB|MM
------
9342232|Mice|C0026809|30594|CT||TI;AB|MM
9342232|Animals|C0003062|1000|CT|Mice, Inbred BALB C;CT Text Lookup: mouse|CT Text Lookup: mouse|MM;RC
9342232|Humans|C0086418|1000|CT|Chromosome 11;CT Text Lookup: human|AB;CT Text Lookup: human|MM
9342232|genetics|C0017399|1111|SH|G05.360.080 (Base Sequence)|AB|MM
9357854|*Epithelial Cells|C0014597|236202|MH|RtM via: Epithelial Cells|TI;AB|MM;RC
9357854|*Lung|C0024109|146079|MH|RtM via: Lung;RtM via: Entire lung|TI;AB|MM;RC
9357854|trimethylenediamine|C0077186|120893|NM|Forced Lookup:1,3-propanediamine||MM
9357854|Diamines|C0011957|120892|HM|RtM via: Propanediamine|AB|MM
9357854|*Apoptosis|C0162638|115191|MH|RtM via: Apoptosis|TI;AB|MM;RC
9357854|Proto-Oncogene Proteins c-jun|C0085296|111327|MH|||RC
9357854|Activator Protein-1|C0085828|90071|ET|Entry Term Replacement for "Transcription Factor AP-1";RtM via: Transcription Factor AP-1;Forced Lookup:activator protein-1|AB|MM;RC
9357854|Hydrogen Peroxide|C0020281|77330|MH|RtM via: Hydrogen Peroxide;Forced Lookup:h2o2|AB|MM;RC
9357854|Proto-Oncogene Proteins c-fos|C0085301|63492|MH|||RC
9357854|rosiglitazone|C0289313|46039|NM|RtM via: rosiglitazone|TI;AB|MM
9357854|*Thiazolidinediones|C1257987|46038|HM|RtM via: rosiglitazone|TI;AB|MM
9357854|N-acetylpenicillamine|C0067768|40098|NM|Forced Lookup:n-acetylpenicillamine||MM
9357854|Penicillamine|C0030817|40097|HM|||MM;RC
9357854|S-Nitroso-N-Acetylpenicillamine|C0073894|38336|MH|Forced Lookup:s-nitroso-n-acetylpenicillamine||MM;RC
9357854|*Oncogenes|C0029016|37974|MH|RtM via: ROS1 gene|TI;AB|MM
9357854|mRNA|C0035696|34584|ET|Entry Term Replacement for "RNA, Messenger";RtM via: RNA, Messenger|AB|MM;RC
9357854|Nitric Oxide|C0028128|29821|MH|RtM via: Nitric Oxide|AB|MM;RC
9357854|Peroxynitrite|C0136157|16128|ET|Entry Term Replacement for "Peroxynitrous Acid";RtM via: Peroxynitrite|AB|MM;RC
9357854|Cells, Cultured|C0007635|16111|MH|||RC
9357854|Cell Line|C0007600|12135|MH|||RC
9357854|Proto-Oncogene Proteins c-myc|C0080065|11240|MH|||RC
9357854|Spermine|C0037874|8869|MH|RtM via: Spermine|AB|MM;RC
9357854|Carcinogens|C0007090|7878|MH|||RC
9357854|Free Radical Scavengers|C0079381|7690|MH|||RC
9357854|Rats, Inbred F344|C0034703|5650|MH|||RC
9357854|Tetradecanoylphorbol Acetate|C0039654|5592|MH|||RC
9357854|*Cell Count|C0007584|5016|MH|RtM via: Epithelial cell count (procedure)|TI;AB|MM
9357854|Early Growth Response Protein 1|C1566493|4802|MH|||RC
9357854|In Situ Hybridization|C0162788|4675|MH|||RC
9357854|Cell Transformation, Neoplastic|C0007621|4608|MH|||RC
9357854|Kinetics|C0022702|4420|MH|||RC
9357854|Flow Cytometry|C0016263|3996|MH|||RC
9357854|Antioxidants|C0003402|3975|MH|||RC
9357854|Signal Transduction|C0037083|3959|MH|||RC
9357854|Endothelium, Vascular|C0014261|3444|MH|||RC
9357854|Base Sequence|C0004793|3401|MH|RtM via: Base Sequence;RtM via: DNA Sequence|AB|MM;RC
9357854|Receptor, Epidermal Growth Factor|C0034802|3395|MH|||RC
9357854|Gene Expression Regulation, Neoplastic|C0017268|3354|MH|||RC
9357854|Administration, Inhalation|C0001559|3338|MH|||RC
9357854|Pulmonary Artery|C0034052|3005|MH|||RC
9357854|Models, Biological|C0026339|2948|MH|||RC
9357854|Dose-Response Relationship, Drug|C0013059|1985|MH|||RC
9357854|Mutation|C0026882|1677|MH|||RC
9357854|Molecular Sequence Data|C0026382|1618|MH|||RC
9357854|Mice, Transgenic|C0025936|1584|MH|||RC
9357854|Recombinant Fusion Proteins|C0034857|1350|MH|||RC
9357854|Rats, Sprague-Dawley|C0034715|1343|MH|||RC
9357854|Motor Activity|C0026606|533|MH|||RC
9357854|Nitrogen|C0028158|334|MH|RtM via: Nitrogen;RtM via: Nitrogen Handling|AB|MM
9357854|Cell Membrane Permeability|C0007605|290|MH|RtM via: Cell Membrane Permeability|AB|MM
------
9357854|Rats|C0034721|851|CT||AB|MM
9357854|Animals|C0003062|1000|CT|Rats, Inbred F344;Mice, Transgenic;Rats, Sprague-Dawley;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9357854|Mice|C0026809|1000|CT|Mice, Transgenic||RC
9357854|genetics|C0017399|1111|SH|G05.360.340.024.340.375.500 (Oncogenes)|TI;AB|MM
9315494|*Trazodone|C0040805|861279|MH|RtM via: Trazodone|TI;AB|MM;RC
9315494|*Erectile Dysfunction|C0242350|599778|MH|RtM via: Erectile dysfunction;RtM via: Psychogenic impotence|TI;AB|MM;RC
9315494|*Double-Blind Method|C0013072|281970|MH|RtM via: Double-Blind Method|TI;AB|MM;RC
9315494|Penile Tumescence|C0087121|149207|ET|Entry Term Replacement for "Penile Erection";RtM via: Penile Tumescence|AB|MM;RC
9315494|Phosphodiesterase Inhibitors|C0031638|18574|MH|||RC
9315494|Libido|C0023618|13542|MH|||RC
9315494|Treatment Outcome|C0085415|9389|MH|||RC
9315494|Placebos|C0032042|7616|MH|RtM via: Placebos;RtM via: Placebo Control;RtM via: Placebo (substance)|AB|MM;RC
9315494|Vasodilator Agents|C0042402|4968|MH|||RC
9315494|Patient Satisfaction|C0030702|2317|MH|||RC
9315494|Questionnaire|C0034394|2028|ET|Entry Term Replacement for "Questionnaires";RtM via: Questionnaires|AB|MM;RC
9315494|Psychophysiologic Disorders|C0033931|1812|MH|RtM via: Psychogenic impotence|AB|MM;RC
9315494|Randomized Controlled Trials as Topic|C0282440|1439|MH|||RC
9315494|Psychiatric Status Rating Scales|C0033871|1373|MH|||RC
9315494|Patient Compliance|C1321605|859|MH|||RC
9315494|Affect|C0001721|750|MH|||RC
9315494|Severity of Illness Index|C0036859|728|MH|||RC
9315494|Administration, Oral|C0001563|621|MH|||RC
9315494|Risk Factors|C0035648|318|MH|||RC
9315494|Drug Therapy, Combination|C0013218|288|MH|||RC
9315494|Time Factors|C0040225|265|MH|||RC
------
9315494|Male|C0024554|1000|CT|Erectile Dysfunction;CT Text Lookup: impotence|TI;AB;CT Text Lookup: impotence|MM;RC
9315494|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9315494|therapy|C0039798|5385|SH1|RtM via: therapeutic aspects;therapy (C0039798)|TI;AB|MM
9315494|methods|C0025664|543|SH1|RtM via: Methodology;methods (C0025664)|AB|MM
9315494|drug therapy|C0013217|9999|SH|new SH add rule - Administration, Oral [E02.319.267.100] (E02.319)||MM
9322229|X Chromosome|C0043292|256084|MH|RtM via: X Chromosome|AB|MM;RC
9322229|*Genes, X-Linked|C0678928|142292|MH|RtM via: Genes, X-Linked;Forced Lookup:x-linked gene;Forced Lookup:x-linked genes|TI|MM
9322229|Genomic Imprinting|C0242614|25786|MH|||RC
9322229|Chromosome Mapping|C0008630|18918|MH|||RC
9322229|*Intuition|C0233828|18525|MH|RtM via: Intuition|TI|MM
9322229|Models, Genetic|C0026343|9987|MH|||RC
9322229|Pedigree|C0030761|6806|MH|||RC
9322229|Chromosomes, Mammalian|C1135972|6194|MH|||RC
9322229|Genome, Human|C0017429|5552|MH|||RC
9322229|Crosses, Genetic|C0010364|4879|MH|||RC
9322229|Phenotype|C0031437|4623|MH|||RC
9322229|Cognition|C0009240|4543|MH|||RC
9322229|Selection, Genetic|C0036576|4318|MH|||RC
9322229|Mutation|C0026882|4215|MH|||RC
9322229|Social Behavior|C0037397|3974|MH|RtM via: Social Behavior|AB|MM;RC
9322229|Chromosomes, Human, Pair 1|C0008651|3718|MH|||RC
9322229|Gene Dosage|C0178655|3581|MH|||RC
9322229|DNA Methylation|C0376452|3180|MH|||RC
9322229|Sex Characteristics|C0036866|3158|MH|RtM via: Sex Characteristics|AB|MM;RC
9322229|Evolution|C0015219|2777|MH|||RC
9322229|Maze Learning|C0242996|2685|MH|||RC
9322229|Chromosomes, Human, Pair 22|C0008665|1960|MH|||RC
9322229|Autistic Disorder|C0004352|1924|MH|||RC
9322229|Mice, Inbred C57BL|C0025921|1776|MH|||RC
9322229|Karyotyping|C0022526|1705|MH|||RC
9322229|Amino Acid Substitution|C0525038|1517|MH|||RC
9322229|Brain|C0006104|1393|MH|||RC
9322229|Space Perception|C0037744|1368|MH|||RC
9322229|Oligonucleotide Array Sequence Analysis|C0600595|1283|MH|||RC
9322229|Diseases in Twins|C0012675|1264|MH|||RC
9322229|Abortion, Spontaneous|C0000786|992|MH|||RC
9322229|Nuclear Proteins|C0028589|741|MH|||RC
9322229|Gestational Age|C0017504|643|MH|||RC
9322229|RNA, Messenger|C0035696|571|MH|||RC
9322229|Databases, Factual|C0079199|522|MH|||RC
9322229|Skin|C1123023|322|MH|||RC
9322229|Kinetics|C0022702|282|MH|||RC
------
9322229|Humans|C0086418|1000|CT|Genome, Human;Chromosomes, Human, Pair 1;Chromosomes, Human, Pair 22;Abortion, Spontaneous||RC
9322229|Animals|C0003062|1000|CT|Mice, Inbred C57BL||RC
9322229|Mice|C0026809|1000|CT|Mice, Inbred C57BL||RC
9322229|Female|C0015780|1000|CT|Abortion, Spontaneous||RC
9322229|Pregnancy|C0032961|1000|CT|Abortion, Spontaneous||RC
9322229|methods|C0025664|45|SH|Methods|AB|MM
9322229|genetics|C0017399|1111|SH|G05.360.162.865.982 (X Chromosome)|AB|MM
9237795|*Mouse, NOD|C0085243|2896845|ET|Entry Term Replacement for "Mice, Inbred NOD";RtM via: Mice, Inbred NOD|TI;AB|MM;RC
9237795|Diabetes, Autoimmune|C0205734|336067|ET|Entry Term Replacement for "Diabetes Mellitus, Type 1";RtM via: Diabetes, Autoimmune|AB|MM;RC
9237795|*Diabetes Mellitus, Type 2|C0011860|303396|MH|RtM via: Diabetes Mellitus, Non-Insulin-Dependent|TI;AB|MM;RC
9237795|GAD65 (524-543)|C1099189|200327|NM|RtM via: GAD65 (524-543)|AB|MM
9237795|Glutamic Acid Decarboxylase|C0017785|200326|ET|Entry Term Replacement for "Glutamate Decarboxylase";RtM via: Glutamate Decarboxylase;RtM via: GAD65 (524-543)|AB|MM;RC
9237795|*Diabetes Mellitus|C0011849|138057|MH|RtM via: Diabetes Mellitus|TI;AB|MM
9237795|T-Lymphocytes|C0039194|114463|MH|RtM via: T-Lymphocyte|AB|MM;RC
9237795|Peptide Fragments|C0030935|96092|HM|RtM via: GAD65 (524-543)|AB|MM;RC
9237795|Lymphocyte Activation|C0024262|76599|MH|||RC
9237795|Hypoglycemic Agents|C0020616|45843|MH|||RC
9237795|Th2 Cells|C0242633|44408|MH|||RC
9237795|Autoantibodies|C0004358|44366|MH|||RC
9237795|Th1 Cells|C0242632|36481|MH|||RC
9237795|IgG1|C0020855|33696|ET|Entry Term Replacement for "Immunoglobulin G";RtM via: IgG1;RtM via: IgG2B|AB|MM;RC
9237795|Immunoglobulin Isotypes|C0021017|31325|MH|RtM via: Immunoglobulin Isotypes|AB|MM;RC
9237795|*Peptides|C0030956|25278|MH|RtM via: Peptides|TI;AB|MM
9237795|Amino Acid Sequence|C0002518|23351|MH|||RC
9237795|Blood Glucose|C0005802|23129|MH|RtM via: Blood Glucose|AB|MM;RC
9237795|Molecular Sequence Data|C0026382|23120|MH|||RC
9237795|Diabetes Mellitus, Experimental|C0011853|22998|MH|||RC
9237795|Cytokines|C0079189|22156|MH|RtM via: cytokine|AB|MM;RC
9237795|Mice, Inbred BALB C|C0025919|21555|MH|||RC
9237795|Injections, Subcutaneous|C0021499|19688|MH|RtM via: Subcutaneous route|AB|MM;RC
9237795|Antigen Presentation|C0206431|17576|MH|||RC
9237795|Mice, Inbred C57BL|C0025921|17497|MH|||RC
9237795|Mice, SCID|C0085112|11848|MH|||RC
9237795|Interferon-gamma|C0021745|8834|MH|||RC
9237795|Immunosuppressive Agents|C0021081|6534|MH|||RC
9237795|Mice, Inbred C3H|C0025920|6512|MH|||RC
9237795|Ovalbumin|C0029923|5689|MH|||RC
9237795|Adjuvants, Immunologic|C0001551|5420|MH|||RC
9237795|Heat-Shock Proteins|C0018850|5197|MH|||RC
9237795|Vaccines, DNA|C0376613|4235|MH|||RC
9237795|CpG Islands|C0282523|3313|MH|||RC
9237795|Antibodies|C0003241|3132|MH|RtM via: Antibodies|AB|MM
9237795|Injections, Intramuscular|C0021492|2339|MH|||RC
9237795|Administration, Intranasal|C0001560|2015|MH|||RC
9237795|Species Specificity|C0037783|1058|MH|||RC
9237795|Cloning, Molecular|C0009017|801|MH|||RC
9237795|*Ions|C0022023|639|MH|RtM via: Molecule|TI;AB|MM
9237795|Dose-Response Relationship, Drug|C0013059|603|MH|||RC
9237795|Cells, Cultured|C0007635|581|MH|||RC
9237795|Infusions, Subcutaneous|C0576773|434|MH|RtM via: Subcutaneous route|AB|MM
9237795|Time Factors|C0040225|408|MH|||RC
------
9237795|Mice|C0026809|90|CT||AB|MM
9237795|Animals|C0003062|1000|CT|Mouse, NOD;Diabetes Mellitus, Experimental;Mice, Inbred BALB C;Mice, Inbred C57BL;Mice, SCID;Mice, Inbred C3H;CT Text Lookup: mice;CT Text Lookup: mouse;CT Text Lookup: nod mice;CT Text Lookup: nod mouse|TI;AB;CT Text Lookup: mice;CT Text Lookup: mouse;CT Text Lookup: nod mice;CT Text Lookup: nod mouse|MM;RC
9237795|Female|C0015780|1000|CT|CT Text Lookup: female|CT Text Lookup: female|MM
9237795|therapy|C0039798|12591|SH1|RtM via: therapeutic aspects;therapy (C0039798)|TI;AB|MM
9237795|drug therapy|C0013217|9999|SH|new SH add rule - Injections, Subcutaneous [E02.319.267.530.620] (E02.319)||MM
9237795|methods|C0025664|195|SH|Methods|TI;AB|MM
9237795|immunology|C1522005|1111|SH|G12.450.050.400.545 (Lymphocyte Activation)||MM
9237795|genetics|C0017399|1111|SH|G05.360.080.380.160 (CpG Islands)||MM
9354327|*NMDA Receptors|C0080093|2242854|ET|Entry Term Replacement for "Receptors, N-Methyl-D-Aspartate";RtM via: N-Methyl-D-Aspartate Receptors;RtM via: N-methyl-D-aspartate selective glutamate receptor activity|TI;AB|MM;RC
9354327|glutamate receptor ionotropic, AMPA 1|C0384865|1407577|NM|RtM via: glutamate receptor ionotropic, AMPA 1|AB|MM
9354327|Receptors, AMPA|C0072899|1407576|HM|RtM via: glutamate receptor ionotropic, AMPA 1|AB|MM;RC
9354327|*Hippocampus|C0019564|1259760|MH|RtM via: Hippocampus (Brain)|TI;AB|MM;RC
9354327|*Neurons|C0027882|729591|MH|RtM via: Neurons|TI;AB|MM;RC
9354327|Synapses|C0039062|557548|MH|RtM via: Synapses|AB|MM;RC
9354327|Synaptophysin|C0085255|121348|MH|RtM via: Synaptophysin|AB|MM;RC
9354327|NMDA|C0079883|98547|ET|Entry Term Replacement for "N-Methylaspartate";RtM via: N-Methylaspartate|AB|MM;RC
9354327|Glutamate|C0220839|93746|ET|Entry Term Replacement for "Glutamic Acid";RtM via: Glutamate|AB|MM;RC
9354327|Excitatory Postsynaptic Potentials|C0524913|89870|MH|||RC
9354327|Synaptic Transmission|C0027793|60465|MH|||RC
9354327|Cells, Cultured|C0007635|57236|MH|||RC
9354327|Neural Inhibition|C0027790|54905|MH|||RC
9354327|Nerve Tissue Proteins|C0027759|47085|MH|||RC
9354327|Receptors, GABA-A|C0034807|26847|MH|||RC
9354327|Carrier Proteins|C0007292|25815|MH|RtM via: receptor activity|AB|MM;RC
9354327|Membrane Proteins|C0025252|23855|MH|||RC
9354327|Rats, Sprague-Dawley|C0034715|21759|MH|||RC
9354327|Nerve Net|C0027755|19138|MH|||RC
9354327|Electrophysiology|C0013865|14759|MH|||RC
9354327|Synaptosomal-Associated Protein 25|C0075689|10769|MH|||RC
9354327|Membrane Potentials|C0025251|8830|MH|||RC
9354327|Patch-Clamp Techniques|C0242625|8743|MH|||RC
9354327|*Physiological Processes|C0031845|8490|MH|RtM via: establishment and maintenance of position|TI;AB|MM
9354327|Protein Subunits|C0599220|7148|MH|||RC
9354327|Cell Differentiation|C0007589|6435|MH|||RC
9354327|Sodium Channel Blockers|C0872271|5530|MH|||RC
9354327|Cell Aging|C0007581|5333|MH|||RC
9354327|Cell Count|C0007584|4778|MH|||RC
9354327|Transfection|C0040669|4237|MH|||RC
9354327|Animals, Newborn|C0003065|3946|MH|||RC
9354327|Embryo, Mammalian|C1956416|3808|MH|||RC
9354327|Brain|C0006104|3747|MH|||RC
9354327|Electric Stimulation|C0013786|3610|MH|||RC
9354327|Signal Transduction|C0037083|3530|MH|||RC
9354327|Gene Transfer Techniques|C0886519|2329|MH|||RC
9354327|Genetic Vectors|C0017397|2156|MH|||RC
9354327|Dose-Response Relationship, Radiation|C0013061|1432|MH|||RC
9354327|Conserved Sequence|C0009802|987|MH|||RC
9354327|Drug Interactions|C0687133|911|MH|||RC
9354327|Time Factors|C0040225|884|MH|||RC
9354327|Solubility|C0037628|474|MH|||RC
------
9354327|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;Animals, Newborn||RC
9354327|Rats|C0034721|1000|CT|Rats, Sprague-Dawley||RC
9354327|genetics|C0017399|1111|SH|G05.355.760.860 (Transfection)||MM
9297573|*Histamine H2 Receptors|C0034815|2519088|ET|Entry Term Replacement for "Receptors, Histamine H2";RtM via: Histamine H2 Receptors|TI;AB|MM;RC
9297573|Receptors, H1|C0034814|577221|ET|Entry Term Replacement for "Receptors, Histamine H1";RtM via: Receptors, Histamine H1|AB|MM;RC
9297573|*Signal Transduction Pathways|C0086982|205929|ET|Entry Term Replacement for "Signal Transduction";RtM via: Signal Transduction Pathways|TI|MM;RC
9297573|Histamine|C0019588|109798|MH|RtM via: Histamine|AB|MM;RC
9297573|H2 Agonists|C0162815|104530|ET|Entry Term Replacement for "Histamine Agonists";RtM via: Histamine H2 Agonists|AB|MM;RC
9297573|Cyclic AMP|C0001455|95480|MH|RtM via: second messenger|AB|MM;RC
9297573|Histamine Receptors|C0034813|72608|ET|Entry Term Replacement for "Receptors, Histamine";RtM via: Histamine Receptor|AB|MM;RC
9297573|Phosphatidylinositol|C0031621|65278|ET|Entry Term Replacement for "Phosphatidylinositols";RtM via: Phosphatidylinositols;RtM via: Dietary Phosphatidylinositol|AB|MM;RC
9297573|Inositol Phosphates|C0021554|63064|MH|RtM via: Inositol Phosphates;RtM via: second messenger|AB|MM;RC
9297573|Second Messengers|C0036522|42736|ET|Entry Term Replacement for "Second Messenger Systems";RtM via: Second Messenger Systems;RtM via: second messenger|AB|MM;RC
9297573|Hydrolysis|C0020291|10948|MH|RtM via: Hydrolysis|AB|MM;RC
9297573|Calcium|C0006675|10497|MH|RtM via: second messenger|AB|MM;RC
9297573|Mast Cell|C0024880|9423|ET|Entry Term Replacement for "Mast Cells";RtM via: mast cell|AB|MM;RC
9297573|*Cell Transformation, Neoplastic|C0007621|6669|MH|RtM via: Skin Carcinogenesis;RtM via: Carcinogenesis|TI;AB|MM
9297573|Skin|C1123023|6582|MH|RtM via: Skin;RtM via: Entire skin;RtM via: Skin Specimen|AB|MM;RC
9297573|Binding, Competitive|C0005458|6174|MH|||RC
9297573|STAT1 Transcription Factor|C0287920|6043|MH|||RC
9297573|Cells, Cultured|C0007635|5281|MH|||RC
9297573|Cell Degranulation|C0007588|4873|MH|||RC
9297573|Muscle, Smooth, Vascular|C0026844|4697|MH|||RC
9297573|Breast|C0006141|3847|MH|RtM via: mast-|AB|MM;RC
9297573|Muscle, Smooth|C1267092|3336|MH|||RC
9297573|Epithelial Cells|C0014597|3293|MH|||RC
9297573|Myocardial Contraction|C0027045|3132|MH|||RC
9297573|Binding Sites|C0005456|2954|MH|||RC
9297573|Endothelium, Vascular|C0014261|2666|MH|||RC
9297573|Gene Expression Regulation, Neoplastic|C0017268|2153|MH|||RC
9297573|Cardiotonic Agents|C0007209|2135|MH|||RC
9297573|Microcirculation|C0025962|1972|MH|||RC
9297573|Mice, Transgenic|C0025936|1870|MH|||RC
9297573|Laser-Doppler Flowmetry|C0162520|1759|MH|||RC
9297573|Regional Blood Flow|C0034965|1449|MH|||RC
9297573|Mice, Inbred C57BL|C0025921|1338|MH|||RC
9297573|Carcinogens|C0007090|1309|MH|||RC
9297573|Mutation|C0026882|936|MH|||RC
9297573|Cold Temperature|C0009264|863|MH|||RC
9297573|Rats, Wistar|C0034716|648|MH|||RC
9297573|Histocytochemistry|C0019635|608|MH|||RC
9297573|Kinetics|C0022702|439|MH|||RC
9297573|1,2-diacylglycerol|C0043791|315|NM|RtM via: second messenger|AB|MM
9297573|Diglycerides|C0012262|314|HM|RtM via: second messenger|AB|MM
9297573|Cyclic GMP|C0018338|290|MH|RtM via: second messenger|AB|MM
------
9297573|Mice|C0026809|19623|CT||TI|MM
9297573|Animals|C0003062|1000|CT|Mice, Transgenic;Mice, Inbred C57BL;Rats, Wistar;CT Text Lookup: mice;CT Text Lookup: mouse;CT Text Lookup: sencar mice|CT Text Lookup: mice;CT Text Lookup: mouse;CT Text Lookup: sencar mice|MM;RC
9297573|Rats|C0034721|1000|CT|Rats, Wistar||RC
9297573|Female|C0015780|1000|CT|CT Text Lookup: female|CT Text Lookup: female|MM
9297573|genetics|C0017399|1111|SH|G05.355.315.370 (Gene Expression Regulation, Neoplastic)||MM
9335237|*Skin Diseases|C0037274|537525|MH|RtM via: Skin lesion|TI;AB|MM;RC
9335237|Pseudolymphoma|C0221269|331573|MH|RtM via: Pseudolymphoma|AB|MM;RC
9335237|*Skin|C1123023|138888|MH|RtM via: Skin|TI;AB|MM;RC
9335237|B-Lymphocytes|C0004561|90821|MH|RtM via: B-Lymphocytes;Forced Lookup:b-cell|AB|MM;RC
9335237|Skin Neoplasms|C0037286|63957|MH|||RC
9335237|Lymphoma, Malignant|C0024299|47408|ET|Entry Term Replacement for "Lymphoma";RtM via: Lymphoma|AB|MM;RC
9335237|T-Lymphocytes|C0039194|41568|MH|RtM via: T-Lymphocyte|AB|MM;RC
9335237|Lupus Erythematosus, Systemic|C0024141|36112|MH|RtM via: Lupus Erythematosus|AB|MM;RC
9335237|*Disease, Connective Tissue|C0009782|26637|ET|Entry Term Replacement for "Connective Tissue Diseases";RtM via: Connective Tissue Diseases|TI;AB|MM
9335237|Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor|C0017293|21783|MH|||RC
9335237|Receptors, Antigen, T-Cell, gamma-delta|C0085246|13960|MH|||RC
9335237|Immunoglobulin Heavy Chains|C0021034|10985|MH|||RC
9335237|Antigens, Neoplasm|C0003335|4211|MH|||RC
9335237|Gene Rearrangement|C0017287|3730|MH|||RC
9335237|Borrelia burgdorferi|C0006034|3237|MH|||RC
9335237|Diagnosis, Differential|C0011906|3203|MH|||RC
9335237|Lyme Disease|C0024198|2924|MH|||RC
9335237|Antibodies, Monoclonal|C0003250|2389|MH|||RC
9335237|Tumor Markers, Biological|C0041366|2372|MH|||RC
9335237|Drug Hypersensitivity|C0013182|1899|MH|||RC
9335237|Prognosis|C0033325|1591|MH|||RC
9335237|Histocytochemistry|C0019635|1544|MH|||RC
9335237|Dermatomyositis|C0011633|776|MH|RtM via: Dermatomyositis|AB|MM
9335237|Treatment Outcome|C0085415|581|MH|||RC
9335237|*Biophysical Processes|C1511162|318|MH|RtM via: Infiltration|TI;AB|MM
9335237|Risk Assessment|C0086930|262|MH|||RC
9335237|Polychondritis, Relapsing|C0032453|241|MH|RtM via: Polychondritis, Relapsing|AB|MM
------
9335237|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9335237|genetics|C0017399|1111|SH|G05.355.330.801.311 (Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor)||MM
9335237|immunology|C1522005|1111|SH|D23.050.285 (Antigens, Neoplasm)||MM
9321417|*Drosophila|C0013138|620685|MH|RtM via: Drosophila <fruit fly, genus>;RtM via: Drosophila <fruit fly, subgenus>;RtM via: obscura group;RtM via: melanogaster subgroup|TI;AB|MM;RC
9321417|mtDNA|C0012929|171620|ET|Entry Term Replacement for "DNA, Mitochondrial";RtM via: DNA, Mitochondrial|AB|MM;RC
9321417|*Mitochondria|C0026237|156549|MH|RtM via: Mitochondria;RtM via: Mitochondrial;RtM via: mitochondrial DNA location|TI;AB|MM;RC
9321417|Genes, Insect|C0162729|122997|MH|||RC
9321417|Codon|C0009221|111730|MH|RtM via: Codon Nucleotides|AB|MM;RC
9321417|Base Composition|C0004790|71561|MH|RtM via: Base Composition|AB|MM;RC
9321417|Drosophila melanogaster|C0013139|65250|MH|||RC
9321417|Selection, Genetic|C0036576|58539|MH|||RC
9321417|Evolution, Molecular|C0282688|54101|MH|||RC
9321417|Phylogeny|C0031797|52309|MH|||RC
9321417|*Cell Nucleus|C0007610|40341|MH|RtM via: Nuclear|TI;AB|MM;RC
9321417|Evolution|C0015219|37428|MH|||RC
9321417|Models, Genetic|C0026343|32344|MH|||RC
9321417|Genetic Variation|C0042333|29839|MH|||RC
9321417|Mutation|C0026882|23376|MH|||RC
9321417|Amino Acid Sequence|C0002518|19569|MH|||RC
9321417|Molecular Sequence Data|C0026382|17087|MH|||RC
9321417|Species Specificity|C0037783|16499|MH|||RC
9321417|Genetics, Population|C0017404|13483|MH|||RC
9321417|Point Mutation|C0162735|9797|MH|RtM via: Transition Mutation|AB|MM;RC
9321417|Gene Frequency|C0017270|8522|MH|||RC
9321417|Conserved Sequence|C0009802|8069|MH|||RC
9321417|Genes, Mitochondrial|C1563761|7492|MH|RtM via: Genes, Mitochondrial|AB|MM
9321417|Mitochondrial Proteins|C0949610|7235|MH|||RC
9321417|Genome, Plant|C0242965|6192|MH|||RC
9321417|DNA, Plant|C0242964|6080|MH|||RC
9321417|Sequence Analysis, DNA|C0162802|5485|MH|||RC
9321417|Sequence Alignment|C0080143|5412|MH|||RC
9321417|Genomics|C0887950|5344|MH|||RC
9321417|Cloning, Molecular|C0009017|2675|MH|||RC
9321417|Time|C0040223|2314|MH|RtM via: Time|AB|MM;RC
9321417|Computer Simulation|C0009609|1234|MH|||RC
9321417|Time Factors|C0040225|963|MH|||RC
9321417|*Effect Modifiers (Epidemiology)|C0013675|288|MH|RtM via: Rating|TI;AB|MM
------
9321417|Animals|C0003062|1000|CT|Drosophila;Drosophila melanogaster|TI;AB|MM;RC
9321417|genetics|C0017399|1111|SH|G05.360.340.024.340.340 (Genes, Insect)||MM
9378240|CD 832|C0219405|1554333|NM|RtM via: CD 832;Forced Lookup:cd-832|TI;AB|MM
9378240|*Nifedipine|C0028066|1554332|MH|RtM via: CD 832;RtM via: Nifedipine|TI;AB|MM;RC
9378240|1,4-dihydropyridine|C0220821|745432|NM|RtM via: dihydropyridine|TI|MM
9378240|*Dihydropyridines|C0012315|745431|MH|RtM via: Dihydropyridines;RtM via: dihydropyridine|TI|MM;RC
9378240|*Vasodilation|C0042401|438801|MH|RtM via: Vasodilation;RtM via: Vasodilation disorder|TI;AB|MM;RC
9378240|*Niacinamide|C0028027|280211|HM|RtM via: CD 832|TI;AB|MM;RC
9378240|Nitroglycerin|C0017887|249408|MH|RtM via: Nitroglycerin|AB|MM;RC
9378240|Nicorandil|C0068700|215675|MH|RtM via: Nicorandil|AB|MM;RC
9378240|*Aorta|C0003483|215511|MH|RtM via: Aorta;RtM via: Entire aorta|TI;AB|MM;RC
9378240|Vasodilator Agents|C0042402|132767|MH|||RC
9378240|Calcium Channel Blockers|C0006684|110252|MH|||RC
9378240|Muscle, Smooth, Vascular|C0026844|45084|MH|||RC
9378240|Norepinephrine|C0028351|44164|MH|RtM via: Norepinephrine|AB|MM;RC
9378240|Aorta, Thoracic|C1522460|28473|MH|||RC
9378240|Muscle Relaxation|C0026836|22068|MH|||RC
9378240|Muscle Contraction|C0026820|19530|MH|||RC
9378240|Potassium Chloride|C0032825|15570|MH|||RC
9378240|Endothelium, Vascular|C0014261|14482|MH|||RC
9378240|Calcium|C0006675|12033|MH|||RC
9378240|*Hyperemia|C0020452|11373|MH|RtM via: Vasodilation disorder|TI;AB|MM
9378240|Potassium|C0032821|11154|MH|||RC
9378240|Vasoconstrictor Agents|C0042397|9959|MH|||RC
9378240|Vasoconstriction|C0042396|9559|MH|||RC
9378240|Anti-Arrhythmia Agents|C0003195|7383|MH|||RC
9378240|Potassium Channel Blockers|C0872245|7176|MH|||RC
9378240|Femoral Artery|C0015801|6766|MH|||RC
9378240|*Flushing|C0016382|6708|MH|RtM via: Vasodilation disorder|TI;AB|MM
9378240|Tunica Intima|C0162864|6281|MH|||RC
9378240|Pulmonary Artery|C0034052|6101|MH|||RC
9378240|Nitrendipine|C0028127|4722|MH|RtM via: Nitrendipine|AB|MM
9378240|Cyclic AMP|C0001455|4112|MH|||RC
9378240|*Hot Flashes|C0600142|3171|MH|RtM via: Vasodilation disorder|TI;AB|MM
9378240|Membrane Potentials|C0025251|2799|MH|||RC
9378240|Picolines|C0031884|1845|MH|||RC
9378240|Models, Cardiovascular|C0026340|1635|MH|||RC
9378240|zaprinast|C0065432|1061|NM|RtM via: zaprinast|AB|MM
9378240|Purinones|C0034142|1060|HM|RtM via: zaprinast|AB|MM
9378240|Rats, Wistar|C0034716|379|MH|||RC
9378240|Models, Animal|C0599779|268|MH|||RC
------
9378240|Animals|C0003062|1000|CT|Rats, Wistar;Models, Animal;CT Text Lookup: rabbit|CT Text Lookup: rabbit|MM;RC
9378240|Rats|C0034721|1000|CT|Rats, Wistar||RC
9378240|Rabbits|C0034493|1000|CT|CT Text Lookup: rabbit|CT Text Lookup: rabbit|MM
9378240|analogs & derivatives|C0002776|654|SH1|RtM via: derivatives;analogs & derivatives (C0002776)|TI|MM
9378240|methods|C0025664|11|SH|Methods|AB|MM
9356032|*Insulin|C0021641|1223682|MH|RtM via: Insulin|TI;AB|MM;RC
9356032|*NIDDM|C0011860|831612|ET|Entry Term Replacement for "Diabetes Mellitus, Type 2";RtM via: Diabetes Mellitus, Non-Insulin-Dependent|TI;AB|MM;RC
9356032|Insulin Resistance|C0021655|458531|MH|RtM via: Insulin Resistance|AB|MM;RC
9356032|Clamp, Euglycaemic|C0079318|336997|ET|Entry Term Replacement for "Glucose Clamp Technique";RtM via: Euglycemic Clamp|AB|MM;RC
9356032|Blood Glucose|C0005802|182773|MH|||RC
9356032|Glucose|C0017725|61633|MH|RtM via: Glucose;RtM via: Plasma Glucose Measurement|AB|MM;RC
9356032|*Muscles|C0026845|46737|MH|RtM via: Muscle Fibers|TI;AB|MM;RC
9356032|Physical Fitness|C0031812|37014|MH|||RC
9356032|Muscle, Skeletal|C0242692|29892|MH|||RC
9356032|Muscle Fibers, Skeletal|C1704336|29630|MH|||RC
9356032|Oxygen Consumption|C0030055|16930|MH|||RC
9356032|Capillary|C0006901|14049|ET|Entry Term Replacement for "Capillaries";RtM via: Blood capillaries;RtM via: Entire capillary blood vessel (organ)|AB|MM;RC
9356032|*Hormones|C0019932|13641|MH|RtM via: Recombinant Insulin|TI;AB|MM
9356032|Exercise|C0015259|9998|MH|||RC
9356032|Exercise Test|C0015260|9449|MH|||RC
9356032|Body Mass Index|C0005893|9004|MH|||RC
9356032|Regression Analysis|C0034980|8958|MH|RtM via: Regression Analysis|AB|MM;RC
9356032|Lipid Metabolism|C0598783|6579|MH|||RC
9356032|Biopsy|C0005558|5526|MH|RtM via: muscle biopsy test;RtM via: Muscle biopsy|AB|MM;RC
9356032|Reference Values|C0034926|5503|MH|||RC
9356032|Linear Regression|C0023733|4642|ET|Entry Term Replacement for "Linear Models";RtM via: Linear Regression;RtM via: Linear Regression Body Surface Area Formula for Infants and Children|AB|MM;RC
9356032|Regional Blood Flow|C0034965|3986|MH|||RC
9356032|Administration, Oral|C0001563|3806|MH|||RC
9356032|Human Growth Hormone|C0169964|3644|MH|||RC
9356032|Pituitary-Adrenal System|C0032022|3395|MH|||RC
9356032|Homeostasis|C0019868|3361|MH|||RC
9356032|Hypothalamo-Hypophyseal System|C0020662|2867|MH|||RC
9356032|Viscera|C0042779|2658|MH|||RC
9356032|Organ Size|C1450569|1801|MH|||RC
9356032|Oxygen|C0030054|1292|MH|||RC
9356032|Genetic Predisposition to Disease|C0314657|1277|MH|||RC
9356032|Kinetics|C0022702|820|MH|||RC
9356032|Infusions, Intravenous|C0021440|556|MH|||RC
9356032|Body Weight|C0005910|544|MH|RtM via: Body Weight|AB|MM
9356032|Patient Selection|C0242802|532|MH|||RC
9356032|Time Factors|C0040225|421|MH|||RC
9356032|Medical Records|C0025102|290|MH|||RC
9356032|Vastus Lateralis|C0224444|269|ET|Entry Term Replacement for "Quadriceps Muscle";RtM via: Entire vastus lateralis muscle;RtM via: Structure of vastus lateralis muscle|AB|MM
------
9356032|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9356032|genetics|C0017399|1111|SH|G05.380.355 (Genetic Predisposition to Disease)||MM
9379020|*Lymphotoxin-alpha|C0024320|1785386|MH|RtM via: Tumor Necrosis Factor-Beta;Forced Lookup:lymphotoxin-alpha|TI;AB|MM;RC
9379020|*Lymph Nodes|C0024204|387198|MH|RtM via: lymph nodes|TI;AB|MM;RC
9379020|Peyer's Patches|C0031272|173791|MH|RtM via: Structure of aggregated lymphoid follicle of small intestine;RtM via: Entire aggregated lymphoid follicle of small intestine|AB|MM;RC
9379020|B-Lymphocytes|C0004561|138694|MH|RtM via: B-Lymphocytes|AB|MM;RC
9379020|Germinal Center|C0282491|129734|MH|RtM via: Structure of germinal center of lymph node|AB|MM;RC
9379020|Spleen|C0037993|108613|MH|RtM via: Spleen;RtM via: Entire spleen|AB|MM;RC
9379020|*Animals, Genetically Modified|C0969757|31980|MH|RtM via: Animals, Transgenic|TI|MM
9379020|Lymphocytes|C0024264|15457|MH|RtM via: Lymphocyte|AB|MM;RC
9379020|Interdigitating Dendritic Cell|C1522445|11488|ET|Entry Term Replacement for "Dendritic Cells";RtM via: Interdigitating Dendritic Cell|AB|MM;RC
9379020|Membrane Proteins|C0025252|10802|MH|||RC
9379020|Mice, Knockout|C0206745|10745|MH|||RC
9379020|*Immunologic Factors|C0021054|9585|MH|RtM via: Recombinant Tumor Necrosis Factor-Beta;RtM via: Recombinant Lymphotoxin Beta|TI;AB|MM
9379020|Immunoglobulin G|C0020852|9373|MH|||RC
9379020|Signal Transduction|C0037083|8207|MH|||RC
9379020|Mice, Inbred C57BL|C0025921|7133|MH|||RC
9379020|Mice, Transgenic|C0025936|6299|MH|||RC
9379020|L-Selectin|C0125090|5091|MH|||RC
9379020|Mice, Inbred BALB C|C0025919|4332|MH|||RC
9379020|Dendritic Cells, Follicular|C0242245|4036|MH|RtM via: Dendritic Cells, Follicular|AB|MM
9379020|Cell Lineage|C0282637|3470|MH|||RC
9379020|Recombinant Fusion Proteins|C0034857|3018|MH|||RC
9379020|Flow Cytometry|C0016263|2291|MH|||RC
9379020|Homeodomain Proteins|C0242617|1708|MH|||RC
9379020|Promoter Regions, Genetic|C0033413|1483|MH|||RC
9379020|Mutation|C0026882|1409|MH|||RC
9379020|Aging|C0001811|1021|MH|||RC
9379020|Insulin|C0021641|813|MH|RtM via: Insulin|AB|MM
9379020|Transgene|C0282641|751|ET|Entry Term Replacement for "Transgenes";RtM via: Transgenes|AB|MM
9379020|Mice, NOD|C0085243|712|ET|Entry Term Replacement for "Mice, Inbred NOD";RtM via: Mice, Inbred NOD|AB|MM
9379020|*Emergency Treatment|C0013969|471|MH|RtM via: Restoring|TI;AB|MM
9379020|Mitogens|C0026249|323|MH|RtM via: Mitogens|AB|MM
9379020|*Emergency Medical Services|C0013961|267|MH|RtM via: Restoring|TI;AB|MM
9379020|Pancreas|C0030274|227|MH|RtM via: Pancreas;RtM via: Entire pancreas;RtM via: Pancreas extract|AB|MM
------
9379020|Mice|C0026809|43536|CT||TI;AB|MM
9379020|Rats|C0034721|9098|CT||AB|MM
9379020|Animals|C0003062|1000|CT|Animals, Genetically Modified;Mice, Knockout;Mice, Inbred C57BL;Mice, Transgenic;Mice, Inbred BALB C;Mice, NOD;CT Text Lookup: mice;CT Text Lookup: rat|TI;AB;CT Text Lookup: mice;CT Text Lookup: rat|MM;RC
9379020|methods|C0025664|31|SH|Methods|AB|MM
9379020|immunology|C1522005|1111|SH|D23.050.301.264.035.850.903 (L-Selectin)||MM
9379020|genetics|C0017399|1111|SH|G05.360.080.689.675 (Promoter Regions, Genetic)||MM
9378367|tempol|C0045283|510406|NM|RtM via: tempol|TI;AB|MM
9378367|*Cyclic N-Oxides|C0010538|510405|HM|RtM via: tempol|TI;AB|MM;RC
9378367|*Spin Labels|C0037914|455514|HM|RtM via: tempol|TI;AB|MM;RC
9378367|*DNA Damage|C0012860|241974|MH|RtM via: DNA Damage;RtM via: DNA Strand Break|TI;AB|MM;RC
9378367|*Hydrogen Peroxide|C0020281|238119|MH|RtM via: Hydrogen Peroxide|TI;AB|MM;RC
9378367|*Neutrophils|C0027950|56511|MH|RtM via: neutrophil|TI;AB|MM;RC
9378367|Radiation-Protective Agents|C0034540|18840|MH|||RC
9378367|DNA Repair|C0012899|14978|MH|||RC
9378367|Free Radicals|C0016693|14613|MH|RtM via: Free Radicals|AB|MM;RC
9378367|Reactive Oxygen Species|C0162772|14510|MH|RtM via: Reactive Oxygen Species|AB|MM;RC
9378367|Dose-Response Relationship, Radiation|C0013061|11056|MH|||RC
9378367|Antioxidants|C0003402|8125|MH|||RC
9378367|Cell Line|C0007600|7643|MH|||RC
9378367|Cell Survival|C0007620|7519|MH|||RC
9378367|Cells, Cultured|C0007635|6960|MH|||RC
9378367|Superoxide Dismutase|C0038838|6897|MH|RtM via: Superoxide Dismutase|AB|MM;RC
9378367|Free Radical Scavengers|C0079381|6593|MH|||RC
9378367|Electron Spin Resonance Spectroscopy|C0013845|6542|MH|||RC
9378367|Radiation Injuries, Experimental|C0034531|5681|MH|||RC
9378367|Tetradecanoylphorbol Acetate|C0039654|4815|MH|RtM via: Tetradecanoylphorbol Acetate|AB|MM;RC
9378367|Oxygen|C0030054|3683|MH|||RC
9378367|Metals|C0025552|3223|MH|RtM via: Metals|AB|MM;RC
9378367|CHO Cells|C0085080|3205|MH|||RC
9378367|Oxidants|C0085403|2779|MH|RtM via: Oxidants|AB|MM
9378367|pristane|C0071986|2745|NM|RtM via: pristane|AB|MM
9378367|Terpenes|C0039561|2744|HM|RtM via: pristane|AB|MM;RC
9378367|Dose-Response Relationship, Drug|C0013059|2496|MH|||RC
9378367|Mice, Inbred C3H|C0025920|2487|MH|||RC
9378367|Epithelial Cells|C0014597|2232|MH|||RC
9378367|Kinetics|C0022702|2155|MH|||RC
9378367|Hydrogen-Ion Concentration|C0020283|1953|MH|||RC
9378367|Mitochondria, Liver|C0026239|1566|MH|||RC
9378367|Cricetulus|C0010320|1516|MH|||RC
9378367|Organ Culture Techniques|C0029205|1207|MH|||RC
9378367|Mice, Inbred BALB C|C0025919|1093|MH|||RC
9378367|Hydroxyl Radical|C0063146|1068|MH|RtM via: Hydroxyl Radical|AB|MM
9378367|Radiation Dosage|C0034524|995|MH|||RC
9378367|Neutrophil Activation|C0242599|934|MH|RtM via: Neutrophil Activation|AB|MM
9378367|Plasmacytoma|C0032131|798|MH|RtM via: Plasmacytoma|AB|MM;RC
9378367|Leukocyte Count|C0023508|663|MH|RtM via: Absolute neutrophil count|AB|MM
9378367|NIH 3T3 Cells|C1257739|616|MH|||RC
9378367|Adenosine Triphosphate|C0001480|605|MH|||RC
9378367|Water|C0043047|236|MH|RtM via: Water;RtM via: Water Specimen|AB|MM
------
9378367|Mice|C0026809|318|CT||AB|MM
9378367|Animals|C0003062|1000|CT|Radiation Injuries, Experimental;CHO Cells;Mice, Inbred C3H;Cricetulus;Mice, Inbred BALB C;NIH 3T3 Cells;CT Text Lookup: mice|CT Text Lookup: mice|MM;RC
9378367|Cricetinae|C0018557|1000|CT|CHO Cells;Cricetulus||RC
9378367|metabolism|C0025520|1632|SH1|RtM via: Inhibited;Metabolism (C0025519);RtM via: Metabolic Inhibition;Metabolism (C0025519)|TI;AB|MM
9378367|genetics|C0017399|1111|SH|G05.355.180 (DNA Damage)|TI;AB|MM
9326899|*Mandible|C0024687|321153|MH|RtM via: Mandible;RtM via: Entire mandible|TI;AB|MM;RC
9326899|Dental Implants|C0011373|319619|MH|||RC
9326899|Dental Implantation, Endosseous|C0011371|270100|MH|||RC
9326899|Dental Prosthesis, Implant-Supported|C0282659|247663|MH|||RC
9326899|Dental Restoration Failure|C0376494|217092|MH|||RC
9326899|Alveolar Bone Loss|C0002382|210545|MH|||RC
9326899|Jaw, Edentulous|C0022366|194967|MH|||RC
9326899|*Follow-Up Study|C0016441|136479|ET|Entry Term Replacement for "Follow-Up Studies";RtM via: Follow-Up Studies|TI|MM;RC
9326899|Dental Prosthesis Design|C0162687|117511|MH|||RC
9326899|Jaw, Edentulous, Partially|C0022367|80605|MH|||RC
9326899|Dental Prosthesis Retention|C0162688|66444|MH|||RC
9326899|*Smoking|C0037369|52029|MH|RtM via: Smoking;RtM via: Medical Device Emits Smoke;RtM via: Tobacco smoking behavior|TI;AB|MM;RC
9326899|Dental Implants, Single-Tooth|C0376511|35448|MH|||RC
9326899|Alveolar Process|C0002386|33766|MH|||RC
9326899|Dental Restoration, Temporary|C0011414|18789|MH|||RC
9326899|Periodontal Index|C0031092|17312|MH|||RC
9326899|Dental Stress Analysis|C0011423|15125|MH|||RC
9326899|Mandibular Diseases|C0024689|12499|MH|||RC
9326899|Periodontal Pocket|C0031094|11077|MH|||RC
9326899|Radiography, Panoramic|C0034579|9441|MH|||RC
9326899|Oral Hygiene|C0029164|9188|MH|RtM via: Dental Hygiene|AB|MM;RC
9326899|Dental Plaque|C0011389|9119|MH|RtM via: Dental Plaque|AB|MM;RC
9326899|*Bone Diseases, Metabolic|C0005944|6084|MH|RtM via: Osteopenia|TI;AB|MM
9326899|Risk Factors|C0035648|4934|MH|||RC
9326899|Treatment Outcome|C0085415|4262|MH|||RC
9326899|*Prostheses and Implants|C0524929|3735|MH|RtM via: Implants;RtM via: Artificial Implants;RtM via: Jaw implant|TI;AB|MM
9326899|Cephalometry|C0007723|3692|MH|||RC
9326899|Analyses, Multivariate|C0026777|1551|ET|Entry Term Replacement for "Multivariate Analysis";RtM via: Multivariate Analysis|AB|MM;RC
9326899|Genotype|C0017431|1054|MH|||RC
9326899|Mouth, Edentulous|C0026644|908|MH|RtM via: Mouth, Edentulous|AB|MM
9326899|Genetic Variation|C0042333|682|MH|||RC
9326899|Outcome Assessment (Health Care)|C0085565|671|MH|||RC
9326899|*Central Nervous System Stimulants|C0002763|483|MH|RtM via: Medical Device Emits Smoke|TI;AB|MM
9326899|Image Processing, Computer-Assisted|C0020911|254|MH|||RC
9326899|Surface Properties|C0038884|238|MH|||RC
9326899|Time Factors|C0040225|203|MH|||RC
------
9326899|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9326899|surgery|C0038895|1111|SH1|RtM via: Implantation procedure;Surgical Procedures, Operative (C0543467)|AB|MM
9326899|radiography|C0034571|1111|SH1|RtM via: Plain x-ray;Radiography (C1962945)|AB|MM
9326899|methods|C0025664|25|SH|Methods|AB|MM
9326899|genetics|C0017399|1111|SH|G05.380 (Genotype)||MM
9312211|*Chloride Channel|C0055363|517908|ET|Entry Term Replacement for "Chloride Channels";RtM via: Chloride Channels|TI;AB|MM;RC
9312211|Bilayer, Lipid|C0023768|84146|ET|Entry Term Replacement for "Lipid Bilayers";RtM via: Lipid Bilayers|AB|MM;RC
9312211|Ion Channel Gating|C0022008|70054|MH|||RC
9312211|Membrane Potentials|C0025251|63651|MH|||RC
9312211|5-nitro-2-(3-phenylpropylamino)benzoic acid|C0049330|55939|NM|RtM via: 5-nitro-2-(3-phenylpropylamino)benzoic acid|AB|MM
9312211|Nitrobenzoates|C0028146|55938|HM|RtM via: 5-nitro-2-(3-phenylpropylamino)benzoic acid|AB|MM;RC
9312211|*Endoplasmic Reticulum, Rough|C0230779|50490|MH|RtM via: Wall of rough endoplasmic reticulum|TI;AB|MM;RC
9312211|Anions|C0003075|33276|MH|RtM via: Anions|AB|MM;RC
9312211|Electric Conductivity|C0013777|30549|MH|||RC
9312211|*Phosphates|C0031603|24318|MH|RtM via: inorganic phosphate|TI;AB|MM
9312211|Chlorides|C0008203|19125|MH|||RC
9312211|*Hepatocytes|C0227525|16734|MH|RtM via: Hepatocyte|TI;AB|MM;RC
9312211|Patch-Clamp Techniques|C0242625|15333|MH|||RC
9312211|Permeability|C0031164|14719|MH|RtM via: Permeability|AB|MM;RC
9312211|Membrane|C0025255|14138|ET|Entry Term Replacement for "Membranes";RtM via: Tissue membrane|AB|MM;RC
9312211|Calcium|C0006675|10026|MH|||RC
9312211|Electrophysiology|C0013865|9764|MH|||RC
9312211|Cell Membrane Permeability|C0007605|9130|MH|||RC
9312211|4,4'-dinitro-2,2'-stilbenedisulfonic acid|C0047820|7961|NM|RtM via: 4,4'-dinitro-2,2'-stilbenedisulfonic acid|AB|MM
9312211|Stilbenes|C0038333|7960|HM|RtM via: 4,4'-dinitro-2,2'-stilbenedisulfonic acid|AB|MM;RC
9312211|Adenosine Triphosphate|C0001480|5306|MH|||RC
9312211|*Dosage Forms|C0013058|4908|MH|RtM via: Block Dosage Form;RtM via: Block Dosing Unit;RtM via: Solution Dosage Form|TI;AB|MM
9312211|Kinetics|C0022702|4904|MH|||RC
9312211|Hydrogen-Ion Concentration|C0020283|4731|MH|||RC
9312211|Sodium|C0037473|4188|MH|||RC
9312211|4-Aminopyridine|C0000477|4008|MH|||RC
9312211|Myocardium|C0027061|2620|MH|||RC
9312211|Membrane Proteins|C0025252|2269|MH|||RC
9312211|Microsomes, Liver|C0026030|2220|MH|||RC
9312211|Potassium Chloride|C0032825|2165|MH|||RC
9312211|Muscle, Skeletal|C0242692|2060|MH|||RC
9312211|Eye Proteins|C0015416|1671|MH|||RC
9312211|Calcium Channel Blockers|C0006684|1379|MH|||RC
9312211|Electric Stimulation|C0013786|1348|MH|||RC
9312211|Models, Biological|C0026339|1347|MH|||RC
9312211|Natriuretic Peptide, C-Type|C0081880|1132|MH|||RC
9312211|Vestibule, Labyrinth|C1735318|709|MH|||RC
9312211|Probability|C0033204|684|MH|RtM via: Probability|AB|MM;RC
9312211|Protein Kinases|C0033640|672|MH|||RC
9312211|Swine|C0039005|568|MH|||RC
9312211|Chromatography, High Pressure Liquid|C0008562|413|MH|||RC
9312211|Time Factors|C0040225|348|MH|||RC
9312211|Sheep|C0036945|320|MH|||RC
9312211|Mathematics|C0024934|278|MH|||RC
------
9312211|Rats|C0034721|15375|CT||TI;AB|MM
9312211|Animals|C0003062|1000|CT|Swine;Sheep;CT Text Lookup: rat;CT Text Lookup: reticulum|CT Text Lookup: rat;CT Text Lookup: reticulum|MM;RC
9342780|*Clozapine|C0009079|3363528|MH|RtM via: Clozapine|TI;AB|MM;RC
9342780|*Haloperidol|C0018546|3083931|MH|RtM via: Haloperidol|TI;AB|MM;RC
9342780|*Dopamine|C0013030|1112007|MH|RtM via: Dopamine Hydrochloride|TI;AB|MM;RC
9342780|Nucleus Accumbens|C0028633|474974|MH|RtM via: Nucleus Accumbens|AB|MM;RC
9342780|Antipsychotic Drugs|C0040615|394860|ET|Entry Term Replacement for "Antipsychotic Agents";RtM via: Antipsychotic Agents|AB|MM;RC
9342780|DOPAC|C0000376|308615|ET|Entry Term Replacement for "3,4-Dihydroxyphenylacetic Acid";RtM via: 3,4-Dihydroxyphenylacetic Acid|AB|MM;RC
9342780|Corpus Striatum|C0010097|281322|MH|RtM via: Corpus striatum structure|AB|MM;RC
9342780|*Kainic Acid|C0022471|132045|MH|RtM via: Kainic Acid|TI;AB|MM;RC
9342780|Dopamine Antagonists|C0242702|44696|MH|||RC
9342780|Receptors, Dopamine D2|C0058698|38391|MH|||RC
9342780|Rats, Sprague-Dawley|C0034715|24415|MH|||RC
9342780|Brain|C0006104|12149|MH|RtM via: Brain region|AB|MM;RC
9342780|Proto-Oncogene Proteins c-fos|C0085301|6154|MH|||RC
9342780|Cardiotonic Agents|C0007209|5049|MH|||RC
9342780|Motor Activity|C0026606|4834|MH|||RC
9342780|Rats, Wistar|C0034716|4681|MH|||RC
9342780|Drug Interactions|C0687133|4505|MH|||RC
9342780|Neurons|C0027882|3807|MH|||RC
9342780|Kinetics|C0022702|2151|MH|||RC
9342780|Cerebral Cortex|C0007776|2005|MH|RtM via: Cerebral cortex|AB|MM
9342780|Membrane Potentials|C0025251|1767|MH|||RC
9342780|Dose-Response Relationship, Drug|C0013059|1676|MH|||RC
9342780|Electric Stimulation|C0013786|1238|MH|||RC
9342780|RNA, Messenger|C0035696|1188|MH|||RC
9342780|Cell Count|C0007584|814|MH|||RC
9342780|Time Factors|C0040225|700|MH|||RC
9342780|Chromatography, High Pressure Liquid|C0008562|656|MH|||RC
9342780|Homovanillic Acid|C0019903|602|MH|RtM via: Homovanillate|AB|MM
9342780|Catecholamines|C0007412|297|MH|RtM via: Homovanillate|AB|MM
9342780|Models, Biological|C0026339|256|MH|||RC
------
9342780|Rats|C0034721|6330|CT||AB|MM
9342780|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;Rats, Wistar;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9342780|methods|C0025664|19|SH|Methods|AB|MM
9376257|Breast Cancer|C0006142|38796|ET|Entry Term Replacement for "Breast Neoplasms";RtM via: Breast Carcinoma;RtM via: Malignant neoplasm of breast|AB|MM;RC
9376257|*Early Detection of Cancer|C2607925|33831|MH|RtM via: Breast neoplasm screening|TI;AB|MM
9376257|Vaginal Smears|C1744620|21767|MH|||RC
9376257|Genetic Counseling|C0017382|20139|MH|||RC
9376257|Counseling|C0010210|17542|MH|RtM via: Counseling;RtM via: Encounter due to counseling;RtM via: prevention program|AB|MM;RC
9376257|*Treatment Outcome|C0085415|16383|MH|RtM via: Treatment outcome|TI;AB|MM
9376257|Nurses|C0028661|14890|MH|RtM via: Nurses|AB|MM;RC
9376257|Clinical Skills|C0008973|12974|ET|Entry Term Replacement for "Clinical Competence";RtM via: Clinical Skill|AB|MM;RC
9376257|Physician's Practice Patterns|C0031828|11873|MH|||RC
9376257|Uterine Cervical Neoplasms|C0007873|9555|MH|||RC
9376257|Health Knowledge, Attitudes, Practice|C0022758|7979|MH|||RC
9376257|Practice Guidelines as Topic|C0162793|7510|MH|||RC
9376257|Education, Nursing, Continuing|C0013639|7501|MH|||RC
9376257|Questionnaires|C0034394|7343|MH|||RC
9376257|Attitude of Health Personnel|C0004272|6760|MH|||RC
9376257|Genetic Testing|C0679560|6355|MH|||RC
9376257|Delivery of Health Care|C0011211|5906|MH|RtM via: Cancer Control|AB|MM;RC
9376257|Risk Factors|C0035648|5752|MH|||RC
9376257|Education, Nursing, Baccalaureate|C0013638|4309|MH|||RC
9376257|Health Care Surveys|C0376688|3583|MH|||RC
9376257|Patient Education as Topic|C0030688|3470|MH|||RC
9376257|Health Education|C0018701|3429|MH|||RC
9376257|Physician-Patient Relations|C0031830|3372|MH|||RC
9376257|Patient Simulation|C0085137|3209|MH|||RC
9376257|Program Evaluation|C0033336|3023|MH|||RC
9376257|Outcome Assessment (Health Care)|C0085565|3013|MH|||RC
9376257|Rural Health Services|C0035961|2898|MH|||RC
9376257|Risk Assessment|C0086930|2357|MH|||RC
9376257|Schools, Nursing|C0036380|2231|MH|||RC
9376257|Program Development|C0033333|2090|MH|||RC
9376257|Dental Care for Children|C0282684|2085|MH|||RC
9376257|Personnel Selection|C0031222|2026|MH|||RC
9376257|State Medicine|C0038195|2023|MH|||RC
9376257|Skin Neoplasms|C0037286|1982|MH|||RC
9376257|Nursing Methodology Research|C0028690|1621|MH|||RC
9376257|Workplace|C0162579|1527|MH|||RC
9376257|Motivation|C0026605|1359|MH|||RC
9376257|Dental Caries|C0011334|717|MH|||RC
9376257|Texas|C0039711|464|MH|RtM via: Texas|AB|MM;RC
------
9376257|Humans|C0086418|1000|CT|Breast Cancer;Vaginal Smears;Counseling;Genetic Testing;Patient Education as Topic;Health Education;Dental Care for Children;CT Text Lookup: patient;CT Text Lookup: patients|AB;CT Text Lookup: patient;CT Text Lookup: patients|MM;RC
9376257|Female|C0015780|1000|CT|Vaginal Smears;Uterine Cervical Neoplasms||RC
9376257|Pregnancy|C0032961|1000|CT|Vaginal Smears||RC
9376257|Child|C0008059|1000|CT|Dental Care for Children||RC
9376257|education|C0013621|251|SH1|RtM via: Training;Education (C0013621);RtM via: Training Programs;Education (C0013621)|AB|MM
9376257|genetics|C0017399|1111|SH|H01.158.273.343.315.384 (Genetic Counseling)||MM
9380972|*Abortions, Recurrent|C0000809|393357|ET|Entry Term Replacement for "Abortion, Habitual";RtM via: Abortion, Habitual|TI;AB|MM;RC
9380972|HLA-B Antigens|C0019737|181101|MH|RtM via: HLA-B Antigens;Forced Lookup:hla-b;Forced Lookup:hla-b antigens|AB|MM;RC
9380972|HLA Antigens|C0019721|162504|MH|RtM via: HLA Antigens|AB|MM;RC
9380972|*Immunogenetic|C0021005|131040|ET|Entry Term Replacement for "Immunogenetics";RtM via: Immunogenetics|TI|MM
9380972|HLA-B7 Antigen|C0019744|51830|MH|RtM via: HLA-B7 Antigen;RtM via: HLA Class I Histocompatibility Antigen, B-7 Alpha Chain;Forced Lookup:hla-b7;Forced Lookup:hla-b7 antigen|AB|MM
9380972|HLA-A Antigens|C0019728|40926|MH|||RC
9380972|Histocompatibility Testing|C0019633|35360|MH|||RC
9380972|Gene Frequency|C0017270|20679|MH|||RC
9380972|*Recurrence|C0034897|17019|MH|RtM via: Recurrence|TI|MM
9380972|Fertility|C0015895|10234|MH|RtM via: Fertility|AB|MM;RC
9380972|Isoantibodies|C0022144|8472|MH|||RC
9380972|Pregnancy Outcome|C0032972|5390|MH|RtM via: Pregnancy Outcome|AB|MM;RC
9380972|Phenotype|C0031437|4072|MH|||RC
9380972|Infertility|C0021359|4057|MH|||RC
9380972|Maternal-Fetal Exchange|C0024929|1614|MH|||RC
9380972|Fertilization in Vitro|C0015915|1297|MH|||RC
9380972|Models, Genetic|C0026343|1249|MH|||RC
9380972|Jews|C0022389|832|MH|||RC
9380972|Computer Simulation|C0009609|667|MH|||RC
9380972|Models, Biological|C0026339|559|MH|||RC
9380972|*Mexican Americans|C0025884|543|MH|RtM via: Mexican|TI;AB|MM
9380972|Abortion, Missed|C0000814|437|MH|RtM via: Unspecified Abortion|AB|MM
9380972|Abortion, Threatened|C0000821|343|MH|RtM via: Unspecified Abortion|AB|MM
------
9380972|Female|C0015780|1000|CT|Abortions, Recurrent;Pregnancy Outcome;Maternal-Fetal Exchange;Abortion, Missed;Abortion, Threatened;CT Text Lookup: abortion;CT Text Lookup: female;CT Text Lookup: females;CT Text Lookup: pregnancy;CT Text Lookup: pregnancy outcome;CT Text Lookup: spontaneous abortion|TI;AB;CT Text Lookup: abortion;CT Text Lookup: female;CT Text Lookup: females;CT Text Lookup: pregnancy;CT Text Lookup: pregnancy outcome;CT Text Lookup: spontaneous abortion|MM;RC
9380972|Humans|C0086418|1000|CT|Abortions, Recurrent;Jews;Mexican Americans;Abortion, Missed;Abortion, Threatened;CT Text Lookup: spontaneous abortion|TI;AB;CT Text Lookup: spontaneous abortion|MM;RC
9380972|Pregnancy|C0032961|1000|CT|Abortions, Recurrent;Pregnancy Outcome;Maternal-Fetal Exchange;Abortion, Missed;Abortion, Threatened;CT Text Lookup: abortion;CT Text Lookup: pregnancy;CT Text Lookup: pregnancy outcome;CT Text Lookup: spontaneous abortion|TI;AB;CT Text Lookup: abortion;CT Text Lookup: pregnancy;CT Text Lookup: pregnancy outcome;CT Text Lookup: spontaneous abortion|MM;RC
9380972|Male|C0024554|1000|CT|CT Text Lookup: male;CT Text Lookup: males|CT Text Lookup: males|MM
9380972|transplantation|C0029216|859|SH1|Transplantation (C0040732)||RC
9380972|immunology|C1522005|1111|SH|D23.050.301.500.400.380 (HLA-B Antigens)|AB|MM
9380972|genetics|C0017399|1111|SH|H01.158.273.343.420 (Immunogenetic)|TI|MM
9354556|Mitral Regurgitation|C0026266|345183|ET|Entry Term Replacement for "Mitral Valve Insufficiency";RtM via: Mitral Valve Insufficiency|AB|MM;RC
9354556|Mitral Valve|C0026264|329558|MH|RtM via: Mitral Valve;RtM via: Entire mitral valve|AB|MM;RC
9354556|*Aorta|C0003483|212163|MH|RtM via: Aorta;RtM via: Entire aorta|TI;AB|MM;RC
9354556|Heart Valve Prosthesis Implantation|C0525023|169719|MH|||RC
9354556|*Cardiac Surgical Procedures|C0018821|134784|MH|RtM via: Mitral valvuloplasty|TI|MM;RC
9354556|Cardiopulmonary Bypass|C0007202|105572|MH|RtM via: Cardiopulmonary Bypass|AB|MM;RC
9354556|Calcinosis|C0006663|88971|MH|RtM via: Calcified Medical Device Material;RtM via: calcium deposit substance|AB|MM;RC
9354556|Aortic Diseases|C0003493|51172|MH|||RC
9354556|Heart Valve Prosthesis|C0018825|21940|MH|||RC
9354556|Circulatory Arrest, Deep Hypothermia Induced|C1564655|13835|MH|||RC
9354556|Hypothermia, Induced|C0020674|10850|MH|||RC
9354556|Blood Vessel Prosthesis Implantation|C0525022|6502|MH|||RC
9354556|Monitoring, Intraoperative|C0079637|3959|MH|||RC
9354556|Treatment Outcome|C0085415|3758|MH|||RC
9354556|Cerebrovascular Circulation|C0007818|3390|MH|||RC
9354556|Stroke Volume|C0038455|2987|MH|||RC
9354556|Tomography, X-Ray Computed|C0040405|2973|MH|||RC
9354556|Postoperative Complications|C0032787|2385|MH|||RC
9354556|*Reconstructive Surgical Procedures|C0524865|2379|MH|RtM via: Mitral valvuloplasty|TI|MM
9354556|Spectroscopy, Near-Infrared|C0376519|2285|MH|||RC
9354556|Prosthesis Design|C0033585|2227|MH|||RC
9354556|Severity of Illness Index|C0036859|1425|MH|||RC
9354556|Brain Ischemia|C0007786|1247|MH|||RC
9354556|Oxygen|C0030054|1014|MH|||RC
9354556|Risk Assessment|C0086930|771|MH|||RC
------
9354556|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: woman|CT Text Lookup: patient;CT Text Lookup: woman|MM
9354556|Female|C0015780|1000|CT|CT Text Lookup: woman|CT Text Lookup: woman|MM
9354556|surgery|C0038895|1111|SH1|RtM via: Operative Surgical Procedures;Surgical Procedures, Operative (C0543467);RtM via: Repair - Remedial Action;Surgical Procedures, Operative (C0543467);RtM via: Surgical repair;Surgical Procedures, Operative (C0543467)|AB|MM
9354556|radiography|C0034571|1111|SH|E01.370.350.700.700.810 (Tomography, X-Ray Computed)||MM
9335178|agarase|C0050952|281899|NM|RtM via: agarase|TI;AB|MM
9335178|*Glycoside Hydrolases|C0017976|281898|HM|RtM via: agarase|TI;AB|MM;RC
9335178|Streptomyces lividans|C0995754|70316|MH|RtM via: Streptomyces lividans|AB|MM;RC
9335178|Genes, Bacterial|C0017339|37644|MH|||RC
9335178|Streptomyces coelicolor|C0995741|31701|MH|RtM via: Streptomyces coelicolor|AB|MM;RC
9335178|Cloning, Molecular|C0009017|21068|MH|||RC
9335178|Gene Expression Regulation, Bacterial|C0017264|20570|MH|||RC
9335178|Bacterial Proteins|C0004627|16520|MH|||RC
9335178|Promoter Regions, Genetic|C0033413|11499|MH|||RC
9335178|Molecular Sequence Data|C0026382|11020|MH|||RC
9335178|Gene|C0017337|10567|ET|Entry Term Replacement for "Genes";RtM via: Genes|AB|MM;RC
9335178|Escherichia coli|C0014834|8341|MH|||RC
9335178|RNA, Bacterial|C0035692|7306|MH|||RC
9335178|beta-Lactamases|C0597979|5799|MH|||RC
9335178|Amino Acid Sequence|C0002518|4897|MH|||RC
9335178|Chromosome Mapping|C0008630|4796|MH|||RC
9335178|*Bacteria|C0004611|4650|MH|RtM via: Bacterial|TI;AB|MM
9335178|DNA, Bacterial|C0012924|4132|MH|||RC
9335178|Chromatography, Affinity|C0008551|3873|MH|RtM via: Chromatography, Affinity|AB|MM;RC
9335178|Mycobacterium tuberculosis|C0026926|3353|MH|||RC
9335178|Culture Media|C0010454|3094|MH|||RC
9335178|Genetic Vectors|C0017397|2865|MH|||RC
9335178|Fermentation|C0015852|2740|MH|||RC
9335178|Molecular Weight|C0026385|2458|MH|RtM via: Molecular Mass|AB|MM;RC
9335178|Recombinant Fusion Proteins|C0034857|2222|MH|||RC
9335178|RNA, Messenger|C0035696|1797|MH|||RC
9335178|Glucose|C0017725|1458|MH|||RC
9335178|Mutation|C0026882|1074|MH|||RC
9335178|Single-Strand Specific DNA and RNA Endonucleases|C2350176|949|MH|||RC
9335178|Temperature|C0039476|603|MH|||RC
9335178|Mice, Inbred BALB C|C0025919|282|MH|||RC
9335178|Lymphocyte Activation|C0024262|257|MH|||RC
9335178|Cell Proliferation|C0596290|237|MH|||RC
------
9335178|Animals|C0003062|1000|CT|Mice, Inbred BALB C||RC
9335178|Mice|C0026809|1000|CT|Mice, Inbred BALB C||RC
9335178|isolation & purification|C0022189|4437|SH1|RtM via: purification aspects;isolation & purification (C0022189)|TI|MM
9335178|genetics|C0017399|1111|SH|G05.360.340.024.340.210 (Genes, Bacterial)||MM
9335178|immunology|C1522005|1111|SH|G12.450.050.400.545 (Lymphocyte Activation)||MM
9271786|*Platelets|C0005821|532863|ET|Entry Term Replacement for "Blood Platelets";RtM via: Blood Platelets|TI;AB|MM;RC
9271786|*Hydroxyl Radical|C0063146|397869|MH|RtM via: Hydroxyl Radical|TI;AB|MM;RC
9271786|*Arachidonic Acid|C0003695|390489|MH|RtM via: Arachidonic Acid|TI;AB|MM;RC
9271786|*Oxidative Stress|C0242606|166002|MH|RtM via: Oxidative Stress|TI;AB|MM;RC
9271786|Platelet Aggregation|C0032176|101614|MH|||RC
9271786|Reactive Oxygen Species|C0162772|91266|MH|RtM via: Reactive Oxygen Species|AB|MM;RC
9271786|Catalase|C0007367|46337|MH|RtM via: CATALASE|AB|MM;RC
9271786|Superoxide Dismutase|C0038838|39677|MH|RtM via: Superoxide Dismutase|AB|MM;RC
9271786|Platelet Aggregation Inhibitors|C0032177|32242|MH|||RC
9271786|Free Radical Scavengers|C0079381|26064|MH|||RC
9271786|Antioxidants|C0003402|25760|MH|RtM via: Antioxidants|AB|MM;RC
9271786|12-Hydroxy-5,8,10,14-eicosatetraenoic Acid|C0044800|14581|MH|||RC
9271786|Redox|C0030012|12865|ET|Entry Term Replacement for "Oxidation-Reduction";RtM via: Oxidation-Reduction|AB|MM;RC
9271786|A23187|C0878412|10475|ET|Entry Term Replacement for "Calcimycin";RtM via: A-23187|AB|MM;RC
9271786|NADPH Oxidase|C0068355|7909|MH|||RC
9271786|Hydrogen Peroxide|C0020281|7031|MH|||RC
9271786|Phospholipids|C0031676|6999|MH|RtM via: Phospholipids|AB|MM;RC
9271786|Adenosine Diphosphate|C0001459|6274|MH|||RC
9271786|Calcium|C0006675|3828|MH|||RC
9271786|Electron Spin Resonance Spectroscopy|C0013845|3531|MH|||RC
9271786|Oxygen|C0030054|2780|MH|||RC
9271786|Signal Transduction|C0037083|2314|MH|||RC
9271786|Epithelial Cells|C0014597|2305|MH|||RC
9271786|Aerobiosis|C0001702|2207|MH|||RC
9271786|Mannitol|C0024730|1876|MH|RtM via: Mannitol|AB|MM;RC
9271786|Plant Extracts|C0032081|1634|MH|||RC
9271786|Areca|C0003749|1572|MH|||RC
9271786|Pyocyanin|C0034211|1560|ET|Entry Term Replacement for "Pyocyanine";RtM via: Pyocyanine|AB|MM
9271786|Feedback, Physiological|C2713398|1459|MH|||RC
9271786|Cell Hypoxia|C0007598|1444|MH|||RC
9271786|Carbon Dioxide|C0007012|1437|MH|||RC
9271786|Phenazines|C0031375|1392|MH|RtM via: Phenazines|AB|MM;RC
9271786|Cells, Cultured|C0007635|842|MH|||RC
9271786|Molecular Structure|C0026383|830|MH|||RC
9271786|Cell Separation|C0007616|724|MH|||RC
9271786|Microscopy, Confocal|C0242842|404|MH|||RC
9271786|Time Factors|C0040225|285|MH|||RC
------
9271786|Humans|C0086418|1000|CT|CT Text Lookup: human|CT Text Lookup: human|MM
9271786|metabolism|C0025520|5976|SH1|RtM via: mobilization;metabolism (C0025520);RtM via: metabolic aspects;metabolism (C0025520);RtM via: Metabolism;RtM via: Inhibited;Metabolism (C0025519);RtM via: Metabolic Inhibition;Metabolism (C0025519)|TI;AB|MM
9271786|surgery|C0038895|417|SH1|RtM via: Therapeutic Mobilization;Surgical Procedures, Operative (C0543467);RtM via: Release (procedure);Surgical Procedures, Operative (C0543467)|TI;AB|MM
9271786|rehabilitation|C0034992|375|SH1|RtM via: physical therapy mobilization (treatment);Rehabilitation (C0034991)|TI|MM
9271786|injuries|C1510467|41|SH|Wounds and Injuries|AB|MM
9271786|methods|C0025664|7|SH|Methods|AB|MM
9329890|*Erythema|C0041834|326694|MH|RtM via: Acral erythema;RtM via: Erythema|TI;AB|MM;RC
9329890|Cytosine Arabinoside|C0010711|246571|ET|Entry Term Replacement for "Cytarabine";RtM via: Cytarabine|AB|MM;RC
9329890|Leukemia, Myeloid, Acute|C0023467|108092|MH|RtM via: Leukemia, Myelocytic, Acute|AB|MM;RC
9329890|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|C0023473|59156|MH|RtM via: Myeloid Leukemia, Chronic|AB|MM;RC
9329890|Blast Phase|C0005699|43110|ET|Entry Term Replacement for "Blast Crisis";RtM via: Blast Phase|AB|MM;RC
9329890|Hand Dermatoses|C0018567|24648|MH|||RC
9329890|Foot Dermatoses|C0016509|21534|MH|||RC
9329890|Bone Marrow Transplantation|C0005961|20583|MH|RtM via: Bone Marrow Transplantation|AB|MM;RC
9329890|Graft vs Host Disease|C0018133|18640|MH|RtM via: Acute GVH disease|AB|MM;RC
9329890|Antimetabolites, Antineoplastic|C0003377|17090|MH|||RC
9329890|Drug Eruptions|C0011609|15741|MH|||RC
9329890|Antineoplastic Combined Chemotherapy Protocols|C0003393|15373|MH|||RC
9329890|Antibiotics, Antineoplastic|C0003236|13996|MH|RtM via: Anthracycline Antibiotics|AB|MM;RC
9329890|Antineoplastic Agents|C0003392|11193|MH|RtM via: Antineoplastic Agents|AB|MM;RC
9329890|Skin|C1123023|9990|MH|||RC
9329890|Sweet Syndrome|C0085077|8719|MH|||RC
9329890|Combined Modality Therapy|C0009429|4732|MH|||RC
9329890|Recurrence|C0034897|3845|MH|RtM via: Recurrence|AB|MM;RC
9329890|Drug Administration Schedule|C0013154|2080|MH|||RC
9329890|Prognosis|C0033325|1543|MH|||RC
9329890|Hand|C0018563|1398|MH|RtM via: Palmar surface|AB|MM;RC
9329890|Treatment Outcome|C0085415|870|MH|||RC
9329890|Dose-Response Relationship, Drug|C0013059|497|MH|||RC
9329890|Incidence|C0021149|452|MH|RtM via: Incidence|AB|MM;RC
9329890|Blood Transfusion|C0005841|434|MH|||RC
9329890|Extremities|C0015385|379|MH|||RC
9329890|DNA Damage|C0012860|359|MH|||RC
9329890|Diagnosis, Differential|C0011906|292|MH|||RC
------
9329890|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9329890|drug therapy|C0013217|9999|SH1|RtM via: pharmacotherapeutic;drug therapy (C0013217);RtM via: Pharmacotherapy;Drug Therapy (C0013216);RtM via: Chemotherapy Regimen;Drug Therapy (C0013216);RtM via: high-dose chemotherapy;Drug Therapy (C0013216)|TI;AB|MM
9329890|methods|C0025664|1050|SH1|RtM via: Methodology;methods (C0025664)|AB|MM
9329890|organization & administration|C0029236|72|SH|Organization and Administration|TI|MM
9329890|transplantation|C0029216|1111|SH|E04.936.580.040 (Bone Marrow Transplantation)|AB|MM
9329890|genetics|C0017399|1111|SH|G05.355.180 (DNA Damage)||MM
9378393|Pseudomembranous Colitis|C1257843|893434|ET|Entry Term Replacement for "Enterocolitis, Pseudomembranous";RtM via: pseudomembranous colitis|AB|MM;RC
9378393|Clostridium difficile|C0079134|419589|MH|||RC
9378393|*Immunoglobulins, Intravenous|C0085297|351591|MH|RtM via: Immunoglobulins, Intravenous;RtM via: Human normal immunoglobulin|TI;AB|MM;RC
9378393|*Immunoglobulin|C0021027|311649|ET|Entry Term Replacement for "Immunoglobulins";RtM via: Immunoglobulins;RtM via: Immunoglobulin measurement;RtM via: immunoglobulin activity|TI;AB|MM;RC
9378393|*Clostridium Infections|C0009062|310452|MH|RtM via: Clostridium difficile colitis|TI|MM;RC
9378393|Antibodies, Bacterial|C0003244|181185|MH|RtM via: Clostridium difficile toxin|AB|MM;RC
9378393|*Immunoglobulin Therapy|C0021022|170304|ET|Entry Term Replacement for "Immunization, Passive";RtM via: Immunoglobulin Therapy;RtM via: Immunotherapy, Passive|TI;AB|MM
9378393|Diarrhea|C0011991|96312|MH|RtM via: Diarrhea;RtM via: Severe diarrhea|AB|MM;RC
9378393|Antitoxins|C0003445|89034|MH|RtM via: Antitoxins|AB|MM;RC
9378393|Immunoglobulin G|C0020852|58606|MH|||RC
9378393|ELISA|C0014441|40575|ET|Entry Term Replacement for "Enzyme-Linked Immunosorbent Assay";RtM via: Enzyme-Linked Immunosorbent Assay|AB|MM;RC
9378393|Antigens, Bacterial|C0003321|22701|MH|||RC
9378393|Bacterial Proteins|C0004627|20856|MH|||RC
9378393|Vancomycin|C0042313|18035|MH|RtM via: Vancomycin|AB|MM;RC
9378393|Metronidazole|C0025872|15731|MH|RtM via: Metronidazole|AB|MM;RC
9378393|Immunoglobulin M|C0020861|14066|MH|||RC
9378393|Immunoglobulin A|C0020835|11628|MH|||RC
9378393|*Enterocolitis|C0014356|11094|MH|RtM via: Clostridium difficile colitis|TI|MM
9378393|Colitis|C0009319|10443|MH|RtM via: Colitis|AB|MM;RC
9378393|Neutralization Tests|C0027944|10109|MH|||RC
9378393|Bacterial Vaccines|C0004632|8676|MH|||RC
9378393|Recurrence|C0034897|4174|MH|RtM via: Recurrence|AB|MM;RC
9378393|Anti-Infective Agents|C0003204|3986|MH|RtM via: Microbicides|AB|MM;RC
9378393|Amino Acid Sequence|C0002518|3494|MH|||RC
9378393|Anti-Bacterial Agents|C0279516|3366|MH|||RC
9378393|*Infusions, Intravenous|C0021440|3321|MH|RtM via: Intravenous route;RtM via: intravenous administration|TI;AB|MM
9378393|Cross Infection|C0010356|3220|MH|||RC
9378393|Antibodies|C0003241|2919|MH|RtM via: Antibodies|AB|MM
9378393|Sequence Homology, Amino Acid|C0162777|2175|MH|||RC
9378393|Molecular Sequence Data|C0026382|1774|MH|||RC
9378393|*Injections, Intravenous|C0021494|1593|MH|RtM via: Intravenous route|TI|MM
9378393|Gastrointestinal Transit|C0017191|902|MH|||RC
9378393|Treatment Outcome|C0085415|874|MH|||RC
9378393|Colony Count, Microbial|C0009380|766|MH|||RC
9378393|Administration, Oral|C0001563|444|MH|||RC
------
9378393|Humans|C0086418|1000|CT|CT Text Lookup: human;CT Text Lookup: man;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: human;CT Text Lookup: man;CT Text Lookup: patient;CT Text Lookup: patients|MM
9378393|Male|C0024554|1000|CT|CT Text Lookup: man|CT Text Lookup: man|MM
9378393|therapy|C0039798|2406|SH1|RtM via: therapeutic aspects;therapy (C0039798)|TI;AB|MM
9378393|immunology|C1522005|1111|SH|D23.050.161 (Antigens, Bacterial)||MM
9378393|genetics|C0017399|1111|SH|G05.810.200 (Sequence Homology, Amino Acid)||MM
9380284|*Dilution Techniques|C0079240|169698|ET|Entry Term Replacement for "Indicator Dilution Techniques";RtM via: Dilution technique|TI;AB|MM;RC
9380284|*Drugs|C0013227|35160|ET|Entry Term Replacement for "Pharmaceutical Preparations";RtM via: Pharmaceutical Preparations;RtM via: Pharmacologic Substance|TI;AB|MM;RC
9380284|Tandem Mass Spectrometry|C0599748|17487|MH|||RC
9380284|Chromatography, High Pressure Liquid|C0008562|7087|MH|||RC
9380284|Spectrophotometry, Ultraviolet|C0037808|5339|MH|||RC
9380284|Molecular Structure|C0026383|4963|MH|||RC
9380284|Stereoisomerism|C0038265|4104|MH|||RC
9380284|Drug Stability|C0013210|3686|MH|||RC
9380284|Kidney Failure, Chronic|C0022661|3661|MH|||RC
9380284|Quality Control|C0034378|3358|MH|||RC
9380284|Catheters, Indwelling|C0007439|3145|MH|||RC
9380284|Drug Discovery|C0920472|2240|MH|||RC
9380284|Environmental Monitoring|C0014416|2155|MH|||RC
9380284|Reference Standards|C0034925|2004|MH|||RC
9380284|Air Pollutants|C0001869|1999|MH|||RC
9380284|Water Pollutants, Chemical|C0043054|1944|MH|||RC
9380284|Vascular Patency|C0042377|1727|MH|||RC
9380284|Administration, Intranasal|C0001560|1654|MH|||RC
9380284|Influenza Vaccines|C0021403|1598|MH|||RC
9380284|Body Water|C0005909|1557|MH|||RC
9380284|Electric Impedance|C0162537|1262|MH|||RC
9380284|*Hydroxides|C0020315|1194|MH|RtM via: Pharmacologic Substance|TI|MM
9380284|Water-Electrolyte Imbalance|C0043065|1038|MH|||RC
9380284|Specimen Handling|C0037793|610|MH|||RC
9380284|Time Factors|C0040225|578|MH|||RC
9380284|Vaccines, Attenuated|C0042211|537|MH|||RC
9380284|Microfluidic Analytical Techniques|C1449576|503|MH|||RC
9380284|Randomized Controlled Trials as Topic|C0282440|468|MH|||RC
9380284|*Oxides|C0030015|432|MH|RtM via: Pharmacologic Substance|TI|MM
9380284|Regional Blood Flow|C0034965|432|MH|||RC
9380284|Breath Tests|C0006153|425|MH|||RC
9380284|Models, Biological|C0026339|425|MH|||RC
9380284|Luminescent Measurements|C1450269|332|MH|||RC
9380284|Spiro Compounds|C0037968|203|MH|||RC
------
9380284|Child|C0008059|1000|CT|CT Text Lookup: children|CT Text Lookup: children|MM
9380284|Humans|C0086418|1000|CT|CT Text Lookup: children|CT Text Lookup: children|MM
9380284|methods|C0025664|499|SH1|RtM via: Methodology;methods (C0025664)|AB|MM
9322874|*Retroviridae|C0035366|956298|MH|RtM via: Retroviridae|TI|MM;RC
9322874|Fanconi's Anemia|C0015625|363294|ET|Entry Term Replacement for "Fanconi Anemia";RtM via: Fanconi's Anemia|AB|MM;RC
9322874|Genetic Vectors|C0017397|194480|MH|RtM via: Retroviral Vector;RtM via: Viral Vector|AB|MM;RC
9322874|Progenitor Cells, Hematopoietic|C0018956|157840|ET|Entry Term Replacement for "Hematopoietic Stem Cells";RtM via: Hematopoietic stem cells|AB|MM;RC
9322874|*Gene|C0017337|116598|ET|Entry Term Replacement for "Genes";RtM via: Genes;RtM via: IL3 gene;RtM via: IL6 gene;RtM via: Genetic|TI;AB|MM
9322874|Cell Cycle Proteins|C0243021|85891|MH|||RC
9322874|Nuclear Proteins|C0028589|84784|MH|||RC
9322874|IL-3|C0021757|72767|ET|Entry Term Replacement for "Interleukin-3";RtM via: Interleukin-3;Forced Lookup:il-3|AB|MM;RC
9322874|Gene Transfer Techniques|C0886519|72203|MH|||RC
9322874|Granulocyte Colony-Stimulating Factor|C0079459|68017|MH|RtM via: Granulocyte Colony-Stimulating Factor;Forced Lookup:g-csf|AB|MM;RC
9322874|Transduction, Genetic|C0040667|64912|MH|||RC
9322874|IL6|C0021760|61478|ET|Entry Term Replacement for "Interleukin-6";RtM via: Interleukin-6;Forced Lookup:il-6|AB|MM;RC
9322874|Gene Therapy|C0017296|56149|MH|||RC
9322874|Lentivirus|C0079679|22303|MH|||RC
9322874|Molecular Sequence Data|C0026382|19536|MH|||RC
9322874|Marrow|C0376152|14989|ET|Entry Term Replacement for "Bone Marrow";RtM via: Marrow|AB|MM;RC
9322874|Hematopoietic Stem Cell Transplantation|C0472699|10317|MH|||RC
9322874|Bone Marrow Cells|C0005955|9053|MH|||RC
9322874|Transfection|C0040669|8383|MH|||RC
9322874|Cell, Lymphoid|C0086574|8191|ET|Entry Term Replacement for "Lymphocytes";RtM via: Lymphoid Cells|AB|MM;RC
9322874|Mitomycin|C0002475|6185|MH|RtM via: Mitomycin|AB|MM;RC
9322874|Mutation|C0026882|6105|MH|RtM via: Mutation|AB|MM;RC
9322874|Cell Lines|C0007600|5454|ET|Entry Term Replacement for "Cell Line";RtM via: Cell Line|AB|MM;RC
9322874|Membrane Proteins|C0025252|4641|MH|||RC
9322874|Transplantation Conditioning|C0376450|3710|MH|||RC
9322874|Proto-Oncogene Proteins c-kit|C0072470|3222|MH|||RC
9322874|Phenotype|C0031437|3156|MH|||RC
9322874|Cell Line, Transformed|C0007601|3042|MH|||RC
9322874|Graft Survival|C0018131|2840|MH|||RC
9322874|Cell Separation|C0007616|2787|MH|||RC
9322874|*Population Groups|C1257890|2751|MH|RtM via: Population Group|TI|MM
9322874|Genetic Complementation Test|C0017381|2603|MH|||RC
9322874|Mice, Knockout|C0206745|2006|MH|||RC
9322874|Mice, Inbred C57BL|C0025921|1950|MH|||RC
9322874|RNA, Messenger|C0035696|1825|MH|||RC
9322874|Flow Cytometry|C0016263|1795|MH|||RC
9322874|Mice, Inbred BALB C|C0025919|1754|MH|||RC
9322874|Leukocytes, Mononuclear|C0023517|1700|MH|||RC
9322874|Apoptosis|C0162638|1505|MH|||RC
9322874|Kinetics|C0022702|1296|MH|||RC
9322874|Cell Culture Techniques|C0007585|1267|MH|||RC
9322874|Models, Genetic|C0026343|1134|MH|||RC
9322874|Stem Cell Factor|C0143630|1035|MH|RtM via: Stem Cell Factor|AB|MM
9322874|Macaca mulatta|C0024400|1022|MH|||RC
9322874|Radiation-Protective Agents|C0034540|937|MH|||RC
9322874|HIV-1|C0019704|921|MH|||RC
9322874|Disease Models, Animal|C0012644|861|MH|||RC
9322874|*Research|C0035168|852|MH|RtM via: Gene Transfer;RtM via: Analysis|TI;AB|MM
9322874|Cryopreservation|C0010405|778|MH|||RC
9322874|Stem Cells|C0038250|546|MH|RtM via: Stem cells|AB|MM
------
9322874|Humans|C0086418|1000|CT|Population Groups;CT Text Lookup: patient;CT Text Lookup: patients|TI;CT Text Lookup: patient;CT Text Lookup: patients|MM
9322874|Animals|C0003062|1000|CT|Mice, Knockout;Mice, Inbred C57BL;Mice, Inbred BALB C;Macaca mulatta;Disease Models, Animal||RC
9322874|Mice|C0026809|1000|CT|Mice, Knockout;Mice, Inbred C57BL;Mice, Inbred BALB C||RC
9322874|genetics|C0017399|1111|SH|G05.360.337 (Genetic Vectors)|AB|MM
9322874|transplantation|C0029216|1111|SH|E04.936.225.687.500 (Hematopoietic Stem Cell Transplantation)||MM
9322874|immunology|C1522005|1111|SH|D23.050.301.264.035.590 (Proto-Oncogene Proteins c-kit)||MM
9350014|Genital Neoplasms, Female|C0017416|123782|MH|RtM via: Malignant Female Reproductive System Neoplasm|AB|MM;RC
9350014|Tumor Markers, Biological|C0041366|42976|MH|||RC
9350014|Premenopause|C0206158|26532|MH|RtM via: Premenopausal - menopausal status|AB|MM;RC
9350014|Post-Menopause|C0206159|22823|ET|Entry Term Replacement for "Postmenopause";RtM via: Postmenopause|AB|MM;RC
9350014|Menopause|C0025320|21960|MH|RtM via: Menopause;RtM via: Postmenopausal state|AB|MM;RC
9350014|Antigens, Neoplasm|C0003335|16364|MH|||RC
9350014|Endometriosis|C0014175|16043|MH|RtM via: Endometriosis, site unspecified|AB|MM;RC
9350014|Neoplasm Staging|C0027646|14529|MH|||RC
9350014|Mucin-1|C0006611|13536|MH|||RC
9350014|Uterine Neoplasms|C0042138|12683|MH|||RC
9350014|Peritoneal Neoplasms|C0031149|8557|MH|||RC
9350014|Uterine Cervical Neoplasms|C0007873|8546|MH|||RC
9350014|Neoplasm Recurrence, Local|C0027643|6269|MH|||RC
9350014|Prognosis|C0033325|3608|MH|||RC
9350014|Mucins|C0026682|3527|MH|||RC
9350014|Treatment Outcome|C0085415|2619|MH|||RC
9350014|Vascular Endothelial Growth Factor A|C0078058|2356|MH|||RC
9350014|False Positive Reactions|C0015563|2352|MH|||RC
9350014|Endosonography|C0376444|2242|MH|||RC
9350014|Lung Neoplasms|C0024121|2178|MH|||RC
9350014|Exudates and Transudates|C0015389|1601|MH|||RC
9350014|Diagnosis, Differential|C0011906|1368|MH|||RC
9350014|Antibodies, Monoclonal|C0003250|1279|MH|||RC
9350014|Genetic Predisposition to Disease|C0314657|1212|MH|||RC
9350014|Age Distribution|C0001782|1091|MH|||RC
9350014|Peptide Fragments|C0030935|1077|MH|||RC
9350014|Aging|C0001811|1038|MH|||RC
9350014|Body Mass Index|C0005893|815|MH|||RC
9350014|Pedigree|C0030761|771|MH|||RC
9350014|Reference Values|C0034926|752|MH|||RC
9350014|Risk Assessment|C0086930|680|MH|||RC
9350014|Preoperative Care|C0033061|672|MH|||RC
9350014|Breast Neoplasms|C1458155|213|MH|RtM via: Breast cancer metastatic|AB|MM
------
9350014|Female|C0015780|1000|CT|Genital Neoplasms, Female;Endometriosis;Uterine Neoplasms;Uterine Cervical Neoplasms;CT Text Lookup: endometriosis;CT Text Lookup: menopause;CT Text Lookup: women|AB;CT Text Lookup: endometriosis;CT Text Lookup: menopause;CT Text Lookup: women|MM;RC
9350014|Humans|C0086418|1000|CT|Preoperative Care;Breast Neoplasms;CT Text Lookup: men;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: women|AB;CT Text Lookup: men;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: women|MM;RC
9350014|Male|C0024554|1000|CT|CT Text Lookup: men|CT Text Lookup: men|MM
9350014|diagnosis|C1704338|211|SH1|RtM via: Diagnosis;RtM via: Mass of body structure;Diagnosis (C0011900);RtM via: Premenopausal symptoms;Diagnosis (C0011900)|AB|MM
9350014|surgery|C0038895|1111|SH1|RtM via: Surgical aspects;surgery (C0038895);RtM via: Operative Surgical Procedures;Surgical Procedures, Operative (C0543467)|AB|MM
9350014|ultrasonography|C0175676|1111|SH1|Ultrasonography (C0041618)||RC
9350014|immunology|C1522005|1111|SH|D23.050.285 (Antigens, Neoplasm)||MM
9350014|genetics|C0017399|1111|SH|G05.380.355 (Genetic Predisposition to Disease)||MM
9306294|*Panic Disorder|C0030319|1011015|MH|RtM via: Panic Disorder;RtM via: PANIC DISORDER 1|TI;AB|MM;RC
9306294|Autonomic Nervous System|C0004388|159628|MH|RtM via: Autonomic nervous system|AB|MM;RC
9306294|Respiratory Rate|C0231832|138575|MH|RtM via: Respiratory rate;RtM via: BREATHS:NRAT:PT:RESPIRATORY SYSTEM:QN;Forced New Lookup:rate, respiratory;Forced New Lookup:respiratory rate;Forced New Lookup:respiratory rates|AB|MM
9306294|Heart Rate|C0018810|97877|MH|RtM via: heart rate|AB|MM;RC
9306294|Cortisol|C0020268|77767|ET|Entry Term Replacement for "Hydrocortisone";RtM via: Hydrocortisone|AB|MM;RC
9306294|*Mental Disorders|C0004936|56841|MH|RtM via: Stressor;RtM via: Emotional distress;RtM via: Stressful|TI;AB|MM;RC
9306294|Pituitary-Adrenal System|C0032022|52076|MH|||RC
9306294|Hypothalamo-Hypophyseal System|C0020662|42616|MH|||RC
9306294|Stress, Psychological|C0038443|41541|MH|||RC
9306294|Stress Disorders, Post-Traumatic|C0038436|30551|MH|||RC
9306294|*Risk Factors|C0035648|28836|MH|RtM via: Stressor|TI|MM;RC
9306294|Galvanic Skin Response|C0016989|25032|MH|||RC
9306294|Electrocardiography|C1623258|23655|MH|RtM via: electrocardiogram rhythm strip 3-lead heart rate (bpm)|AB|MM;RC
9306294|Child Behavior Disorders|C0008066|19056|MH|||RC
9306294|Saliva|C0036087|18880|MH|||RC
9306294|Sympathetic Nervous System|C0039044|16931|MH|||RC
9306294|Social Environment|C0037414|16740|MH|||RC
9306294|Psychiatric Status Rating Scales|C0033871|15278|MH|||RC
9306294|*Behaviors|C0004927|15231|ET|Entry Term Replacement for "Behavior";RtM via: Behavior;RtM via: Health Care Visit;RtM via: Visit|TI;AB|MM
9306294|Life Change Events|C0023670|13971|MH|||RC
9306294|Vagus Nerve|C0042276|12376|MH|||RC
9306294|Combat Disorders|C0009426|10966|MH|||RC
9306294|Blood Pressure|C0005823|10594|MH|||RC
9306294|Inhibition|C0021467|10059|ET|Entry Term Replacement for "Inhibition (Psychology)";RtM via: Psychological inhibition|AB|MM;RC
9306294|Social Behavior|C0037397|9595|MH|RtM via: Prosocial Behavior|AB|MM;RC
9306294|Adaptation, Psychological|C0683269|9519|MH|||RC
9306294|Personality Inventory|C0031213|7082|MH|||RC
9306294|Internal-External Control|C0021783|7078|MH|||RC
9306294|Personality Assessment|C0031209|6305|MH|||RC
9306294|Pain|C0030193|4462|MH|RtM via: Distress;RtM via: Sensory Discomfort|AB|MM;RC
9306294|Electroshock|C0013870|3315|MH|||RC
9306294|Psychometrics|C0033920|3050|MH|||RC
9306294|Sex Factors|C0036881|2581|MH|||RC
9306294|Socioeconomic Factors|C0037464|2428|MH|||RC
9306294|Mental Recall|C0034770|2329|MH|||RC
9306294|Signal Processing, Computer-Assisted|C0037082|2225|MH|||RC
9306294|Imagination|C0020913|2117|MH|||RC
9306294|Carbon Dioxide|C0007012|2074|MH|||RC
9306294|Age Factors|C0001783|2020|MH|||RC
9306294|Severity of Illness Index|C0036859|1047|MH|||RC
9306294|Genetic Predisposition to Disease|C0314657|1046|MH|||RC
9306294|Videotape Recording|C0042654|964|MH|||RC
9306294|Time Factors|C0040225|801|MH|||RC
9306294|Reference Values|C0034926|550|MH|||RC
9306294|Salivation|C0036104|451|MH|RtM via: secretion of saliva|AB|MM
9306294|Psychophysiology|C0033933|445|MH|RtM via: Psychophysiology|AB|MM
------
9306294|Child|C0008059|1000|CT|Child Behavior Disorders;CT Text Lookup: children|CT Text Lookup: children|MM;RC
9306294|Humans|C0086418|1000|CT|CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients|MM
9306294|genetics|C0017399|1111|SH|G05.380.355 (Genetic Predisposition to Disease)||MM
9305762|*Rice|C0035567|1817004|ET|Entry Term Replacement for "Oryza sativa";RtM via: Rice;RtM via: Oryza (plant);RtM via: Rice Preparation;RtM via: Oryza sativa|TI;AB|MM;RC
9305762|*Multigene Family|C0017363|495864|MH|RtM via: Multigene Family|TI;AB|MM;RC
9305762|lipid transfer protein|C0065031|301021|NM|RtM via: lipid transfer protein|TI;AB|MM
9305762|*Carrier Proteins|C0007292|301020|HM|RtM via: lipid transfer protein|TI;AB|MM;RC
9305762|Abscisic Acid|C0000843|269878|MH|RtM via: Abscisic Acid|AB|MM;RC
9305762|Plant Proteins|C0032089|189924|MH|||RC
9305762|Genes, Plant|C0162728|181947|MH|||RC
9305762|Gene Expression Regulation, Plant|C0242717|179129|MH|||RC
9305762|Molecular Sequence Data|C0026382|144054|MH|||RC
9305762|cDNA|C0006556|94313|ET|Entry Term Replacement for "DNA, Complementary";RtM via: DNA, Complementary|AB|MM;RC
9305762|Amino Acid Sequence|C0002518|83187|MH|||RC
9305762|Sequence Homology, Amino Acid|C0162777|64654|MH|||RC
9305762|Cloning, Molecular|C0009017|61191|MH|||RC
9305762|Salicylic Acid|C0036079|60292|MH|RtM via: Salicylic Acid|AB|MM;RC
9305762|Sequence Alignment|C0080143|59681|MH|||RC
9305762|Antigens, Plant|C1567994|52865|MH|||RC
9305762|Northern Blot|C1621557|51718|ET|Entry Term Replacement for "Blotting, Northern";RtM via: Northern Blot;RtM via: Northern Blotting|AB|MM;RC
9305762|DNA, Plant|C0242964|44714|MH|||RC
9305762|Sodium Chloride|C0037494|43073|MH|RtM via: Sodium Chloride|AB|MM;RC
9305762|Sequence Analysis, DNA|C0162802|37290|MH|||RC
9305762|Genome, Plant|C0242965|30158|MH|||RC
9305762|Arabidopsis Proteins|C0969730|23299|MH|||RC
9305762|Plants, Genetically Modified|C0950153|22891|MH|||RC
9305762|Promoter Regions, Genetic|C0033413|20542|MH|||RC
9305762|Droughts|C0013140|19992|MH|||RC
9305762|RNA, Messenger|C0035696|16407|MH|||RC
9305762|Gene Expression|C0017262|16092|MH|RtM via: Gene Expression|AB|MM;RC
9305762|Plant Diseases|C0032080|14009|MH|||RC
9305762|Chromosome Mapping|C0008630|12102|MH|||RC
9305762|Cold Temperature|C0009264|9455|MH|||RC
9305762|Plant Stems|C0242767|9066|MH|||RC
9305762|Gene Expression Regulation, Developmental|C0242718|8913|MH|||RC
9305762|Gene Expression Profiling|C0752248|8325|MH|||RC
9305762|Phylogeny|C0031797|6273|MH|||RC
9305762|In Situ Hybridization|C0162788|5054|MH|||RC
9305762|Protein Synthesis Inhibitors|C0033671|4561|MH|||RC
9305762|Computational Biology|C0376528|4204|MH|||RC
9305762|Recombinant Fusion Proteins|C0034857|4139|MH|||RC
9305762|Light|C0023693|2851|MH|||RC
9305762|Temperature|C0039476|2585|MH|||RC
9305762|Open Reading Frames|C0079941|1728|MH|RtM via: Open Reading Frames|AB|MM
9305762|Hydrogen-Ion Concentration|C0020283|1463|MH|||RC
9305762|Tissue Distribution|C0040287|830|MH|||RC
9305762|Cereal|C0007757|566|ET|Entry Term Replacement for "Cereals";RtM via: Cereals|AB|MM
9305762|Microscopy, Confocal|C0242842|559|MH|||RC
9305762|Molecular Weight|C0026385|443|MH|RtM via: Molecular Mass|AB|MM
9305762|Time Factors|C0040225|338|MH|||RC
9305762|Dose-Response Relationship, Drug|C0013059|331|MH|||RC
9305762|Blotting, Southern|C0005862|320|MH|RtM via: Southern blot assay (procedure)|AB|MM
------
9305762|genetics|C0017399|1111|SH|G05.360.340.024.340.645 (Multigene Family)|TI;AB|MM
9305762|immunology|C1522005|1111|SH|D23.050.291 (Antigens, Plant)||MM
9382350|*Prematurity Retinopathy|C0035344|917556|ET|Entry Term Replacement for "Retinopathy of Prematurity";RtM via: Retinopathy of Prematurity|TI;AB|MM;RC
9382350|*Risk Factors|C0035648|102540|MH|RtM via: risk factors|TI;AB|MM;RC
9382350|Gestational Age|C0017504|70542|MH|RtM via: Gestational Age|AB|MM;RC
9382350|Infant, Premature|C0021294|68756|MH|RtM via: Infant, Premature|AB|MM;RC
9382350|Birth Weight|C0005612|52148|MH|RtM via: Birth Weight|AB|MM;RC
9382350|Oxygen Inhalation Therapy|C0184633|35887|MH|RtM via: Oxygen Therapy Care;RtM via: Inspired fraction of oxygen;RtM via: fraction of inspired oxygen (FiO2) (treatment)|AB|MM;RC
9382350|Retrospective Study|C0035363|25431|ET|Entry Term Replacement for "Retrospective Studies";RtM via: Retrospective Studies|AB|MM;RC
9382350|Birth Weight, Low|C0024032|21299|ET|Entry Term Replacement for "Infant, Low Birth Weight";RtM via: Low Birth Weights|AB|MM;RC
9382350|Logistic Regression|C0206031|16982|ET|Entry Term Replacement for "Logistic Models";RtM via: Logistic Regression|AB|MM;RC
9382350|Infant, Small for Gestational Age|C0021296|13265|MH|||RC
9382350|Neonatal Screening|C0027617|11914|MH|||RC
9382350|Intensive Care, Neonatal|C0021711|8374|MH|||RC
9382350|Mechanical Ventilation|C0199470|5027|ET|Entry Term Replacement for "Respiration, Artificial";RtM via: Mechanical ventilation|AB|MM;RC
9382350|Ophthalmoscopy|C0029090|4990|MH|RtM via: Indirect ophthalmoscopy|AB|MM;RC
9382350|Laser Coagulation|C0086524|4665|MH|||RC
9382350|Blood Transfusion|C0005841|1735|MH|RtM via: Blood Transfusion|AB|MM;RC
9382350|Enteral Nutrition|C0014327|1664|MH|||RC
9382350|Fat Emulsions, Intravenous|C0015667|1027|MH|||RC
9382350|False Positive Reactions|C0015563|704|MH|||RC
9382350|Oxygen|C0030054|623|MH|RtM via: Oxygen|AB|MM
9382350|Population Surveillance|C0032687|526|MH|||RC
9382350|Bronchodilator Agents|C0006280|474|MH|||RC
9382350|Severity of Illness Index|C0036859|444|MH|||RC
9382350|Developing Countries|C0011750|404|MH|||RC
------
9382350|Infant, Newborn|C0021289|1000|CT|Prematurity Retinopathy;Infant, Premature;Birth Weight, Low;Infant, Small for Gestational Age;Neonatal Screening;Intensive Care, Neonatal;CT Text Lookup: retinopathy of prematurity|TI;AB;CT Text Lookup: retinopathy of prematurity|MM;RC
9382350|Humans|C0086418|1000|CT|Prematurity Retinopathy;Infant, Premature;Birth Weight, Low;Infant, Small for Gestational Age;Neonatal Screening;Intensive Care, Neonatal;CT Text Lookup: infant;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: retinopathy of prematurity|TI;AB;CT Text Lookup: infant;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: retinopathy of prematurity|MM;RC
9382350|Child|C0008059|1000|CT|Intensive Care, Neonatal||RC
9382350|Infant|C0021270|1000|CT|CT Text Lookup: infant|CT Text Lookup: infant|MM
9382350|surgery|C0038895|1111|SH|E04.014.520.530 (Laser Coagulation)||MM
9376273|*Breast Cancer|C0006142|1348113|ET|Entry Term Replacement for "Breast Neoplasms";RtM via: Breast Carcinoma;RtM via: Malignant neoplasm of breast|TI;AB|MM;RC
9376273|CHOP protocol|C0055598|757339|NM|RtM via: CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine|AB|MM
9376273|Antineoplastic Combined Chemotherapy Protocols|C0003393|757338|HM|RtM via: CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine|AB|MM;RC
9376273|Neoadjuvant Therapy|C0600558|407355|MH|RtM via: Neoadjuvant Therapy|AB|MM;RC
9376273|Cyclophosphamide|C0010583|377353|MH|RtM via: CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine;RtM via: Cyclophosphamide|AB|MM;RC
9376273|Doxorubicin|C0013089|258352|MH|RtM via: CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine;RtM via: Doxorubicin|AB|MM;RC
9376273|Vincristine|C0042679|254508|MH|RtM via: CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine;RtM via: Vincristine|AB|MM;RC
9376273|Lymphatic Metastasis|C0024232|182429|MH|||RC
9376273|Chemotherapy, Adjuvant|C0085533|176500|MH|||RC
9376273|Lymph Nodes|C0024204|162859|MH|RtM via: Axillary lymph node group|AB|MM;RC
9376273|Axilla|C0004454|123989|MH|RtM via: Axillary lymph node group|AB|MM;RC
9376273|Receptors, Estrogen|C0034804|98103|MH|RtM via: Estrogen Receptors|AB|MM;RC
9376273|Prognosis|C0033325|77507|MH|RtM via: Forecast of outcome|AB|MM;RC
9376273|Neoplasm Staging|C0027646|73242|MH|||RC
9376273|Prednisone|C0032952|66642|HM|RtM via: CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine|AB|MM;RC
9376273|Combined Modality Therapy|C0009429|44160|MH|||RC
9376273|Antineoplastic Agents, Hormonal|C0282559|43660|MH|||RC
9376273|Treatment Outcome|C0085415|29117|MH|||RC
9376273|Neoplasm Recurrence, Local|C0027643|19049|MH|||RC
9376273|Antineoplastic Agents, Alkylating|C0282532|16847|MH|||RC
9376273|Ki-67 Antigen|C0208804|13570|MH|||RC
9376273|Drug Resistance, Neoplasm|C0282588|13419|MH|||RC
9376273|Tumor Markers, Biological|C0041366|12760|MH|||RC
9376273|Prednisolone|C0032950|11242|MH|RtM via: prednisolone|AB|MM;RC
9376273|Proto-Oncogene Proteins c-bcl-2|C0107696|10083|MH|||RC
9376273|Gene Expression Regulation, Neoplastic|C0017268|7672|MH|||RC
9376273|Drug Administration Schedule|C0013154|7464|MH|||RC
9376273|Ovariectomy|C0029936|6068|MH|||RC
9376273|Randomized Controlled Trials as Topic|C0282440|2829|MH|||RC
9376273|ESR1 protein, human|C1521863|2695|NM|RtM via: ESR1 protein, human|AB|MM
9376273|Estrogen Receptor alpha|C0665341|2694|HM|RtM via: ESR1 protein, human|AB|MM
9376273|Time Factors|C0040225|2471|MH|||RC
9376273|Dose-Response Relationship, Drug|C0013059|2355|MH|||RC
9376273|Models, Biological|C0026339|950|MH|||RC
9376273|Infusions, Intravenous|C0021440|784|MH|||RC
------
9376273|Humans|C0086418|1000|CT|Breast Cancer;CT Text Lookup: women|TI;AB;CT Text Lookup: women|MM;RC
9376273|Female|C0015780|1000|CT|Ovariectomy;CT Text Lookup: women|CT Text Lookup: women|MM;RC
9376273|drug therapy|C0013217|75177|SH1|RtM via: pharmacotherapeutic;drug therapy (C0013217);RtM via: Pharmacotherapy;Drug Therapy (C0013216);RtM via: Endocrine therapy;Drug Therapy (C0013216);RtM via: Chemotherapy Regimen;Drug Therapy (C0013216);RtM via: Preoperative Chemotherapy;Drug Therapy (C0013216)|TI;AB|MM
9376273|mortality|C0026566|987|SH1|RtM via: survival aspects;mortality (C0026566)|TI;AB|MM
9376273|secondary|C1522484|14306|SH|Neoplasm Metastasis||RC
9376273|therapy|C0039798|2223|SH|Therapeutics|TI;AB|MM
9376273|immunology|C1522005|1111|SH|D23.050.290.500 (Ki-67 Antigen)||MM
9376273|genetics|C0017399|1111|SH|G05.355.315.370 (Gene Expression Regulation, Neoplastic)||MM
9376273|surgery|C0038895|1111|SH|E04.270.282.685 (Ovariectomy)||MM
9376966|*Central Nervous System Infections|C0007684|258543|MH|RtM via: Central Nervous System Infections|TI|MM;RC
9376966|AIDS-Related Opportunistic Infections|C0162526|93659|MH|||RC
9376966|Cytomegalovirus Infections|C0010823|38267|MH|||RC
9376966|HIV Infections|C0019693|31116|MH|RtM via: HIV Infections|AB|MM;RC
9376966|HIV-1|C0019704|18309|MH|||RC
9376966|Encephalitis, Viral|C0243010|14951|MH|||RC
9376966|Central Nervous System|C0927232|9620|MH|RtM via: Neuraxis|AB|MM;RC
9376966|Brain|C0006104|7590|MH|||RC
9376966|Diagnostic Imaging|C0011923|6798|MH|RtM via: neuroimaging|AB|MM;RC
9376966|Brain Neoplasms|C0006118|6391|MH|||RC
9376966|Tomography, X-Ray Computed|C0040405|4892|MH|||RC
9376966|Toxoplasma|C0040556|3158|MH|||RC
9376966|Brain Ischemia|C0007786|1625|MH|||RC
9376966|Opportunistic Infections|C0029118|427|MH|RtM via: Opportunistic Infections|AB|MM
------
9376966|Humans|C0086418|1000|CT|CT Text Lookup: human|CT Text Lookup: human|MM
9376966|diagnosis|C1704338|207|SH1|RtM via: diagnosis aspect;RtM via: Complication;Diagnosis (C0011900);RtM via: Diagnosis;RtM via: Diagnosis Study;RtM via: Diagnosis Study;diagnosis (C1704338)|AB|MM
9376966|radiography|C0034571|1111|SH|E01.370.350.700.700.810 (Tomography, X-Ray Computed)||MM
9332524|*Histoplasmosis|C0019655|2717754|MH|RtM via: Histoplasmosis;RtM via: Extrapulmonary histoplasmosis|TI;AB|MM;RC
9332524|Histoplasma capsulatum|C0319941|816991|ET|Entry Term Replacement for "Histoplasma";RtM via: Histoplasma capsulatum|AB|MM;RC
9332524|Itraconazole|C0064113|502079|MH|RtM via: Itraconazole|AB|MM;RC
9332524|*AIDS|C0001175|253017|ET|Entry Term Replacement for "Acquired Immunodeficiency Syndrome";RtM via: Acquired Immunodeficiency Syndrome|TI;AB|MM;RC
9332524|AIDS-Related Opportunistic Infections|C0162526|111537|MH|||RC
9332524|Antifungal Agents|C0003308|70419|MH|||RC
9332524|Dermatomycoses|C0011630|31227|MH|||RC
9332524|*Kidney Disease|C0022658|28695|ET|Entry Term Replacement for "Kidney Diseases";RtM via: Kidney Diseases;RtM via: Family history of kidney disease;RtM via: reported prior kidney disease (history)|TI;AB|MM
9332524|Antigens, Fungal|C0003330|18440|MH|||RC
9332524|Kidney Failure|C0035078|11105|MH|RtM via: Progressive renal failure|AB|MM;RC
9332524|Kidney|C0022646|8020|MH|RtM via: Kidney|AB|MM;RC
9332524|Biopsy|C0005558|6521|MH|RtM via: Biopsy|AB|MM;RC
9332524|Antibodies, Fungal|C0003245|5159|MH|||RC
9332524|Kidney Failure, Acute|C0022660|3173|MH|||RC
9332524|Drug Therapy, Combination|C0013218|2033|MH|||RC
9332524|Staining|C0487602|1572|ET|Entry Term Replacement for "Staining and Labeling";RtM via: Fungus stain method;RtM via: Staining method|AB|MM;RC
9332524|Gingival Diseases|C0017563|1521|MH|||RC
9332524|HIV Infections|C0019693|1156|MH|RtM via: HIV Infections|AB|MM
9332524|Proteinuria|C0033687|1052|MH|RtM via: Proteinuria;RtM via: Nephrotic range proteinuria;RtM via: Proteinuria of undiagnosed cause|AB|MM
9332524|Treatment Outcome|C0085415|899|MH|||RC
9332524|Diagnosis, Differential|C0011906|792|MH|||RC
9332524|Nephrotic Syndrome|C0027726|610|MH|RtM via: Nephrotic Syndrome|AB|MM
9332524|Skin|C1123023|564|MH|||RC
9332524|Treatment Refusal|C0040809|424|MH|||RC
9332524|Coloring Agents|C1566391|409|MH|||RC
9332524|Kidney Function Tests|C0022662|336|MH|RtM via: Kidney Function Tests|AB|MM
9332524|*Chromosome Disorders|C0008626|321|MH|RtM via: Family history of kidney disease|TI|MM
9332524|Immune Complexes|C0003313|206|ET|Entry Term Replacement for "Antigen-Antibody Complex";RtM via: Antigen-Antibody Complex|AB|MM
------
9332524|Humans|C0086418|1000|CT|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|MM
9332524|methods|C0025664|25|SH|Methods|AB|MM
9332524|immunology|C1522005|1111|SH|D23.050.202 (Antigens, Fungal)||MM
9341963|Fentanyl|C0015846|783114|MH|RtM via: Fentanyl|AB|MM;RC
9341963|Opioids|C0242402|652521|ET|Entry Term Replacement for "Analgesics, Opioid";RtM via: Opioids|AB|MM;RC
9341963|Pain|C0030193|339201|MH|RtM via: Pain;RtM via: Actual Pain;RtM via: Cancer pain|AB|MM;RC
9341963|Morphine|C0026549|236439|MH|RtM via: Morphine|AB|MM;RC
9341963|Pain Measurement|C0030198|158180|MH|||RC
9341963|Administration, Cutaneous|C0001558|103332|MH|RtM via: Transdermal substance administration;RtM via: transdermal|AB|MM;RC
9341963|Cancer|C0006826|68895|ET|Entry Term Replacement for "Neoplasms";RtM via: Cancer pain;RtM via: Malignant Neoplasms;RtM via: Neoplasm;RtM via: Primary malignant neoplasm|AB|MM;RC
9341963|Palliative Care|C0030231|33358|MH|||RC
9341963|Patient Satisfaction|C0030702|11777|MH|||RC
9341963|Dose-Response Relationship, Drug|C0013059|7178|MH|||RC
9341963|Treatment Outcome|C0085415|5533|MH|||RC
9341963|Administration, Oral|C0001563|4087|MH|||RC
9341963|Quality of Life|C0034380|3780|MH|||RC
9341963|Practice Guidelines as Topic|C0162793|2644|MH|||RC
------
9341963|Humans|C0086418|1000|CT|Palliative Care;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM;RC
9341963|therapy|C0039798|510|SH1|RtM via: therapeutic aspects;therapy (C0039798)|AB|MM
9341963|secondary|C1522484|9601|SH|Neoplasm Metastasis||RC
9341963|drug therapy|C0013217|9999|SH|new SH add rule - Administration, Cutaneous [E02.319.267.120.060] (E02.319)||MM
9341963|methods|C0025664|23|SH|Methods|AB|MM
9339616|*Hepatitis C|C0019196|118668|MH|RtM via: Viral hepatitis|TI|MM;RC
9339616|*Prevalence|C0033105|43254|MH|RtM via: Statistical Prevalence|TI|MM;RC
9339616|Hepatitis E|C0085293|42195|MH|||RC
9339616|*Hepatitis A|C0019159|34020|MH|RtM via: Viral hepatitis;RtM via: Hepatitis A|TI;AB|MM
9339616|Pregnancy Complications, Infectious|C0032965|21046|MH|||RC
9339616|Hepatic Encephalopathy|C0019151|14128|MH|RtM via: Encephalopathies|AB|MM;RC
9339616|Hepatic Failure, Fulminant|C0162557|8983|ET|Entry Term Replacement for "Liver Failure, Acute";RtM via: Liver Failure, Acute|AB|MM;RC
9339616|Maternal Mortality|C0024923|5824|MH|RtM via: Maternal Mortality|AB|MM;RC
9339616|Prognosis|C0033325|5642|MH|||RC
9339616|Acute Disease|C0001314|3549|MH|RtM via: Acute hepatitis|AB|MM;RC
9339616|Risk Factors|C0035648|3263|MH|||RC
9339616|Pregnancy Complications|C0032962|2567|MH|||RC
9339616|Immunoglobulin M|C0020861|1973|MH|||RC
9339616|RNA, Viral|C0035736|1760|MH|||RC
9339616|Antibodies, Viral|C0003253|1618|MH|||RC
9339616|Gestational Age|C0017504|1467|MH|||RC
9339616|Reverse Transcriptase Polymerase Chain Reaction|C0599161|1082|MH|||RC
9339616|Hepatitis B|C0019163|1006|MH|RtM via: Hepatitis B|AB|MM
9339616|Immunoglobulin G|C0020852|820|MH|||RC
9339616|Perinatal Mortality|C0031062|791|MH|RtM via: Perinatal mortality demographics|AB|MM
9339616|Severity of Illness Index|C0036859|600|MH|||RC
9339616|Genotype|C0017431|438|MH|||RC
9339616|*Asian Continental Ancestry Group|C1257906|222|MH|RtM via: Pakistani race|TI|MM
------
9339616|Pregnancy|C0032961|1000|CT|Pregnancy Complications, Infectious;CT Text Lookup: pregnant;CT Text Lookup: pregnant women|CT Text Lookup: pregnant women|MM;RC
9339616|Female|C0015780|1000|CT|Pregnancy Complications, Infectious;CT Text Lookup: pregnant;CT Text Lookup: pregnant women;CT Text Lookup: women|CT Text Lookup: pregnant women;CT Text Lookup: women|MM;RC
9339616|Humans|C0086418|1000|CT|Asian Continental Ancestry Group;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: women|TI;CT Text Lookup: patient;CT Text Lookup: patients;CT Text Lookup: women|MM
9339616|epidemiology|C0014508|2997|SH1|RtM via: Prevalence aspects;epidemiology (C0014508)|TI|MM
9339616|injuries|C1510467|2|SH|Wounds and Injuries|AB|MM
9339616|genetics|C0017399|1111|SH|G05.380 (Genotype)||MM
9323036|*Immunoglobulin Fragments|C0021009|1904052|MH|RtM via: Immunoglobulin Fragments|TI|MM;RC
9323036|Immunoglobulin Variable Region|C0877857|215464|MH|||RC
9323036|*Escherichia coli|C0014834|104193|MH|RtM via: Escherichia coli|TI;AB|MM;RC
9323036|*Immunoglobulin|C0021027|99687|ET|Entry Term Replacement for "Immunoglobulins";RtM via: Immunoglobulins;RtM via: Immunoglobulin measurement;RtM via: immunoglobulin activity|TI|MM
9323036|Molecular Sequence Data|C0026382|86915|MH|||RC
9323036|Base Sequence|C0004793|85376|MH|RtM via: DNA Sequence;RtM via: Base Sequence|AB|MM;RC
9323036|Amino Acid Sequence|C0002518|75750|MH|||RC
9323036|Cloning, Molecular|C0009017|58918|MH|||RC
9323036|Antibodies, Monoclonal|C0003250|36155|MH|RtM via: Monoclonal Antibodies|AB|MM;RC
9323036|Immunoglobulin Heavy Chains|C0021034|19628|MH|||RC
9323036|Recombinant Fusion Proteins|C0034857|18085|MH|||RC
9323036|Immunoglobulin Light Chains|C0021038|15341|MH|||RC
9323036|Protein Engineering|C0033629|11258|MH|||RC
9323036|PCR|C0032520|10037|ET|Entry Term Replacement for "Polymerase Chain Reaction";RtM via: Polymerase Chain Reaction;RtM via: In complete remission|AB|MM;RC
9323036|cDNA|C0006556|7851|ET|Entry Term Replacement for "DNA, Complementary";RtM via: DNA, Complementary|AB|MM;RC
9323036|*Gelatinase B|C0165519|6486|ET|Entry Term Replacement for "Matrix Metalloproteinase 9";RtM via: Gelatinase B|TI;AB|MM
9323036|Bacterial Outer Membrane Proteins|C0004625|5939|MH|||RC
9323036|Neutralization Tests|C0027944|5459|MH|||RC
9323036|Protein Folding|C0162847|4844|MH|||RC
9323036|Rh-Hr Blood-Group System|C0035406|4239|MH|||RC
9323036|Genetic Vectors|C0017397|4067|MH|||RC
9323036|Bacterial Proteins|C0004627|4009|MH|||RC
9323036|*Single-Chain Antibodies|C1883036|3537|MH|RtM via: Single-Chain Variable Fragment|TI;AB|MM
9323036|Hepatitis B Surface Antigens|C0019168|3383|MH|||RC
9323036|Transfection|C0040669|3360|MH|||RC
9323036|Alkaline Phosphatase|C0002059|2809|MH|||RC
9323036|Cancer Vaccines|C0376659|2099|MH|||RC
9323036|Sequence Homology, Amino Acid|C0162777|2098|MH|||RC
9323036|Flow Cytometry|C0016263|2044|MH|||RC
9323036|Interferon-gamma|C0021745|1905|MH|||RC
9323036|Surface Plasmon Resonance|C0597731|1807|MH|||RC
9323036|Cell Line|C0007600|1601|MH|||RC
9323036|Dimerization|C0376525|1479|MH|||RC
9323036|Cytotoxicity, Immunologic|C0010864|1444|MH|||RC
9323036|Periplasm|C0525009|1421|MH|RtM via: periplasm|AB|MM
9323036|Cell Line, Tumor|C0085983|1360|MH|||RC
9323036|Mice, Inbred BALB C|C0025919|1211|MH|||RC
9323036|Uterine Cervical Neoplasms|C0007873|799|MH|||RC
9323036|Solubility|C0037628|508|MH|||RC
9323036|*Drug Toxicity|C0013221|456|MH|RtM via: immunoglobulin activity|TI|MM
9323036|Erythrocyte Aggregation|C0014766|386|MH|||RC
9323036|*Biophysical Processes|C1511162|360|MH|RtM via: immunoglobulin activity|TI|MM
------
9323036|Mice|C0026809|133|CT||AB|MM
9323036|Animals|C0003062|1000|CT|Mice, Inbred BALB C||RC
9323036|Female|C0015780|1000|CT|Uterine Cervical Neoplasms||RC
9323036|Humans|C0086418|1000|CT|CT Text Lookup: human|CT Text Lookup: human|MM
9323036|metabolism|C0025520|840|SH1|RtM via: Metabolic Inhibition;Metabolism (C0025519);RtM via: Catabolism;Metabolism (C0025519);RtM via: Inhibited;Metabolism (C0025519);RtM via: degradation aspects;metabolism (C0025520)|TI;AB|MM
9323036|surgery|C0038895|684|SH1|RtM via: Expression procedure;Surgical Procedures, Operative (C0543467);RtM via: Clipping;surgery (C0038895);RtM via: Closure by clip procedure;Surgical Procedures, Operative (C0543467)|TI;AB|MM
9323036|genetics|C0017399|1111|SH|G05.360.080 (Base Sequence)|AB|MM
9323036|immunology|C1522005|1111|SH|D23.050.301.290.775 (Rh-Hr Blood-Group System)||MM
9337362|*Status Asthmaticus|C0038218|405048|MH|RtM via: Status Asthmaticus|TI;AB|MM;RC
9337362|Mechanical Ventilation|C0199470|53560|ET|Entry Term Replacement for "Respiration, Artificial";RtM via: Mechanical ventilation|AB|MM;RC
9337362|Hypercapnia|C0020440|14666|MH|RtM via: Hypercapnia|AB|MM;RC
9337362|*Emergency|C0013956|14244|ET|Entry Term Replacement for "Emergencies";RtM via: Emergency Situation|TI|MM;RC
9337362|Lung|C0024109|6400|MH|RtM via: pulmonary function|AB|MM;RC
9337362|Carbon Dioxide|C0007012|3216|MH|RtM via: partial pressure of carbon dioxide in arterial blood|AB|MM;RC
9337362|Treatment Outcome|C0085415|2954|MH|||RC
9337362|Respiratory Mechanics|C0035230|2953|MH|||RC
9337362|Oxygen|C0030054|1985|MH|||RC
9337362|Registries|C0034975|1523|MH|||RC
9337362|Outcome Assessment (Health Care)|C0085565|1143|MH|||RC
9337362|Bronchoscopy|C0006290|1135|MH|||RC
9337362|Oxygen Consumption|C0030055|941|MH|||RC
9337362|Cause of Death|C0007465|900|MH|||RC
9337362|Age Factors|C0001783|891|MH|||RC
9337362|Severity of Illness Index|C0036859|592|MH|||RC
9337362|Sex Factors|C0036881|541|MH|||RC
9337362|Patient Selection|C0242802|527|MH|||RC
9337362|*Health Services|C0018747|474|MH|RtM via: Life support procedure|TI;AB|MM
9337362|Time Factors|C0040225|363|MH|||RC
9337362|*Drug Administration Routes|C0013153|303|MH|RtM via: Extracorporeal Circulation Route of Drug Administration|TI;AB|MM
9337362|Catheters, Indwelling|C0007439|242|MH|||RC
9337362|Recovery of Function|C0599766|233|MH|||RC
9337362|Hydrogen-Ion Concentration|C0020283|205|MH|||RC
------
9337362|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9337362|methods|C0025664|429|SH1|RtM via: Methodology;methods (C0025664)|AB|MM
9337362|injuries|C1510467|1870|SH|Wounds and Injuries|AB|MM;RC
9323783|Pharyngitis|C0031350|712884|MH|RtM via: Sore Throat|AB|MM;RC
9323783|*Streptococcus|C0038402|712056|MH|RtM via: Beta-hemolytic streptococcus|TI;AB|MM;RC
9323783|*Throat|C0031354|339600|ET|Entry Term Replacement for "Pharynx";RtM via: Pharyngeal structure|TI;AB|MM;RC
9323783|Streptococcal Infections|C0038395|245978|MH|||RC
9323783|Carrier State|C0560175|90264|MH|RtM via: Carrier of disorder|AB|MM;RC
9323783|*Prevalence|C0033105|52983|MH|RtM via: Statistical Prevalence|TI;AB|MM;RC
9323783|Serotyping|C0036759|7400|MH|||RC
9323783|Bacterial Outer Membrane Proteins|C0004625|3956|MH|||RC
9323783|Antigens, Bacterial|C0003321|3757|MH|||RC
9323783|Season|C0036497|3662|ET|Entry Term Replacement for "Seasons";RtM via: Seasons;RtM via: summer;RtM via: winter|AB|MM;RC
9323783|Anti-Bacterial Agents|C0279516|2869|MH|||RC
9323783|Crowding|C0010383|2586|MH|||RC
9323783|Bacteriological Techniques|C0004642|2571|MH|||RC
9323783|Population Surveillance|C0032687|1827|MH|||RC
9323783|Tropical Climate|C0041183|1571|MH|||RC
9323783|Age Factors|C0001783|1482|MH|||RC
9323783|Oceanic Ancestry Group|C1257908|1277|MH|||RC
9323783|Culture Media|C0010454|1276|MH|||RC
9323783|*Laboratory Techniques and Procedures|C0600201|945|MH|RtM via: Throat culture|TI;AB|MM
9323783|Risk Factors|C0035648|888|MH|||RC
9323783|Sex Factors|C0036881|832|MH|||RC
9323783|Emergency Service, Hospital|C0013967|579|MH|||RC
9323783|*Research|C0035168|330|MH|RtM via: Throat culture|TI;AB|MM
9323783|Hospitals, Public|C0020022|269|MH|||RC
------
9323783|Humans|C0086418|1000|CT|Oceanic Ancestry Group;CT Text Lookup: adult;CT Text Lookup: aged;CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: adult;CT Text Lookup: aged;CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients|MM;RC
9323783|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9323783|Child|C0008059|1000|CT|CT Text Lookup: children|CT Text Lookup: children|MM
9323783|epidemiology|C0014508|1794|SH1|RtM via: Prevalence aspects;epidemiology (C0014508)|TI;AB|MM
9323783|organization & administration|C0029236|591|SH|Organization and Administration|TI;AB|MM
9323783|instrumentation|C0021632|2|SH|Equipment and Supplies|AB|MM
9323783|immunology|C1522005|1111|SH|D23.050.161 (Antigens, Bacterial)||MM
9344868|*Escherichia coli|C0014834|246654|MH|RtM via: Escherichia coli|TI;AB|MM;RC
9344868|DNA, Bacterial|C0012924|55623|MH|||RC
9344868|Nucleic Acid Conformation|C0028599|20856|MH|||RC
9344868|Enzyme Assays|C2717977|19645|MH|Forced New Lookup:enzymatic assay||MM
9344868|Cloning, Molecular|C0009017|12225|MH|||RC
9344868|Genes, Bacterial|C0017339|8319|MH|||RC
9344868|Bacterial Proteins|C0004627|6978|MH|||RC
9344868|Molecular Sequence Data|C0026382|6398|MH|||RC
9344868|Adenosine Triphosphatases|C0001473|5787|MH|||RC
9344868|Adenosine Triphosphate|C0001480|5654|MH|||RC
9344868|*Pressure|C0033095|4965|MH|RtM via: Pressure- physical agent|TI;AB|MM
9344868|Adenosine Diphosphate|C0001459|4587|MH|||RC
9344868|Deoxyribonucleases|C0011522|3738|MH|||RC
9344868|Substrate Specificity|C0038592|3531|MH|||RC
9344868|Anti-Bacterial Agents|C0279516|3125|MH|||RC
9344868|Promoter Regions, Genetic|C0033413|2452|MH|||RC
9344868|DNA Gyrase|C0949782|1882|MH|RtM via: DNA Gyrase|AB|MM
9344868|Gene Amplification|C0017256|1689|MH|||RC
9344868|*Biophysical Processes|C1511162|1548|MH|RtM via: DNA gyrase activity|TI|MM
9344868|Drug Design|C0013171|1215|MH|||RC
9344868|Spectrometry, Fluorescence|C0037802|960|MH|||RC
9344868|Models, Biological|C0026339|949|MH|||RC
9344868|Models, Chemical|C0026341|874|MH|||RC
9344868|Energy Metabolism|C0014272|743|MH|||RC
9344868|Binding, Competitive|C0005458|665|MH|||RC
------
9344868|genetics|C0017399|1111|SH|G05.360.580 (Nucleic Acid Conformation)||MM
9323782|*Enterobius vermicularis|C0600211|6634257|ET|Entry Term Replacement for "Enterobius";RtM via: Enterobius vermicularis;RtM via: Enterobius vermicularis Antigen|TI;AB|MM;RC
9323782|Parasite Egg Count|C0030495|15014|MH|||RC
9323782|Prevalence|C0033105|13218|MH|RtM via: Statistical Prevalence|AB|MM;RC
9323782|Cross-Sectional Survey|C0010362|5353|ET|Entry Term Replacement for "Cross-Sectional Studies";RtM via: Cross-Sectional Studies|AB|MM;RC
9323782|Schools|C0036375|2084|MH|RtM via: School (environment);RtM via: Day care center (for any age)|AB|MM;RC
9323782|*Finger Sucking|C0016130|2076|ET|Entry Term Replacement for "Fingersucking";RtM via: Fingersucking|TI;AB|MM
9323782|Urban Population|C0041935|896|MH|||RC
9323782|Socioeconomic Factors|C0037464|729|MH|||RC
9323782|Risk Factors|C0035648|445|MH|||RC
9323782|Rural Health|C0035959|285|MH|||RC
9323782|Geography|C0017447|225|MH|||RC
9323782|Sex Factors|C0036881|192|MH|||RC
9323782|Questionnaire|C0034394|181|ET|Entry Term Replacement for "Questionnaires";RtM via: Questionnaires|AB|MM;RC
9323782|Anal Canal|C0227411|165|MH|||RC
------
9323782|Animals|C0003062|1000|CT|Enterobius vermicularis|TI;AB|MM;RC
9323782|Female|C0015780|1000|CT|CT Text Lookup: both sexes|CT Text Lookup: both sexes|MM
9323782|Male|C0024554|1000|CT|CT Text Lookup: both sexes|CT Text Lookup: both sexes|MM
9323782|Child|C0008059|1000|CT|CT Text Lookup: children|CT Text Lookup: children|MM
9323782|Humans|C0086418|1000|CT|CT Text Lookup: children|CT Text Lookup: children|MM
9323782|instrumentation|C0021632|3|SH|Equipment and Supplies|AB|MM
9327226|Uterine Cervical Neoplasms|C0007873|92614|MH|||RC
9327226|Uterine Neoplasms|C0042138|92127|MH|||RC
9327226|*Radiation|C0851346|19980|MH|RtM via: Electromagnetic Energy;RtM via: Radiation|TI|MM
9327226|Radiotherapy Dosage|C0034620|12022|MH|||RC
9327226|Combined Modality Therapy|C0009429|11923|MH|||RC
9327226|Lymphatic Metastasis|C0024232|7760|MH|||RC
9327226|Breast Neoplasms|C1458155|6256|MH|||RC
9327226|Neoplasm Recurrence, Local|C0027643|5394|MH|||RC
9327226|Antineoplastic Combined Chemotherapy Protocols|C0003393|5155|MH|||RC
9327226|Neoplasm Staging|C0027646|3515|MH|||RC
9327226|Health Physics|C0018725|3265|MH|||RC
9327226|Radiation Tolerance|C0034537|2289|MH|||RC
9327226|Prognosis|C0033325|1340|MH|||RC
9327226|Radium|C0034625|1182|MH|||RC
9327226|*Research|C0035168|516|MH|RtM via: Radiotherapy Research|TI|MM
9327226|Alkylating Agents|C0002073|486|MH|||RC
9327226|Hyperbaric Oxygenation|C0020431|318|MH|||RC
------
9327226|Female|C0015780|1000|CT|Uterine Cervical Neoplasms;Uterine Neoplasms||RC
9327226|Humans|C0086418|1000|CT|Breast Neoplasms;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM;RC
9327226|radiotherapy|C1522449|202578|SH1|RtM via: Therapeutic radiology procedure;Radiotherapy (C1522449);RtM via: Clinic/Center - Oncology, Radiation;Radiotherapy (C1522449);RtM via: Physicians - Radiation Oncology;Radiotherapy (C1522449);RtM via: diagnostic service sources radiology labs radiation oncology;Radiotherapy (C1522449);RtM via: Radiation Ionizing Radiotherapy;RtM via: radiotherapeutic;radiotherapy (C0034619)|TI;AB|MM;RC
9327226|methods|C0025664|316|SH1|RtM via: Methodology;methods (C0025664)|AB|MM
9327226|organization & administration|C0029236|5|SH|Organization and Administration|AB|MM
9344556|*Glutamate|C0220839|547761|ET|Entry Term Replacement for "Glutamic Acid";RtM via: Glutamate|TI;AB|MM;RC
9344556|*GABA|C0016904|482052|ET|Entry Term Replacement for "gamma-Aminobutyric Acid";RtM via: gamma-Aminobutyric Acid|TI;AB|MM;RC
9344556|*Cerebral Ischemia|C0917798|479658|ET|Entry Term Replacement for "Brain Ischemia";RtM via: Brain Ischemia;RtM via: Cerebral Ischemia|TI;AB|MM;RC
9344556|*Substantia Nigra|C0038590|364140|MH|RtM via: Substantia nigra structure;RtM via: Entire substantia nigra|TI;AB|MM;RC
9344556|*Gerbils|C0017462|206649|ET|Entry Term Replacement for "Gerbillinae";RtM via: Gerbils|TI;AB|MM;RC
9344556|*Cerebral Infarction|C0007785|145161|MH|RtM via: Cerebral Infarction|TI;AB|MM
9344556|*Glutamates|C0017789|138399|MH|RtM via: Glutamates|TI;AB|MM;RC
9344556|nipecotic acid|C0068781|50387|NM|RtM via: nipecotic acid|AB|MM
9344556|Nipecotic Acids|C0028108|50386|HM|RtM via: nipecotic acid|AB|MM;RC
9344556|Corpus Striatum|C0010097|45251|MH|RtM via: Corpus striatum structure|AB|MM;RC
9344556|Extracellular Space|C0015352|40557|MH|RtM via: Extracellular|AB|MM;RC
9344556|Microdialysis|C0206056|31516|MH|RtM via: Microdialysis|AB|MM;RC
9344556|Neostriatum|C0162512|26970|MH|RtM via: Neostriatum|AB|MM;RC
9344556|Neurons|C0027882|18510|MH|RtM via: Neuronal|AB|MM;RC
9344556|Brain|C0006104|6259|MH|||RC
9344556|Hypothermia, Induced|C0020674|5635|MH|||RC
9344556|Rats, Wistar|C0034716|5561|MH|||RC
9344556|Disease Models, Animal|C0012644|2715|MH|||RC
9344556|Membrane Potentials|C0025251|1655|MH|||RC
9344556|Potassium Chloride|C0032825|1418|MH|||RC
9344556|Time Factors|C0040225|1149|MH|||RC
9344556|Behavior, Animal|C0004935|1031|MH|||RC
9344556|Chromatography, High Pressure Liquid|C0008562|905|MH|||RC
9344556|*Communication Disorders|C0009460|714|MH|RtM via: speech fluency repetition (physical finding)|TI;AB|MM
9344556|Drug Synergism|C0013215|363|MH|||RC
------
9344556|Animals|C0003062|1000|CT|Gerbils;Rats, Wistar;Disease Models, Animal;Behavior, Animal;CT Text Lookup: animals|TI;AB;CT Text Lookup: animals|MM;RC
9344556|Rats|C0034721|1000|CT|Rats, Wistar||RC
9344556|methods|C0025664|3|SH|Methods|AB|MM
9344556|injuries|C1510467|1|SH|Wounds and Injuries|AB|MM
9327635|*Industry|C0021267|121062|MH|RtM via: Industry|TI;AB|MM;RC
9327635|Occupational Exposure|C0028798|66319|MH|||RC
9327635|Occupational Diseases|C0028797|62810|MH|||RC
9327635|*Risk|C0035647|42495|MH|RtM via: Risk|TI;AB|MM
9327635|Occupational Health|C0079920|30083|MH|||RC
9327635|Air Pollutants, Occupational|C0001871|16139|MH|||RC
9327635|*Water|C0043047|13719|MH|RtM via: Water;RtM via: Water Specimen|TI;AB|MM
9327635|Biofouling|C2718047|13400|MH|Forced New Lookup:biofouling||MM
9327635|Risk Assessment|C0086930|13059|MH|||RC
9327635|Disinfectants|C0012682|12109|MH|||RC
9327635|Inhalation Exposure|C0524800|11294|MH|||RC
9327635|Safety Management|C0206216|8702|MH|||RC
9327635|Risk Factors|C0035648|8498|MH|||RC
9327635|Corrosion|C0010106|6554|MH|RtM via: Corrosion;RtM via: Corrosion of Medical Device Material|AB|MM;RC
9327635|Industrial Waste|C0021265|6135|MH|||RC
9327635|Air Pollution, Indoor|C0085420|5682|MH|||RC
9327635|Environmental Monitoring|C0014416|5569|MH|||RC
9327635|Soil Pollutants|C0037594|3701|MH|||RC
9327635|Water Microbiology|C0043051|3578|MH|||RC
9327635|Water Purification|C0242719|3467|MH|||RC
9327635|Water Pollutants, Chemical|C0043054|3337|MH|||RC
9327635|Consumer Product Safety|C0009826|3009|MH|||RC
9327635|Geologic Sediments|C0282590|2939|MH|||RC
9327635|Sulfur-Reducing Bacteria|C0085509|2854|MH|||RC
9327635|Dermatitis, Allergic Contact|C0162820|2558|MH|||RC
9327635|Hand Dermatoses|C0018567|2550|MH|||RC
9327635|Health Surveys|C0018762|2342|MH|||RC
9327635|Soil Microbiology|C0037593|1788|MH|||RC
9327635|Heart Valve Prosthesis|C0018825|1706|MH|||RC
9327635|Guidelines as Topic|C0162791|1637|MH|||RC
9327635|Nurse Administrators|C0028652|1455|MH|||RC
9327635|Food Handling|C0016469|1396|MH|||RC
9327635|Health Promotion|C0018738|1372|MH|||RC
9327635|Questionnaires|C0034394|1233|MH|||RC
9327635|Public Opinion|C0034030|1119|MH|||RC
9327635|Plants, Genetically Modified|C0950153|1100|MH|||RC
9327635|Leadership|C0023181|1095|MH|||RC
9327635|Product Surveillance, Postmarketing|C0033267|860|MH|||RC
9327635|Decision Making|C0011109|827|MH|||RC
9327635|Nutritive Value|C0028722|806|MH|||RC
9327635|Models, Animal|C0599779|744|MH|||RC
9327635|Electrochemistry|C0013803|683|MH|||RC
9327635|Industrial Microbiology|C0021262|679|MH|||RC
9327635|Nurse's Role|C0597109|621|MH|||RC
9327635|Patient Care Team|C0030679|490|MH|||RC
9327635|Animal Feed|C0003050|458|MH|||RC
9327635|Gastroenterology|C0017163|445|MH|||RC
9327635|Safety|C0036043|347|MH|RtM via: Safety|AB|MM
------
9327635|Animals|C0003062|1000|CT|Models, Animal||RC
9327635|toxicity|C0040539|26079|SH|Toxicology|TI|MM
9327635|methods|C0025664|2256|SH|Methods|TI;AB|MM
9327635|injuries|C1510467|160|SH|Wounds and Injuries|AB|MM
9345269|*Exocytosis|C0015283|676353|MH|RtM via: Exocytosis|TI;AB|MM;RC
9345269|*Pheochromocytoma|C0031511|466614|MH|RtM via: Pheochromocytoma;RtM via: Benign pheochromocytoma of adrenal gland|TI|MM;RC
9345269|*Catecholamines|C0007412|375777|MH|RtM via: Catecholamines|TI;AB|MM;RC
9345269|*Acetylcholine|C0001041|171171|MH|RtM via: Acetylcholine|TI;AB|MM;RC
9345269|Calcium|C0006675|59370|MH|RtM via: Calcium ion|AB|MM;RC
9345269|PC12 Cells|C0085262|53545|MH|RtM via: PC12 Cells|AB|MM;RC
9345269|GTP gamma S|C0079469|50980|ET|Entry Term Replacement for "Guanosine 5'-O-(3-Thiotriphosphate)";RtM via: Guanosine 5'-O-(3-Thiotriphosphate)|AB|MM;RC
9345269|Adrenal Gland Neoplasms|C0001624|42074|MH|||RC
9345269|MgATP|C0024471|40858|ET|Entry Term Replacement for "Adenosine Triphosphate";RtM via: Adenosine Triphosphate, Magnesium Salt|AB|MM;RC
9345269|Secretory Vesicles|C0886515|36880|MH|RtM via: Secretory Vesicles|AB|MM;RC
9345269|GTP|C0018353|36705|ET|Entry Term Replacement for "Guanosine Triphosphate";RtM via: Guanosine Triphosphate|AB|MM;RC
9345269|Digitonin|C0012256|19047|MH|RtM via: Digitonin|AB|MM;RC
9345269|Cell Membrane Permeability|C0007605|17748|MH|||RC
9345269|Potassium|C0032821|15476|MH|||RC
9345269|Calcium-Binding Proteins|C0006732|10414|MH|||RC
9345269|Protein Kinase C|C0033634|9516|MH|RtM via: Protein Kinase C|AB|MM;RC
9345269|Vesicular Transport Proteins|C1135986|8714|MH|||RC
9345269|Presynaptic Terminals|C0206181|7776|MH|||RC
9345269|Biological Transport|C0005528|7457|MH|RtM via: Cell secretion|AB|MM;RC
9345269|Cells, Cultured|C0007635|7234|MH|||RC
9345269|*Cells|C0007634|7095|MH|RtM via: Cells|TI;AB|MM
9345269|Signal Transduction|C0037083|6190|MH|||RC
9345269|Membrane Transport Proteins|C0596902|5520|MH|||RC
9345269|Tetradecanoylphorbol Acetate|C0039654|5365|MH|||RC
9345269|Membrane Potentials|C0025251|5206|MH|||RC
9345269|Synaptic Transmission|C0027793|4308|MH|||RC
9345269|Calcineurin|C0054450|4167|MH|||RC
9345269|Kinetics|C0022702|3924|MH|||RC
9345269|Wasp Venoms|C0043040|3833|MH|||RC
9345269|Nerve Tissue Proteins|C0027759|3553|MH|||RC
9345269|Patch-Clamp Techniques|C0242625|3173|MH|||RC
9345269|Cell Line|C0007600|2677|MH|||RC
9345269|Hemolysin Proteins|C0019053|2419|MH|||RC
9345269|Subcellular Fractions|C0038528|2179|MH|||RC
9345269|Mammary Glands, Animal|C0024659|2137|MH|||RC
9345269|Aspartic Acid|C0004015|2057|MH|||RC
9345269|Dose-Response Relationship, Drug|C0013059|1883|MH|||RC
9345269|Peptide Fragments|C0030935|1747|MH|||RC
9345269|Chromatography, High Pressure Liquid|C0008562|1684|MH|||RC
9345269|Electrophoresis, Polyacrylamide Gel|C0013862|1628|MH|||RC
9345269|Lactation|C0022925|1605|MH|||RC
9345269|Models, Biological|C0026339|918|MH|||RC
9345269|Carbon Radioisotopes|C0007021|893|MH|||RC
9345269|Cloning, Molecular|C0009017|800|MH|||RC
9345269|Transfection|C0040669|597|MH|||RC
9345269|*Blister|C0005758|366|MH|RtM via: vesicle|TI;AB|MM
9345269|Organelles|C0029219|333|MH|RtM via: Organelles|AB|MM
9345269|Time Factors|C0040225|225|MH|||RC
------
9345269|Rats|C0034721|37812|CT||TI|MM
9345269|Animals|C0003062|1000|CT|Mammary Glands, Animal;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9345269|Female|C0015780|1000|CT|Lactation||RC
9345269|genetics|C0017399|1111|SH|G05.355.760.860 (Transfection)||MM
9297786|3,4,5,3',4'-pentachlorobiphenyl|C0046929|637528|NM|Forced Lookup:3,3',4,4',5-pentachlorobiphenyl||MM
9297786|*Polychlorinated Biphenyls|C0032447|637527|HM|RtM via: Polychlorinated Biphenyls|TI;AB|MM;RC
9297786|2,5,2',5'-tetrachlorobiphenyl|C0045536|581896|NM|Forced Lookup:2,2',5,5'-tetrachlorobiphenyl||MM
9297786|Mice, DBA|C0025923|207396|ET|Entry Term Replacement for "Mice, Inbred DBA";RtM via: Mice, Inbred DBA|AB|MM;RC
9297786|*Liver|C0023884|83115|MH|RtM via: Hepatic|TI;AB|MM;RC
9297786|Mice, Inbred C57BL|C0025921|55153|MH|RtM via: Mice, Inbred C57BL|AB|MM;RC
9297786|*Species Specificity|C0037783|39462|MH|RtM via: Species Specificity|TI;AB|MM;RC
9297786|Microsomes, Liver|C0026030|30606|MH|||RC
9297786|Environmental Pollutants|C0014417|26079|MH|||RC
9297786|Chlorodiphenyl (54% Chlorine)|C2350767|12387|MH|||RC
9297786|Organ Size|C1450569|11552|MH|||RC
9297786|Structure-Activity Relationship|C0038477|7833|MH|||RC
9297786|Dehydrogenase|C0030016|6849|ET|Entry Term Replacement for "Oxidoreductases";RtM via: Oxidoreductase|AB|MM;RC
9297786|Carcinogens|C0007090|5599|MH|||RC
9297786|*Hydrocarbons|C0020242|5373|MH|RtM via: Hydrocarbons|TI;AB|MM
9297786|Dose-Response Relationship, Drug|C0013059|4849|MH|||RC
9297786|*Hepatophyta|C0996514|4224|MH|RtM via: Hepatophyta|TI;AB|MM
9297786|*Glucose-6-Phosphate Dehydrogenase|C0017757|4191|ET|Entry Term Replacement for "Glucosephosphate Dehydrogenase";RtM via: Glucose-6-phosphate dehydrogenase measurement, quantitative;RtM via: Glucosephosphate Dehydrogenase|TI;AB|MM
9297786|Cell Differentiation|C0007589|2829|MH|RtM via: induction activity|AB|MM;RC
9297786|Reverse Transcriptase Polymerase Chain Reaction|C0599161|2574|MH|||RC
9297786|diphenyl|C0058372|2475|NM|RtM via: diphenyl|AB|MM
9297786|Biphenyl Compounds|C0005580|2474|HM|RtM via: diphenyl|AB|MM
9297786|Molecular Structure|C0026383|2331|MH|||RC
9297786|3T3-L1 Cells|C1257743|2326|MH|||RC
9297786|Mice, Knockout|C0206745|2231|MH|||RC
9297786|Apoptosis|C0162638|1871|MH|||RC
9297786|Cell Proliferation|C0596290|1665|MH|||RC
9297786|Immunosuppressive Agents|C0021081|1545|MH|||RC
9297786|PPAR gamma|C0166417|1447|MH|||RC
9297786|RNA, Messenger|C0035696|1171|MH|||RC
9297786|Inflammation Mediators|C0243042|1146|MH|||RC
9297786|Rats, Sprague-Dawley|C0034715|1035|MH|||RC
9297786|Chemistry, Pharmaceutical|C0008003|798|MH|||RC
9297786|Binding, Competitive|C0005458|644|MH|||RC
9297786|Propionic Acids|C0033482|624|MH|||RC
9297786|Quality Control|C0034378|224|MH|||RC
------
9297786|Rats|C0034721|315|CT||AB|MM
9297786|Mice|C0026809|148|CT||AB|MM
9297786|Guinea Pigs|C0085979|75|CT||AB|MM
9297786|Animals|C0003062|1000|CT|Mice, DBA;Mice, Inbred C57BL;3T3-L1 Cells;Mice, Knockout;Rats, Sprague-Dawley;CT Text Lookup: dba mice;CT Text Lookup: guinea pigs;CT Text Lookup: mice;CT Text Lookup: rat|AB;CT Text Lookup: dba mice;CT Text Lookup: guinea pigs;CT Text Lookup: mice;CT Text Lookup: rat|MM;RC
9297786|enzymology|C0014445|5145|SH1|RtM via: glucose-6-phosphate dehydrogenase activity;enzymology (C0014445);RtM via: glucose dehydrogenase (acceptor) activity;enzymology (C0014445);RtM via: glucose dehydrogenase activity;enzymology (C0014445)|TI;AB|MM
9380946|Trophoblast|C0041178|152886|ET|Entry Term Replacement for "Trophoblasts";RtM via: trophoblast|AB|MM;RC
9380946|Placenta|C0032043|114044|MH|RtM via: Placenta;RtM via: Eutheria|AB|MM;RC
9380946|*Mother-Fetus Relationship|C1135956|67053|ET|Entry Term Replacement for "Maternal-Fetal Relations";RtM via: Maternal-Fetal Relations|TI|MM
9380946|HLA Antigens|C0019721|61189|MH|RtM via: HLA Antigens|AB|MM;RC
9380946|Fetus|C0015965|58159|MH|RtM via: Fetus;RtM via: Entire fetus;RtM via: Fetal|AB|MM;RC
9380946|Maternal-Fetal Exchange|C0024929|48763|MH|||RC
9380946|Immune Tolerance|C0020963|32426|MH|RtM via: Natural immunosuppression|AB|MM;RC
9380946|Histocompatibility Antigens Class I|C0019629|20266|MH|||RC
9380946|Abortions, Recurrent|C0000809|19602|ET|Entry Term Replacement for "Abortion, Habitual";RtM via: Abortion, Habitual|AB|MM;RC
9380946|Cytokines|C0079189|11376|MH|RtM via: cytokine|AB|MM;RC
9380946|Pregnancy, Animal|C0032986|10567|MH|||RC
9380946|Th1 Cells|C0242632|9745|MH|RtM via: T-helper cell type 1|AB|MM;RC
9380946|T-Lymphocyte Subsets|C0080202|5091|MH|||RC
9380946|Lymphocytes|C0024264|4879|MH|RtM via: Lymphocyte|AB|MM;RC
------
9380946|Mice|C0026809|128|CT||AB|MM
9380946|Female|C0015780|1000|CT|Placenta;Maternal-Fetal Exchange;Abortions, Recurrent;Pregnancy, Animal;CT Text Lookup: abortion;CT Text Lookup: female;CT Text Lookup: females;CT Text Lookup: pregnancy;CT Text Lookup: spontaneous abortion;CT Text Lookup: women|AB;CT Text Lookup: abortion;CT Text Lookup: female;CT Text Lookup: females;CT Text Lookup: pregnancy;CT Text Lookup: spontaneous abortion;CT Text Lookup: women|MM;RC
9380946|Pregnancy|C0032961|1000|CT|Placenta;Maternal-Fetal Exchange;Abortions, Recurrent;Pregnancy, Animal;CT Text Lookup: abortion;CT Text Lookup: pregnancy;CT Text Lookup: spontaneous abortion|AB;CT Text Lookup: abortion;CT Text Lookup: pregnancy;CT Text Lookup: spontaneous abortion|MM;RC
9380946|Humans|C0086418|1000|CT|Abortions, Recurrent;CT Text Lookup: spontaneous abortion;CT Text Lookup: women|AB;CT Text Lookup: spontaneous abortion;CT Text Lookup: women|MM;RC
9380946|Animals|C0003062|1000|CT|Pregnancy, Animal;CT Text Lookup: mouse|CT Text Lookup: mouse|MM;RC
9380946|methods|C0025664|3|SH|Methods|AB|MM
9380946|immunology|C1522005|1111|SH|D23.050.301.500.450 (HLA Antigens)|AB|MM
9347825|*Carcinoma, Non-Small-Cell Lung|C0007131|4587717|MH|RtM via: Carcinoma, Non-Small-Cell Lung|TI;AB|MM;RC
9347825|Lung Neoplasms|C0024121|731756|MH|RtM via: Lung Neoplasms|AB|MM;RC
9347825|*Breast Neoplasms|C1458155|132816|MH|RtM via: Secondary malignant neoplasm of female breast|TI|MM;RC
9347825|Neoplasm Staging|C0027646|60591|MH|||RC
9347825|Breast|C0006141|47453|MH|RtM via: Breast;RtM via: Entire breast|AB|MM;RC
9347825|Pneumonectomy|C0032284|33295|MH|||RC
9347825|Fluorodeoxyglucose F18|C0046056|13723|MH|||RC
9347825|Tumor Markers, Biological|C0041366|11344|MH|||RC
9347825|Positron-Emission Tomography|C0032743|10030|MH|||RC
9347825|Prognosis|C0033325|7118|MH|||RC
9347825|Ki-67 Antigen|C0208804|7102|MH|||RC
9347825|Gene Expression Regulation, Neoplastic|C0017268|5998|MH|||RC
9347825|Radiopharmaceuticals|C0182638|5736|MH|||RC
9347825|Tomography, X-Ray Computed|C0040405|4195|MH|||RC
9347825|Palliative Care|C0030231|3647|MH|||RC
9347825|Spinal Neoplasms|C0037939|3636|MH|||RC
9347825|Brain Neoplasms|C0006118|3628|MH|||RC
9347825|Skin Neoplasms|C0037286|3114|MH|||RC
9347825|Carcinoma, Bronchogenic|C0007121|1552|MH|RtM via: Carcinoma of lung|AB|MM
9347825|Risk Assessment|C0086930|1425|MH|||RC
9347825|Cervical Atlas|C0004170|1197|MH|||RC
9347825|Treatment Outcome|C0085415|1180|MH|||RC
9347825|Diagnosis, Differential|C0011906|906|MH|||RC
9347825|Lung|C0024109|375|MH|RtM via: Lung;RtM via: Entire lung|AB|MM
------
9347825|Humans|C0086418|1000|CT|Breast Neoplasms;Palliative Care|TI|MM;RC
9347825|secondary|C1522484|44337|SH1|RtM via: Secondary malignant neoplasm of female breast;secondary (C1522484);RtM via: metastatic qualifier;secondary (C1522484)|TI;AB|MM
9347825|organization & administration|C0029236|8|SH|Organization and Administration|AB|MM
9347825|methods|C0025664|1|SH|Methods|AB|MM
9347825|surgery|C0038895|1111|SH|E04.928.600.600 (Pneumonectomy)||MM
9347825|radionuclide imaging|C0034607|1111|SH|E01.370.384.730.800.399 (Positron-Emission Tomography)||MM
9347825|immunology|C1522005|1111|SH|D23.050.290.500 (Ki-67 Antigen)||MM
9347825|genetics|C0017399|1111|SH|G05.355.315.370 (Gene Expression Regulation, Neoplastic)||MM
9347825|radiography|C0034571|1111|SH|E01.370.350.700.700.810 (Tomography, X-Ray Computed)||MM
9323766|*Pseudoaneurysms|C1510412|559701|ET|Entry Term Replacement for "Aneurysm, False";RtM via: Pseudoaneurysm|TI;AB|MM;RC
9323766|Femoral Artery|C0015801|96283|MH|||RC
9323766|*Pressure|C0033095|49314|MH|RtM via: Compression|TI;AB|MM;RC
9323766|Catheterization|C0007430|38530|MH|RtM via: Arterial catheterization|AB|MM;RC
9323766|Heart Catheterization|C0018795|33027|MH|||RC
9323766|Catheterization, Peripheral|C0007436|26074|MH|||RC
9323766|Popliteal Artery|C0032649|25727|MH|||RC
9323766|Ultrasonography, Interventional|C0206521|15125|MH|||RC
9323766|Hemostatic Techniques|C0019119|13999|MH|||RC
9323766|Ultrasonography, Doppler, Duplex|C0242845|11049|MH|||RC
9323766|Ultrasonography, Doppler, Color|C0242844|10253|MH|||RC
9323766|Brachial Artery|C0006087|6007|MH|||RC
9323766|Transducer|C0040661|5725|ET|Entry Term Replacement for "Transducers";RtM via: Transducers|AB|MM;RC
9323766|Coronary Angiography|C0085532|5032|MH|||RC
------
9323766|ultrasonography|C0175676|39381|SH1|RtM via: Ultrasonography;RtM via: Ultrasonic;ultrasonography (C0175676);RtM via: ultrasound device;Ultrasonography (C0041618);RtM via: ultrasound device;ultrasonography (C0175676)|TI;AB|MM;RC
9323766|instrumentation|C0021632|1956|SH1|RtM via: Guide device;instrumentation (C0021632)|TI;AB|MM
9323766|surgery|C0038895|1899|SH1|RtM via: Surgical repair;Surgical Procedures, Operative (C0543467);RtM via: Repair - Remedial Action;Surgical Procedures, Operative (C0543467);RtM via: Compression procedure;Surgical Procedures, Operative (C0543467);RtM via: Surgical aspects;surgery (C0038895);RtM via: Operative Surgical Procedures;Surgical Procedures, Operative (C0543467);RtM via: Application procedure;Surgical Procedures, Operative (C0543467)|TI;AB|MM
9323766|methods|C0025664|2245|SH1|RtM via: Methodology;methods (C0025664)|AB|MM
9323766|drug therapy|C0013217|9999|SH|new SH add rule - Injections, Intra-Arterial [E02.319.267.530.370] (E02.319)||MM
9323766|radiography|C0034571|1111|SH|E01.370.350.700.060.200 (Coronary Angiography)||MM
9300992|Common Carotid Artery|C0162859|130878|ET|Entry Term Replacement for "Carotid Artery, Common";RtM via: Common carotid artery;RtM via: Entire common carotid artery|AB|MM;RC
9300992|Tunica Media|C0162867|101724|MH|||RC
9300992|*Arteries|C0003842|91755|MH|RtM via: Arteries;RtM via: Arterial|TI;AB|MM;RC
9300992|ECHO protocol|C0058928|88393|NM|RtM via: ECHO protocol|TI;AB|MM
9300992|*Cyclophosphamide|C0010583|59172|HM|RtM via: ECHO protocol|TI;AB|MM
9300992|*Etoposide|C0015133|57609|HM|RtM via: ECHO protocol|TI;AB|MM
9300992|Tunica Intima|C0162864|52800|MH|||RC
9300992|Carotid Arteries|C0007272|47711|MH|RtM via: CAROTID ARTERY DISTENTION|AB|MM;RC
9300992|*Doxorubicin|C0013089|46200|HM|RtM via: ECHO protocol|TI;AB|MM
9300992|Signal Processing, Computer-Assisted|C0037082|20676|MH|||RC
9300992|Algorithms|C0002045|18299|MH|||RC
9300992|Artificial Intelligence|C0003916|12135|MH|||RC
9300992|Pattern Recognition, Automated|C1448473|11149|MH|||RC
9300992|Elasticity|C0013764|10018|MH|||RC
9300992|Image Processing, Computer-Assisted|C0020911|9658|MH|||RC
9300992|Image Interpretation, Computer-Assisted|C0020910|8959|MH|||RC
9300992|Blood Flow Velocity|C0005798|7286|MH|||RC
9300992|*Dilatation, Pathologic|C0012359|6933|MH|RtM via: Pathological Dilatation|TI;AB|MM
9300992|Image Enhancement|C0020909|6736|MH|||RC
9300992|Information Storage and Retrieval|C0021427|6242|MH|||RC
9300992|Carotid Artery Diseases|C0007273|5505|MH|||RC
9300992|Endothelium, Vascular|C0014261|3438|MH|||RC
9300992|Femoral Artery|C0015801|3030|MH|||RC
9300992|Time Factors|C0040225|2845|MH|||RC
9300992|Vasodilation|C0042401|2481|MH|||RC
9300992|Electrocardiography|C1623258|2436|MH|||RC
9300992|Blood Pressure|C0005823|2128|MH|||RC
9300992|Aorta, Thoracic|C1522460|1753|MH|||RC
9300992|Aging|C0001811|593|MH|||RC
9300992|Reference Values|C0034926|407|MH|||RC
9300992|Fourier Series|C0282182|368|ET|Entry Term Replacement for "Fourier Analysis";RtM via: Fourier Series|AB|MM
------
9300992|*Antineoplastic Combined Chemotherapy Protocols|C0003393|56499|HM|RtM via: ECHO protocol|TI;AB|MM
9300992|*Vincristine|C0042679|88392|HM|RtM via: ECHO protocol|TI;AB|MM
9300992|methods|C0025664|8505|SH1|RtM via: Methodology;methods (C0025664)|TI;AB|MM
9300992|ultrasonography|C0175676|3020|SH1|RtM via: Ultrasonic;ultrasonography (C0175676);RtM via: Ultrasonography;RtM via: ultrasound device;Ultrasonography (C0041618);RtM via: ultrasound device;ultrasonography (C0175676)|AB|MM;RC
9335407|*Nucleus Tractus Solitarius|C0175518|980733|ET|Entry Term Replacement for "Solitary Nucleus";RtM via: Nucleus solitarius;RtM via: Entire nucleus of tractus solitarius|TI;AB|MM;RC
9335407|*Endothelin-1|C0079281|328757|MH|RtM via: Endothelin-1;Forced Lookup:endothelin-1|TI;AB|MM;RC
9335407|Blood Pressure|C0005823|327921|MH|RtM via: Arterial pulse pressure;RtM via: Normal blood pressure|AB|MM;RC
9335407|Rats, Spontaneously Hypertensive|C0034705|285167|ET|Entry Term Replacement for "Rats, Inbred SHR";RtM via: Rats, Inbred SHR|AB|MM;RC
9335407|Rats, Wistar Kyoto|C0034709|264174|ET|Entry Term Replacement for "Rats, Inbred WKY";RtM via: Rats, Inbred WKY|AB|MM;RC
9335407|Baroreflex|C0206162|237391|MH|RtM via: Baroreflex|AB|MM;RC
9335407|*Endothelin|C0079284|234186|ET|Entry Term Replacement for "Endothelins";RtM via: Endothelin|TI;AB|MM;RC
9335407|Heart Rate|C0018810|204800|MH|RtM via: heart rate|AB|MM;RC
9335407|Hypertension|C0020538|147080|MH|RtM via: Hypertensive (finding)|AB|MM;RC
9335407|*Hemodynamic|C0019010|130023|ET|Entry Term Replacement for "Hemodynamics";RtM via: Hemodynamics|TI;AB|MM;RC
9335407|Rats, Sprague-Dawley|C0034715|102075|MH|RtM via: Rats, Sprague-Dawley;Forced Lookup:sprague-dawley rats|AB|MM;RC
9335407|alpha-Chloralose|C0008162|71288|ET|Entry Term Replacement for "Chloralose";RtM via: Chloralose;Forced Lookup:alpha-chloralose|AB|MM
9335407|Antihypertensive Agents|C0003364|39852|MH|||RC
9335407|Cardiovascular System|C0007226|35551|MH|RtM via: Cardiovascular.central|AB|MM;RC
9335407|Receptor, Endothelin A|C0217843|24361|MH|||RC
9335407|Microinjections|C0025991|23442|MH|RtM via: Microinjections|AB|MM;RC
9335407|Rats, Wistar|C0034716|21114|MH|||RC
9335407|Bradycardia|C0428977|18119|MH|RtM via: Bradycardia|AB|MM;RC
9335407|Sympathetic Nervous System|C0039044|13345|MH|||RC
9335407|Receptor, Endothelin B|C0218584|12987|MH|||RC
9335407|Hexamethonium|C0062637|8975|MH|RtM via: Hexamethonium|AB|MM;RC
9335407|Decerebrate State|C0011103|5468|MH|||RC
9335407|Synaptic Transmission|C0027793|5028|MH|||RC
9335407|Neurons|C0027882|4666|MH|||RC
9335407|Injections, Intraventricular|C0021495|4423|MH|||RC
9335407|Brain|C0006104|4278|MH|||RC
9335407|Carrier Proteins|C0007292|3534|MH|RtM via: receptor|AB|MM;RC
9335407|Melanins|C0025196|3372|MH|||RC
9335407|Peptide Fragments|C0030935|3169|MH|||RC
9335407|Splanchnic Nerves|C0037991|3081|MH|||RC
9335407|Signal Transduction|C0037083|2478|MH|||RC
9335407|Adenosine|C0001443|2297|MH|||RC
9335407|Electric Stimulation|C0013786|1251|MH|||RC
9335407|Disease Models, Animal|C0012644|1234|MH|||RC
9335407|Hormone Antagonists|C0019927|1230|MH|||RC
9335407|Succinates|C0038617|1078|MH|||RC
9335407|Proto-Oncogene Proteins c-jun|C0085296|1001|MH|||RC
9335407|Drug Administration Schedule|C0013154|985|MH|||RC
9335407|Reflex|C0034929|514|MH|RtM via: Reflex action|AB|MM
9335407|Electrochemistry|C0013803|338|MH|||RC
9335407|Dose-Response Relationship, Drug|C0013059|267|MH|||RC
9335407|Time Factors|C0040225|247|MH|||RC
9335407|Urethan|C0041964|225|ET|Entry Term Replacement for "Urethane";RtM via: Urethane|AB|MM
------
9335407|Rats|C0034721|127752|CT||TI;AB|MM
9335407|Animals|C0003062|1000|CT|Rats, Spontaneously Hypertensive;Rats, Wistar Kyoto;Rats, Sprague-Dawley;Disease Models, Animal;CT Text Lookup: rat;CT Text Lookup: spontaneously hypertensive rat;CT Text Lookup: spontaneously hypertensive rats;CT Text Lookup: sprague-dawley rats;CT Text Lookup: wky rat;CT Text Lookup: wky rats|AB;CT Text Lookup: rat;CT Text Lookup: spontaneously hypertensive rat;CT Text Lookup: spontaneously hypertensive rats;CT Text Lookup: sprague-dawley rats;CT Text Lookup: wky rat;CT Text Lookup: wky rats|MM;RC
9335407|antagonists & inhibitors|C0003139|5442|SH1|RtM via: antagonists;antagonists & inhibitors (C0003139)|TI;AB|MM
9378510|*Carbon Tetrachloride Poisoning|C0392622|1539102|MH|RtM via: Carbon tetrachloride, homeopathic preparation|TI|MM;RC
9378510|*Carbon Tetrachloride|C0007022|237336|MH|RtM via: Carbon Tetrachloride;RtM via: Carbon tetrachloride, homeopathic preparation|TI|MM
9378510|Liver|C0023884|57199|MH|RtM via: Liver;RtM via: Entire liver;RtM via: Liver Flavor;RtM via: Hepatic|AB|MM;RC
9378510|*Parathyroidectomy|C0079989|22302|MH|RtM via: Parathyroidectomy|TI;AB|MM;RC
9378510|Hepatic Cells|C0227525|16643|ET|Entry Term Replacement for "Hepatocytes";RtM via: Hepatocyte|AB|MM;RC
9378510|Drug-Induced Liver Injury|C0860207|12638|MH|||RC
9378510|Necrosis|C0027540|12563|MH|RtM via: Necrosis;RtM via: Focal necrosis|AB|MM;RC
9378510|Rats, Wistar|C0034716|8652|MH|||RC
9378510|Microsomes, Liver|C0026030|6955|MH|||RC
9378510|Antioxidants|C0003402|6910|MH|||RC
9378510|Cirrhosis|C1623038|5214|ET|Entry Term Replacement for "Fibrosis";RtM via: Cirrhosis|AB|MM;RC
9378510|Plant Extracts|C0032081|3247|MH|||RC
9378510|Rats, Inbred WKY|C0034709|2755|MH|||RC
9378510|Organ Size|C1450569|2700|MH|||RC
9378510|Propanols|C0175804|2496|MH|||RC
9378510|Mice, Inbred BALB C|C0025919|949|MH|||RC
9378510|Kinetics|C0022702|920|MH|||RC
9378510|Calcium|C0006675|917|MH|||RC
9378510|Immunosuppressive Agents|C0021081|903|MH|||RC
9378510|Medroxyprogesterone Acetate|C0065864|833|MH|||RC
9378510|Histocytochemistry|C0019635|731|MH|||RC
9378510|Liver Cirrhosis|C0023890|672|MH|RtM via: Liver Cirrhosis|AB|MM
9378510|Dose-Response Relationship, Drug|C0013059|644|MH|||RC
9378510|Macaca mulatta|C0024400|219|MH|||RC
9378510|Cell Nucleus|C0007610|218|MH|RtM via: Cell Nucleus|AB|MM
------
9378510|Rats|C0034721|24384|CT||TI;AB|MM
9378510|Animals|C0003062|1000|CT|Rats, Wistar;Rats, Inbred WKY;Mice, Inbred BALB C;Macaca mulatta;CT Text Lookup: rat;CT Text Lookup: reticulum|CT Text Lookup: rat;CT Text Lookup: reticulum|MM;RC
9378510|Mice|C0026809|1000|CT|Mice, Inbred BALB C||RC
9378510|methods|C0025664|29|SH|Methods|AB|MM
9378510|surgery|C0038895|1111|SH|E04.270.694 (Parathyroidectomy)|TI;AB|MM
9335288|*Rhizobium meliloti|C0085474|1228002|ET|Entry Term Replacement for "Sinorhizobium meliloti";RtM via: Sinorhizobium meliloti|TI;AB|MM;RC
9335288|*Operon|C0029073|611814|MH|RtM via: Operon|TI;AB|MM;RC
9335288|Flagella|C0016192|388355|MH|RtM via: Flagella|AB|MM;RC
9335288|Gene Expression Regulation, Bacterial|C0017264|59155|MH|||RC
9335288|Bacterial Proteins|C0004627|50073|MH|||RC
9335288|Molecular Motor Proteins|C1720835|46384|MH|||RC
9335288|*Movement|C0026649|45252|MH|RtM via: Speed (motion)|TI;AB|MM;RC
9335288|Escherichia coli|C0014834|38576|MH|RtM via: Escherichia coli|AB|MM;RC
9335288|Periplasm|C0525009|35920|MH|RtM via: periplasm|AB|MM;RC
9335288|Molecular Sequence Data|C0026382|27507|MH|||RC
9335288|Amino Acid Sequence|C0002518|27367|MH|||RC
9335288|Membrane Proteins|C0025252|14247|MH|||RC
9335288|Sequence Deletion|C0162773|13213|MH|RtM via: Deletion Mutation;RtM via: Deletion (action)|AB|MM;RC
9335288|Base Sequence|C0004793|12856|MH|RtM via: Base Sequence;RtM via: DNA Sequence|AB|MM;RC
9335288|Genes, Bacterial|C0017339|10936|MH|||RC
9335288|Genetic Complementation Test|C0017381|10731|MH|||RC
9335288|RNA, Bacterial|C0035692|7820|MH|||RC
9335288|Amino Acid Substitution|C0525038|5843|MH|||RC
9335288|Protein Structure, Tertiary|C0162808|5479|MH|||RC
9335288|Repressor Proteins|C0035147|5223|MH|||RC
9335288|Sequence Homology, Amino Acid|C0162777|4889|MH|||RC
9335288|Models, Biological|C0026339|4443|MH|||RC
9335288|Mutation|C0026882|4434|MH|||RC
9335288|Rotation|C0035868|4349|MH|RtM via: Musculoskeletal rotation|AB|MM;RC
9335288|Mutagenesis, Site-Directed|C0079870|4177|MH|||RC
9335288|Binding Sites|C0005456|2947|MH|||RC
9335288|Bacillus subtilis|C0004595|2841|MH|RtM via: Bacillus subtilis|AB|MM
9335288|Sequence Alignment|C0080143|2792|MH|||RC
9335288|Signal Transduction|C0037083|2556|MH|||RC
9335288|Gene Deletion|C0017260|2530|MH|||RC
9335288|Cell Fractionation|C0007593|2370|MH|||RC
9335288|Recombinant Fusion Proteins|C0034857|1988|MH|||RC
9335288|Phenotype|C0031437|1815|MH|||RC
9335288|Static Electricity|C0337036|1111|MH|||RC
9335288|Dimerization|C0376525|1039|MH|||RC
9335288|Mutagenesis, Insertional|C0079868|975|MH|RtM via: Insertion Mutation|AB|MM
9335288|Peptide Fragments|C0030935|757|MH|||RC
9335288|Sequence, Signal|C0037081|668|ET|Entry Term Replacement for "Protein Sorting Signals";RtM via: Signal Peptides|AB|MM
9335288|Cell Count|C0007584|564|MH|||RC
9335288|Swimming|C0039003|343|MH|RtM via: Swimming|AB|MM
------
9335288|genetics|C0017399|1111|SH|G05.360.340.024.686 (Operon)|TI;AB|MM
9350135|*Zea mays|C0010028|516048|MH|RtM via: Maize;RtM via: Zea mays|TI;AB|MM;RC
9350135|Chromosome Mapping|C0008630|54083|MH|||RC
9350135|Chromosomes, Plant|C1135923|52252|MH|||RC
9350135|Genome, Plant|C0242965|34986|MH|||RC
9350135|Genes|C0017337|28138|MH|RtM via: Genes|AB|MM;RC
9350135|Centromere|C0007709|25150|MH|RtM via: Centromere|AB|MM;RC
9350135|Genes, Plant|C0162728|22752|MH|||RC
9350135|Chromosome|C0008633|21587|ET|Entry Term Replacement for "Chromosomes";RtM via: Chromosomes|AB|MM;RC
9350135|In Situ Hybridization, Fluorescence|C0162789|20651|MH|||RC
9350135|Chromosomes, Artificial, Bacterial|C0887889|16681|MH|||RC
9350135|Karyotyping|C0022526|11900|MH|||RC
9350135|Cloning, Molecular|C0009017|9898|MH|||RC
9350135|Coix|C0997159|9317|MH|||RC
9350135|Plants, Genetically Modified|C0950153|8917|MH|||RC
9350135|Molecular Sequence Data|C0026382|7475|MH|||RC
9350135|Plant Proteins|C0032089|6411|MH|||RC
9350135|In Situ Hybridization|C0162788|6348|MH|||RC
9350135|Gene Expression Regulation, Plant|C0242717|5311|MH|||RC
9350135|Genes, Recessive|C0017361|4266|MH|||RC
9350135|Nucleolus Organizer Region|C0028609|3921|MH|||RC
9350135|Saccharomyces cerevisiae Proteins|C0949987|2852|MH|||RC
9350135|Saccharomyces cerevisiae|C0036025|2818|MH|||RC
9350135|Multigene Family|C0017363|2715|MH|||RC
9350135|Phenotype|C0031437|2699|MH|||RC
9350135|Amino Acid Sequence|C0002518|2392|MH|||RC
9350135|Genetic Complementation Test|C0017381|2265|MH|||RC
9350135|RNA, Messenger|C0035696|2129|MH|||RC
9350135|Cold Temperature|C0009264|1065|MH|||RC
9350135|Flow Cytometry|C0016263|918|MH|||RC
9350135|Sequence Homology, Amino Acid|C0162777|902|MH|||RC
9350135|Gene Expression Regulation, Enzymologic|C0017265|768|MH|||RC
9350135|Chromosome 4|C0008667|750|ET|Entry Term Replacement for "Chromosomes, Human, Pair 4";RtM via: Chromosomes, Human, Pair 4|AB|MM
9350135|cDNA|C0006556|472|ET|Entry Term Replacement for "DNA, Complementary";RtM via: DNA, Complementary|AB|MM
9350135|Glycogen Synthase Kinase 3|C0244989|247|MH|||RC
------
9350135|Humans|C0086418|1000|CT|Chromosome 4|AB|MM
9350135|methods|C0025664|0|SH|Methods|AB|MM
9350135|genetics|C0017399|1111|SH|G05.360.162.560 (Chromosomes, Plant)||MM
9306444|*Hallucinations, Visual|C0233763|463302|ET|Entry Term Replacement for "Hallucinations";RtM via: Hallucinations, Visual|TI;AB|MM;RC
9306444|Vision, Low|C0042798|19687|MH|RtM via: Visual phenomena|AB|MM;RC
9306444|Eye Evisceration|C0162662|13656|MH|||RC
9306444|Eye|C0015392|13369|MH|Forced Lookup:ocular||MM
9306444|Visual Fields|C0042826|10497|MH|||RC
9306444|Syndrome|C0039082|9093|MH|||RC
9306444|Visual Acuity|C0042812|8709|MH|||RC
9306444|Eye Enucleation|C0015400|7884|MH|||RC
9306444|Cognition|C0009240|2914|MH|||RC
9306444|Sensory Deprivation|C0036674|2219|MH|||RC
9306444|Neurosurgical Procedures|C0524850|1412|MH|||RC
9306444|Visual Pathways|C0042829|1389|MH|||RC
9306444|Functional Laterality|C1720777|1286|MH|||RC
9306444|Questionnaires|C0034394|983|MH|||RC
------
9306444|Female|C0015780|1000|CT|CT Text Lookup: female|CT Text Lookup: female|MM
9306444|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9306444|surgery|C0038895|1111|SH1|RtM via: Enucleation procedure;Surgical Procedures, Operative (C0543467);RtM via: Surgical aspects;surgery (C0038895);RtM via: Operative Surgical Procedures;Surgical Procedures, Operative (C0543467)|TI;AB|MM
9306444|methods|C0025664|6|SH|Methods|AB|MM
9347706|Hospice Care|C0085555|185919|MH|RtM via: Hospice Care|AB|MM;RC
9347706|*Death|C0011065|175992|MH|RtM via: Cessation of life|TI;AB|MM;RC
9347706|Palliative Care|C0030231|168214|MH|RtM via: Palliative Care|AB|MM;RC
9347706|Terminal Care|C0039548|151848|MH|||RC
9347706|Attitude to Death|C0004274|35260|MH|||RC
9347706|Physician's Role|C0031829|31833|MH|||RC
9347706|Physician-Patient Relations|C0031830|30535|MH|||RC
9347706|Communication|C0009452|28291|MH|RtM via: Conversation|AB|MM;RC
9347706|Withholding Treatment|C0871549|27895|MH|||RC
9347706|Ethics, Medical|C0015004|21735|MH|||RC
9347706|Patient Rights|C0030706|21233|MH|RtM via: Dignity|AB|MM;RC
9347706|Home Care Services|C0019855|14610|MH|||RC
9347706|Decision Making|C0011109|10929|MH|RtM via: Decision Making|AB|MM;RC
9347706|Professional-Family Relations|C0033289|9757|MH|||RC
9347706|Informed Consent|C0021430|7924|MH|||RC
9347706|Religion and Medicine|C0035041|6500|MH|||RC
9347706|Clinical Competence|C0008956|6377|MH|||RC
9347706|Catholicism|C0007444|6122|MH|||RC
9347706|Nursing Homes|C0028688|6000|MH|||RC
9347706|Hospitals, Religious|C0035047|5869|MH|||RC
9347706|Moral Obligations|C0026528|5455|MH|||RC
9347706|Medical Staff, Hospital|C0025109|5194|MH|||RC
9347706|Attitude of Health Personnel|C0004272|4716|MH|||RC
9347706|Quality of Health Care|C0034379|4703|MH|||RC
9347706|Internship and Residency|C0021794|4477|MH|||RC
9347706|Confidentiality|C0009669|4225|MH|||RC
9347706|Narration|C1135957|3932|MH|||RC
9347706|Health Services for the Aged|C0018753|3821|MH|||RC
9347706|Patient Satisfaction|C0030702|3738|MH|||RC
9347706|Education, Medical, Continuing|C0013632|3690|MH|||RC
9347706|Social Values|C0037439|3500|MH|||RC
9347706|Malpractice|C0024650|3214|MH|||RC
9347706|Patient Care Team|C0030679|3032|MH|||RC
9347706|Social Support|C0037438|2924|MH|||RC
9347706|Organizational Policy|C0079945|2625|MH|||RC
9347706|Health Care Surveys|C0376688|2591|MH|||RC
9347706|Suffering|C0683278|2428|ET|Entry Term Replacement for "Stress, Psychological";RtM via: Mental Suffering|AB|MM;RC
9347706|Socioeconomic Factors|C0037464|2280|MH|||RC
9347706|Health Services Accessibility|C0018748|2255|MH|||RC
9347706|Organizational Culture|C0029242|2244|MH|||RC
9347706|Health Policy|C0018735|2219|MH|||RC
9347706|Patient Compliance|C1321605|2103|MH|||RC
9347706|Academic Medical Centers|C0000872|1955|MH|||RC
9347706|Leadership|C0023181|1952|MH|||RC
9347706|Government Regulation|C0034982|1830|MH|||RC
9347706|*Life Cycle Stages|C0023675|1713|MH|RtM via: Dying Process|TI;AB|MM
9347706|Housing|C0020056|917|MH|||RC
9347706|Risk Assessment|C0086930|789|MH|||RC
9347706|Physicians|C0031831|496|MH|RtM via: Physicians|AB|MM
9347706|Uncertainty|C0087130|344|MH|RtM via: Uncertainty|AB|MM
------
9347706|Humans|C0086418|1000|CT|Hospice Care;Palliative Care;Terminal Care;Withholding Treatment;Home Care Services;Health Services for the Aged;CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|AB;CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|MM;RC
9347706|Aged|C0001792|1000|CT|Health Services for the Aged||RC
9347706|Animals|C0003062|1000|CT|Life Cycle Stages|TI;AB|MM
9347706|injuries|C1510467|1890|SH|Wounds and Injuries|TI;AB|MM
9347706|ethics|C1527243|1111|SH|K01.316.333.132.750 (Ethics, Medical)||MM
9376763|*Cholinesterase Reactivators|C0008428|411540|MH|RtM via: Cholinesterase Reactivators|TI;AB|MM;RC
9376763|*Cholinolytics|C0242897|176538|ET|Entry Term Replacement for "Cholinergic Antagonists";RtM via: Cholinergic Antagonists|TI;AB|MM;RC
9376763|*Drug Interactions|C0687133|31455|MH|RtM via: Pharmacokinetic interaction|TI|MM;RC
9376763|Chlorofos|C0040898|30605|ET|Entry Term Replacement for "Trichlorfon";RtM via: Trichlorfon|AB|MM;RC
9376763|*Brain|C0006104|24177|MH|RtM via: Brain tissue;RtM via: Entire brain|TI;AB|MM;RC
9376763|Cholinesterase Inhibitors|C0008425|9555|MH|||RC
9376763|Muscarine|C0026814|7164|MH|RtM via: Muscarine|AB|MM;RC
9376763|N-Methylscopolamine|C0301374|7045|MH|||RC
9376763|Radioligand Assay|C0034596|5899|MH|RtM via: Radioligand Assay|AB|MM;RC
9376763|Receptors, Cholinergic|C0034792|5061|MH|||RC
9376763|Antidotes|C0003295|4553|MH|||RC
9376763|Insecticides|C0021576|4007|MH|||RC
9376763|LD50|C0023378|3413|ET|Entry Term Replacement for "Lethal Dose 50";RtM via: Lethal Dose 50|AB|MM;RC
9376763|Carbon Radioisotopes|C0007021|3267|MH|||RC
9376763|Binding, Competitive|C0005458|2980|MH|||RC
9376763|Organophosphorus Compounds|C0029254|2685|MH|||RC
9376763|Dose-Response Relationship, Drug|C0013059|2459|MH|||RC
9376763|Kinetics|C0022702|1833|MH|||RC
9376763|Rats, Wistar|C0034716|1707|MH|||RC
9376763|Binding Sites|C0005456|1637|MH|RtM via: Binding Sites|AB|MM;RC
9376763|Tissue Distribution|C0040287|1338|MH|||RC
9376763|Presynaptic Terminals|C0206181|1010|MH|||RC
9376763|Drug Synergism|C0013215|888|MH|||RC
9376763|Hyperbaric Oxygenation|C0020431|855|MH|||RC
9376763|Rats, Sprague-Dawley|C0034715|827|MH|||RC
9376763|Protein Binding|C0033618|808|MH|||RC
9376763|Stereoisomerism|C0038265|559|MH|||RC
9376763|Injections, Intramuscular|C0021492|392|MH|||RC
9376763|Chromatography, High Pressure Liquid|C0008562|380|MH|||RC
9376763|Time Factors|C0040225|379|MH|||RC
9376763|Molecular Structure|C0026383|373|MH|||RC
9376763|Antioxidants|C0003402|365|MH|||RC
9376763|Species Specificity|C0037783|296|MH|||RC
9376763|Swimming|C0039003|296|MH|||RC
9376763|Potassium|C0032821|295|MH|||RC
9376763|Calcium Channel Blockers|C0006684|280|MH|||RC
9376763|Physical Exertion|C0031807|280|MH|||RC
9376763|Drug Evaluation, Preclinical|C0013206|270|MH|||RC
9376763|Area Under Curve|C0376690|267|MH|||RC
9376763|Drug Administration Schedule|C0013154|266|MH|||RC
9376763|Vasodilation|C0042401|249|MH|||RC
9376763|aprofen|C0052232|203|NM|RtM via: aprofen|AB|MM
------
9376763|Phenylpropionates|C0031497|202|HM|RtM via: aprofen|AB|MM
9376763|Animals|C0003062|1000|CT|Rats, Wistar;Rats, Sprague-Dawley;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9376763|Rats|C0034721|1000|CT|Rats, Wistar;Rats, Sprague-Dawley;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9376763|poisoning|C0032344|3296|SH1|RtM via: Intoxication;Poisoning (C0032343)|AB|MM;RC
9376763|pharmacokinetics|C0031328|1266|SH1|RtM via: Binding aspects;pharmacokinetics (C0031328);RtM via: absorption characteristics;pharmacokinetics (C0031328)|TI;AB|MM
9376763|metabolism|C0025520|984|SH1|RtM via: Binding action;Metabolism (C0025519);RtM via: Binding action;metabolism (C0025520)|TI;AB|MM
9263063|*Diet|C0012155|402186|MH|RtM via: Diet|TI;AB|MM;RC
9263063|*Meat|C0025017|328188|MH|RtM via: Meat|TI;AB|MM;RC
9263063|Animal Feed|C0003050|154090|MH|||RC
9263063|Animal Nutritional Physiological Phenomena|C1720746|129189|MH|||RC
9263063|Digestion|C0012238|122673|MH|||RC
9263063|Energy Intake|C0006777|53227|MH|RtM via: Energy Intake;RtM via: % energy intake|AB|MM;RC
9263063|Dietary Proteins|C0012177|46074|MH|||RC
9263063|Dietary Supplements|C0242295|44389|MH|||RC
9263063|Phosphorus|C0031705|36708|MH|RtM via: Phosphorus;RtM via: Phosphorus, homeopathic preparation|AB|MM;RC
9263063|beta Carotene|C0053396|35732|MH|RtM via: Beta Carotene;Forced Lookup:beta-carotene|AB|MM
9263063|Swine|C0039005|29819|MH|||RC
9263063|Calcium|C0006675|21695|MH|RtM via: Calcium|AB|MM;RC
9263063|Eating|C0013470|17669|MH|||RC
9263063|Nutritive Value|C0028722|12034|MH|||RC
9263063|Dietary Carbohydrates|C0012170|11426|MH|||RC
9263063|Endo-1,4-beta Xylanases|C0059102|10848|MH|||RC
9263063|retinol palmitate|C0073115|10492|NM|RtM via: retinyl palmitate|AB|MM
9263063|Vitamin A|C0042839|10491|MH|RtM via: All-Trans-Retinol;RtM via: Vitamin A;RtM via: retinyl palmitate|AB|MM;RC
9263063|Dietary Fats|C0012171|9628|MH|||RC
9263063|Food Irradiation|C0016474|8413|MH|||RC
9263063|Chickens|C0008051|8038|MH|||RC
9263063|Glutens|C0017842|6376|MH|||RC
9263063|*Sand|C0037098|5865|ET|Entry Term Replacement for "Silicon Dioxide";RtM via: Silicon Dioxide|TI;AB|MM
9263063|Taurine|C0039350|4761|MH|RtM via: Taurine|AB|MM;RC
9263063|Energy Metabolism|C0014272|4035|MH|||RC
9263063|Colony Count, Microbial|C0009380|2791|MH|||RC
9263063|Clostridium perfringens|C0009063|2725|MH|||RC
9263063|Blood Glucose|C0005802|2305|MH|||RC
9263063|Animals, Zoo|C0003071|2186|MH|||RC
9263063|alpha-Amylases|C0002245|2043|MH|||RC
9263063|Phosphorus, Dietary|C0080014|2036|MH|RtM via: Dietary Phosphorus|AB|MM
9263063|Bone Density|C0005938|1237|MH|||RC
9263063|Calcium, Dietary|C0006726|566|MH|RtM via: Calcium, Dietary|AB|MM
------
9263063|Cats|C0007450|1861|CT||AB|MM
9263063|Animals|C0003062|1000|CT|Animal Nutritional Physiological Phenomena;Swine;Chickens;Animals, Zoo;CT Text Lookup: cat;CT Text Lookup: felis|CT Text Lookup: cat;CT Text Lookup: felis|MM;RC
9263063|utilization|C0042153|2091|SH1|RtM via: utilization qualifier|TI;AB|MM
9263063|urine|C0042037|310|SH1|Urine (C0042036)||RC
9311427|Motor Skills|C0026612|97241|MH|||RC
9311427|Hand|C0018563|67429|MH|RtM via: Hand;RtM via: Entire hand|AB|MM;RC
9311427|Psychomotor Performance|C0033923|63512|MH|||RC
9311427|Child Development|C0008071|47605|MH|||RC
9311427|Developmental Disabilities|C0008073|27061|MH|||RC
9311427|Functional Laterality|C1720777|25376|MH|||RC
9311427|Hand Strength|C0242959|14102|MH|||RC
9311427|Proprioception|C0033499|7210|MH|||RC
9311427|Posture|C1262869|5595|MH|||RC
9311427|Autistic Disorder|C0004352|5445|MH|||RC
9311427|Age Factors|C0001783|4988|MH|||RC
9311427|Touch|C0702221|4910|MH|||RC
9311427|Sex Factors|C0036881|4213|MH|||RC
9311427|Cognition|C0009240|3150|MH|||RC
9311427|Aging|C0001811|2501|MH|||RC
9311427|Reference Values|C0034926|2478|MH|||RC
9311427|Extremities|C0015385|1405|MH|||RC
9311427|*Musculoskeletal Manipulations|C0949741|1218|MH|RtM via: Hand manipulation|TI;AB|MM
9311427|Time Factors|C0040225|607|MH|||RC
9311427|Interpersonal Relations|C0021797|551|MH|||RC
9311427|Self Care|C0036592|233|MH|||RC
------
9311427|Humans|C0086418|1000|CT|Child Development;Self Care;CT Text Lookup: child;CT Text Lookup: children|CT Text Lookup: children|MM;RC
9311427|Child|C0008059|1000|CT|Developmental Disabilities;CT Text Lookup: child;CT Text Lookup: children|CT Text Lookup: children|MM;RC
9311427|methods|C0025664|36|SH|Methods|AB|MM
9311427|therapy|C0039798|18|SH|Therapeutics|AB|MM
9323504|*Renal Dialysis|C0917873|953439|MH|RtM via: dialysis device|TI;AB|MM;RC
9323504|*Urea|C0041942|394857|MH|RtM via: Urea;RtM via: Blood Urea Nitrogen|TI;AB|MM;RC
9323504|Dialysis Solutions|C0011947|271779|MH|RtM via: Dialysis Solutions;RtM via: Dialysate - Specimen Source Codes|AB|MM;RC
9323504|Kidney Failure, Chronic|C0022661|120901|MH|||RC
9323504|Blood Urea Nitrogen|C0005845|63955|MH|RtM via: Blood urea nitrogen measurement|AB|MM;RC
9323504|*Kinetics|C0022702|45777|MH|RtM via: Kinetics|TI;AB|MM;RC
9323504|Arteriovenous Shunt, Surgical|C0684204|34403|MH|||RC
9323504|Kidney Failure, Acute|C0022660|21810|MH|||RC
9323504|Metabolic Clearance Rate|C0025515|6139|MH|||RC
9323504|Nutritional Status|C0392209|4649|MH|||RC
9323504|Time Factors|C0040225|4621|MH|||RC
9323504|Peritoneal Dialysis|C0031139|3963|MH|RtM via: peritoneal dialysate (treatment)|AB|MM
9323504|Dietary Proteins|C0012177|2906|MH|||RC
9323504|*Electrolytes|C0013832|2154|MH|RtM via: Dialysate sample|TI;AB|MM
9323504|Regional Blood Flow|C0034965|2127|MH|||RC
9323504|Therapy, Computer-Assisted|C0039799|1906|MH|||RC
9323504|Blood Flow Velocity|C0005798|1873|MH|||RC
9323504|Models, Biological|C0026339|1814|MH|||RC
9323504|Models, Cardiovascular|C0026340|1340|MH|||RC
9323504|Blood Vessel Prosthesis Implantation|C0525022|1223|MH|||RC
9323504|Treatment Outcome|C0085415|1183|MH|||RC
9323504|Algorithms|C0002045|1072|MH|||RC
9323504|Quality Control|C0034378|957|MH|||RC
9323504|Reference Standards|C0034925|893|MH|||RC
9323504|Specimen Handling|C0037793|766|MH|||RC
9323504|Age Factors|C0001783|445|MH|||RC
------
9323504|surgery|C0038895|1111|SH1|RtM via: Excision;Surgical Procedures, Operative (C0543467)|AB|MM
9344906|vpu protein, Human immunodeficiency virus 1|C0079409|2230007|NM|RtM via: vpu protein, Human immunodeficiency virus 1|AB|MM
9344906|Human Immunodeficiency Virus Proteins|C1955876|2230006|HM|RtM via: vpu protein, Human immunodeficiency virus 1|AB|MM;RC
9344906|Viral Regulatory and Accessory Proteins|C1955893|1336044|HM|RtM via: vpu protein, Human immunodeficiency virus 1|AB|MM;RC
9344906|gag Protein|C0017279|691101|ET|Entry Term Replacement for "Gene Products, gag";RtM via: Gene Products, gag|AB|MM;RC
9344906|*HIV-1|C0019704|676441|MH|RtM via: HIV-1;Forced Lookup:hiv-1|TI;AB|MM;RC
9344906|Virus Particle|C0042760|155216|ET|Entry Term Replacement for "Virion";RtM via: Virion|AB|MM;RC
9344906|gag Gene Products, Human Immunodeficiency Virus|C1955878|143913|MH|||RC
9344906|vif Gene Products, Human Immunodeficiency Virus|C0079529|110602|MH|||RC
9344906|vpr Gene Products, Human Immunodeficiency Virus|C1955890|69961|MH|||RC
9344906|nef Gene Products, Human Immunodeficiency Virus|C1739664|51382|MH|||RC
9344906|Virus Assembly|C0282629|46514|MH|||RC
9344906|env Gene Products, Human Immunodeficiency Virus|C1955877|45658|MH|||RC
9344906|Virus Replication|C0042774|34157|MH|||RC
9344906|*Proteins|C0033684|29118|MH|RtM via: Proteins;RtM via: Protein measurement|TI;AB|MM
9344906|Viral Proteins|C0042736|25737|MH|||RC
9344906|HIV Infections|C0019693|21476|MH|||RC
9344906|Hela Cells|C0018873|15488|MH|||RC
9344906|Genes, Viral|C0017376|15149|MH|RtM via: Genes, Viral|AB|MM;RC
9344906|Capsid Proteins|C1136102|10558|MH|||RC
9344906|Gene Expression Regulation, Viral|C0017269|9012|MH|||RC
9344906|Mutations|C0026882|8396|ET|Entry Term Replacement for "Mutation";RtM via: Mutation|AB|MM;RC
9344906|Reassortant Viruses|C0085391|8298|MH|||RC
9344906|Cell Line|C0007600|8061|MH|||RC
9344906|Viral Envelope Proteins|C0042711|7782|MH|||RC
9344906|Recombinant Fusion Proteins|C0034857|6288|MH|||RC
9344906|Endocytosis|C0014139|6136|MH|||RC
9344906|Amino Acid Sequence|C0002518|5092|MH|||RC
9344906|DNA Mutational Analysis|C0012878|3326|MH|RtM via: mutation analysis|AB|MM;RC
9344906|Protein Structure, Tertiary|C0162808|2968|MH|||RC
9344906|Microtubule-Associated Proteins|C0026045|2691|MH|||RC
9344906|Binding Sites|C0005456|2220|MH|||RC
9344906|Molecular Sequence Data|C0026382|1725|MH|||RC
9344906|Microscopy, Confocal|C0242842|767|MH|||RC
9344906|Species Specificity|C0037783|508|MH|||RC
9344906|Mutant Protein|C1564139|245|ET|Entry Term Replacement for "Mutant Proteins";RtM via: Mutant Proteins|AB|MM
------
9344906|Humans|C0086418|1000|CT|Hela Cells||RC
9344906|virology|C0205466|3369|SH1|RtM via: Viral;virology (C0205466)|TI;AB|MM
9344906|genetics|C0017399|1111|SH|G05.360.340.024.340.490 (Genes, Viral)|AB|MM
9267510|*Vitamine E|C2351020|333027|ET|Entry Term Replacement for "Tocopherols";RtM via: Vitamine E GNR;RtM via: Tocopherols|TI;AB|MM;RC
9267510|*Vitamin E|C0042874|261327|MH|RtM via: Vitamin E;RtM via: Serum vitamin E measurement|TI;AB|MM;RC
9267510|Placenta, Retained|C0242669|174842|MH|RtM via: Placenta, Retained|AB|MM;RC
9267510|alpha-Tocopherol|C0969677|82246|MH|RtM via: alpha Tocopherol;Forced Lookup:alpha-tocopherol|AB|MM;RC
9267510|Abomasum|C0000780|50512|MH|RtM via: Abomasum;RtM via: Entire abomasum|AB|MM;RC
9267510|Lactation|C0022925|27673|MH|RtM via: Lactation|AB|MM;RC
9267510|Cattle Diseases|C0007453|25227|MH|||RC
9267510|Ketosis|C0022638|23457|MH|RtM via: Acetonemia|AB|MM;RC
9267510|Mastitis, Bovine|C0024895|15405|MH|||RC
9267510|Parturition|C0005615|15171|MH|RtM via: Birth;RtM via: Childbirth|AB|MM;RC
9267510|Antioxidants|C0003402|8458|MH|||RC
9267510|Incidence|C0021149|7485|MH|RtM via: Incidence|AB|MM;RC
9267510|Placenta Diseases|C0032045|5108|MH|||RC
9267510|Obstetric Labor Complications|C0022865|4102|MH|||RC
9267510|Animal Nutritional Physiological Phenomena|C1720746|3738|MH|||RC
9267510|Dinoprost|C0012471|3267|MH|||RC
9267510|Animal Husbandry|C0003052|3235|MH|||RC
9267510|Oxytocics|C0030094|2148|MH|||RC
9267510|Prospective Study|C0033522|2042|ET|Entry Term Replacement for "Prospective Studies";RtM via: Prospective Studies|AB|MM;RC
9267510|Risk Factors|C0035648|1931|MH|||RC
9267510|Vitamin|C0042890|946|ET|Entry Term Replacement for "Vitamins";RtM via: Vitamins|AB|MM
9267510|Energy Metabolism|C0014272|943|MH|||RC
9267510|Mastitis|C0024894|938|MH|RtM via: mastitis|AB|MM
9267510|Calcium|C0006675|933|MH|||RC
9267510|Body Temperature|C0005903|904|MH|||RC
9267510|Contraceptive Agents, Female|C0009873|772|MH|||RC
9267510|Models, Biological|C0026339|636|MH|||RC
9267510|Injections, Intramuscular|C0021492|539|MH|||RC
9267510|Injections, Subcutaneous|C0021499|526|MH|||RC
9267510|Food, Fortified|C0016498|502|MH|||RC
9267510|Health Status|C0018759|494|MH|||RC
9267510|Abortifacient Agents, Nonsteroidal|C0000783|474|MH|||RC
9267510|Hypocalcemia|C0020598|292|MH|RtM via: Hypocalcemia|AB|MM
9267510|Treatment Outcome|C0085415|285|MH|||RC
9267510|Questionnaires|C0034394|213|MH|||RC
------
9267510|Cattle|C0007452|47793|CT||TI;AB|MM
9267510|Pregnancy|C0032961|1000|CT|Placenta, Retained;Placenta Diseases;Obstetric Labor Complications;CT Text Lookup: placenta|AB;CT Text Lookup: placenta|MM;RC
9267510|Female|C0015780|1000|CT|Placenta, Retained;Lactation;Mastitis, Bovine;Parturition;Placenta Diseases;Obstetric Labor Complications;Contraceptive Agents, Female;CT Text Lookup: lactation;CT Text Lookup: mastitis;CT Text Lookup: placenta|AB;CT Text Lookup: lactation;CT Text Lookup: mastitis;CT Text Lookup: placenta|MM;RC
9267510|Animals|C0003062|1000|CT|Abomasum;Cattle Diseases;Mastitis, Bovine;Animal Nutritional Physiological Phenomena;CT Text Lookup: abomasum;CT Text Lookup: animals;CT Text Lookup: cattle|AB;CT Text Lookup: abomasum;CT Text Lookup: animals;CT Text Lookup: cattle|MM;RC
9267510|Humans|C0086418|1000|CT|Mastitis|AB|MM
9267510|therapy|C0039798|792|SH|Therapeutics|TI;AB|MM
9267510|methods|C0025664|48|SH|Procedure|AB|MM
9377678|*Gastrectomy|C0017118|595410|MH|RtM via: Gastric resection;RtM via: Subtotal gastrectomy|TI;AB|MM;RC
9377678|*Peptic Ulcer|C0030920|549600|MH|RtM via: Peptic Ulcer|TI|MM;RC
9377678|Duodenal Ulcer|C0013295|415672|MH|RtM via: Duodenal Ulcer|AB|MM;RC
9377678|*Stomach|C0038351|283758|MH|RtM via: Stomach;RtM via: Gastric (qualifier value)|TI;AB|MM;RC
9377678|Vagotomy|C0394374|191906|MH|RtM via: Vagotomy|AB|MM;RC
9377678|Anastomosis, Surgical|C0002805|26111|MH|||RC
9377678|Gastroplasty|C0017193|11553|MH|||RC
9377678|Postoperative Complications|C0032787|8085|MH|||RC
9377678|Suture Techniques|C0038968|7539|MH|||RC
9377678|Treatment Outcome|C0085415|1534|MH|||RC
9377678|Age Factors|C0001783|1260|MH|||RC
9377678|Risk Factors|C0035648|376|MH|||RC
9377678|Time Factors|C0040225|282|MH|||RC
9377678|Decision Making|C0011109|102|MH|||RC
------
9377678|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9377678|surgery|C0038895|5442|SH1|RtM via: Excision;Surgical Procedures, Operative (C0543467);RtM via: Operative Surgical Procedures;Surgical Procedures, Operative (C0543467);RtM via: Surgical aspects;surgery (C0038895);RtM via: Anastomosis - action;Surgical Procedures, Operative (C0543467)|TI;AB|MM
9377678|complications|C1171258|1239|SH1|RtM via: Complication Aspects;complications (C1171258)|TI;AB|MM
9377678|diagnosis|C1704338|1146|SH1|RtM via: Complication;Diagnosis (C0011900)|TI;AB|MM
9322197|*Antibiotic Prophylaxis|C0282638|1432977|MH|RtM via: Antibiotic Prophylaxis|TI|MM;RC
9322197|*Bacterial Infections|C0004623|524277|MH|RtM via: Resistance to infection|TI|MM;RC
9322197|Neutropenia|C0027947|199243|MH|RtM via: Neutropenia|AB|MM;RC
9322197|Antibiotics|C0003232|169925|ET|Entry Term Replacement for "Anti-Bacterial Agents";RtM via: Antibiotics|AB|MM;RC
9322197|*Tumor|C0027651|145377|ET|Entry Term Replacement for "Neoplasms";RtM via: Neoplasm|TI|MM;RC
9322197|Fever|C0015967|94355|MH|RtM via: Fever|AB|MM;RC
9322197|Drug Therapy, Combination|C0013218|82757|MH|||RC
9322197|Surgical Wound Infection|C0038941|62114|MH|||RC
9322197|Bone Neoplasms|C0005967|14718|MH|RtM via: Malignant Bone Neoplasm|AB|MM;RC
9322197|Treatment Outcome|C0085415|9515|MH|||RC
9322197|Escherichia coli Infections|C0014836|8731|MH|||RC
9322197|Reconstructive Surgical Procedures|C0524865|7966|MH|RtM via: Bone reconstruction|AB|MM;RC
9322197|Chemotherapy, Adjuvant|C0085533|6770|MH|||RC
9322197|Postoperative Complications|C0032787|5510|MH|||RC
9322197|Administration, Oral|C0001563|4718|MH|||RC
9322197|Radiotherapy, Adjuvant|C0242939|4032|MH|||RC
9322197|Prognosis|C0033325|3872|MH|||RC
9322197|Surgical Flaps|C0038925|3478|MH|||RC
9322197|Risk Assessment|C0086930|3442|MH|||RC
9322197|Bone Transplantation|C0005976|3094|MH|||RC
9322197|Preoperative Care|C0033061|2961|MH|||RC
9322197|Skull Base Neoplasms|C0376527|2841|MH|||RC
9322197|Neoplasm Staging|C0027646|2829|MH|||RC
9322197|Lung Neoplasms|C0024121|2790|MH|||RC
9322197|Risk Factors|C0035648|2635|MH|||RC
9322197|Infusions, Intravenous|C0021440|2425|MH|||RC
9322197|Neurosurgical Procedures|C0524850|2306|MH|||RC
9322197|Cause of Death|C0007465|1787|MH|||RC
9322197|Outpatient Clinics, Hospital|C0029916|1082|MH|||RC
9322197|Patient Compliance|C1321605|869|MH|||RC
------
9322197|Humans|C0086418|1000|CT|Preoperative Care;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM;RC
9322197|drug therapy|C0013217|40158|SH1|RtM via: pharmacotherapeutic;drug therapy (C0013217);RtM via: Pharmacotherapy;Drug Therapy (C0013216);RtM via: Chemotherapy Regimen;Drug Therapy (C0013216);RtM via: Postoperative chemotherapy;Drug Therapy (C0013216)|TI;AB|MM
9322197|surgery|C0038895|1111|SH1|RtM via: Excision;Surgical Procedures, Operative (C0543467)|AB|MM
9322197|radiotherapy|C1522449|1111|SH|E02.815.600 (Radiotherapy, Adjuvant)||MM
9322197|transplantation|C0029216|1111|SH|E04.936.450.050 (Bone Transplantation)||MM
9299752|*Microsporum|C0026033|1875660|MH|RtM via: Microsporum gypseum|TI;AB|MM;RC
9299752|*Dermatophytosis|C0011636|1189104|ET|Entry Term Replacement for "Dermatomycoses";RtM via: Disseminated dermatophytosis;RtM via: Dermatophytosis;RtM via: Tinea corporis (disorder)|TI;AB|MM;RC
9299752|*Acquired Immunodeficiency Syndrome|C0001175|166404|MH|RtM via: Acquired Immunodeficiency Syndrome|TI;AB|MM;RC
9299752|Antifungal Agents|C0003308|28597|MH|||RC
9299752|AIDS-Related Opportunistic Infections|C0162526|18062|MH|||RC
9299752|Foot Dermatoses|C0016509|12849|MH|||RC
9299752|Candidiasis|C0006840|10939|MH|||RC
9299752|Skin|C1123023|8662|MH|||RC
9299752|Scalp Dermatoses|C0036271|3449|MH|||RC
9299752|Hand Dermatoses|C0018567|2883|MH|||RC
9299752|Drug Eruptions|C0011609|1381|MH|||RC
9299752|Treatment Outcome|C0085415|1364|MH|||RC
9299752|Cat Diseases|C0007350|1182|MH|||RC
9299752|HIV Infections|C0019693|761|MH|RtM via: HIV Infections|AB|MM
9299752|Dose-Response Relationship, Drug|C0013059|359|MH|||RC
9299752|Administration, Oral|C0001563|329|MH|||RC
9299752|Diagnosis, Differential|C0011906|250|MH|||RC
------
9299752|Brazil|C0006137|150|MH-S|RtM via: Brazil|AB|MM
9299752|Animals|C0003062|1000|CT|Cat Diseases||RC
9299752|Cats|C0007450|1000|CT|Cat Diseases||RC
9299752|Humans|C0086418|1000|CT|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|MM
9299752|etiology|C0015127|2250|SH1|RtM via: Etiology;Causality (C1314792);RtM via: Etiology aspects;etiology (C0015127)|TI;AB|MM
9299752|methods|C0025664|5|SH|Methods|AB|MM
9377115|*Astemizole|C0085170|1203669|MH|RtM via: Astemizole|TI;AB|MM;RC
9377115|*Pseudoephedrine|C0033798|669006|MH|RtM via: Pseudoephedrine;RtM via: CARBINOXAMINE/PSEUDOEPHEDRINE|TI;AB|MM;RC
9377115|*Serous Otitis Media|C0271453|108330|ET|Entry Term Replacement for "Otitis Media with Effusion";RtM via: Serous otitis media|TI;AB|MM;RC
9377115|Anti-Allergic Agents|C0282555|71892|MH|||RC
9377115|Rhinitis, Allergic, Perennial|C0035457|46297|MH|||RC
9377115|Rhinitis, Allergic, Seasonal|C0018621|37524|MH|||RC
9377115|carbinoxamine|C0054672|23287|NM|RtM via: CARBINOXAMINE/PSEUDOEPHEDRINE;RtM via: carbinoxamine|TI;AB|MM
9377115|*Pyridines|C0034255|23286|MH|RtM via: CARBINOXAMINE/PSEUDOEPHEDRINE;RtM via: carbinoxamine|TI;AB|MM
9377115|Bronchodilator Agents|C0006280|22994|MH|||RC
9377115|Hypersensitivity|C0020517|12023|MH|RtM via: Hypersensitivity|AB|MM;RC
9377115|Nasal Mucosa|C0027428|7528|MH|||RC
9377115|Drug Therapy, Combination|C0013218|6621|MH|||RC
9377115|Allergens|C0002092|5578|MH|||RC
9377115|Treatment Outcome|C0085415|2639|MH|||RC
9377115|*Epidemiologic Research Design|C0038500|2184|MH|RtM via: comparative study research|TI|MM
9377115|Administration, Intranasal|C0001560|1820|MH|||RC
9377115|Randomized Controlled Trials as Topic|C0282440|1818|MH|||RC
9377115|Dose-Response Relationship, Drug|C0013059|935|MH|||RC
9377115|Administration, Oral|C0001563|884|MH|||RC
9377115|Research|C0035168|797|MH|RtM via: Study|AB|MM;RC
9377115|Anti-Bacterial Agents|C0279516|536|MH|||RC
9377115|Blood Pressure|C0005823|377|MH|||RC
9377115|Severity of Illness Index|C0036859|260|MH|||RC
9377115|Time Factors|C0040225|255|MH|||RC
9377115|*Sex Characteristics|C0036866|252|MH|RtM via: comparative study research|TI|MM
9377115|Language Tests|C0023016|221|MH|||RC
------
9377115|Mexico|C0025885|4|MH-S|RtM via: Mexico|AB|MM
9377115|Child|C0008059|1000|CT|CT Text Lookup: child;CT Text Lookup: children|CT Text Lookup: children|MM
9377115|Humans|C0086418|1000|CT|CT Text Lookup: child;CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients|MM
9377115|Female|C0015780|1000|CT|CT Text Lookup: female|CT Text Lookup: female|MM
9377115|Male|C0024554|1000|CT|CT Text Lookup: male|CT Text Lookup: male|MM
9377115|methods|C0025664|13|SH|Methods|AB|MM
9377115|immunology|C1522005|1111|SH|D23.050.063 (Allergens)||MM
9379424|*Temporomandibular Joint|C0039493|1968030|MH|RtM via: Temporomandibular Joint;RtM via: Entire temporomandibular joint|TI;AB|MM;RC
9379424|*Synovial Membrane|C0039099|538815|MH|RtM via: Synovial Membrane|TI;AB|MM;RC
9379424|Temporomandibular Joint Disk|C0376491|439475|MH|||RC
9379424|Temporomandibular Joint Disorders|C0039494|235854|MH|||RC
9379424|Synovitis|C0039103|156107|MH|RtM via: Synovitis|AB|MM;RC
9379424|*Capillaries|C0006901|113268|MH|RtM via: Blood capillaries|TI;AB|MM;RC
9379424|Temporomandibular Joint Dysfunction Syndrome|C0039496|17284|MH|||RC
9379424|Arthroscopy|C0003904|7826|MH|||RC
9379424|Endothelium, Vascular|C0014261|6138|MH|||RC
9379424|von Willebrand Factor|C0042971|5259|MH|RtM via: von Willebrand Factor|AB|MM;RC
9379424|Microcirculation|C0025962|3265|MH|||RC
9379424|Hyperplasia|C0020507|2722|MH|RtM via: Hyperplasia|AB|MM;RC
9379424|In Situ Hybridization|C0162788|2623|MH|||RC
9379424|Antibodies, Monoclonal|C0003250|1852|MH|||RC
9379424|Neovascularization, Pathologic|C0027686|1766|MH|||RC
9379424|RNA, Messenger|C0035696|569|MH|||RC
9379424|Homeostasis|C0019868|442|MH|||RC
9379424|Lymph|C0024202|400|MH|RtM via: Lymph|AB|MM
9379424|Membrane Proteins|C0025252|313|MH|||RC
------
9379424|Humans|C0086418|1000|CT|CT Text Lookup: human|CT Text Lookup: human|MM
9379424|methods|C0025664|2|SH|Methods|AB|MM
9347012|*Apolipoprotein A1|C0085201|718071|ET|Entry Term Replacement for "Apolipoprotein A-I";RtM via: Apolipoprotein A-I|TI;AB|MM;RC
9347012|*Reference Values|C0034926|356907|MH|RtM via: Reference Values|TI;AB|MM;RC
9347012|*Standardization|C0038136|331578|ET|Entry Term Replacement for "Reference Standards";RtM via: Standardization|TI;AB|MM;RC
9347012|Calibration|C0006751|27877|MH|RtM via: Calibration;RtM via: CALIBRATOR (pharmalogic substance);RtM via: Calibrator Device Component;RtM via: Calibrators (device)|AB|MM;RC
9347012|Quality Control|C0034378|12594|MH|RtM via: quality control|AB|MM;RC
9347012|Drug Stability|C0013210|1456|MH|||RC
9347012|International Cooperation|C0021785|1309|MH|||RC
9347012|Nephelometry and Turbidimetry|C0027693|1288|MH|||RC
9347012|Freezing|C0016701|1257|MH|RtM via: Freezing|AB|MM;RC
9347012|Societies, Scientific|C0037463|793|MH|||RC
9347012|Time Factors|C0040225|631|MH|||RC
9347012|Temperature|C0039476|552|MH|||RC
9347012|Hot Temperature|C2350229|548|MH|||RC
9347012|Specimen Handling|C0037793|456|MH|||RC
9347012|Blood Preservation|C0005822|416|MH|||RC
------
9347012|Humans|C0086418|1000|CT|CT Text Lookup: men;CT Text Lookup: women|CT Text Lookup: men;CT Text Lookup: women|MM
9347012|Male|C0024554|1000|CT|CT Text Lookup: men|CT Text Lookup: men|MM
9347012|Female|C0015780|1000|CT|CT Text Lookup: women|CT Text Lookup: women|MM
9347012|methods|C0025664|263|SH|Methods|AB|MM
9347012|organization & administration|C0029236|51|SH|Organization and Administration|AB|MM
9347012|prevention & control|C0033107|8|SH|Preventive Medicine|AB|MM
9315328|*Selenoproteins|C0074302|536850|MH|RtM via: Selenoproteins|TI;AB|MM;RC
9315328|Electrophoresis, Polyacrylamide Gel|C0013862|74411|MH|RtM via: SDS-PAGE|AB|MM;RC
9315328|Molecular Weight|C0026385|60401|MH|RtM via: Molecular Mass|AB|MM;RC
9315328|Proteins|C0033684|45247|MH|RtM via: Proteins;RtM via: Protein measurement|AB|MM;RC
9315328|*Cell Nucleus|C0007610|40923|MH|RtM via: Cell Nucleus|TI;AB|MM;RC
9315328|*Spermatid|C0037857|35499|ET|Entry Term Replacement for "Spermatids";RtM via: Spermatid|TI;AB|MM
9315328|Glutathione Peroxidase|C0017822|21990|MH|RtM via: GLUTATHIONE PEROXIDASE|AB|MM;RC
9315328|Tissue Distribution|C0040287|13950|MH|||RC
9315328|Subcellular Fractions|C0038528|12403|MH|||RC
9315328|Cytosol|C1383501|10433|MH|RtM via: Cytoplasmic matrix|AB|MM;RC
9315328|Electrophoresis, Gel, Two-Dimensional|C0013860|8952|MH|||RC
9315328|*Epithelium|C0014609|8562|MH|RtM via: Epithelium of prostatic gland;RtM via: Prostatic epithelium|TI;AB|MM;RC
9315328|Testis|C0039597|8479|MH|RtM via: Testis;RtM via: Entire testis|AB|MM;RC
9315328|Electrophoresis|C0013855|8053|MH|RtM via: two-dimensional electrophoresis|AB|MM;RC
9315328|Prostate|C0033572|7296|MH|RtM via: Prostate;RtM via: Prostatic epithelium;RtM via: Prostatic secretions|AB|MM;RC
9315328|Cell Fractionation|C0007593|5354|MH|||RC
9315328|Rats, Wistar|C0034716|4392|MH|||RC
9315328|Iodide Peroxidase|C0021965|3200|MH|||RC
9315328|Mitochondria, Liver|C0026239|2149|MH|||RC
9315328|Selenocysteine|C0074289|1611|MH|RtM via: Selenocysteine|AB|MM
9315328|Microsomes, Liver|C0026030|1297|MH|||RC
9315328|Spectrometry, Fluorescence|C0037802|1148|MH|||RC
9315328|Chromatography, High Pressure Liquid|C0008562|658|MH|||RC
9315328|Gel Chromatography|C0008559|504|ET|Entry Term Replacement for "Chromatography, Gel";RtM via: Gel Chromatography|AB|MM
9315328|Scintillation Counting|C0036406|430|MH|||RC
9315328|Myocardium|C0027061|416|MH|||RC
9315328|Brain|C0006104|270|MH|||RC
------
9315328|Rats|C0034721|482|CT||AB|MM
9315328|Male|C0024554|1000|CT|Spermatid;Testis;Prostate;CT Text Lookup: prostate;CT Text Lookup: sperm maturation;CT Text Lookup: testis|TI;AB;CT Text Lookup: prostate;CT Text Lookup: sperm maturation;CT Text Lookup: testis|MM;RC
9315328|Animals|C0003062|1000|CT|Rats, Wistar;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9315328|methods|C0025664|37|SH|Methods|AB|MM
9341945|*Tongue|C0040408|75312|MH|RtM via: Tongue;RtM via: Fungiform papilla;RtM via: Entire tongue|TI;AB|MM;RC
9341945|Scanning Electron Microscopy|C0026020|28774|ET|Entry Term Replacement for "Microscopy, Electron, Scanning";RtM via: Scanning Electron Microscopy|AB|MM;RC
9341945|Capillary|C0006901|13368|ET|Entry Term Replacement for "Capillaries";RtM via: Blood capillaries;RtM via: Entire capillary blood vessel (organ)|AB|MM;RC
9341945|*Bullfrog|C0034651|13131|ET|Entry Term Replacement for "Rana catesbeiana";RtM via: Rana catesbeiana|TI;AB|MM
9341945|Microcirculation|C0025962|7331|MH|||RC
9341945|Taste|C0039336|1805|MH|||RC
9341945|Taste Buds|C0039337|1792|MH|RtM via: Papilla of tongue|AB|MM
9341945|Image Processing, Computer-Assisted|C0020911|1406|MH|||RC
9341945|Rats, Wistar|C0034716|1306|MH|||RC
9341945|Computer Graphics|C0009601|960|MH|||RC
9341945|Sex Characteristics|C0036866|439|MH|||RC
9341945|Species Specificity|C0037783|409|MH|||RC
9341945|Aging|C0001811|192|MH|||RC
9341945|Crosses, Genetic|C0010364|102|MH|||RC
------
9341945|Animals|C0003062|1000|CT|Bullfrog;Rats, Wistar|TI;AB|MM;RC
9341945|Rats|C0034721|1000|CT|Rats, Wistar||RC
9341945|classification|C0008903|2961|SH1|RtM via: Taxonomic;classification (C0008903)|TI;AB|MM
9341945|diagnosis|C1704338|453|SH1|RtM via: ENT surgical result tongue;Diagnosis (C0011900)|TI;AB|MM
9341945|methods|C0025664|11|SH|Methods|AB|MM
9341945|organization & administration|C0029236|7|SH|Organization and Administration|AB|MM
9341945|therapy|C0039798|4|SH|Therapeutics|AB|MM
9341945|instrumentation|C0021632|0|SH|Equipment and Supplies|AB|MM
9341945|drug therapy|C0013217|9999|SH|new SH add rule - Injections [E02.319.267.530] (E02.319)||MM
9378660|Soil Pollutants, Radioactive|C0037595|98501|MH|||RC
9378660|Water Pollutants, Radioactive|C0043055|69837|MH|||RC
9378660|Cesium Radioisotopes|C0007889|67152|MH|||RC
9378660|Radiation Monitoring|C0034532|59642|MH|||RC
9378660|Radiation Protection|C0034533|47762|MH|||RC
9378660|*Risk Management|C0035649|29772|MH|RtM via: Medical Surveillance|TI;AB|MM;RC
9378660|Soil Pollutants|C0037594|12862|MH|||RC
9378660|Risk Assessment|C0086930|12276|MH|||RC
9378660|Environmental Exposure|C0014412|12060|MH|||RC
9378660|Body Burden|C0005884|11664|MH|||RC
9378660|Conservation of Natural Resources|C0009799|11236|MH|||RC
9378660|Environmental Monitoring|C0014416|10643|MH|||RC
9378660|Radiation Dosage|C0034524|9663|MH|||RC
9378660|Risk|C0035647|8931|MH|RtM via: Risk|AB|MM;RC
9378660|Nuclear Warfare|C0028594|7638|MH|||RC
9378660|*Research|C0035168|6435|MH|RtM via: Analysis;RtM via: Analysis of substances;RtM via: Medical Surveillance|TI;AB|MM
9378660|Biodiversity|C0282469|4864|MH|||RC
9378660|Agriculture|C0001829|4017|MH|||RC
9378660|Meteorological Concepts|C2350639|3981|MH|||RC
9378660|Occupational Exposure|C0028798|3810|MH|||RC
9378660|Public Opinion|C0034030|3597|MH|||RC
9378660|Radiation Injuries|C0034530|3548|MH|||RC
9378660|Geography|C0017447|2887|MH|||RC
9378660|Consumer Participation|C0009824|1975|MH|||RC
9378660|Occupational Health|C0079920|1646|MH|||RC
9378660|Health Policy|C0018735|1638|MH|||RC
9378660|International Cooperation|C0021785|1588|MH|||RC
9378660|Models, Biological|C0026339|1190|MH|||RC
9378660|Time Factors|C0040225|787|MH|||RC
9378660|*Laboratory Techniques and Procedures|C0600201|738|MH|RtM via: Analysis of substances;RtM via: Sampling|TI;AB|MM
------
9378660|New Mexico|C0027972|107|MH-S|RtM via: New Mexico|AB|MM
9378660|Humans|C0086418|1000|CT|Consumer Participation||RC
9378660|analysis|C1524024|12594|SH1|RtM via: analysis aspect|TI;AB|MM
9378660|organization & administration|C0029236|2982|SH|Organization and Administration|TI;AB|MM
9378660|therapy|C0039798|1983|SH|Therapeutics|TI;AB|MM
9378660|methods|C0025664|102|SH|Methods|AB|MM
9378660|economics|C0013557|1111|SH|N03.219.463.800 (Risk Management)|TI;AB|MM
9380039|Mineralocorticoid Receptors|C0066563|307749|ET|Entry Term Replacement for "Receptors, Mineralocorticoid";RtM via: Mineralocorticoid Receptor|AB|MM;RC
9380039|Glucocorticoid Receptors|C0034809|214828|ET|Entry Term Replacement for "Receptors, Glucocorticoid";RtM via: Glucocorticoid Receptor|AB|MM;RC
9380039|Aldosterone|C0002006|145942|MH|RtM via: Aldosterone|AB|MM;RC
9380039|6,19-oxidoprogesterone|C2351295|126490|NM|Forced Lookup:6,19-oxidoprogesterone||MM
9380039|Progesterone|C0033308|126489|MH|RtM via: Progesterone;RtM via: 21-hydroxy-6,19-oxidoprogesterone|AB|MM;RC
9380039|21-hydroxy-6,19-oxidoprogesterone|C0667025|98523|NM|RtM via: 21-hydroxy-6,19-oxidoprogesterone;Forced Lookup:21-hydroxy-6,19-oxidoprogesterone;Forced Lookup:21oh-6op|AB|MM
9380039|Corticosterone|C0010124|76561|MH|RtM via: Corticosterone|AB|MM;RC
9380039|Glucocorticoids|C0017710|61453|MH|RtM via: Glucocorticoids|AB|MM;RC
9380039|Dexamethasone|C0011777|56886|MH|RtM via: Dexamethasone|AB|MM;RC
9380039|Mineralocorticoids|C0026160|56733|MH|RtM via: Mineralocorticoids|AB|MM;RC
9380039|*Steroids|C0038317|46149|MH|RtM via: Synthetic steroid;RtM via: Steroids|TI;AB|MM;RC
9380039|Kidney|C0022646|27382|MH|RtM via: Kidney;RtM via: Entire kidney|AB|MM;RC
9380039|Receptors, Progesterone|C0034833|14087|MH|RtM via: Receptors, Progesterone|AB|MM;RC
9380039|Cytosols|C1383501|12874|ET|Entry Term Replacement for "Cytosol";RtM via: Cytoplasmic matrix|AB|MM;RC
9380039|Thymus|C0040113|11869|ET|Entry Term Replacement for "Thymus Gland";RtM via: Thymus Gland|AB|MM;RC
9380039|Rats, Sprague-Dawley|C0034715|9692|MH|||RC
9380039|Binding, Competitive|C0005458|8827|MH|||RC
9380039|Sodium|C0037473|3979|MH|||RC
9380039|Kinetics|C0022702|3919|MH|||RC
9380039|Structure-Activity Relationship|C0038477|3758|MH|||RC
9380039|Molecular Structure|C0026383|2943|MH|||RC
9380039|Tyrosine Aminotransferase|C0041487|2655|ET|Entry Term Replacement for "Tyrosine Transaminase";RtM via: TYROSINE AMINOTRANSFERASE|AB|MM
9380039|Molecular Conformation|C0026377|2577|MH|RtM via: Molecular Conformation|AB|MM;RC
9380039|Binding Sites|C0005456|2533|MH|||RC
9380039|Potassium|C0032821|2176|MH|||RC
9380039|Substrate Specificity|C0038592|1636|MH|||RC
9380039|Transfection|C0040669|1187|MH|||RC
9380039|Tissue Distribution|C0040287|1017|MH|||RC
9380039|Cell Line|C0007600|791|MH|||RC
9380039|Apoptosis|C0162638|637|MH|||RC
9380039|Brain|C0006104|536|MH|||RC
9380039|Models, Molecular|C0026344|453|MH|||RC
9380039|Temperature|C0039476|267|MH|||RC
------
9380039|Rats|C0034721|103851|CT||TI;AB|MM
9380039|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9380039|Female|C0015780|1000|CT|CT Text Lookup: uterus|CT Text Lookup: uterus|MM
9380039|genetics|C0017399|1111|SH|G05.355.760.860 (Transfection)||MM
9288441|*Depression, Bipolar|C0005587|1380498|ET|Entry Term Replacement for "Bipolar Disorder";RtM via: Depression, Bipolar;RtM via: Manic;RtM via: Manic mood|TI;AB|MM;RC
9288441|Antidepressants|C0003289|339691|ET|Entry Term Replacement for "Antidepressive Agents";RtM via: Antidepressive Agents|AB|MM;RC
9288441|Electroconvulsive Therapy|C0013806|160682|MH|RtM via: Electroconvulsive Therapy|AB|MM;RC
9288441|Antimanic Agents|C0242911|50165|MH|||RC
9288441|lamotrigine|C0064636|47943|NM|RtM via: lamotrigine|AB|MM
9288441|Triazines|C0040877|47942|HM|RtM via: lamotrigine|AB|MM;RC
9288441|Lithium|C0023870|42832|MH|RtM via: Lithium|AB|MM;RC
9288441|Monoamine Oxidase Inhibitors|C0026457|15178|MH|RtM via: Monoamine Oxidase Inhibitors|AB|MM;RC
9288441|Treatment Outcome|C0085415|11431|MH|||RC
9288441|Combined Modality Therapy|C0009429|6296|MH|||RC
9288441|Mood|C0026516|5269|ET|Entry Term Replacement for "Affect";RtM via: Mood (psychological function)|AB|MM;RC
9288441|Drug Therapy, Combination|C0013218|4727|MH|||RC
9288441|Randomized Controlled Trials as Topic|C0282440|4721|MH|||RC
9288441|Clinical Trials as Topic|C0008976|4036|MH|RtM via: Clinical Trials|AB|MM;RC
------
9288441|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9288441|therapy|C0039798|2280|SH|Treatments|TI;AB|MM
9288441|drug therapy|C0013217|9999|SH|new SH add rule - Drug Therapy, Combination [E02.319.310] (E02.319)||MM
9228551|*Gene Therapy|C0017296|655311|MH|RtM via: gene therapy;RtM via: Gene Delivery;RtM via: gene delivery process|TI;AB|MM;RC
9228551|*Kallikrein|C0022478|556215|ET|Entry Term Replacement for "Kallikreins";RtM via: Kininogenase;RtM via: Kininogenase activity|TI;AB|MM;RC
9228551|*Hypertension|C0020538|510798|MH|RtM via: Hypertensive disease;RtM via: Hypertensive (finding)|TI;AB|MM;RC
9228551|Rats, Spontaneously Hypertensive|C0034705|480187|ET|Entry Term Replacement for "Rats, Inbred SHR";RtM via: Rats, Inbred SHR|AB|MM;RC
9228551|Blood Pressure|C0005823|283879|MH|RtM via: Blood Pressure;RtM via: blood pressure homeostasis|AB|MM;RC
9228551|Adenovirus|C0001483|242854|ET|Entry Term Replacement for "Adenoviridae";RtM via: Adenoviruses|AB|MM;RC
9228551|Genetic Vectors|C0017397|207084|MH|RtM via: Adenoviral Vector|AB|MM;RC
9228551|beta-Galactosidase|C0005220|107350|MH|RtM via: beta-Galactosidase;Forced Lookup:beta-galactosidase|AB|MM;RC
9228551|Gene Transfer Techniques|C0886519|86331|MH|RtM via: Gene Delivery;RtM via: gene delivery process|AB|MM;RC
9228551|Tissue Kallikrein|C0076726|81161|ET|Entry Term Replacement for "Tissue Kallikreins";RtM via: Human Glandular Kallikrein 2;RtM via: Tissue Kallikrein|AB|MM;RC
9228551|Kallikrein-Kinin System|C0079652|73851|MH|RtM via: Kallikrein-Kinin System;Forced Lookup:kallikrein-kinin system|AB|MM
9228551|DNA, Recombinant|C0012931|66631|MH|RtM via: Recombinant DNA|AB|MM;RC
9228551|Lac Operon|C0022895|58718|MH|RtM via: LacZ Genes|AB|MM;RC
9228551|Transfection|C0040669|42870|MH|||RC
9228551|Rats, Inbred WKY|C0034709|27060|MH|||RC
9228551|Hypotension|C0020649|17709|MH|RtM via: Hypotensive|AB|MM;RC
9228551|Plasmid|C0032136|17382|ET|Entry Term Replacement for "Plasmids";RtM via: Plasmids|AB|MM;RC
9228551|Injections, Intravenous|C0021494|12109|MH|RtM via: Intravenous route|AB|MM;RC
9228551|Kidney|C0022646|10733|MH|RtM via: Epithelial cell of renal tubule|AB|MM;RC
9228551|RNA, Messenger|C0035696|9008|MH|||RC
9228551|Cytomegalovirus|C0010825|8917|MH|RtM via: Cytomegalovirus|AB|MM;RC
9228551|Molecular Sequence Data|C0026382|4352|MH|||RC
9228551|Injections, Intramuscular|C0021492|4092|MH|RtM via: Intramuscular injection|AB|MM;RC
9228551|Reverse Transcriptase Polymerase Chain Reaction|C0599161|4040|MH|||RC
9228551|Cell Line|C0007600|3985|MH|||RC
9228551|Vasodilator Agents|C0042402|3634|MH|||RC
9228551|Tissue Distribution|C0040287|3168|MH|||RC
9228551|Animals, Newborn|C0003065|2668|MH|||RC
9228551|Promoter Regions, Genetic|C0033413|2648|MH|||RC
9228551|Cells, Cultured|C0007635|1721|MH|||RC
9228551|Injections, Intraventricular|C0021495|1680|MH|||RC
9228551|Aging|C0001811|1478|MH|||RC
9228551|Homeostasis|C0019868|1468|MH|||RC
9228551|Injections, Subcutaneous|C0021499|1170|MH|||RC
9228551|Gene, Reporter|C0206414|1027|ET|Entry Term Replacement for "Genes, Reporter";RtM via: Genes, Reporter|AB|MM
9228551|Muscle, Skeletal|C0242692|1011|MH|||RC
9228551|Portal Vein|C0032718|974|MH|RtM via: Portal vein structure;RtM via: Entire portal vein;RtM via: Entire trunk of portal vein;RtM via: Structure of trunk of portal vein|AB|MM;RC
9228551|Brain|C0006104|942|MH|||RC
9228551|Sex Factors|C0036881|861|MH|||RC
9228551|Gene Targeting|C0242613|454|MH|RtM via: Homologous Recombination|AB|MM
9228551|Rous sarcoma virus|C0086943|438|MH|RtM via: Rous sarcoma virus|AB|MM
9228551|Element, Response|C0600508|327|ET|Entry Term Replacement for "Response Elements";RtM via: Response Elements|AB|MM
9228551|Time Factors|C0040225|320|MH|||RC
9228551|Terminal Repeat Sequences|C0039551|233|MH|RtM via: Long Terminal Repeat|AB|MM
------
9228551|Rats|C0034721|1939|CT||AB|MM
9228551|Animals|C0003062|1000|CT|Rats, Spontaneously Hypertensive;Rats, Inbred WKY;Animals, Newborn;CT Text Lookup: rat;CT Text Lookup: spontaneously hypertensive rat;CT Text Lookup: spontaneously hypertensive rats|AB;CT Text Lookup: rat;CT Text Lookup: spontaneously hypertensive rat;CT Text Lookup: spontaneously hypertensive rats|MM;RC
9228551|Humans|C0086418|1000|CT|CT Text Lookup: human|CT Text Lookup: human|MM
9228551|blood supply|C0005839|402|SH|Blood Circulation|AB|MM
9228551|genetics|C0017399|1111|SH|G05.360.337 (Genetic Vectors)|AB|MM
9263235|*Insulin-Like Growth Factor I|C0021665|1170438|MH|RtM via: Insulin-Like Growth Factor I;Forced Lookup:igf-1|TI;AB|MM;RC
9263235|*Growth Hormone|C0037663|1073556|MH|RtM via: Somatotropin|TI|MM;RC
9263235|*Human Growth Hormone|C0169964|949761|MH|RtM via: Somatropin;RtM via: Recombinant Human Growth Hormone (Mammalian)|TI;AB|MM;RC
9263235|*Proteins|C0033684|419736|MH|RtM via: Proteins|TI;AB|MM;RC
9263235|Rats, Sprague-Dawley|C0034715|140113|MH|RtM via: Rats, Sprague-Dawley;Forced Lookup:sprague-dawley rats|AB|MM;RC
9263235|Parenteral Nutrition, Total|C0030548|103825|MH|RtM via: Parenteral Nutrition, Total;RtM via: infusion of total parenteral nutrition|AB|MM;RC
9263235|*Burns|C0006434|73893|MH|RtM via: Burn injury;RtM via: Burned Medical Device or Device Component;RtM via: Third degree burn;RtM via: Scalding injury|TI;AB|MM;RC
9263235|Insulin|C0021641|66742|MH|RtM via: Insulin|AB|MM;RC
9263235|Organ Size|C1450569|50417|MH|||RC
9263235|Growth|C0018270|43121|MH|RtM via: Growth;RtM via: Height|AB|MM;RC
9263235|Blood Glucose|C0005802|28715|MH|RtM via: Blood Glucose|AB|MM;RC
9263235|Intestine, Small|C0021852|26676|MH|RtM via: Intestinal villus|AB|MM;RC
9263235|Intestinal Mucosa|C0021839|25011|MH|RtM via: Intestinal Mucosa;RtM via: Intestinal villus|AB|MM;RC
9263235|*Gastrointestinal Tract|C0017189|22233|MH|RtM via: Gastrointestinal tract structure|TI|MM
9263235|Rats, Wistar|C0034716|17465|MH|||RC
9263235|*Cell-Mediated Immunity|C0020966|16806|ET|Entry Term Replacement for "Immunity, Cellular";RtM via: Immunity, Cellular|TI|MM;RC
9263235|Somatomedins|C0037657|8943|MH|RtM via: Somatomedins|AB|MM
9263235|Triiodothyronine|C0041014|8874|MH|||RC
9263235|*Abdomen|C0000726|8499|MH|RtM via: Gut|TI|MM
9263235|RNA, Messenger|C0035696|7715|MH|||RC
9263235|Thyroxine|C0040165|7281|MH|||RC
9263235|Muscle Proteins|C0026832|6858|MH|||RC
9263235|Lipid Metabolism|C0598783|5661|MH|||RC
9263235|Energy Metabolism|C0014272|4745|MH|||RC
9263235|Injections, Subcutaneous|C0021499|4314|MH|||RC
9263235|Endotoxins|C0014264|3330|MH|||RC
9263235|Muscle, Skeletal|C0242692|2338|MH|||RC
9263235|Oxygen Consumption|C0030055|1955|MH|||RC
9263235|Adaptation, Physiological|C0001400|1288|MH|||RC
9263235|Immunoglobulin A|C0020835|1269|MH|||RC
9263235|Dose-Response Relationship, Drug|C0013059|1225|MH|||RC
9263235|Recovery of Function|C0599766|596|MH|||RC
9263235|Drug Interactions|C0687133|563|MH|||RC
9263235|*Accidents|C0000924|507|MH|RtM via: Burned Medical Device or Device Component|TI;AB|MM
9263235|Drug-Induced Liver Injury|C0860207|391|MH|||RC
9263235|Body Height|C0005890|387|MH|RtM via: BODY HEIGHT:LENGTH:POINT IN TIME:^PATIENT:QUANTITATIVE|AB|MM
------
9263235|Rats|C0034721|127449|CT||TI;AB|MM
9263235|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;Rats, Wistar;CT Text Lookup: rat;CT Text Lookup: sprague-dawley rats|AB;CT Text Lookup: rat;CT Text Lookup: sprague-dawley rats|MM;RC
9263235|Humans|C0086418|1000|CT|Body Height;CT Text Lookup: human|AB;CT Text Lookup: human|MM
9263235|metabolism|C0025520|14865|SH1|RtM via: Protein Metabolism;RtM via: Metabolism|TI;AB|MM
9263235|anatomy & histology|C0002809|4533|SH1|RtM via: Science of Morphology;anatomy & histology (C0002809);RtM via: morphological;anatomy & histology (C0002809)|TI|MM
9263235|growth & development|C1457898|1472|SH1|RtM via: Growth & development aspects;growth & development (C1457898);RtM via: growth aspects;growth & development (C1457898)|AB|MM
9263235|immunology|C1522005|1111|SH|G12.450.050.400 (Cell-Mediated Immunity)|TI|MM
9325098|endoglucanase 1|C0059240|1491070|NM|RtM via: endoglucanase 1|TI;AB|MM
9325098|*Endoglucanase|C0007641|1491069|ET|Entry Term Replacement for "Cellulase";RtM via: endoglucanase 1;RtM via: CELLULASE|TI;AB|MM;RC
9325098|*Trichoderma|C0040914|800955|MH|RtM via: Trichoderma|TI;AB|MM;RC
9325098|Cellobiohydrolase|C0059939|680021|ET|Entry Term Replacement for "Cellulose 1,4-beta-Cellobiosidase";RtM via: Cellulose 1,4-beta-cellobiosidase;RtM via: Cellobiohydrolase I;RtM via: cellobiohydrolase I activity|AB|MM;RC
9325098|*Endoglucanase I|C0115924|445359|ET|Entry Term Replacement for "Cellulases";RtM via: Endoglucanase I;RtM via: Cellulases|TI;AB|MM
9325098|R388|C0602450|325461|NM|RtM via: R-factor;Forced Lookup:r-factor|AB|MM
9325098|Tetrahydrofolate Dehydrogenase|C0039667|325460|HM|RtM via: R-factor|AB|MM
9325098|*Catalytic Domain|C0600499|188178|MH|RtM via: Catalytic Domain;RtM via: Active Site|TI;AB|MM;RC
9325098|Cellulose|C0007648|54766|MH|RtM via: Cellulose|AB|MM;RC
9325098|Crystallography, X-Ray|C0206755|35488|MH|||RC
9325098|Protein Conformation|C0033625|30721|MH|||RC
9325098|Models, Molecular|C0026344|29612|MH|||RC
9325098|Mitosporic Fungi|C0011746|28659|MH|RtM via: Humicola insolens|AB|MM;RC
9325098|Binding Sites|C0005456|26562|MH|||RC
9325098|Amino Acid Sequence|C0002518|19140|MH|||RC
9325098|Catalyses|C0007382|17387|ET|Entry Term Replacement for "Catalysis";RtM via: Catalysis|AB|MM;RC
9325098|Substrate Specificity|C0038592|13820|MH|||RC
9325098|Molecular Sequence Data|C0026382|12695|MH|||RC
9325098|Models, Chemical|C0026341|11479|MH|||RC
9325098|Molecular Structure|C0026383|10310|MH|||RC
9325098|Sequence Homology, Amino Acid|C0162777|7705|MH|||RC
9325098|Ascomycota|C0003965|6648|MH|RtM via: Humicola insolens|AB|MM;RC
9325098|Computer Simulation|C0009609|6519|MH|||RC
9325098|Hydrolysis|C0020291|6373|MH|RtM via: Hydrolysis|AB|MM;RC
9325098|Binding, Competitive|C0005458|5439|MH|||RC
9325098|Crystallization|C0010423|4210|MH|||RC
9325098|Sequence Alignment|C0080143|4111|MH|||RC
9325098|Hydrogen-Ion Concentration|C0020283|3263|MH|RtM via: pH profile measurement|AB|MM;RC
9325098|Kinetics|C0022702|2299|MH|||RC
9325098|Adsorption|C0001674|2017|MH|||RC
9325098|Models, Statistical|C0026348|1964|MH|||RC
9325098|Mutagenesis, Site-Directed|C0079870|1706|MH|||RC
9325098|Amidohydrolases|C0002488|1581|MH|||RC
9325098|Fungal Proteins|C0016829|1531|MH|||RC
9325098|Glucose|C0017725|1367|MH|||RC
9325098|Computer Graphics|C0009601|1268|MH|||RC
9325098|Crystallographies|C0010424|1043|ET|Entry Term Replacement for "Crystallography";RtM via: Crystallography|AB|MM
9325098|Time Factors|C0040225|1024|MH|||RC
9325098|Iodides|C0021966|665|MH|RtM via: Iodides|AB|MM
9325098|Chromatography, High Pressure Liquid|C0008562|658|MH|||RC
9325098|*Computers|C0009622|582|MH|RtM via: Core Device Component;RtM via: Processor Core|TI;AB|MM
9325098|*Virion|C0042760|459|MH|RtM via: cell core|TI;AB|MM
------
9325098|enzymology|C0014445|14310|SH1|RtM via: enzymology;RtM via: cellobiohydrolase I activity;enzymology (C0014445)|TI;AB|MM
9325098|genetics|C0017399|1111|SH|G05.810.200 (Sequence Homology, Amino Acid)||MM
9305568|*Succinylcholine|C0038627|542619|MH|RtM via: Succinylcholine|TI;AB|MM;RC
9305568|*Tacrine|C0039245|250476|MH|RtM via: Tacrine|TI;AB|MM;RC
9305568|Muscle Contraction|C0026820|26805|MH|||RC
9305568|Cholinesterase Inhibitors|C0008425|22149|MH|RtM via: Cholinesterase Inhibitors|AB|MM;RC
9305568|Soleus Muscle|C0242694|18867|ET|Entry Term Replacement for "Muscle, Skeletal";RtM via: Soleus muscle structure|AB|MM;RC
9305568|Rats, Sprague-Dawley|C0034715|9761|MH|||RC
9305568|Muscles|C0026845|7124|MH|RtM via: Tibialis;RtM via: Muscle;RtM via: Set of muscles|AB|MM;RC
9305568|Muscle Fibers, Skeletal|C1704336|6339|MH|||RC
9305568|Receptors, Cholinergic|C0034792|6093|MH|||RC
9305568|Electric Stimulation|C0013786|5584|MH|||RC
9305568|Alzheimer Disease|C0002395|4190|MH|RtM via: Alzheimer's Disease|AB|MM;RC
9305568|Muscle Relaxation|C0026836|3905|MH|||RC
9305568|Drug Interactions|C0687133|3825|MH|||RC
9305568|Dose-Response Relationship, Drug|C0013059|3111|MH|||RC
9305568|Phrenic Nerve|C0031774|2529|MH|||RC
9305568|Synaptic Transmission|C0027793|2452|MH|||RC
9305568|Injections, Intravenous|C0021494|1941|MH|||RC
9305568|Administration, Oral|C0001563|994|MH|||RC
9305568|Drug Synergism|C0013215|701|MH|||RC
9305568|Infusions, Intravenous|C0021440|470|MH|||RC
9305568|Animals, Newborn|C0003065|393|MH|||RC
9305568|Respiration, Artificial|C0035205|313|MH|||RC
9305568|Fasciculation|C0015644|211|MH|RtM via: Muscle twitch|AB|MM
------
9305568|Rats|C0034721|42858|CT||TI;AB|MM
9305568|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;Animals, Newborn;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9305568|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9305568|Humans|C0086418|1000|CT|CT Text Lookup: adult;CT Text Lookup: human;CT Text Lookup: man;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: adult;CT Text Lookup: human;CT Text Lookup: man;CT Text Lookup: patient;CT Text Lookup: patients|MM
9305568|Male|C0024554|1000|CT|CT Text Lookup: man|CT Text Lookup: man|MM
9334875|*Hispanics|C0086409|354462|ET|Entry Term Replacement for "Hispanic Americans";RtM via: Hispanics;RtM via: Hispanic Americans|TI;AB|MM;RC
9334875|*Intergenerational Relations|C0085419|321372|MH|RtM via: intergenerational|TI|MM;RC
9334875|Mexico|C0025885|178182|MH|RtM via: Mexican|TI|MM;RC
9334875|*Families|C0015576|142890|ET|Entry Term Replacement for "Family";RtM via: grandparent;RtM via: Family;RtM via: grandchild|TI;AB|MM;RC
9334875|*European Continental Ancestry Group|C1257905|91290|MH|RtM via: English race|TI;AB|MM;RC
9334875|*American, Mexican|C0025884|86388|ET|Entry Term Replacement for "Mexican Americans";RtM via: Mexican Americans|TI;AB|MM
9334875|*Age Factors|C0001783|52218|MH|RtM via: intergenerational|TI|MM;RC
9334875|Satisfaction|C0242428|21001|ET|Entry Term Replacement for "Personal Satisfaction";RtM via: Satisfaction|AB|MM;RC
9334875|Cross-Cultural Comparison|C0010358|15679|MH|||RC
9334875|Communication Barriers|C0009454|14168|MH|||RC
9334875|Communication|C0009452|12300|MH|RtM via: Establishing Action|AB|MM;RC
9334875|Social Support|C0037438|12237|MH|||RC
9334875|Personality Inventory|C0031213|8481|MH|||RC
9334875|*Perceptions|C0030971|8355|ET|Entry Term Replacement for "Perception";RtM via: Perception|TI|MM
9334875|Sex Factors|C0036881|7478|MH|||RC
9334875|Medicaid|C0025071|7473|MH|RtM via: Medicaid|AB|MM;RC
9334875|Interpersonal Relations|C0021797|6821|MH|||RC
9334875|Social Values|C0037439|5294|MH|||RC
9334875|Analyses, Multivariate|C0026777|5271|ET|Entry Term Replacement for "Multivariate Analysis";RtM via: Multivariate Analysis|AB|MM;RC
9334875|Medicare|C0018717|5164|MH|RtM via: Medicare|AB|MM;RC
9334875|Questionnaires|C0034394|4379|MH|||RC
9334875|Socioeconomic Factors|C0037464|4244|MH|||RC
9334875|Health Status|C0018759|3903|MH|||RC
9334875|Adaptation, Psychological|C0683269|3837|MH|||RC
9334875|Self Concept|C0036594|3540|MH|||RC
9334875|Health Education|C0018701|3401|MH|||RC
9334875|Child Behavior Disorders|C0008066|2934|MH|||RC
9334875|Stress, Psychological|C0038443|2681|MH|||RC
9334875|*Speech|C0037817|2292|MH|RtM via: Speaking|TI;AB|MM
9334875|Health Care Surveys|C0376688|2273|MH|||RC
9334875|Geriatric Assessment|C0017463|2165|MH|||RC
9334875|Aging|C0001811|2149|MH|||RC
9334875|Curriculum|C0010478|1948|MH|||RC
9334875|Patient Satisfaction|C0030702|1817|MH|||RC
9334875|Quality of Health Care|C0034379|1578|MH|||RC
9334875|Parents|C0030551|616|MH|RtM via: parent|AB|MM
9334875|Time Factors|C0040225|536|MH|||RC
9334875|Poverty|C0032854|472|MH|RtM via: Poverty;RtM via: Encounter due to poverty|AB|MM
9334875|Frustration|C0016770|425|MH|RtM via: Frustration|AB|MM
9334875|Minority Groups|C0026192|312|MH|RtM via: Minority Groups|AB|MM
9334875|Health Care Reform|C0206597|208|MH|RtM via: Health Care Reform|AB|MM
------
9334875|United States|C0041703|1000|MH+|Medicare;CT Text Lookup: medicaid||MM
9334875|Humans|C0086418|1000|CT|Hispanics;European Continental Ancestry Group;American, Mexican;Health Education;Geriatric Assessment;CT Text Lookup: adolescent;CT Text Lookup: adolescents;CT Text Lookup: children|TI;AB;CT Text Lookup: adolescent;CT Text Lookup: adolescents;CT Text Lookup: children|MM;RC
9334875|Child|C0008059|1000|CT|Child Behavior Disorders;CT Text Lookup: children|CT Text Lookup: children|MM;RC
9334875|Aged|C0001792|1000|CT|Geriatric Assessment||RC
9334875|Adolescent|C0205653|1000|CT|CT Text Lookup: adolescent;CT Text Lookup: adolescents|CT Text Lookup: adolescents|MM
9334875|methods|C0025664|27|SH|Methods|AB|MM
9334875|economics|C0013557|1111|SH|N03.219.521.346.506.564.655 (Medicaid)|AB|MM
9350179|*Lymphoblastic Leukemia, Acute, Adult|C0023453|1046019|ET|Entry Term Replacement for "Precursor Cell Lymphoblastic Leukemia-Lymphoma";RtM via: Leukemia, Lymphocytic, Acute, L2;RtM via: Precursor Cell Lymphoblastic Leukemia Lymphoma|TI;AB|MM;RC
9350179|Disease-Free Survival|C0242793|123039|MH|RtM via: Disease-Free Survival;Forced Lookup:disease-free survival|AB|MM;RC
9350179|Antineoplastic Combined Chemotherapy Protocols|C0003393|40089|MH|||RC
9350179|Relapse|C0035020|39190|ET|Entry Term Replacement for "Recurrence";RtM via: Relapse|AB|MM;RC
9350179|Prognosis|C0033325|31589|MH|RtM via: prognostic|AB|MM;RC
9350179|Transplantation, Homologous|C0040739|30493|MH|||RC
9350179|Combined Modality Therapy|C0009429|28395|MH|||RC
9350179|*Leukemia, Lymphoid|C0023448|24807|MH|RtM via: Adult Acute Lymphocytic Leukemia;RtM via: Acute lymphocytic leukemia|TI;AB|MM
9350179|Precursor B-Cell Lymphoblastic Leukemia-Lymphoma|C0023485|19214|MH|||RC
9350179|Hematopoietic Stem Cell Transplantation|C0472699|18139|MH|||RC
9350179|Treatment Outcome|C0085415|17362|MH|||RC
9350179|*Acute Disease|C0001314|16764|MH|RtM via: Adult Acute Lymphocytic Leukemia;RtM via: Acute lymphocytic leukemia|TI;AB|MM;RC
9350179|Leukemic Infiltration|C0162679|13976|MH|||RC
9350179|Transplantation, Autologous|C0040736|8433|MH|||RC
------
9350179|Adult|C0001675|1000|CT|CT Text Lookup: adult|CT Text Lookup: adult|MM
9350179|Humans|C0086418|1000|CT|CT Text Lookup: adult;CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: adult;CT Text Lookup: children;CT Text Lookup: patient;CT Text Lookup: patients|MM
9350179|Child|C0008059|1000|CT|CT Text Lookup: children|CT Text Lookup: children|MM
9350179|therapy|C0039798|9417|SH1|RtM via: therapeutic aspects;therapy (C0039798)|TI;AB|MM
9350179|transplantation|C0029216|2166|SH1|RtM via: Organ Transplantation;RtM via: transplantation aspects;RtM via: Transplantation|AB|MM
9350179|methods|C0025664|1374|SH|Methods|TI;AB|MM
9350179|injuries|C1510467|1|SH|Wounds and Injuries|AB|MM
9350179|surgery|C0038895|1111|SH|E04.936.225.687.500 (Hematopoietic Stem Cell Transplantation)||MM
9326222|*Thrombopoietin|C0040052|1349367|MH|RtM via: Thrombopoietin|TI;AB|MM;RC
9326222|*Granulocyte Colony-Stimulating Factor|C0079459|984929|MH|RtM via: Granulocyte Colony-Stimulating Factor;Forced Lookup:g-csf;Forced Lookup:granulocyte colony-stimulating factor|TI|MM;RC
9326222|*Granulocyte|C0018183|247584|ET|Entry Term Replacement for "Granulocytes";RtM via: granulocyte;RtM via: Granulocytes:Number Concentration (count/vol):Point in time:Cerebral spinal fluid:Quantitative|TI;AB|MM;RC
9326222|*Granulocyte Colony Stimulating Factor, Recombinant|C0376562|181212|MH|RtM via: Recombinant Granulocyte Colony Stimulating Factor|TI|MM
9326222|Granulocyte-Macrophage Colony-Stimulating Factor|C0079460|122617|MH|RtM via: Granulocyte-Macrophage Colony-Stimulating Factor;Forced Lookup:gm-csf|AB|MM;RC
9326222|BFU-E|C1257771|84316|ET|Entry Term Replacement for "Erythroid Precursor Cells";RtM via: Burst-Forming Units, Erythroid;Forced Lookup:bfu-e|AB|MM;RC
9326222|Total Body Irradiation|C0043162|83307|ET|Entry Term Replacement for "Whole-Body Irradiation";RtM via: Whole-Body Irradiation|AB|MM;RC
9326222|GM-CFU|C0314589|72671|ET|Entry Term Replacement for "Granulocyte-Macrophage Progenitor Cells";RtM via: Granulocyte-Macrophage Colony Forming Units;Forced Lookup:gm-cfu|AB|MM
9326222|Colony-Stimulating Factors|C0009392|71731|MH|Forced Lookup:colony-stimulating factor||MM
9326222|Macrophage Colony-Stimulating Factor|C0079784|71731|MH|Forced Lookup:macrophage colony-stimulating factor||MM
9326222|Platelet Count|C0032181|66780|MH|RtM via: Platelet Count measurement|AB|MM;RC
9326222|Thrombocytopenia|C0040034|58544|MH|RtM via: Thrombocytopenia|AB|MM;RC
9326222|Bone Marrow Cells|C0005955|51968|MH|RtM via: Bone Marrow Cells|AB|MM;RC
9326222|*Macrophage|C0024432|48018|ET|Entry Term Replacement for "Macrophages";RtM via: macrophage|TI;AB|MM;RC
9326222|Platelet|C0005821|30928|ET|Entry Term Replacement for "Blood Platelets";RtM via: Blood Platelets|AB|MM;RC
9326222|Neutropenia|C0027947|29894|MH|RtM via: Neutropenia|AB|MM;RC
9326222|Neutrophils|C0027950|25825|MH|RtM via: neutrophil|AB|MM;RC
9326222|*Monkeys, Rhesus|C0024400|25425|ET|Entry Term Replacement for "Macaca mulatta";RtM via: Macaca mulatta|TI;AB|MM;RC
9326222|Hematopoietic Stem Cell Transplantation|C0472699|16787|MH|||RC
9326222|Transplantation, Autologous|C0040736|9352|MH|||RC
9326222|Progenitor Cells|C0038250|9128|ET|Entry Term Replacement for "Stem Cells";RtM via: Stem cells|AB|MM;RC
9326222|Flow Cytometry|C0016263|8104|MH|||RC
9326222|Bone Marrow Diseases|C0005956|6125|MH|||RC
9326222|Cell Separation|C0007616|5950|MH|||RC
9326222|Cell Count|C0007584|3860|MH|||RC
9326222|Drug Therapy, Combination|C0013218|2709|MH|||RC
9326222|Antineoplastic Combined Chemotherapy Protocols|C0003393|1887|MH|||RC
9326222|Drug Synergism|C0013215|1815|MH|||RC
9326222|Radiation Injuries, Experimental|C0034531|1797|MH|||RC
9326222|Neoplasm Proteins|C0027642|1532|MH|||RC
9326222|Models, Animal|C0599779|1445|MH|||RC
9326222|Membrane Proteins|C0025252|1290|MH|||RC
9326222|Combined Modality Therapy|C0009429|1279|MH|||RC
9326222|Mice, Inbred BALB C|C0025919|749|MH|||RC
9326222|*Clinical Protocols|C0008971|666|MH|RtM via: Unit dose;RtM via: dose|TI;AB|MM
9326222|Injections, Subcutaneous|C0021499|504|MH|||RC
9326222|Time Factors|C0040225|504|MH|||RC
9326222|Reticulocyte|C0035286|398|ET|Entry Term Replacement for "Reticulocytes";RtM via: Reticulocytes|AB|MM
9326222|Alkylating Agents|C0002073|360|MH|||RC
9326222|Injections, Intravenous|C0021494|278|MH|||RC
9326222|Pancytopenia|C0030312|237|MH|RtM via: Pancytopenia;RtM via: Myelosuppression|AB|MM
9326222|Drug Evaluation, Preclinical|C0013206|216|MH|||RC
------
9326222|Animals|C0003062|1000|CT|Monkeys, Rhesus;Radiation Injuries, Experimental;Models, Animal;Mice, Inbred BALB C|TI;AB|MM;RC
9326222|Mice|C0026809|1000|CT|Mice, Inbred BALB C||RC
9326222|administration & dosage|C0001555|1314|SH1|RtM via: Unit dose;administration & dosage (C0001555);RtM via: dose;administration & dosage (C0001555)|TI;AB|MM
9326222|radiotherapy|C1522449|1111|SH1|RtM via: Therapeutic radiology procedure;Radiotherapy (C1522449)|AB|MM
9326222|methods|C0025664|2430|SH|Methods|TI;AB|MM
9326222|organization & administration|C0029236|66|SH|Administration|TI;AB|MM
9326222|transplantation|C0029216|1111|SH|E04.936.225.687.500 (Hematopoietic Stem Cell Transplantation)||MM
9326222|surgery|C0038895|1111|SH|E04.936.664 (Transplantation, Autologous)||MM
9251867|*Traumatic Brain Injury|C0876926|1171158|ET|Entry Term Replacement for "Brain Injuries";RtM via: Traumatic Brain Injury|TI;AB|MM;RC
9251867|Neuropsychological Tests|C0027902|437641|MH|RtM via: Neuropsychological Tests|AB|MM;RC
9251867|Cognition Disorders|C0009241|115122|MH|||RC
9251867|Brain|C0006104|60668|MH|RtM via: Brain;RtM via: Entire brain|AB|MM;RC
9251867|Post-Traumatic Stress Disorder|C0038436|57037|ET|Entry Term Replacement for "Stress Disorders, Post-Traumatic";RtM via: Stress Disorders, Post-Traumatic;Forced Lookup:post-traumatic stress disorder|AB|MM;RC
9251867|Working Memory|C0025265|36868|ET|Entry Term Replacement for "Memory, Short-Term";RtM via: Memory, Short-Term|AB|MM;RC
9251867|Emotions|C0013987|18929|MH|RtM via: Emotions|AB|MM;RC
9251867|Attention|C0004268|14860|MH|||RC
9251867|Mental Disorders|C0004936|13697|MH|RtM via: Actual Depression;RtM via: Stress;RtM via: Cognitive deficits|AB|MM;RC
9251867|Problem Solving|C0033211|12904|MH|||RC
9251867|Cognition|C0009240|12658|MH|||RC
9251867|Psychomotor Performance|C0033923|12489|MH|||RC
9251867|Diffusion Magnetic Resonance Imaging|C1136216|11055|MH|||RC
9251867|Recovery of Function|C0599766|9325|MH|||RC
9251867|Severity of Illness Index|C0036859|8902|MH|||RC
9251867|Depression|C0011570|8730|MH|RtM via: Mental Depression;RtM via: Depressed mood;RtM via: Depressive episode, unspecified|AB|MM;RC
9251867|Nerve Fibers, Myelinated|C0027750|7870|MH|||RC
9251867|Reaction Time|C0034746|7723|MH|||RC
9251867|Verbal Behavior|C0042530|6288|MH|||RC
9251867|Tomography, X-Ray Computed|C0040405|5959|MH|||RC
9251867|Decision Making|C0011109|3364|MH|||RC
9251867|Neural Pathways|C0027792|3316|MH|||RC
9251867|Outcome Assessment (Health Care)|C0085565|2262|MH|||RC
9251867|Questionnaires|C0034394|2212|MH|||RC
9251867|Health Status|C0018759|2099|MH|||RC
9251867|Prognosis|C0033325|1875|MH|||RC
9251867|Age Factors|C0001783|1805|MH|||RC
9251867|Treatment Outcome|C0085415|1765|MH|||RC
9251867|Socioeconomic Factors|C0037464|1211|MH|||RC
9251867|Risk Factors|C0035648|1179|MH|||RC
9251867|Memory|C0025260|859|MH|RtM via: Memory|AB|MM
9251867|Time Factors|C0040225|816|MH|||RC
9251867|Anxiety|C0003467|408|MH|RtM via: Anxiety;RtM via: Anxiety symptoms|AB|MM
9251867|Depressive Disorder|C0011581|233|MH|RtM via: Depressive disorder|AB|MM
------
9251867|injuries|C1510467|167|SH|Injury|AB|MM
9251867|methods|C0025664|63|SH|Methods|AB|MM
9251867|radiography|C0034571|1111|SH|E01.370.350.700.700.810 (Tomography, X-Ray Computed)||MM
9310011|*Tuberculosis, Pulmonary|C0041327|2129064|MH|RtM via: Tuberculosis, Pulmonary|TI;AB|MM;RC
9310011|Isoniazid|C0022209|1137371|MH|RtM via: isoniazid;RtM via: isoniazid 300 MG|AB|MM;RC
9310011|Antitubercular Agents|C0003448|503151|MH|||RC
9310011|*Ciprofloxacin|C0008809|493446|MH|RtM via: Ciprofloxacin;RtM via: Ciprofloxacin 500 MG|TI;AB|MM;RC
9310011|Sputum|C0038056|319069|MH|RtM via: Sputum|AB|MM;RC
9310011|Mycobacterium tuberculosis|C0026926|194523|MH|||RC
9310011|Anti-Bacterial Agents|C0279516|26103|MH|RtM via: Anti-Mycobacterial Agents;RtM via: Bactericide, NOS|AB|MM;RC
9310011|Microbial Sensitivity Tests|C0025948|23432|MH|||RC
9310011|Drug Therapy, Combination|C0013218|11570|MH|||RC
9310011|Colony Count, Microbial|C0009380|10227|MH|||RC
9310011|AIDS-Related Opportunistic Infections|C0162526|7125|MH|||RC
9310011|Dose-Response Relationship, Drug|C0013059|4086|MH|||RC
9310011|Drug Administration Schedule|C0013154|3147|MH|||RC
9310011|Specimen Handling|C0037793|2834|MH|||RC
9310011|Drug Monitoring|C0085421|2771|MH|||RC
9310011|Time Factors|C0040225|1275|MH|||RC
9310011|Treatment Outcome|C0085415|588|MH|||RC
9310011|Genotype|C0017431|420|MH|||RC
9310011|HIV-1|C0019704|398|MH|||RC
9310011|Research Design|C0035171|304|MH|||RC
------
9310011|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9310011|methods|C0025664|76|SH|Methods|AB|MM
9310011|injuries|C1510467|2|SH|Wounds and Injuries|AB|MM
9310011|drug therapy|C0013217|9999|SH|new SH add rule - Drug Therapy, Combination [E02.319.310] (E02.319)||MM
9310011|genetics|C0017399|1111|SH|G05.380 (Genotype)||MM
9350007|*Myosin|C0027096|504102|ET|Entry Term Replacement for "Myosins";RtM via: Myosin ATPase|TI;AB|MM;RC
9350007|Heavy Chain, Myosin|C0027100|204281|ET|Entry Term Replacement for "Myosin Heavy Chains";RtM via: Myosin Heavy Chains|AB|MM;RC
9350007|*Muscles|C0026845|108387|MH|RtM via: Muscle;RtM via: Set of muscles|TI;AB|MM;RC
9350007|*Isoforms|C0597298|79410|ET|Entry Term Replacement for "Protein Isoforms";RtM via: Protein Isoforms|TI;AB|MM;RC
9350007|Muscle, Skeletal|C0242692|72842|MH|RtM via: Tibialis anterior muscle structure;RtM via: Entire extensor digitorum longus muscle of foot;RtM via: Structure of extensor digitorum longus muscle of foot|AB|MM;RC
9350007|Hyperthyroidism|C0020550|25856|MH|RtM via: Hyperthyroidism|AB|MM;RC
9350007|Muscle Fibers, Skeletal|C1704336|23960|MH|||RC
9350007|Satellite Cells, Skeletal Muscle|C1135926|13673|MH|||RC
9350007|Electric Stimulation|C0013786|12961|MH|||RC
9350007|Muscle Contraction|C0026820|11119|MH|||RC
9350007|ATPase|C1706373|10920|ET|Entry Term Replacement for "Adenosine Triphosphatases";RtM via: Adenosine Triphosphatases;RtM via: Adenosinetriphosphatase|AB|MM;RC
9350007|Sarcoplasmic Reticulum Calcium-Transporting ATPases|C0916181|6529|MH|||RC
9350007|Rats, Wistar|C0034716|5380|MH|||RC
9350007|Triiodothyronine|C0041014|2741|MH|||RC
9350007|RNA, Messenger|C0035696|1903|MH|||RC
9350007|Electrophoresis, Polyacrylamide Gel|C0013862|1805|MH|||RC
9350007|Organ Size|C1450569|1747|MH|||RC
9350007|Aging|C0001811|1693|MH|||RC
9350007|Calcium|C0006675|1408|MH|||RC
9350007|In Situ Hybridization|C0162788|1324|MH|||RC
9350007|Adaptation, Physiological|C0001400|1307|MH|||RC
9350007|Reverse Transcriptase Polymerase Chain Reaction|C0599161|955|MH|||RC
9350007|Electrophoresis, Gel, Two-Dimensional|C0013860|816|MH|||RC
9350007|Rats, Inbred Lew|C0034704|573|MH|||RC
9350007|*Ataxia|C0004134|393|MH|RtM via: No incoordination|TI|MM
9350007|Age Factors|C0001783|343|MH|||RC
9350007|Cell Count|C0007584|290|MH|||RC
------
9350007|Animals|C0003062|1000|CT|Rats, Wistar;Rats, Inbred Lew;CT Text Lookup: rabbit|CT Text Lookup: rabbit|MM;RC
9350007|Rats|C0034721|1000|CT|Rats, Wistar;Rats, Inbred Lew||RC
9350007|Rabbits|C0034493|1000|CT|CT Text Lookup: rabbit|CT Text Lookup: rabbit|MM
9350007|methods|C0025664|10|SH|Methods|AB|MM
9283235|saiboku-to|C0141409|2684927|NM|RtM via: saiboku-to;Forced Lookup:saiboku-to|TI;AB|MM
9283235|*Medicine, Kampo|C0752221|2684926|HM|RtM via: saiboku-to|TI;AB|MM;RC
9283235|saiko-ka-ryukotsu-borei-to|C0381095|378059|NM|RtM via: saiko-ka-ryukotsu-borei-to;Forced Lookup:saiko-ka-ryukotsu-borei-to|TI;AB|MM
9283235|*Drugs, Chinese Herbal|C0013229|378058|HM|RtM via: saiko-ka-ryukotsu-borei-to|TI;AB|MM;RC
9283235|*Traditional Oriental Medicines|C0025129|75288|ET|Entry Term Replacement for "Medicine, East Asian Traditional";RtM via: Medicine, East Asian Traditional|TI;AB|MM
9283235|*Herbal Medicine|C1533719|49491|MH|RtM via: Discipline of Herbal Medicine|TI;AB|MM
9283235|HPLC|C0008562|13424|ET|Entry Term Replacement for "Chromatography, High Pressure Liquid";RtM via: High pressure liquid chromatography procedure|AB|MM;RC
9283235|Administration, Oral|C0001563|7812|MH|RtM via: Administration, Oral|AB|MM;RC
9283235|Drug Interactions|C0687133|6802|MH|||RC
9283235|Herb-Drug Interactions|C1257749|5806|MH|||RC
9283235|Spectrophotometry, Ultraviolet|C0037808|4568|MH|||RC
9283235|Microsomes, Liver|C0026030|4145|MH|||RC
9283235|*Central Nervous Systems|C0927232|3759|ET|Entry Term Replacement for "Central Nervous System";RtM via: Neuraxis|TI;AB|MM
9283235|*Electroencephalography|C0013819|3441|MH|RtM via: Electroencephalography|TI;AB|MM
9283235|Rats, Wistar|C0034716|2936|MH|||RC
9283235|Stress, Physiological|C0449430|2105|MH|||RC
9283235|Drug Synergism|C0013215|2079|MH|||RC
9283235|Dose-Response Relationship, Drug|C0013059|2078|MH|||RC
9283235|Rats, Sprague-Dawley|C0034715|1382|MH|||RC
9283235|Organ Size|C1450569|1191|MH|||RC
9283235|Escape Reaction|C0014832|928|MH|||RC
9283235|Motor Activity|C0026606|845|MH|||RC
9283235|Receptors, GABA-A|C0034807|820|MH|||RC
9283235|Gastric Mucosa|C0017136|669|MH|||RC
9283235|Protein Binding|C0033618|646|MH|||RC
9283235|Drug Therapy, Combination|C0013218|524|MH|||RC
9283235|Time Factors|C0040225|507|MH|||RC
9283235|Disease Models, Animal|C0012644|481|MH|||RC
9283235|Reference Values|C0034926|314|MH|||RC
9283235|Calcium|C0006675|228|MH|||RC
------
9283235|Animals|C0003062|1000|CT|Rats, Wistar;Rats, Sprague-Dawley;Disease Models, Animal||RC
9283235|Rats|C0034721|1000|CT|Rats, Wistar;Rats, Sprague-Dawley||RC
9283235|Humans|C0086418|1000|CT|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|MM
9283235|Male|C0024554|1000|CT|CT Text Lookup: male|CT Text Lookup: male|MM
9283235|pharmacokinetics|C0031328|26946|SH1|RtM via: Pharmacokinetic;pharmacokinetics (C0031328);RtM via: Drug Kinetics;Pharmacokinetics (C0031327)|TI;AB|MM
9283235|methods|C0025664|80|SH|Methods|AB|MM
9335543|*Base Sequence|C0004793|304464|MH|RtM via: Base Sequence;RtM via: DNA Sequence|TI;AB|MM;RC
9335543|*Sodium-Hydrogen Antiporter|C0074785|256785|MH|RtM via: NHE1 Antiporter;RtM via: Sodium-Hydrogen Antiporter;RtM via: NHE2 Antiporter|TI;AB|MM;RC
9335543|Calmodulin|C0006772|73198|MH|RtM via: Calmodulin;RtM via: Calmodulin 1|AB|MM;RC
9335543|Molecular Sequence Data|C0026382|41073|MH|||RC
9335543|Ionomycin|C0022020|33137|MH|RtM via: Ionomycin|AB|MM;RC
9335543|Amino Acid Sequence|C0002518|31939|MH|||RC
9335543|Calcium|C0006675|25121|MH|RtM via: Calcium ion|AB|MM;RC
9335543|Sodium|C0037473|20602|MH|||RC
9335543|Cytoplasm|C0010834|15653|MH|RtM via: Protoplasm|AB|MM;RC
9335543|Binding Sites|C0005456|15538|MH|||RC
9335543|Hydrogen-Ion Concentration|C0020283|13596|MH|||RC
9335543|Thrombin|C0040018|13071|MH|RtM via: Thrombin|AB|MM;RC
9335543|Mutagenesis, Site-Directed|C0079870|11941|MH|||RC
9335543|Transfection|C0040669|11643|MH|||RC
9335543|Cell Line|C0007600|7121|MH|||RC
9335543|Biological Transport|C0005528|5902|MH|RtM via: Uptake|AB|MM;RC
9335543|Plasma Membrane|C0007603|5574|ET|Entry Term Replacement for "Cell Membrane";RtM via: Cell membrane|AB|MM;RC
9335543|Cells, Cultured|C0007635|5257|MH|||RC
9335543|Recombinant Fusion Proteins|C0034857|5135|MH|||RC
9335543|Isoforms|C0597298|5109|ET|Entry Term Replacement for "Protein Isoforms";RtM via: Protein Isoforms|AB|MM;RC
9335543|Kinetics|C0022702|4504|MH|||RC
9335543|Cricetulus|C0010320|4042|MH|||RC
9335543|Cloning, Molecular|C0009017|3530|MH|||RC
9335543|Protein Structure, Tertiary|C0162808|3395|MH|||RC
9335543|Amino Acid Substitution|C0525038|3193|MH|||RC
9335543|Adenosine Triphosphate|C0001480|2122|MH|||RC
9335543|Cell Membrane Permeability|C0007605|1986|MH|||RC
9335543|Mutation|C0026882|1684|MH|||RC
9335543|Tetradecanoylphorbol Acetate|C0039654|1680|MH|||RC
9335543|Dimerization|C0376525|1650|MH|||RC
9335543|Sequence Homology, Amino Acid|C0162777|1576|MH|||RC
9335543|Electrophoresis, Polyacrylamide Gel|C0013862|1271|MH|||RC
9335543|Osmotic Pressure|C0029393|1129|MH|||RC
9335543|Disulfides|C0012771|1099|MH|||RC
9335543|Cell Adhesion|C0007577|1041|MH|||RC
9335543|Protein Kinases|C0033640|1012|MH|||RC
9335543|Models, Molecular|C0026344|875|MH|||RC
9335543|Anti-Arrhythmia Agents|C0003195|859|MH|||RC
9335543|Cross-Linking Reagents|C0010360|739|MH|||RC
9335543|Peptide Fragments|C0030935|684|MH|||RC
9335543|Calmodulin-Dependent Protein Kinase II|C0248868|517|ET|Entry Term Replacement for "Calcium-Calmodulin-Dependent Protein Kinase Type 2";RtM via: calmodulin-dependent protein kinase II|AB|MM
9335543|Culture Media|C0010454|370|MH|||RC
9335543|Drug Stability|C0013210|310|MH|||RC
------
9335543|Rats|C0034721|125|CT||AB|MM
9335543|Animals|C0003062|1000|CT|Cricetulus;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9335543|Cricetinae|C0018557|1000|CT|Cricetulus||RC
9335543|genetics|C0017399|1111|SH|G05.360.080 (Base Sequence)|TI;AB|MM
9356063|*Blast Injury|C0005700|315552|ET|Entry Term Replacement for "Blast Injuries";RtM via: Blast Injuries|TI|MM;RC
9356063|Lung Injury|C0273115|54197|MH|||RC
9356063|Explosions|C0015329|47420|MH|RtM via: Blast (physical force)|AB|MM;RC
9356063|Lung|C0024109|19584|MH|RtM via: Lung|AB|MM;RC
9356063|Thoracic Injuries|C0039980|13594|MH|||RC
9356063|Respiration|C0035203|12051|MH|RtM via: Respiration|AB|MM;RC
9356063|Rats, Sprague-Dawley|C0034715|5749|MH|||RC
9356063|Abdominal Injuries|C0000733|5151|MH|||RC
9356063|Vagus Nerve|C0042276|5149|MH|||RC
9356063|Systemic Vascular Resistance|C1258192|5037|ET|Entry Term Replacement for "Vascular Resistance";RtM via: Total Peripheral Resistance|AB|MM;RC
9356063|Air Pressure|C0001876|4573|MH|||RC
9356063|Heart|C0018787|4389|MH|RtM via: Cardiopulmonary|AB|MM;RC
9356063|Stroke Volume|C0038455|2547|MH|RtM via: Stroke Volume|AB|MM;RC
9356063|Rats, Wistar|C0034716|2241|MH|||RC
9356063|Blood Pressure|C0005823|1781|MH|||RC
9356063|High-Energy Shock Waves|C0376484|1759|MH|||RC
9356063|Plasma Substitutes|C0032121|1639|MH|||RC
9356063|Embolism, Air|C0013926|1606|MH|||RC
9356063|Exercise Test|C0015260|1601|MH|||RC
9356063|Oxygen Consumption|C0030055|1575|MH|||RC
9356063|Disease Models, Animal|C0012644|1271|MH|||RC
9356063|Microcirculation|C0025962|1236|MH|||RC
9356063|Pressure|C0033095|1194|MH|RtM via: Pressure blast|AB|MM;RC
9356063|Bomb|C0441726|1064|ET|Entry Term Replacement for "Bombs";RtM via: Bomb device|AB|MM
9356063|Physical Conditioning, Animal|C0031802|893|MH|||RC
9356063|Sheep|C0036945|545|MH|||RC
9356063|Afferent Pathways|C0001728|508|MH|||RC
9356063|Peroxidase|C0027021|496|MH|||RC
9356063|Stress, Mechanical|C0038442|416|MH|||RC
9356063|Hypotension|C0020649|287|MH|RtM via: Hypotension|AB|MM
9356063|Shock|C0036974|268|MH|RtM via: Shock|AB|MM
9356063|Hypoxia|C0242184|261|ET|Entry Term Replacement for "Anoxia";RtM via: Hypoxia;RtM via: Hypoxia Adverse Event|AB|MM
------
9356063|Rats|C0034721|1717|CT||AB|MM
9356063|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;Rats, Wistar;Disease Models, Animal;Physical Conditioning, Animal;Sheep;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9356063|physiology|C0031843|4668|SH1|RtM via: Cardiopulmonary Physiology;RtM via: Physiology|TI|MM
9356063|injuries|C1510467|199|SH|Injury|AB|MM
9323920|Hepatitis B Antibodies|C0019164|576327|MH|RtM via: Hepatitis B Virus Surface Antibody;RtM via: Antibody to hepatitis B core antigen;RtM via: HEPATITIS B VIRUS CORE ANTIBODY.IMMUNOGLOBULIN M|AB|MM;RC
9323920|Hepatitis B|C0019163|524558|MH|RtM via: Hepatitis B|AB|MM;RC
9323920|Hepatitis B Vaccines|C2240392|419641|MH|||RC
9323920|Hepatitis B virus|C0019169|239506|MH|RtM via: Hepatitis B Virus|AB|MM;RC
9323920|Hepatitis B Surface Antigens|C0019168|221731|MH|||RC
9323920|*Health Personnel|C0018724|131067|MH|RtM via: Health Personnel|TI;AB|MM;RC
9323920|Vaccination|C0042196|80899|MH|RtM via: Vaccination|AB|MM;RC
9323920|Hepatitis C|C0019196|59394|MH|RtM via: Viral hepatitis|AB|MM;RC
9323920|Personnel, Hospital|C0031228|14310|MH|||RC
9323920|Infectious Disease Transmission, Patient-to-Professional|C0206229|11674|MH|||RC
9323920|Immunization, Secondary|C0020975|11044|MH|||RC
9323920|DNA, Viral|C0012939|10615|MH|||RC
9323920|Occupational Diseases|C0028797|9995|MH|||RC
9323920|Carrier State|C0560175|8629|MH|||RC
9323920|Occupational Exposure|C0028798|5071|MH|||RC
9323920|Universities|C0041740|4980|MH|RtM via: College|AB|MM;RC
9323920|Injections, Intradermal|C0021489|4552|MH|||RC
9323920|Occupational Health|C0079920|4255|MH|||RC
9323920|Antibodies, Viral|C0003253|4243|MH|||RC
9323920|Medical Staff, Hospital|C0025109|3366|MH|||RC
9323920|Injections, Intramuscular|C0021492|2686|MH|||RC
9323920|RNA, Viral|C0035736|2614|MH|||RC
9323920|Hospital|C0019994|2588|ET|Entry Term Replacement for "Hospitals";RtM via: Hospitals|AB|MM;RC
9323920|Health Knowledge, Attitudes, Practice|C0022758|2263|MH|||RC
9323920|Nursing Staff, Hospital|C0028699|2205|MH|||RC
9323920|*Research|C0035168|2049|MH|RtM via: hepatitis B markers;RtM via: Study Subject|TI;AB|MM
9323920|*Laboratory Techniques and Procedures|C0600201|1650|MH|RtM via: hepatitis B markers|TI|MM
9323920|Attitude of Health Personnel|C0004272|1551|MH|||RC
9323920|Health Policy|C0018735|1056|MH|||RC
9323920|National Health Programs|C0027459|1036|MH|||RC
9323920|Patient Compliance|C1321605|813|MH|||RC
9323920|Risk Factors|C0035648|660|MH|||RC
9323920|Questionnaires|C0034394|608|MH|||RC
9323920|Hepatitis A|C0019159|566|MH|RtM via: Viral hepatitis|AB|MM
9323920|False Positive Reactions|C0015563|451|MH|||RC
9323920|Time Factors|C0040225|387|MH|||RC
9323920|Treatment Outcome|C0085415|376|MH|||RC
------
9323920|organization & administration|C0029236|2376|SH|Organization and Administration|TI|MM
9323920|immunology|C1522005|1111|SH|D23.050.327.495.500.475 (Hepatitis B Surface Antigens)||MM
9323920|transmission|C0040722|1111|SH|N06.850.310.410 (Infectious Disease Transmission, Patient-to-Professional)||MM
9380133|*Pleural Neoplasms|C0032229|1180044|MH|RtM via: Malignant Pleural Mesothelioma;RtM via: Pleural Mesothelioma|TI;AB|MM;RC
9380133|*Mesothelioma|C0025500|1144635|MH|RtM via: Malignant Pleural Mesothelioma;RtM via: Pleural Mesothelioma|TI;AB|MM;RC
9380133|*Pain|C0030193|276930|MH|RtM via: Pain;RtM via: Actual Pain|TI|MM;RC
9380133|Opioids|C0242402|241121|ET|Entry Term Replacement for "Analgesics, Opioid";RtM via: Opioids|AB|MM;RC
9380133|*Pleura|C0032225|224931|MH|RtM via: Pleura|TI;AB|MM;RC
9380133|Pain, Intractable|C0030200|113776|MH|RtM via: Pain, Intractable|AB|MM;RC
9380133|Lung Neoplasms|C0024121|42225|MH|||RC
9380133|Occupational Exposure|C0028798|22606|MH|||RC
9380133|Solitary Pulmonary Nodule|C2350019|19003|MH|||RC
9380133|Pain Measurement|C0030198|15419|MH|||RC
9380133|Palliative Care|C0030231|12321|MH|||RC
9380133|Occupational Diseases|C0028797|9482|MH|||RC
9380133|*Nervous System Neoplasms|C0027766|8532|MH|RtM via: Malignant Pleural Mesothelioma|TI;AB|MM
9380133|Neoplasm Staging|C0027646|8122|MH|||RC
9380133|Incidence|C0021149|7603|MH|RtM via: Incidence|AB|MM;RC
9380133|Carcinogens|C0007090|7318|MH|||RC
9380133|Prognosis|C0033325|6552|MH|||RC
9380133|Tomography, X-Ray Computed|C0040405|5000|MH|||RC
9380133|Adjuvants, Pharmaceutic|C0001552|4190|MH|RtM via: Pharmaceutical Adjuvants|AB|MM;RC
9380133|Smoking|C0037369|2670|MH|||RC
9380133|Questionnaires|C0034394|1964|MH|||RC
9380133|Risk Factors|C0035648|1519|MH|||RC
9380133|*General Practice|C0086343|1464|ET|Entry Term Replacement for "Family Practice";RtM via: general practice (field)|TI;AB|MM
9380133|Age Factors|C0001783|958|MH|||RC
9380133|Time Factors|C0040225|483|MH|||RC
9380133|Internationality|C1138414|437|MH|||RC
9380133|Mining|C0026175|425|MH|RtM via: Mining|AB|MM
------
9380133|Humans|C0086418|1000|CT|Palliative Care;CT Text Lookup: aged;CT Text Lookup: men;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: aged;CT Text Lookup: men;CT Text Lookup: patient;CT Text Lookup: patients|MM;RC
9380133|Male|C0024554|1000|CT|CT Text Lookup: men|CT Text Lookup: men|MM
9380133|radiography|C0034571|1111|SH|E01.370.350.700.700.810 (Tomography, X-Ray Computed)||MM
9303578|*Endothelin Receptor|C0059285|1362168|ET|Entry Term Replacement for "Receptors, Endothelin";RtM via: Endothelin Receptor|TI|MM;RC
9303578|Endothelins|C0079284|337145|MH|RtM via: Endothelin|AB|MM;RC
9303578|Endothelin-1|C0079281|223031|MH|RtM via: Endothelin-1|AB|MM;RC
9303578|Receptor, Endothelin B|C0218584|200816|MH|||RC
9303578|Receptor, Endothelin A|C0217843|170356|MH|||RC
9303578|cyclo(Trp-Asp-Pro-Val-Leu)|C0905077|169881|NM|RtM via: BQ 123|AB|MM
9303578|Peptides, Cyclic|C0030957|169880|HM|RtM via: BQ 123|AB|MM;RC
9303578|Vasoconstriction|C0042396|88220|MH|RtM via: Vascular constriction (function)|AB|MM;RC
9303578|Prostacyclin|C0033567|55773|ET|Entry Term Replacement for "Epoprostenol";RtM via: Epoprostenol|AB|MM;RC
9303578|Bronchoconstriction|C0079043|41137|MH|RtM via: Bronchoconstriction|AB|MM;RC
9303578|Lung|C0024109|26490|MH|RtM via: Lung|AB|MM;RC
9303578|Vasoconstrictor Agents|C0042397|23346|MH|||RC
9303578|Peptide Fragments|C0030935|17321|MH|||RC
9303578|Antihypertensive Agents|C0003364|13540|MH|||RC
9303578|Rats, Wistar|C0034716|11951|MH|||RC
9303578|Respiratory Mechanics|C0035230|11455|MH|||RC
9303578|Pulmonary Circulation|C0034057|8355|MH|||RC
9303578|Nitric Oxide|C0028128|5498|MH|||RC
9303578|Vasodilator Agents|C0042402|5178|MH|||RC
9303578|Vasodilation|C0042401|5119|MH|||RC
9303578|6-Ketoprostaglandin F1 alpha|C0000617|4730|MH|||RC
9303578|Rats, Sprague-Dawley|C0034715|4681|MH|||RC
9303578|Pulmonary Artery|C0034052|4576|MH|||RC
9303578|Muscle, Smooth, Vascular|C0026844|4074|MH|||RC
9303578|Blood Pressure|C0005823|3706|MH|||RC
9303578|Viper Venoms|C0042700|3322|MH|||RC
9303578|Muscle, Smooth|C1267092|3252|MH|||RC
9303578|Endothelium, Vascular|C0014261|2309|MH|||RC
9303578|Carotid Arteries|C0007272|1819|MH|||RC
9303578|Muscle Contraction|C0026820|1731|MH|||RC
9303578|Cardiovascular Diseases|C0007222|1367|MH|||RC
9303578|Myocardium|C0027061|1133|MH|||RC
9303578|Potassium Chloride|C0032825|951|MH|||RC
9303578|Oxygen Consumption|C0030055|935|MH|||RC
9303578|Dose-Response Relationship, Drug|C0013059|827|MH|||RC
9303578|RNA, Messenger|C0035696|656|MH|||RC
9303578|Reverse Transcriptase Polymerase Chain Reaction|C0599161|621|MH|||RC
9303578|IC50|C0600495|425|ET|Entry Term Replacement for "Inhibitory Concentration 50";RtM via: Inhibitory Concentration 50|AB|MM
9303578|Self Administration|C0036589|403|MH|||RC
9303578|Image Processing, Computer-Assisted|C0020911|359|MH|||RC
9303578|Area Under Curve|C0376690|311|MH|||RC
9303578|Electric Stimulation|C0013786|299|MH|||RC
9303578|prostaglandin F1|C0072279|253|NM|RtM via: Prostaglandin F>1< alpha|AB|MM
9303578|Prostaglandins F|C0033561|252|HM|RtM via: Prostaglandin F>1< alpha|AB|MM
------
9303578|Rats|C0034721|41055|CT||TI;AB|MM
9303578|Animals|C0003062|1000|CT|Rats, Wistar;Rats, Sprague-Dawley;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9303578|methods|C0025664|55|SH|Methods|AB|MM
9358126|desirudin|C0378366|1899504|NM|RtM via: desirudin|AB|MM
9358126|*Hirudins|C1451270|1899503|MH|RtM via: lepirudin;RtM via: desirudin|TI;AB|MM;RC
9358126|lepirudin|C0772394|1892878|NM|RtM via: lepirudin|TI;AB|MM
9358126|*Heparin, Low-Molecular-Weight|C0019139|1522169|MH|RtM via: Heparin, Low-Molecular-Weight;RtM via: Low Molecular Weight Heparin External Pharmacologic Class;Forced Lookup:low-molecular-weight heparin|TI;AB|MM;RC
9358126|*Thromboembolism|C0040038|1262487|MH|RtM via: Thromboembolic|TI;AB|MM;RC
9358126|Enoxaparin|C0206460|664956|MH|RtM via: Enoxaparin|AB|MM;RC
9358126|*Hip Replacement, Total|C0040508|325998|ET|Entry Term Replacement for "Arthroplasty, Replacement, Hip";RtM via: Total Hip Replacement (procedure)|TI;AB|MM;RC
9358126|Anticoagulants|C0003280|258462|MH|||RC
9358126|Deep Vein Thrombosis|C0149871|255755|ET|Entry Term Replacement for "Venous Thrombosis";RtM via: Deep Vein Thrombosis;RtM via: Venous Thrombosis;RtM via: Deep vein thrombosis of lower limb|AB|MM;RC
9358126|*Recombinant Proteins|C0034861|246670|MH|RtM via: lepirudin;RtM via: desirudin|TI;AB|MM;RC
9358126|Hip Prosthesis|C0019560|70026|MH|||RC
9358126|Postoperative Complications|C0032787|38374|MH|||RC
9358126|Venography|C0031545|33974|ET|Entry Term Replacement for "Phlebography";RtM via: Venography - procedure|AB|MM;RC
9358126|Fibrin Fibrinogen Degradation Products|C0163275|23866|MH|||RC
9358126|Fibrinolytic Agents|C0016018|15462|MH|||RC
9358126|Double-Blind Method|C0013072|13860|MH|RtM via: Double-Blind Method|AB|MM;RC
9358126|Injections, Subcutaneous|C0021499|6640|MH|||RC
9358126|Treatment Outcome|C0085415|2902|MH|||RC
9358126|Risk|C0035647|2762|MH|RtM via: Risk|AB|MM;RC
9358126|Risk Factors|C0035648|2590|MH|||RC
9358126|Drug Administration Schedule|C0013154|1883|MH|||RC
9358126|Peptide Fragments|C0030935|1545|MH|||RC
9358126|Dose-Response Relationship, Drug|C0013059|1262|MH|||RC
9358126|Thrombin|C0040018|1237|MH|RtM via: Thrombin|AB|MM
------
9358126|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9358126|diagnosis|C1704338|2112|SH1|RtM via: Complication;Diagnosis (C0011900);RtM via: Aspects of signs;diagnosis (C1704338)|TI;AB|MM
9358126|complications|C1171258|2088|SH1|RtM via: Complication Aspects;complications (C1171258)|TI;AB|MM
9358126|therapy|C0039798|555|SH1|RtM via: therapeutic aspects;therapy (C0039798)|AB|MM
9358126|surgery|C0038895|1111|SH1|RtM via: Surgical aspects;surgery (C0038895);RtM via: Operative Surgical Procedures;Surgical Procedures, Operative (C0543467)|AB|MM
9358126|drug therapy|C0013217|9999|SH|new SH add rule - Hirudin Therapy [E02.319.913.500] (E02.319)||MM
9358126|radiography|C0034571|1111|SH|E01.370.350.700.060.600 (Venography)|AB|MM
9377034|Occupational Exposure|C0028798|99915|MH|||RC
9377034|Occupational Diseases|C0028797|89609|MH|||RC
9377034|Fire|C0016141|52725|ET|Entry Term Replacement for "Fires";RtM via: Fire - disasters;RtM via: Fire - physical phenomenon|AB|MM;RC
9377034|Air Pollutants, Occupational|C0001871|48540|MH|||RC
9377034|Environmental Exposure|C0014412|13572|MH|||RC
9377034|Rescue Work|C0242857|12540|MH|||RC
9377034|Accidents|C0000924|12250|MH|RtM via: Fire - physical phenomenon;RtM via: Fire as a heat source|AB|MM;RC
9377034|Sick Leave|C0242807|11665|MH|||RC
9377034|Neuroses|C0027932|5846|ET|Entry Term Replacement for "Neurotic Disorders";RtM via: Neurotic Disorders|AB|MM;RC
9377034|Environmental Monitoring|C0014416|5452|MH|||RC
9377034|Transportation|C0040756|4674|MH|||RC
9377034|*Human Activities|C0020115|4539|MH|RtM via: Fire fighter|TI|MM
9377034|Agriculture|C0001829|3913|MH|||RC
9377034|Time Factors|C0040225|1782|MH|||RC
9377034|Patient Admission|C0030673|1631|MH|||RC
9377034|*Population Groups|C1257890|1527|MH|RtM via: Fire fighter|TI|MM
9377034|World Health|C0043236|1455|MH|||RC
9377034|*Drug Toxicity|C0013221|1425|MH|RtM via: Adverse effects|TI|MM
9377034|Neuropsychological Tests|C0027902|1305|MH|||RC
9377034|Risk Factors|C0035648|850|MH|||RC
9377034|Age Distribution|C0001782|762|MH|||RC
9377034|Cognition|C0009240|745|MH|||RC
9377034|Psychomotor Performance|C0033923|584|MH|||RC
9377034|Diagnosis, Differential|C0011906|375|MH|||RC
9377034|Titanium|C0040302|254|MH|||RC
------
9377034|Humans|C0086418|1000|CT|Patient Admission;Population Groups|TI|MM;RC
9377034|adverse effects|C0001688|9315|SH1|RtM via: aspects of adverse effects|TI|MM
9377034|injuries|C1510467|7879|SH|Wounds and Injuries|AB|MM;RC
9377034|therapy|C0039798|3639|SH|Therapeutics|TI|MM
9377034|methods|C0025664|5|SH|Methods|AB|MM
9322672|*Thoracic Outlet Syndrome|C0039984|1630521|MH|RtM via: Thoracic Outlet Syndrome|TI;AB|MM;RC
9322672|Cervical Ribs|C0158779|96036|ET|Entry Term Replacement for "Cervical Rib";RtM via: Cervical rib;Forced New Lookup:cervical rib;Forced New Lookup:cervical ribs|AB|MM
9322672|Venography|C0031545|44906|ET|Entry Term Replacement for "Phlebography";RtM via: Venography - procedure|AB|MM;RC
9322672|Venous Thrombosis|C0042487|44487|MH|RtM via: Venous Thrombosis;RtM via: Venous thrombosis after immobility|AB|MM;RC
9322672|Thrombosis|C0040053|37880|MH|RtM via: Embolus upper extremity|AB|MM;RC
9322672|Aneurysm|C0002940|33311|MH|RtM via: Aneurysm of subclavian artery|AB|MM;RC
9322672|Decompression, Surgical|C0376530|24407|MH|RtM via: Decompression, Surgical;RtM via: Decompressive incision|AB|MM;RC
9322672|Angioplasty, Balloon|C0002996|20257|MH|RtM via: Angioplasty, Balloon|AB|MM;RC
9322672|Blood Vessel Prosthesis Implantation|C0525022|19595|MH|||RC
9322672|Embolism|C0013922|14102|MH|RtM via: Arterial embolism;RtM via: Embolus upper extremity|AB|MM;RC
9322672|Fibrinolytic Agents|C0016018|11094|MH|||RC
9322672|Stents|C0038257|10502|MH|||RC
9322672|Endarterectomy|C0014098|10215|MH|RtM via: Endarterectomy|AB|MM;RC
9322672|*Blood Vessels|C0005847|8289|MH|RtM via: Blood Vessels|TI;AB|MM
9322672|Angioplasty, Transluminal, Percutaneous Coronary|C0002997|6835|MH|||RC
9322672|Treatment Outcome|C0085415|4695|MH|||RC
9322672|Ultrasonography, Doppler, Duplex|C0242845|4124|MH|||RC
9322672|Vascular Patency|C0042377|4072|MH|||RC
9322672|Time Factors|C0040225|2426|MH|||RC
9322672|Intraoperative Period|C0021891|1362|MH|||RC
9322672|Patient Selection|C0242802|938|MH|||RC
9322672|Posture|C1262869|633|MH|||RC
9322672|Algorithms|C0002045|472|MH|||RC
9322672|Combined Modality Therapy|C0009429|347|MH|||RC
9322672|Exercise|C0015259|251|MH|||RC
------
9322672|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9322672|diagnosis|C1704338|1047|SH1|RtM via: vascular complications;Diagnosis (C0011900);RtM via: Symptoms;Diagnosis (C0011900);RtM via: Symptoms aspect;diagnosis (C1704338)|TI;AB|MM
9322672|surgery|C0038895|1111|SH1|RtM via: Stenting;Surgical Procedures, Operative (C0543467);RtM via: Excision;Surgical Procedures, Operative (C0543467)|AB|MM
9322672|methods|C0025664|1044|SH|Methods|AB|MM;RC
9322672|radiography|C0034571|1111|SH|E01.370.350.700.060.600 (Venography)|AB|MM
9322672|ultrasonography|C0175676|1111|SH|E01.370.350.850.850.850 (Ultrasonography, Doppler, Duplex)||MM
9379505|*Carcinoma, Non-Small-Cell Lung|C0007131|5885961|MH|RtM via: Carcinoma, Non-Small-Cell Lung|TI;AB|MM;RC
9379505|*Tumor Suppressor Protein p53|C0080055|513207|MH|RtM via: Protein p53|TI;AB|MM;RC
9379505|Lung Neoplasms|C0024121|443788|MH|||RC
9379505|*Mutation|C0026882|318498|MH|RtM via: Mutation|TI;AB|MM;RC
9379505|Adenocarcinomas|C0001418|276971|ET|Entry Term Replacement for "Adenocarcinoma";RtM via: Adenocarcinoma|AB|MM;RC
9379505|Polymorphism, Single-Stranded Conformational|C0243031|182338|MH|RtM via: Single-Stranded Conformational Polymorphism|AB|MM;RC
9379505|Neoplasm Staging|C0027646|165487|MH|RtM via: Tumor stage|AB|MM;RC
9379505|Adenosquamous Carcinomas|C0206623|157312|ET|Entry Term Replacement for "Carcinoma, Adenosquamous";RtM via: Adenosquamous carcinoma|AB|MM;RC
9379505|Exons|C0015295|69099|MH|RtM via: Exons|AB|MM;RC
9379505|Prognosis|C0033325|36342|MH|||RC
9379505|Lymphatic Metastasis|C0024232|30354|MH|||RC
9379505|Molecular Sequence Data|C0026382|23651|MH|||RC
9379505|Receptor, Epidermal Growth Factor|C0034802|20850|MH|||RC
9379505|ras Proteins|C0242853|17301|MH|||RC
9379505|Rates, Survival|C0038954|16903|ET|Entry Term Replacement for "Survival Rate";RtM via: Survival Rate|AB|MM;RC
9379505|Smoking|C0037369|13058|MH|||RC
9379505|Gene Amplification|C0017256|11671|MH|||RC
9379505|Gene Expression Regulation, Neoplastic|C0017268|11140|MH|||RC
9379505|Proto-Oncogene Proteins c-met|C0072453|9837|MH|||RC
9379505|Genetic Testing|C0679560|9808|MH|||RC
9379505|Proto-Oncogene Proteins c-bcl-2|C0107696|8639|MH|||RC
9379505|Neoplasm Recurrence, Local|C0027643|7518|MH|||RC
9379505|Tissue Fixation|C0085254|3805|MH|||RC
9379505|Analyses, Multivariate|C0026777|2423|ET|Entry Term Replacement for "Multivariate Analysis";RtM via: Multivariate Analysis|AB|MM;RC
9379505|RNA, Messenger|C0035696|2109|MH|||RC
9379505|Risk Factors|C0035648|1140|MH|||RC
9379505|Lung|C0024109|522|MH|RtM via: Lung;RtM via: Entire lung|AB|MM
9379505|Tumor Burden|C1449699|360|MH|RtM via: Large tumor|AB|MM
9379505|Epithelial Cells|C0014597|245|MH|RtM via: Squamous epithelial cell;RtM via: Bronchial Epithelial Cell|AB|MM
------
9379505|Humans|C0086418|1000|CT|Genetic Testing;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM;RC
9379505|genetics|C0017399|1111|SH|G05.365.590 (Mutation)|TI;AB|MM
9331500|*Bone Marrow Transplantation|C0005961|815619|MH|RtM via: Autologous bone marrow transplant|TI;AB|MM;RC
9331500|*Colony-Forming Units Assay|C0009385|655059|MH|RtM via: Colony-Forming Units Assay|TI|MM;RC
9331500|*Autograft|C0040736|428406|ET|Entry Term Replacement for "Transplantation, Autologous";RtM via: Autologous bone marrow transplant;RtM via: Transplantation, Autologous|TI;AB|MM;RC
9331500|*Bone Marrow|C0005953|379959|MH|RtM via: Bone Marrow;RtM via: Marrow|TI;AB|MM;RC
9331500|*Neutrophils|C0027950|330255|MH|RtM via: neutrophil|TI;AB|MM;RC
9331500|Lymphoma, Non-Hodgkin's|C0024305|270343|ET|Entry Term Replacement for "Lymphoma, Non-Hodgkin";RtM via: Lymphoma, Non-Hodgkin's;Forced Lookup:non-hodgkin's lymphoma|AB|MM;RC
9331500|*Platelet Count|C0032181|216744|MH|RtM via: Platelet Count measurement|TI;AB|MM;RC
9331500|Granulocyte|C0018183|185676|ET|Entry Term Replacement for "Granulocytes";RtM via: granulocyte|AB|MM;RC
9331500|Disease, Hodgkin|C0019829|148411|ET|Entry Term Replacement for "Hodgkin Disease";RtM via: Hodgkins Disease|AB|MM;RC
9331500|Stem Cells|C0038250|112132|MH|Forced Lookup:colony-forming unit||MM;RC
9331500|Leukocyte Count|C0023508|92583|MH|RtM via: Absolute neutrophil count|AB|MM;RC
9331500|Granulocyte-Macrophage Progenitor Cells|C2350243|90406|MH|RtM via: Granulocyte-Macrophage Colony Forming Units;Forced Lookup:cfu-gm|AB|MM
9331500|Hematopoietic Stem Cell Transplantation|C0472699|70194|MH|||RC
9331500|Macrophage|C0024432|46420|ET|Entry Term Replacement for "Macrophages";RtM via: macrophage|AB|MM;RC
9331500|*Platelet|C0005821|40485|ET|Entry Term Replacement for "Blood Platelets";RtM via: Blood Platelets|TI;AB|MM
9331500|Etoposide|C0015133|40381|MH|RtM via: Etoposide|AB|MM;RC
9331500|Bone Marrow Cells|C0005955|33685|MH|||RC
9331500|Transplantation, Allogeneic|C0040739|31965|ET|Entry Term Replacement for "Transplantation, Homologous";RtM via: Transplantation, Homologous|AB|MM;RC
9331500|Melphalan|C0025241|21812|MH|RtM via: Melphalan|AB|MM;RC
9331500|*Leukocytes|C0023516|20679|MH|RtM via: Mononuclear cell count|TI;AB|MM
9331500|Antineoplastic Combined Chemotherapy Protocols|C0003393|14638|MH|||RC
9331500|*Immunologic Factors|C0021054|9177|MH|RtM via: Colony forming unit-granulocyte/macrophage assay|TI|MM
9331500|Combined Modality Therapy|C0009429|9137|MH|||RC
9331500|Leukocytes, Mononuclear|C0023517|6436|MH|||RC
9331500|Erythroid Precursor Cells|C0014802|5709|MH|||RC
9331500|Cell Differentiation|C0007589|5668|MH|||RC
9331500|Immunosuppressive Agents|C0021081|5337|MH|||RC
9331500|Graft Survival|C0018131|4581|MH|||RC
9331500|Drug Therapy, Combination|C0013218|3930|MH|||RC
9331500|Graft Rejection|C0018129|3060|MH|||RC
9331500|Prognosis|C0033325|1481|MH|||RC
9331500|Treatment Outcome|C0085415|1305|MH|||RC
9331500|Hematologic Malignancies|C0376545|1299|ET|Entry Term Replacement for "Hematologic Neoplasms";RtM via: Hematologic Neoplasms|AB|MM
9331500|Dose-Response Relationship, Drug|C0013059|960|MH|||RC
9331500|Length of Stay|C0023303|853|MH|||RC
9331500|Kinetics|C0022702|460|MH|||RC
9331500|Time Factors|C0040225|450|MH|||RC
9331500|Outcome Assessment (Health Care)|C0085565|414|MH|||RC
9331500|Cell Count|C0007584|300|MH|RtM via: Cell Count|AB|MM
------
9331500|Humans|C0086418|1000|CT|Length of Stay;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM;RC
9331500|methods|C0025664|16|SH|Methods|AB|MM
9331500|transplantation|C0029216|1111|SH|E04.936.580.040 (Bone Marrow Transplantation)|TI;AB|MM
9331500|surgery|C0038895|1111|SH|E04.936.664 (Autograft)|TI;AB|MM
9382486|*Proteases|C0030940|73296|ET|Entry Term Replacement for "Peptide Hydrolases";RtM via: Peptide Hydrolases|TI|MM;RC
9382486|*Hemoglobins|C0019046|40986|MH|RtM via: Hemoglobin|TI;AB|MM;RC
9382486|*Taste|C0039336|27696|MH|RtM via: Feeling bitter;RtM via: Taste Perception;RtM via: bitter|TI;AB|MM;RC
9382486|2-butanol|C0045967|26309|NM|Forced Lookup:2-butanol||MM
9382486|Butanols|C0001977|26308|HM|RtM via: Butanols|AB|MM
9382486|Peptides|C0030956|16660|MH|RtM via: Peptides|AB|MM;RC
9382486|Hydrolysis|C0020291|14859|MH|RtM via: Hydrolysis|AB|MM;RC
9382486|Papain|C0030346|9828|MH|RtM via: Papain|AB|MM;RC
9382486|Alcalase|C0038597|7648|ET|Entry Term Replacement for "Subtilisins";RtM via: Subtilisin Carlsberg|AB|MM;RC
9382486|Amino Acid Sequence|C0002518|7378|MH|||RC
9382486|Molecular Sequence Data|C0026382|6683|MH|||RC
9382486|Peptide Fragments|C0030935|5453|MH|||RC
9382486|Ultrafiltration|C0041612|4914|MH|RtM via: Ultrafiltration (procedure);RtM via: Ultrafiltration Issue Associated with Medical Device|AB|MM;RC
9382486|Food Handling|C0016469|3137|MH|||RC
9382486|Chromatography|C0008550|2813|MH|RtM via: Column Chromatography|AB|MM;RC
9382486|Nutritive Value|C0028722|2709|MH|||RC
9382486|Chromatography, High Pressure Liquid|C0008562|1894|MH|||RC
9382486|Dietary Proteins|C0012177|1553|MH|||RC
9382486|Health Food|C0282679|1481|MH|||RC
9382486|Muscle, Smooth|C1267092|1025|MH|||RC
9382486|Antigens|C0003320|1005|MH|RtM via: Compound (substance)|AB|MM;RC
9382486|Plant Proteins|C0032089|850|MH|||RC
9382486|Microbial Sensitivity Tests|C0025948|771|MH|||RC
9382486|Muscle Contraction|C0026820|769|MH|||RC
9382486|Electrophoresis, Polyacrylamide Gel|C0013862|721|MH|||RC
9382486|Hot Temperature|C2350229|715|MH|||RC
9382486|Free Radical Scavengers|C0079381|328|MH|||RC
9382486|Anti-Bacterial Agents|C0279516|315|MH|||RC
9382486|Superose 12|C0075646|277|NM|RtM via: Superose 12|AB|MM
9382486|Sepharose|C0036681|276|HM|RtM via: Superose 12|AB|MM
------
9382486|Cattle|C0007452|92|CT||AB|MM
9382486|Animals|C0003062|1000|CT|CT Text Lookup: bovine|CT Text Lookup: bovine|MM
9382486|surgery|C0038895|1111|SH1|RtM via: Extraction;Surgical Procedures, Operative (C0543467)|AB|MM
9382486|methods|C0025664|9|SH|Methods|AB|MM
9382486|immunology|C1522005|1111|SH|D23.050 (Antigens)|AB|MM
9335335|*DNA Replication|C0598312|2447316|MH|RtM via: DNA biosynthesis;RtM via: DNA Replication Fork;RtM via: DNA replication origin|TI;AB|MM;RC
9335335|*S Phase|C0080129|1710729|MH|RtM via: S Phase|TI;AB|MM;RC
9335335|Eucarya|C0684063|815771|ET|Entry Term Replacement for "Eukaryota";RtM via: Eukaryota|AB|MM
9335335|Saccharomyces cerevisiae Proteins|C0949987|432415|MH|||RC
9335335|Fungal Proteins|C0016829|341582|MH|||RC
9335335|Cell Cycle Proteins|C0243021|313925|MH|||RC
9335335|Saccharomyces cerevisiae|C0036025|300744|MH|||RC
9335335|Nuclear Proteins|C0028589|240841|MH|||RC
9335335|Chromosomes, Fungal|C0008642|190873|MH|||RC
9335335|DNA, Fungal|C0012927|183119|MH|||RC
9335335|G1 Phase|C0079395|97037|MH|RtM via: G1 Phase|AB|MM;RC
9335335|Cell Nucleus|C0007610|56943|MH|RtM via: Pre-Replication Complex|AB|MM;RC
9335335|*Proteins|C0033684|35961|MH|RtM via: MCM Protein;RtM via: Pre-Replication Complex|TI;AB|MM
9335335|Schizosaccharomyces pombe Proteins|C0949988|31942|MH|||RC
9335335|Protein Binding|C0033618|22736|MH|||RC
9335335|Protein Kinases|C0033640|20374|MH|||RC
9335335|Adenosine Triphosphatases|C0001473|16537|MH|||RC
9335335|G2 Phase|C0079396|15504|MH|||RC
9335335|Molecular Sequence Data|C0026382|13657|MH|||RC
9335335|Amino Acid Sequence|C0002518|13535|MH|||RC
9335335|Mutation|C0026882|12611|MH|||RC
9335335|DNA Polymerase epsilon|C0012889|7018|ET|Entry Term Replacement for "DNA Polymerase II";RtM via: DNA Polymerase II|AB|MM
9335335|Binding Sites|C0005456|6912|MH|||RC
9335335|Peptide Chain Initiation, Translational|C1448475|5990|MH|||RC
9335335|Cloning, Molecular|C0009017|4081|MH|||RC
9335335|Subcellular Fractions|C0038528|3335|MH|||RC
9335335|Temperature|C0039476|3130|MH|||RC
9335335|Thermodynamics|C0039808|2743|MH|||RC
9335335|Cross-Linking Reagents|C0010360|2493|MH|||RC
9335335|Crosses, Genetic|C0010364|1544|MH|||RC
9335335|Transcription, Genetic|C0040649|322|MH|RtM via: Initiation;RtM via: Transcription Initiation|AB|MM
------
9335335|instrumentation|C0021632|48|SH|Equipment and Supplies|TI;AB|MM
9335335|methods|C0025664|10|SH|Methods|AB|MM
9335335|genetics|C0017399|1111|SH|G05.355.200 (DNA Replication)|TI;AB|MM
9330258|*Anopheles|C0003117|1015266|MH|RtM via: Anopheles stephensi mysorensis|TI;AB|MM;RC
9330258|Plasmodium yoelii|C0032155|328935|MH|RtM via: Plasmodium yoelii|AB|MM;RC
9330258|*Infection, Plasmodium|C0024530|285297|ET|Entry Term Replacement for "Malaria";RtM via: Malaria|TI|MM;RC
9330258|*Egg|C0029974|116346|ET|Entry Term Replacement for "Ovum";RtM via: Ovum|TI|MM;RC
9330258|Insect Vectors|C0021573|42969|MH|||RC
9330258|Ovary|C0029939|30310|MH|RtM via: Ovary;RtM via: Entire ovary|AB|MM;RC
9330258|Fecundity|C0015895|19286|ET|Entry Term Replacement for "Fertility";RtM via: Fertility|AB|MM;RC
9330258|Ovarian Follicle|C0018120|15111|MH|RtM via: Ovarian Follicle|AB|MM;RC
9330258|Oviposition|C0029957|8538|MH|||RC
9330258|Insect Bites and Stings|C0021568|4542|MH|||RC
9330258|Host-Parasite Interactions|C0020034|3771|MH|||RC
9330258|Feeding Behavior|C0015745|1343|MH|||RC
9330258|Apoptosis|C0162638|500|MH|||RC
9330258|Oogenesis|C0029047|473|MH|RtM via: Oogenesis|AB|MM
9330258|Digestion|C0012238|457|MH|||RC
9330258|Epithelial Cells|C0014597|386|MH|||RC
9330258|*Physiological Processes|C0031845|312|MH|RtM via: Development|TI;AB|MM
------
9330258|Animals|C0003062|1000|CT|Anopheles;Insect Vectors|TI;AB|MM;RC
9330258|Female|C0015780|1000|CT|Ovary;Ovarian Follicle;CT Text Lookup: female;CT Text Lookup: females;CT Text Lookup: ovary|AB;CT Text Lookup: female;CT Text Lookup: females;CT Text Lookup: ovary|MM;RC
9330258|growth & development|C1457898|2433|SH1|RtM via: Biologic Development;Growth and Development (C0018271);RtM via: development aspects;growth & development (C1457898)|TI;AB|MM
9330258|therapy|C0039798|10|SH|Therapeutics|AB|MM
9330258|classification|C0008903|2|SH|Classification|AB|MM
9330258|transmission|C0040722|1111|SH|N06.850.310.350.100.500 (Insect Vectors)||MM
9346280|*Protein Kinase CK2|C0108555|456978|ET|Entry Term Replacement for "Casein Kinase II";RtM via: casein kinase II|TI;AB|MM;RC
9346280|*Catalytic Subunit|C0600499|224850|ET|Entry Term Replacement for "Catalytic Domain";RtM via: Catalytic Domain|TI;AB|MM;RC
9346280|Protein-Threonine Kinase|C0072402|132018|ET|Entry Term Replacement for "Protein-Serine-Threonine Kinases";RtM via: Protein-Serine-Threonine Kinases|AB|MM;RC
9346280|Phosphorylation|C0031715|116438|MH|RtM via: Phosphorylation|AB|MM;RC
9346280|Amino Acid Sequence|C0002518|57340|MH|||RC
9346280|Molecular Sequence Data|C0026382|47103|MH|||RC
9346280|polypeptide C|C0071642|46353|NM|RtM via: polypeptide C|AB|MM
9346280|Peptides|C0030956|46352|MH|RtM via: Peptides;RtM via: polypeptide C|AB|MM;RC
9346280|Calmodulin|C0006772|44324|MH|RtM via: Calmodulin;RtM via: Calmodulin 1|AB|MM;RC
9346280|Protein Kinases|C0033640|30557|MH|||RC
9346280|Down-Regulation|C0013081|24209|MH|RtM via: Down-Regulation|AB|MM;RC
9346280|Binding Sites|C0005456|21018|MH|||RC
9346280|Holoenzymes|C0282109|17368|MH|RtM via: Holoenzymes|AB|MM;RC
9346280|Peptide Fragments|C0030935|14421|MH|||RC
9346280|Serine|C0036720|12531|MH|RtM via: Serine|AB|MM;RC
9346280|Base Sequence|C0004793|12400|MH|RtM via: DNA Sequence|AB|MM;RC
9346280|Substrate Specificity|C0038592|11480|MH|||RC
9346280|Mutation|C0026882|10532|MH|RtM via: Mutation;RtM via: Mutate|AB|MM;RC
9346280|Structure-Activity Relationship|C0038477|9679|MH|||RC
9346280|Kinetics|C0022702|9328|MH|||RC
9346280|Protein Structure, Tertiary|C0162808|9046|MH|||RC
9346280|Mutagenesis, Site-Directed|C0079870|8428|MH|||RC
9346280|Protein Binding|C0033618|7183|MH|||RC
9346280|Amino Acid Substitution|C0525038|6120|MH|||RC
9346280|Conserved Sequence|C0009802|5185|MH|||RC
9346280|Dimerization|C0376525|4799|MH|||RC
9346280|Protein Conformation|C0033625|3885|MH|||RC
9346280|Catalysis|C0007382|3606|MH|RtM via: Catalysis|AB|MM;RC
9346280|Polylysine|C0032518|3113|MH|||RC
9346280|Sequence Homology, Amino Acid|C0162777|3072|MH|||RC
9346280|Cloning, Molecular|C0009017|2855|MH|||RC
9346280|Transfection|C0040669|2522|MH|||RC
9346280|Models, Molecular|C0026344|1854|MH|||RC
9346280|Polyamines|C0032433|1392|MH|||RC
9346280|Escherichia coli|C0014834|1363|MH|||RC
9346280|Xenopus laevis|C0043343|1363|MH|||RC
9346280|Hydrogen-Ion Concentration|C0020283|1312|MH|||RC
9346280|Calcium|C0006675|1181|MH|||RC
9346280|Temperature|C0039476|982|MH|||RC
9346280|Hot Temperature|C2350229|806|MH|||RC
9346280|Potassium Chloride|C0032825|641|MH|||RC
------
9346280|Animals|C0003062|1000|CT|Xenopus laevis||RC
9346280|methods|C0025664|92|SH|Methods|AB|MM
9346280|genetics|C0017399|1111|SH|G05.355.315.200 (Down-Regulation)|AB|MM
9378063|*Hydrothorax|C0020312|1673157|MH|RtM via: Hydrothorax|TI;AB|MM;RC
9378063|*Portasystemic Shunt, Transjugular Intrahepatic|C0339897|1516602|MH|RtM via: Transjugular intrahepatic portosystemic shunt procedure|TI;AB|MM;RC
9378063|Hypertension, Portal|C0020541|100750|MH|RtM via: Hypertension, Portal|AB|MM;RC
9378063|Liver Cirrhosis|C0023890|99167|MH|RtM via: Liver Cirrhosis|AB|MM;RC
9378063|Ascites|C0003962|65353|MH|RtM via: Ascites|AB|MM;RC
9378063|*Portasystemic Shunt|C0032720|45366|ET|Entry Term Replacement for "Portasystemic Shunt, Surgical";RtM via: Transjugular intrahepatic portosystemic shunt morphologic abnormality;RtM via: Surgical Portosystemic Shunt;RtM via: Portasystemic shunt (finding)|TI;AB|MM
9378063|Pleural Effusion|C0032227|41571|MH|RtM via: Pleural effusion disorder;RtM via: right-sided pleural effusion;RtM via: chest x-ray pleural effusion|AB|MM;RC
9378063|*Treatment Outcome|C0085415|36171|MH|RtM via: treatment success|TI|MM;RC
9378063|*Primary Biliary Cirrhosis|C0008312|12186|ET|Entry Term Replacement for "Liver Cirrhosis, Biliary";RtM via: Primary biliary cirrhosis|TI;AB|MM
9378063|*Stent|C0038257|4614|ET|Entry Term Replacement for "Stents";RtM via: Stent, device;RtM via: Stent Device Component|TI;AB|MM
9378063|Respiration Disorders|C0035204|2671|MH|RtM via: Decreased breath sounds|AB|MM;RC
9378063|Portal Pressure|C0162523|2552|MH|RtM via: Portal Pressure|AB|MM
9378063|Radiography, Thoracic|C0039985|2216|MH|RtM via: Chest X-ray|AB|MM;RC
9378063|Severity of Illness Index|C0036859|1835|MH|||RC
9378063|Postoperative Complications|C0032787|950|MH|||RC
9378063|Serum Albumin|C0036773|734|MH|||RC
9378063|Time Factors|C0040225|599|MH|||RC
9378063|Diagnosis, Differential|C0011906|309|MH|||RC
9378063|Ascitic Fluid|C0003964|291|MH|RtM via: Peritoneal Fluid|AB|MM
------
9378063|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: woman|CT Text Lookup: patient;CT Text Lookup: woman|MM
9378063|Female|C0015780|1000|CT|CT Text Lookup: woman|CT Text Lookup: woman|MM
9378063|radiography|C0034571|1111|SH1|RtM via: Radiographic imaging procedure;Radiography (C1962945);RtM via: roentgenographic;radiography (C0034571);RtM via: Radiologic Technologist - Radiography;RtM via: Radiologic Technologist - Radiography;radiography (C0034571)|AB|MM
9378063|surgery|C0038895|1111|SH1|RtM via: Implantation procedure;Surgical Procedures, Operative (C0543467)|AB|MM
9378063|methods|C0025664|14|SH|Methods|AB|MM
9345446|Heart Rate|C0018810|250748|MH|RtM via: heart rate|AB|MM;RC
9345446|Autonomic Nervous System|C0004388|239171|MH|RtM via: Autonomic nervous system|AB|MM;RC
9345446|Parasympathetic Nervous System|C0030510|138566|MH|RtM via: Parasympathetic Nervous System;RtM via: Entire parasympathetic nervous system|AB|MM;RC
9345446|*Cardiovascular System|C0007226|112632|MH|RtM via: Cardiovascular system|TI|MM;RC
9345446|Blood Pressure|C0005823|62574|MH|||RC
9345446|Electrocardiography|C1623258|56167|MH|RtM via: electrocardiogram rhythm strip 3-lead heart rate (bpm)|AB|MM;RC
9345446|Vagus Nerve|C0042276|54182|MH|||RC
9345446|*Multiple Sclerosis|C0026769|53646|MH|RtM via: Multiple Sclerosis|TI;AB|MM;RC
9345446|Breathing|C0035203|35780|ET|Entry Term Replacement for "Respiration";RtM via: Respiration|AB|MM;RC
9345446|Sympathetic Nervous System|C0039044|23527|MH|||RC
9345446|Heart|C0018787|18763|MH|RtM via: Heart;RtM via: Entire heart;RtM via: Cardiac|AB|MM;RC
9345446|Heart Conduction System|C0018796|8458|MH|||RC
9345446|Exercise Test|C0015260|7708|MH|||RC
9345446|Multiple Sclerosis, Relapsing-Remitting|C0751967|5187|MH|||RC
9345446|Posture|C1262869|4577|MH|||RC
9345446|Exercise Tolerance|C0162521|4003|MH|||RC
9345446|Circadian Rhythm|C0008810|3838|MH|||RC
9345446|Age Factors|C0001783|3088|MH|||RC
9345446|Electrophysiology|C0013865|2899|MH|||RC
9345446|Sex Factors|C0036881|2018|MH|||RC
9345446|Aging|C0001811|1455|MH|||RC
9345446|Disability Evaluation|C0012605|1432|MH|||RC
9345446|Adjuvants, Immunologic|C0001551|1156|MH|||RC
9345446|Body Mass Index|C0005893|1119|MH|||RC
9345446|Electrodes, Implanted|C0013814|901|MH|||RC
9345446|Reference Values|C0034926|573|MH|||RC
9345446|Psychiatric Status Rating Scales|C0033871|447|MH|||RC
------
9345446|Humans|C0086418|1000|CT|CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: patients|MM
9345446|methods|C0025664|14|SH|Methods|AB|MM
9316922|*Toxoplasma gondii|C0040557|1931331|ET|Entry Term Replacement for "Toxoplasma";RtM via: Toxoplasma gondii|TI;AB|MM;RC
9316922|Toxoplasmosis, Cerebral|C0085315|1026387|MH|RtM via: Toxoplasmosis, Cerebral|AB|MM;RC
9316922|Toxoplasmosis|C0040558|524607|MH|RtM via: Toxoplasmosis|AB|MM;RC
9316922|*HIV Infections|C0019693|188733|MH|RtM via: HIV Infections|TI;AB|MM;RC
9316922|*PCR|C0032520|159456|ET|Entry Term Replacement for "Polymerase Chain Reaction";RtM via: Polymerase Chain Reaction;RtM via: In complete remission|TI;AB|MM;RC
9316922|DNA, Protozoan|C0079250|156481|MH|||RC
9316922|AIDS-Related Opportunistic Infections|C0162526|99813|MH|||RC
9316922|Toxoplasmosis, Animal|C0040559|81896|MH|||RC
9316922|Antibodies, Protozoan|C0003252|69517|MH|||RC
9316922|Toxoplasmosis, Ocular|C0040561|48584|MH|||RC
9316922|Specificity|C0037791|25410|ET|Entry Term Replacement for "Sensitivity and Specificity";RtM via: Specificity;RtM via: Statistical sensitivity|AB|MM;RC
9316922|Molecular Sequence Data|C0026382|24299|MH|||RC
9316922|Antigens, Protozoan|C0003338|16270|MH|||RC
9316922|Protozoan Proteins|C0033742|8480|MH|||RC
9316922|Pregnancy Complications, Infectious|C0032965|7929|MH|||RC
9316922|Abortion, Veterinary|C0000823|5468|MH|||RC
9316922|Cat Diseases|C0007350|5004|MH|||RC
9316922|Sheep Diseases|C0036946|3409|MH|||RC
9316922|Dog Diseases|C0012979|2629|MH|||RC
9316922|Blotting, Southern|C0005862|2486|MH|RtM via: Southern blot assay (procedure)|AB|MM
9316922|Immunoglobulin G|C0020852|2182|MH|||RC
9316922|Immunocompetence|C0020987|2029|MH|||RC
9316922|Disease Models, Animal|C0012644|960|MH|||RC
9316922|*Remission Induction|C0035052|717|MH|RtM via: In complete remission|TI;AB|MM
9316922|Sheep|C0036945|622|MH|||RC
------
9316922|Animals|C0003062|1000|CT|Toxoplasmosis, Animal;Abortion, Veterinary;Cat Diseases;Sheep Diseases;Dog Diseases;Disease Models, Animal||RC
9316922|Pregnancy|C0032961|1000|CT|Pregnancy Complications, Infectious;Abortion, Veterinary||RC
9316922|Female|C0015780|1000|CT|Pregnancy Complications, Infectious;Abortion, Veterinary||RC
9316922|Humans|C0086418|1000|CT|Abortion, Veterinary;CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: human;CT Text Lookup: patient;CT Text Lookup: patients|MM;RC
9316922|Cats|C0007450|1000|CT|Cat Diseases||RC
9316922|Dogs|C0012984|1000|CT|Dog Diseases||RC
9316922|blood|C0005768|54009|SH1|RtM via: In Blood;blood (C0005768);RtM via: Blood;Blood (C0005767)|TI;AB|MM;RC
9316922|cerebrospinal fluid|C0007807|3379|SH1|Cerebrospinal Fluid (C0007806)||RC
9316922|organization & administration|C0029236|3639|SH|Organization and Administration|TI;AB|MM
9316922|parasitology|C2239174|3350|SH|Parasitology||RC
9316922|methods|C0025664|1056|SH|Methods|TI;AB|MM
9316922|immunology|C1522005|1111|SH|D23.050.293 (Antigens, Protozoan)||MM
9296268|*Cloning, Molecular|C0009017|338523|MH|RtM via: Cloning, Molecular|TI|MM;RC
9296268|tuftelin|C0059090|105136|NM|RtM via: enamelin|TI;AB|MM
9296268|*Dental Enamel Proteins|C0011353|105135|HM|RtM via: enamelin|TI;AB|MM;RC
9296268|cDNA|C0006556|82012|ET|Entry Term Replacement for "DNA, Complementary";RtM via: DNA, Complementary|AB|MM;RC
9296268|Molecular Sequence Data|C0026382|81076|MH|||RC
9296268|Amino Acid Sequence|C0002518|76541|MH|RtM via: Amino Acid Sequence|AB|MM;RC
9296268|Exons|C0015295|75805|MH|RtM via: Exons|AB|MM;RC
9296268|Intron|C0021920|63358|ET|Entry Term Replacement for "Introns";RtM via: Introns|AB|MM;RC
9296268|Sequence Analysis, DNA|C0162802|38540|MH|RtM via: Sequence Analysis, DNA|AB|MM;RC
9296268|DNA|C0012854|37552|MH|RtM via: DNA|AB|MM;RC
9296268|Sequence Alignment|C0080143|29576|MH|||RC
9296268|Chromosome Mapping|C0008630|28466|MH|||RC
9296268|Alternative Splicing|C0002345|14938|MH|||RC
9296268|Sequence Homology, Amino Acid|C0162777|13116|MH|||RC
9296268|Genome|C0017428|11942|MH|RtM via: Genome|AB|MM;RC
9296268|Promoter Regions, Genetic|C0033413|8282|MH|||RC
9296268|RNA Splicing|C0035687|7205|MH|RtM via: RNA Splicing|AB|MM;RC
9296268|Reverse Transcriptase Polymerase Chain Reaction|C0599161|6947|MH|RtM via: Reverse Transcriptase Polymerase Chain Reaction|AB|MM;RC
9296268|Genome, Human|C0017429|4109|MH|||RC
9296268|Chromosomes, Human, Pair 1|C0008651|3013|MH|||RC
9296268|Gene Expression Profiling|C0752248|2544|MH|||RC
9296268|Models, Genetic|C0026343|2372|MH|||RC
9296268|In Situ Hybridization|C0162788|2295|MH|||RC
9296268|Membrane Proteins|C0025252|1767|MH|||RC
9296268|Polymorphism, Single Nucleotide|C0752046|1716|MH|||RC
9296268|Swine|C0039005|1651|MH|||RC
9296268|Genotype|C0017431|1592|MH|||RC
9296268|3' Untranslated Regions|C0600600|1533|MH|||RC
9296268|Transfection|C0040669|1516|MH|||RC
9296268|RNA, Messenger|C0035696|1423|MH|||RC
9296268|Cation Transport Proteins|C0969710|1226|MH|||RC
9296268|Hybrid Cells|C0020200|1203|MH|||RC
9296268|In Situ Hybridization, Fluorescence|C0162789|1110|MH|||RC
9296268|Species Specificity|C0037783|1069|MH|||RC
9296268|Phylogeny|C0031797|901|MH|||RC
9296268|Frame, Open Reading|C0079941|734|ET|Entry Term Replacement for "Open Reading Frames";RtM via: Open Reading Frames|AB|MM
9296268|Amino Acid Substitution|C0525038|675|MH|||RC
9296268|Escherichia coli|C0014834|620|MH|||RC
9296268|Gene Expression Regulation, Neoplastic|C0017268|589|MH|||RC
9296268|Cell Line|C0007600|551|MH|||RC
9296268|Chickens|C0008051|510|MH|||RC
9296268|Codon, Termination|C0242611|444|ET|Entry Term Replacement for "Codon, Terminator";RtM via: Codon, Terminator|AB|MM
9296268|Kinetics|C0022702|239|MH|||RC
------
9296268|Cattle|C0007452|11730|CT||TI;AB|MM
9296268|Humans|C0086418|1000|CT|Genome, Human;Chromosomes, Human, Pair 1||RC
9296268|Animals|C0003062|1000|CT|Swine;Chickens;CT Text Lookup: bovine|CT Text Lookup: bovine|MM;RC
9296268|genetics|C0017399|1111|SH|G05.360.340.024.340.137.232 (Exons)|AB|MM
9343165|*Abelson murine leukemia virus|C0000742|4795221|MH|RtM via: Abelson murine leukemia virus|TI;AB|MM;RC
9343165|*Lymphoid Cells|C0086574|410688|ET|Entry Term Replacement for "Lymphocytes";RtM via: Lymphoid Cells|TI|MM;RC
9343165|Pre-B Cell|C0312738|397248|ET|Entry Term Replacement for "Precursor Cells, B-Lymphoid";RtM via: Pre-B Lymphocytes;Forced Lookup:pre-b cell;Forced Lookup:pre-b-cell;Forced Lookup:pre-b cells|AB|MM
9343165|B-Lymphocytes|C0004561|195214|MH|Forced Lookup:b-cell||MM;RC
9343165|Tumor Suppressor Protein p53|C0080055|166735|MH|RtM via: Protein p53|AB|MM;RC
9343165|Cell Transformation, Viral|C0007622|140872|MH|||RC
9343165|B Cell Lymphoma|C0079731|132153|ET|Entry Term Replacement for "Lymphoma, B-Cell";RtM via: B-Cell Lymphomas;Forced Lookup:b-cell lymphoma|AB|MM
9343165|*Mutation|C0026882|112164|MH|RtM via: Mutation|TI;AB|MM;RC
9343165|Cell Line, Transformed|C0007601|63227|MH|||RC
9343165|*Phenotype|C0031437|47241|MH|RtM via: Phenotype|TI;AB|MM;RC
9343165|Apoptosis|C0162638|44232|MH|RtM via: Apoptosis|AB|MM;RC
9343165|Cell Transformation, Neoplastic|C0007621|38302|MH|||RC
9343165|Cell Lines|C0007600|33091|ET|Entry Term Replacement for "Cell Line";RtM via: Cell Line|AB|MM;RC
9343165|Proteins|C0033684|27450|MH|RtM via: Proteins;RtM via: Protein measurement|AB|MM;RC
9343165|Lymphoma|C0024299|22274|MH|RtM via: Lymphoma|AB|MM;RC
9343165|Signal Transduction|C0037083|17843|MH|RtM via: Signal|AB|MM;RC
9343165|Cyclin-Dependent Kinase Inhibitor p16|C0249880|17404|MH|||RC
9343165|Cells, Cultured|C0007635|13491|MH|RtM via: Clone;RtM via: Clonality|AB|MM;RC
9343165|Cyclin-Dependent Kinase Inhibitor p21|C0288472|12567|MH|||RC
9343165|Bone Marrow Cells|C0005955|11808|MH|||RC
9343165|Proto-Oncogene Proteins c-myc|C0080065|9926|MH|||RC
9343165|MutS Homolog 2 Protein|C1571621|7291|MH|||RC
9343165|Virus Integration|C0085224|7282|MH|||RC
9343165|Genotype|C0017431|7187|MH|RtM via: Wild Type|AB|MM;RC
9343165|Mice, Inbred BALB C|C0025919|7154|MH|||RC
9343165|DNA Repair|C0012899|6983|MH|||RC
9343165|Gene Expression Regulation|C0017263|6879|MH|RtM via: cell transformation|AB|MM;RC
9343165|ras Proteins|C0242853|6782|MH|||RC
9343165|Cell Lineage|C0282637|6130|MH|||RC
9343165|Loss of Heterozygosity|C0524869|6038|MH|||RC
9343165|Mice, Knockout|C0206745|5668|MH|||RC
9343165|Precursor B-Cell Lymphoblastic Leukemia-Lymphoma|C0023485|5588|MH|||RC
9343165|Gene Deletion|C0017260|4512|MH|||RC
9343165|Transfection|C0040669|4316|MH|RtM via: cell transformation|AB|MM;RC
9343165|Viral Proteins|C0042736|4142|MH|||RC
9343165|Mice, Inbred CBA|C0025922|4035|MH|||RC
9343165|Mice, Inbred C57BL|C0025921|3267|MH|||RC
9343165|Genetic Predisposition to Disease|C0314657|2549|MH|||RC
9343165|Peptide Fragments|C0030935|1603|MH|||RC
9343165|DNA, Viral|C0012939|1492|MH|||RC
9343165|Chromosome Mapping|C0008630|1478|MH|||RC
9343165|Temperature|C0039476|1432|MH|||RC
9343165|Oncogenes|C0029016|1357|MH|RtM via: Oncogenes|AB|MM
9343165|Neoplasm Transplantation|C0027648|1042|MH|||RC
9343165|*Laboratory Techniques and Procedures|C0600201|738|MH|RtM via: Phenotype determination|TI;AB|MM
9343165|DNA Damage|C0012860|568|MH|RtM via: DNA Damage|AB|MM
9343165|Mutations, Point|C0162735|389|ET|Entry Term Replacement for "Point Mutation";RtM via: Point Mutation|AB|MM
9343165|Oncogens|C0007090|370|ET|Entry Term Replacement for "Carcinogens";RtM via: Carcinogens|AB|MM
------
9343165|Animals|C0003062|1000|CT|Mice, Inbred BALB C;Mice, Knockout;Mice, Inbred CBA;Mice, Inbred C57BL||RC
9343165|Mice|C0026809|1000|CT|Mice, Inbred BALB C;Mice, Knockout;Mice, Inbred CBA;Mice, Inbred C57BL||RC
9343165|virology|C0205466|1111|SH|G06.920.875.210 (Cell Transformation, Viral)||MM
9343165|genetics|C0017399|1111|SH|G05.365.590 (Mutation)|TI;AB|MM
9351973|Shab Potassium Channels|C1566224|188013|MH|||RC
9351973|Dendrites|C0011305|121935|MH|RtM via: Dendrites|AB|MM;RC
9351973|Membrane Potentials|C0025251|114113|MH|RtM via: Membrane Potentials|AB|MM;RC
9351973|*Phosphorylation|C0031715|103815|MH|RtM via: Phosphorylation|TI;AB|MM;RC
9351973|Patch-Clamp Techniques|C0242625|76494|MH|||RC
9351973|Neurons|C0027882|67224|MH|RtM via: Cell body of neuron|AB|MM;RC
9351973|Ion Channel Gating|C0022008|47797|MH|||RC
9351973|Potassium|C0032821|33267|MH|||RC
9351973|Cells, Cultured|C0007635|21728|MH|||RC
9351973|Action Potentials|C0001272|20004|MH|||RC
9351973|Potassium Channel Blockers|C0872245|19825|MH|||RC
9351973|Interneurons|C0021792|18938|MH|RtM via: Central neuron|AB|MM;RC
9351973|Nerve Tissue Proteins|C0027759|15318|MH|||RC
9351973|Synaptic Transmission|C0027793|10820|MH|||RC
9351973|Neuronal Plasticity|C0027880|8654|MH|||RC
9351973|Rats, Sprague-Dawley|C0034715|8001|MH|||RC
9351973|Cell Line|C0007600|7804|MH|||RC
9351973|Transfection|C0040669|7649|MH|||RC
9351973|Membrane Proteins|C0025252|6551|MH|||RC
9351973|Synaptosomal-Associated Protein 25|C0075689|6142|MH|||RC
9351973|Recombinant Fusion Proteins|C0034857|5491|MH|||RC
9351973|Calcium Signaling|C0600431|5359|MH|||RC
9351973|Calcium|C0006675|4707|MH|||RC
9351973|Protein Subunits|C0599220|4677|MH|||RC
9351973|Sequence Homology, Amino Acid|C0162777|4660|MH|||RC
9351973|Cloning, Molecular|C0009017|4564|MH|||RC
9351973|Amino Acid Sequence|C0002518|4469|MH|||RC
9351973|Mutagenesis, Site-Directed|C0079870|4339|MH|||RC
9351973|Signal Transduction|C0037083|4280|MH|||RC
9351973|Taste Buds|C0039337|4201|MH|||RC
9351973|Xenopus laevis|C0043343|4093|MH|||RC
9351973|Calcineurin|C0054450|4048|MH|||RC
9351973|Cell Count|C0007584|4039|MH|||RC
9351973|Oocytes|C0029045|3942|MH|||RC
9351973|Receptor-Like Protein Tyrosine Phosphatases, Class 4|C1955993|3633|MH|||RC
9351973|Structure-Activity Relationship|C0038477|2987|MH|||RC
9351973|Embryo, Mammalian|C1956416|2948|MH|||RC
9351973|Sequence Alignment|C0080143|2933|MH|||RC
9351973|Rats, Long-Evans|C0324537|2877|MH|||RC
9351973|Protein Structure, Tertiary|C0162808|2833|MH|||RC
9351973|Kinetics|C0022702|2726|MH|RtM via: Kinetics|AB|MM;RC
9351973|Electric Conductivity|C0013777|2713|MH|||RC
9351973|Binding Sites|C0005456|2549|MH|||RC
9351973|Biolistics|C0376638|2548|MH|||RC
9351973|Potassium Chloride|C0032825|2517|MH|||RC
9351973|Amino Acid Substitution|C0525038|2481|MH|||RC
9351973|Molecular Sequence Data|C0026382|2432|MH|||RC
9351973|Sympathetic Nervous System|C0039044|2296|MH|||RC
9351973|Electric Stimulation|C0013786|2228|MH|||RC
9351973|Microscopy, Fluorescence|C0026022|2176|MH|||RC
------
9351973|Animals|C0003062|1000|CT|Rats, Sprague-Dawley;Xenopus laevis;Rats, Long-Evans;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9351973|Rats|C0034721|1000|CT|Rats, Sprague-Dawley;Rats, Long-Evans;CT Text Lookup: rat|CT Text Lookup: rat|MM;RC
9351973|genetics|C0017399|1111|SH|G05.355.760.860 (Transfection)||MM
9309626|*Exercise|C0015259|706878|MH|RtM via: Exercise;RtM via: Moderate Exercise|TI;AB|MM;RC
9309626|Glycogen|C0017911|220666|MH|RtM via: Glycogen|AB|MM;RC
9309626|Glucose|C0017725|160647|MH|RtM via: Glucose;RtM via: Plasma Glucose Measurement;RtM via: Plasma glucose result|AB|MM;RC
9309626|Insulin|C0021641|113013|MH|RtM via: Insulin|AB|MM;RC
9309626|Free Fatty Acids|C0015688|108214|ET|Entry Term Replacement for "Fatty Acids, Nonesterified";RtM via: Fatty Acids, Nonesterified|AB|MM;RC
9309626|Blood Glucose|C0005802|94758|MH|||RC
9309626|Rest|C0035253|88954|MH|RtM via: Rest|AB|MM;RC
9309626|Oxygen Consumption|C0030055|83848|MH|||RC
9309626|*Estradiol|C0014912|80841|MH|RtM via: Estradiol|TI;AB|MM;RC
9309626|Physical Endurance|C0031808|59937|MH|||RC
9309626|Lactate|C0376261|57833|ET|Entry Term Replacement for "Lactic Acid";RtM via: Lactate|AB|MM;RC
9309626|Glycerol|C0017861|52465|MH|RtM via: Glycerin|AB|MM;RC
9309626|Lipid Metabolism|C0598783|42825|MH|||RC
9309626|Carbohydrate Metabolism|C0302820|41657|MH|RtM via: glucose metabolism|AB|MM;RC
9309626|Fatty Acids|C0015684|38548|MH|RtM via: Free fatty acids measurement|AB|MM;RC
9309626|Physical Fitness|C0031812|37037|MH|||RC
9309626|Exercise Test|C0015260|36862|MH|RtM via: Treadmill, device|AB|MM;RC
9309626|Epinephrine|C0014563|30915|MH|RtM via: Epinephrine|AB|MM;RC
9309626|Muscle, Skeletal|C0242692|29016|MH|||RC
9309626|Fatigue|C0015672|27194|MH|RtM via: Exhaustion|AB|MM;RC
9309626|Energy Metabolism|C0014272|22725|MH|||RC
9309626|Physical Exertion|C0031807|20541|MH|||RC
9309626|Dietary Carbohydrates|C0012170|19036|MH|||RC
9309626|Carbon Dioxide|C0007012|13777|MH|RtM via: Calculation|AB|MM;RC
9309626|Muscle|C0026845|10338|ET|Entry Term Replacement for "Muscles";RtM via: Muscle|AB|MM;RC
9309626|Oxidation-Reduction|C0030012|7800|MH|RtM via: Oxidation|AB|MM;RC
9309626|Body Temperature|C0005903|4759|MH|||RC
9309626|Regional Blood Flow|C0034965|4609|MH|||RC
9309626|Human Growth Hormone|C0169964|3922|MH|||RC
9309626|Oxygen|C0030054|3850|MH|||RC
9309626|Kinetics|C0022702|3795|MH|||RC
9309626|Carbon Isotopes|C0007017|3078|MH|||RC
9309626|Metabolic Clearance Rate|C0025515|2336|MH|||RC
9309626|Breath Tests|C0006153|1779|MH|||RC
9309626|Time Factors|C0040225|1301|MH|||RC
9309626|Infusions, Intravenous|C0021440|1217|MH|||RC
9309626|Phosphodiesterase Inhibitors|C0031638|1091|MH|||RC
9309626|Running|C0035953|1066|MH|RtM via: Running (physical activity)|AB|MM
9309626|Thermodynamics|C0039808|628|MH|||RC
9309626|Microscopy, Fluorescence|C0026022|547|MH|||RC
9309626|Norepinephrine|C0028351|505|MH|RtM via: Norepinephrine|AB|MM
9309626|*Personnel Turnover|C0031227|405|MH|RtM via: Personnel Turnover|TI|MM
9309626|Algorithms|C0002045|362|MH|||RC
------
9309626|Female|C0015780|1000|CT|CT Text Lookup: female;CT Text Lookup: females|CT Text Lookup: females|MM
9309626|metabolism|C0025520|2418|SH1|RtM via: Biochemical turnover;metabolism (C0025520)|TI|MM
9309626|methods|C0025664|13|SH|Methods|AB|MM
9296327|*Citalopram|C0008845|1454577|MH|RtM via: Citalopram|TI;AB|MM;RC
9296327|*Breast Milk|C0026140|1117866|ET|Entry Term Replacement for "Milk, Human";RtM via: Milk, Human|TI;AB|MM;RC
9296327|Sertraline|C0074393|394929|MH|RtM via: Sertraline|AB|MM;RC
9296327|Serotonin Uptake Inhibitors|C0162758|339336|MH|RtM via: Serotonin Uptake Inhibitors|AB|MM;RC
9296327|Paroxetine|C0070122|196130|MH|RtM via: Paroxetine|AB|MM;RC
9296327|Fluvoxamine|C0085228|123292|MH|RtM via: Fluvoxamine|AB|MM;RC
9296327|Fluoxetine|C0016365|115365|MH|RtM via: Fluoxetine|AB|MM;RC
9296327|Depressive Disorder|C0011581|106558|MH|RtM via: Depressive disorder|AB|MM;RC
9296327|Lactation|C0022925|42402|MH|||RC
9296327|Maternal Exposure|C0243033|4922|MH|||RC
9296327|Milk|C0026131|3541|MH|RtM via: Milk;RtM via: Milk Specimen|AB|MM
9296327|Child Development|C0008071|1635|MH|||RC
9296327|Depression|C0011570|1070|MH|RtM via: Mental Depression;RtM via: Depressed mood;RtM via: Depressive episode, unspecified|AB|MM
9296327|Chromatography, High Pressure Liquid|C0008562|981|MH|||RC
9296327|Pregnancy Complications|C0032962|980|MH|||RC
9296327|Pharmacogenetics|C0031325|953|MH|||RC
9296327|Ingestion|C0232478|872|ET|Entry Term Replacement for "Eating";RtM via: Ingestion|AB|MM
9296327|Genotype|C0017431|794|MH|||RC
9296327|Tissue Distribution|C0040287|536|MH|||RC
9296327|Phenotype|C0031437|527|MH|||RC
9296327|Area Under Curve|C0376690|447|MH|||RC
9296327|Dose-Response Relationship, Drug|C0013059|396|MH|||RC
9296327|Protein Binding|C0033618|344|MH|||RC
------
9296327|Female|C0015780|1000|CT|Lactation;Maternal Exposure;Pregnancy Complications||RC
9296327|Animals|C0003062|1000|CT|Milk|AB|MM
9296327|Humans|C0086418|1000|CT|Child Development;CT Text Lookup: infant;CT Text Lookup: patient;CT Text Lookup: patients|CT Text Lookup: infant;CT Text Lookup: patient;CT Text Lookup: patients|MM;RC
9296327|Pregnancy|C0032961|1000|CT|Pregnancy Complications||RC
9296327|Infant|C0021270|1000|CT|CT Text Lookup: infant|CT Text Lookup: infant|MM
9296327|secretion|C0036536|364|SH1|RtM via: Process of secretion|AB|MM
9296327|organization & administration|C0029236|12|SH|Organization and Administration|AB|MM
9296327|genetics|C0017399|1111|SH|H01.158.273.343.750 (Pharmacogenetics)||MM
9348196|*Gonadotropin-Releasing Hormone|C0023610|1348553|MH|RtM via: Gonadorelin;Forced Lookup:gonadotropin-releasing hormone|TI|MM;RC
9348196|*Pituitary Gland|C0032005|418356|MH|RtM via: Pituitary Gland|TI;AB|MM;RC
9348196|Estradiol|C0014912|123723|MH|RtM via: Estradiol|AB|MM;RC
9348196|Progesterone|C0033308|109120|MH|RtM via: Progesterone|AB|MM;RC
9348196|Sheep|C0036945|54475|MH|RtM via: Sheep|AB|MM;RC
9348196|Ovariectomy|C0029936|39271|MH|||RC
9348196|*Third Ventricle|C0149555|9219|MH|RtM via: Third ventricle structure;RtM via: Entire third ventricle|TI;AB|MM
9348196|Periodicity|C0031084|7756|MH|RtM via: Hourly|AB|MM;RC
9348196|Hypothalamo-Hypophyseal System|C0020662|6475|MH|||RC
9348196|Lactation|C0022925|3169|MH|||RC
9348196|*Liver|C0023884|2652|MH|RtM via: Hepatic|TI;AB|MM
9348196|Macaca mulatta|C0024400|2062|MH|||RC
9348196|Time Factors|C0040225|1001|MH|||RC
9348196|Pulsatile Flow|C0034106|908|MH|||RC
9348196|RNA, Messenger|C0035696|740|MH|||RC
9348196|*Heart Ventricles|C0018827|585|MH|RtM via: Heart Ventricle|TI;AB|MM
9348196|Heart Rate|C0018810|423|MH|RtM via: Pulse Rate|AB|MM
9348196|Kinetics|C0022702|415|MH|||RC
9348196|Signal Transduction|C0037083|415|MH|||RC
9348196|Injections, Intraventricular|C0021495|390|MH|||RC
------
9348196|Animals|C0003062|1000|CT|Sheep;Macaca mulatta|AB|MM;RC
9348196|Female|C0015780|1000|CT|Ovariectomy;Lactation||RC
9348196|blood|C0005768|44154|SH1|RtM via: In Blood;blood (C0005768);RtM via: Blood|TI;AB|MM
9348196|cerebrospinal fluid|C0007807|25782|SH1|RtM via: Cerebrospinal Fluid;RtM via: In Cerebrospinal Fluid;cerebrospinal fluid (C0007807)|TI;AB|MM
9348196|surgery|C0038895|1111|SH1|RtM via: Operative Surgical Procedures;Surgical Procedures, Operative (C0543467);RtM via: Excision;Surgical Procedures, Operative (C0543467)|AB|MM
9348196|methods|C0025664|3|SH|Methods|AB|MM
